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Electrophysiology can reveal changes in neuronal oscillatory activity in the brain 
in relation to neurodegenerative disorders, including dementia with Lewy bodies (DLB). 
DLB, characterised by abnormal α-synuclein (α-syn) aggregation within neurons, is the 
second most common cause of dementia after Alzheimer’s disease (AD). This thesis 
had two aims. Firstly, to identify resting-state EEG changes that reflect cognitive 
fluctuations, a DLB core symptom, and differentiate DLB from AD and Parkinson’s 
disease dementia (PDD) patients and healthy controls. Secondly, to detect 
electrophysiological alterations in young mice over-expressing human mutant α-syn  
while under urethane-induced anaesthesia, mimicking deep-sleep. The resulting slow-
oscillation (SO) composed of Up-states (neuronal firing) and Down-states (neuronal 
“silence”), was recorded intra-cortically, from the hippocampus and medial prefrontal 
cortex (mPFC). The human EEG analysis replicated reports of a shift of power and 
dominant frequency (DF) from alpha to theta frequencies, in DLB/PDD patients 
compared to AD patients and controls. Contrary to previous work, the DF variability 
(DFV) over time was increased in AD and not in DLB/PDD patients, although a DLB-
specific correlation between the DFV and cognitive fluctuations persisted. The DFV 
and power/DF distribution could differentiate between AD and DLB patients with high 
sensitivity (92.26%) and specificity (83.3%). Analysis of sleep patterns in α-syn mice 
in both the mPFC and hippocampus revealed increased SO frequency, aberrant 
neuronal firing activity on Down-states, altered power distribution on Up-states and 
disturbed sleep spindle activity, compared to WTs. A novel infra-slow modulation (ISM) 
was described in WTs, presenting as bursts of power across frequencies every ~ 3.5 
min. In α-syn mice, the ISM induced abnormally high levels of high frequency 
oscillatory power in the hippocampus. Our findings indicate altered neuronal oscillatory 
activity in DLB patients and α-syn mice during rest and sleep respectively, suggesting 
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1.1. Dementia with Lewy bodies: pathology and diagnosis  
1.1.1. Lewy body dementia  
According to the World Health Organization, dementia is “an umbrella term for 
several diseases affecting memory, other cognitive abilities and behaviour that 
interfere significantly with the ability to maintain daily living activities”. Although age is 
its strongest risk factor, dementia is not a normal part of ageing (WHO, 2017). The 
most common subtypes of dementia are progressive neurodegenerative types, 
including Alzheimer’s disease (AD) accounting for > 80% of all cases, Lewy body 
dementia (LBD) and frontotemporal dementia (FTD) (Ponjoan et al., 2019). There has 
been a steep increase in the number of worldwide dementia cases from 35.6 million in 
2010 to 50 million in 2017, with the numbers expected to reach 152 million by 2050 
(Fymat, 2018). In view of the increasing age of the population in the western world and 
the enormous economic burden dementia poses for the individual and the state, 
identifying better and more permanent ways of treating the different dementia subtypes 
is essential (MacLin et al., 2019).   
Lewy body dementia (LBD) is a term encompassing dementia with Lewy bodies 
(DLB) and Parkinson’s disease dementia (PDD). Both conditions share a common 
symptom profile, pathology and treatment (McKeith et al., 1996; Walker et al., 2015; 
McKeith et al., 2004). DLB is the second most common cause of dementia, with Lewy 
body pathology discovered in approximately 15 - 20% of dementia cases to reach post-
mortem examination (Jellinger & Attems, 2011). A recent meta-analysis of 
epidemiological studies estimated DLB prevalence to reach 7.5% of all dementia cases 
(Vann Jones & O’Brien, 2014). However, only 5% of dementia patients receive a DLB 
diagnosis suggesting that DLB is currently underdiagnosed (Kane et al., 2018). The 
main DLB symptoms are dementia, cognitive fluctuations, rapid eye movement (REM) 
sleep behaviour disorder (RBD), parkinsonism and visual hallucinations, with all or 
some symptoms occurring at the same time (McKeith et al., 2017). DLB and PDD are 
managed in similar ways, but DLB is considered a primary dementia diagnosis and 




1.1.2. Dementia pathology 
1.1.2.1. Lewy body dementia  
LBDs are characterised by the presence of abnormal intracellular aggregated 
α-synuclein (α-syn) inclusions, the Lewy bodies, in the somata of neuronal and non-
neuronal cells in the brain (Spillantini et al., 1998). Similar inclusions in the neuronal 
processes are known as Lewy neurites. Lewy body and Lewy neurite pathology is also 
characteristic of Parkinson’s disease (PD), while another α-synucleinopathy called 
multiple system atrophy (MSA) is characterised by α-syn accumulation in 
oligodendrocytes, but not Lewy body pathology (Jellinger & Lantos, 2010). Α-synuclein 
(α-syn) is a 140 amino-acid protein encoded by the SNCA gene, and it is normally 
predominantly localized in the pre-synaptic terminal where it is involved in synaptic 
vesicle trafficking in a neuronal activity-dependent manner (Fortin et al., 2005). 
Specifically, α-syn complements the function of cysteine-string protein α (CSPα), which 
is a molecular chaperone that facilicates conformational changes in the synaptic 
proteins necessary for neurotransmitter release, vesicle recycling and synaptic 
integrity (Bonini & Giasson, 2005). Pre-synaptic α-syn also interacts with microtubules, 
promoting their assembly (Cartelli et al., 2016).  
In LBDs, α-syn becomes misfolded and aggregates to form of oligomers and/or 
Lewy bodies (Ghosh et al., 2017), hence resulting in a loss of α-syn function as well 
as in the formation of toxic protein species that contribute to the neurodegeneration 
that is evident in LBDs (Kim et al., 2014). Autosomal recessive mutations have been 
described in the SNCA gene in rare cases of familial of PD, which increase the intrinsic 
propensity of α-syn to aggregate (Siddiqui et al., 2016). Although the majority of DLB 
and PD cases were initially classified as sporadic (Chai & Lim, 2014), today we know 
that there are a number of genetic factors that can increase the risk of developing these 
diseases (review by Del Tredici & Braak, 2016). The most interesting findings come 
from whole genome-association studies (GWAS), which have identified genetic 
variants in a number of protein-encoding genes that in combination could explain 31% 
of cases (Guerreiro et al., 2018). Finally, the risk of developing dementia has also been 
correlated with phenotypic traits such as education, which together with genetic 
variation factors can explain 60% of DLB cases (Guerreiro et al., 2019). 
DLB and PDD cases show a similar spread of pathology, although DLB cases 
have been proposed to show more pathology in the neocortex, and the PDD cases in 
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the substantia nigra (SN) (Figure 1.1; Outeiro et al., 2019). Lewy bodies have also 
been detected in the peripheral nervous system and in several organs including the 
gastro-intestinal, respiratory and cardiovascular systems of LBD patients (Beach et al., 
2010). Interestingly, the Lewy body distribution does not correlate with disease 
duration, age of onset or the presence or absence of cognitive and motor symptoms 
(Weisman et al., 2007). Therefore, new theories support the idea that neurotoxicity is 
in fact mediated by heterogeneously folded oligomeric α-syn and not Lewy bodies 
(Ghiglieri et al., 2018). The detrimental effects of α-syn oligomers have been 
characterised and include membrane permeabilisation, altered synaptic transmission 
and plasticity, reduced protein degradation and impairment of mitochondrial and 
endoplasmic reticular function (Feng et al., 2010; Rockenstein et al., 2014; Tsigelny et 
al., 2012). Moreover, it has been proposed that the clustering of α-syn in Lewy bodies 
may in fact be a neuroprotective mechanism aimed at removing toxic oligomers 
(Tanaka et al., 2004). 
 
Figure 1.1: The spread of pathology in the brain of patients with Lewy body dementia 
(LDB) according to the Newcastle-McKeith criteria (2017). The main Lewy body 
staging subtypes in LBD are: the brainstem-dominant (IX/X motor nucleus, locus 
coeruleus, and substantia nigra), limbic (amygdala, transentorhinal cortex, cingulate 
cortex), diffuse neocortical (frontal, temporal, parietal, lobes) and the olfactory only, 
and amygdala predominant stages. Adapted from Outeiro et al., (2019). 
 
1.1.2.2. Alzheimer’s disease 
The main pathological hallmark of Alzheimer’s disease (AD) is the misfolding 
and aggregation of amyloid-β (Aβ) and hyper-phosphorylated tau, which cluster to form 
extracellular amyloid plaques and intracellular neurofibrillary tangles respectively 
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(Ashford, 2019; Perl, 2010). The most popular hypothesis for the development and 
spread AD pathology is the amyloid cascade hypothesis, which states that the amyloid 
precursor protein (APP) is aberrantly processed resulting in greater production than 
clearance of the Aβ peptide, especially of the “sticky” Aβ42 isoform (Hardy & Higgins, 
1992). Aβ42 monomers cluster into soluble oligomers, and then into insoluble fibrils of 
the beta-sheet conformation, before finally forming plaques (Barage & Sonawane, 
2015). Aβ oligomers are the main neurotoxic form as they induce oxidative damage 
and promote tau hyperphopshorylation and hence oligomerisation (Sakono & Zako, 
2010; Sengupta et al., 2016). Tau accumulation also has deleterious effects on 
synapses and mitochondria and correlates better than Aβ with neuronal and synaptic 
loss (Kumar et al., 2015). Like α-syn, both Aβ42 and tau act in a seed-like manner, 
spreading pathology from subcortical structures, or the entorhinal cortex (EC), to the 
rest of the brain (DeVos et al., 2018). Late stage amyloid plaques also have a defined 
toxic effect as they attract microglia, that in turn release proinflammatory cytokines, 
promoting further Aβ42 production (Dal Prà et al., 2015) 
1.1.2.3. Mixed pathology 
LBD and AD pathology often occur concomitantly (Hansen et al., 1989). Post-
mortem studies have shown that about a third to half of AD patients have some level 
of Lewy body pathology (Murray et al., 2010) and vice versa, 50% of DLB patients have 
amyloid plaques and tau tangles. The cases that were deemed as “mixed” also showed 
a faster disease evolution, with greater cognitive dysfunction compared to AD and 
DLB, and greater cortical atrophy compared to DLB (Toledo et al., 2016). Analysis of 
the cerebrospinal fluid (CSF) can provide valuable insight into early biochemical 
changes in the brain in relation to dementia, as it comes into direct contact with the 
extracellular space of the brain (Maji et al., 2010). CSF studies have shown that 40% 
of DLB patients tested had high levels Aβ that correlated with lower cognition (van 
Steenoven et al., 2019), and high tau levels that correlated with greater disease 
severity and mortality (Lemstra et al., 2017). Moreover, tau exists in 50% of LBD 
pathology and is particularly toxic, as it correlates with greater Lewy body load and 
faster disease progression (Bohnen & Hu, 2019). Finally, mixed AD/Lewy body 
pathology is believed to influence the topographic distribution of α-syn pathology, 
rendering the areas of their location more susceptible to α-syn aggregation and 
neurodegeneration (Outeiro et al., 2019).  
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1.1.3. DLB Diagnosis  
Clinical DLB diagnosis requires the presence of dementia, the central symptom 
of this disease, which is defined as a progressive cognitive decline (McKeith et al., 
2017). In the 2005 consensus DLB criteria, dementia needs to occur in conjunction 
with two out of three core clinical features of DLB as specified at the time, these are: 
cognitive fluctuations (CF), recurrent visual hallucinations and parkinsonism, for a 
probable DLB diagnosis (McKeith et al., 2005). At the updated 2017 criteria, RBD was 
added as a fourth core feature (McKeith et al., 2017). RBD is a condition where the 
mechanisms causing muscle atonia during REM sleep are lost and is the best known 
predictor of synucleinopathies, occurring in 80 – 90% of patients (Peever & Fuller, 
2017). In the 2017 DLB criteria (McKeith et al., 2017), the importance of biomarkers 
was also acknowledged. A biomarker, or “biological marker”, is an objective indication 
of the medical state of a patient that can be measured accurately and reproducibly 
(Strimbu & Tavel, 2010). Hence, with the 2017 DLB criteria a probable DLB diagnosis 
can alternatively be supported by one core clinical feature and one or more 
biomarker(s), even with the absence of other core clinical features (McKeith et al., 
2017).  
The suggested indicative biomarkers according to the 2017 DLB criteria include 
a loss in nigrostriatal dopaminergic neurons that is assessed by single photon emission 
computed tomography (SPECT) and positron emission tomography (PET) imaging, 
and changes in the  sleep profile assessed by polysomnography (McKeith et al., 2017). 
Polysomnography measuring brain activity during sleep with concomitant assessment 
of eye and muscle movement to ensure REM sleep and identify changes in muscle 
tone respectively, identify RBD with a sensitivity of 98% for synucleinopathies (Boeve 
et al., 2013). There are also supportive biomarkers, including a relative preservation of 
medial lobe grey matter assessed by magnetic resonance imaging (MRI) / computed 
tomography (CT), and changes in the electroencephalogram (EEG; Cromarty et al., 
2016), which are the focus of this thesis and are extensively discussed below 
(section1.3.1). 
Although it is currently too early for a rigorous assessment of the specificity and 
sensitivity of the 2017 criteria, the specificity and sensitivity of the 2005 criteria has 
been improving over time (Rizzo et al., 2018). A 2013 meta-analysis has estimated 
high specificity for DLB diagnosis at 79-100% (Huang et al., 2013), suggesting that this 
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high percentage of patients diagnosed with DLB had indeed received the right 
diagnosis. However, the same study found a low sensitivity in DLB diagnosis ranging 
from a low of 12% to 88% (Huang et al., 2013), suggesting that several DLB patients 
did not receive a DLB diagnosis. The low sensitivity in diagnosing DLB can at least 
partly be attributed to the misdiagnosis of DLB as AD, especially at early disease 
stages, as DLB can have a similar diagnostic profile to AD characterised by 
progressive cognitive decline (Metzler-Baddeley, 2007). Since LBD patients are 
sensitive to neuroleptics (McKeith et al., 1992) and demonstrate a faster disease 
progression (Olichney et al., 1998), an early, accurate diagnosis is important.  
In order to distinguish between PDD and DLB an arbitrary 1-year rule was 
introduced, where the occurrence of dementia before, or within 1 year after motor 
features appear, leads to a primary DLB diagnosis (McKeith et al., 2005). However, 
distinguishing between PDD and DLB is not as critical as distinguishing between DLB 
and AD, as the patients usually have similar disease management and treatments. 
However, when it comes to routine patient care, differentiating a primary movement 
disorder or dementia diagnosis can be important (Lippa et al., 2007). As previously 
mentioned, the Lewy pathology in PDD and DLB is identical in terms of the molecular 
profile of α-syn aggregation and may only have subtle differences in the progression 




1.2. The electrophysiological rhythms of the brain during wakefulness  
1.2.1. Origin of the EEG 
Ionic transmembrane currents in the brain produced by the synchronised activity 
of large neuronal populations (Henry, 2006). Excitatory postsynaptic potentials 
(EPSPs) arise due to the inflow of positive ions (e.g. Na+) while inhibitory post-synaptic 
potentials (IPSP), arise either by the inflow of negative ions (e.g. Cl-) or the outflow of 
positive ions (e.g. K+) (Amzica & da Silva, 2017). This ion movement results in the 
formation of active sinks and sources in the extracellular space around the active 
excitatory and inhibitory synapse that are compensated by currents of the opposite 
direction along the soma-dendritic membrane, resulting in a sink-source configuration 
(dipole) (Henry, 2006). The dendrites of cortical pyramidal neurons are aligned 
perpendicularly to the cortical surface and when these cells are activated in a 
synchronous way, they form electrical dipoles between the soma and apical dendrites 
(da Silva, 2009). These dipoles are detectable by electrodes on the surface of the scalp 
during electroencephalography (EEG), or through surface or intra-cortical electrode 
probes most commonly used in animal models (Hooper & Schmidt, 2017).  
In the next paragraphs we will examine the neuronal circuits of the hippocampus 
and the medial prefrontal cortex (mPFC), two regions that are involved in cognitive 
function with a pivotal role in memory consolidation (Colgin, 2011). These circuits are 
particularly rich in pyramidal neurons that release the neurotransmitter glutamate, the 
most abundant excitatory neurotransmitter in the brain (Spruston, 2008). The 
hippocampal and cortical circuits are also rich in different subtypes οf interneurons, 
which release the neurotransmitter γ-amino-butyric acid (GABA) and have an inhibitory 
function (Massi et al., 2012). Neurotransmitters are chemical agents that bind to 
specific receptors and induce EPSPs or IPSPs on target cells, depending on whether 
they have an excitatory or an inhibitory function (Snyder, 2017). Glutamate binds to 
the ionotropic N-methyl-D-aspartate receptors (NMDAR), 2 α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionicacid receptors (AMPAR) and kainate receptors, directly 
eliciting the opening of an ion channel in the cell membrane, allowing the inflow of ions 
into the target neuron (Meldrum, 2000). Glutamate also binds to metabotropic 
receptors (mGluR1-8), initiating an intracellular signalling cascade that can lead to a 
change in membrane potential (Meldrum, 2000). GABA can bind to the ionotropic 
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GABAA receptor (GABAAR) and the metabotropic GABAB receptor (GABABR), inducing 
inhibition in the target neuron.  
Another type of neurotransmitter that will be discussed in this thesis is 
acetylcholine (ACh) which acts as a neuromodulator in the brain, as it can be either 
excitatory or inhibitory, ultimately changing the state of a group of neurons in response 
to a change in the environmental conditions (Picciotto et al., 2012). ACh acts through 
two types of receptors that can be pre- and post-synaptic: metabotropic muscarinic 
receptors (mAChRs) that can have an inhibitory or excitatory effect, and ionotropic 
nicotinic receptors (nAChRs) that always have an excitatory effect (Changeux et al., 
1998). Other neurotransmitters that act as neuromodulators in the brain are dopamine, 
serotonin and norepinephrine (Avery & Krichmar, 2017). Dopamine originates from the 
ventral tegmental area (VTA) or the substantia nigra pars compacta (SNc) and acts 
through the dopaminergic receptors D1-D5 found in the striatum, thalamus, amygdala, 
hippocampus, and PFC. Serotonin originates from the raphe nuclei (RN) and acts on 
5-HT receptors in the cortex, ventral striatum, hippocampus, and amygdala, while 
norepinephrine originates from the locus coeruleus (LC) and acts on adrenergic 
receptors in numerous cortical and sub-cortical regions (review by Avery & Krichmar, 
2017).  
1.2.2. The hippocampus   
The hippocampus is a structure that lies deep in the medial temporal cortex and 
consists of the dentate gyrus (DG), the subiculum and the pyramidal cornu ammonis 
(CA) and its subfields (CA1 - 4; Figure 1.2; review by Somogyi et al., 2010). As 
mentioned above, the hippocampus is composed of pyramidal neurons, and inhibitory 
GABAergic interneurons that make up about 10% of the total neuronal population 
(Buzsáki et al., 1983). The pyramidal cell somata are in the pyramidal layer and their 
basal dendrites arborise in the stratum oriens and the apical dendrites in the stratum 
radiatum and lacunosum moleculare (Freund & Buzsáki, 1998). In the hippocampus 
there is a large population of parvalbumin expressing (PV+) interneurons, reaching 20 
- 25% of all interneurons. PV+ interneurons are fast spiking and can be classified as 
basket cells or axo-axonic/chandelier cells. Each PV+ basket cell contacts the cell 
soma and proximal dendrites of > 1500 - 2500 pyramidal cells, while axo-axonic 
interneurons contact the axons of > 1000 pyramidal cells (Klausberger & Somogyi, 
2008). Interneurons contact both pyramidal cells and other interneurons, while both 
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interneurons and pyramidal cells are regulated by cholinergic, dopaminergic, 
serotonergic and noradrenergic neurons (Avery & Krichmar, 2017). 
The hippocampus has a pivotal role in memory as was evident early in patients 
with hippocampal damage, who were impaired in forming and recalling declarative 
episodic memories, especially ones recently formed (Clark et al., 2005; Savage et al., 
2004; Bird & Burgess, 2008). The hippocampus may influence long-established 
episodic memory but is not involved in declarative semantic memory (Kropotov & 
Kropotov, 2009a). Rodent studies have revealed that the hippocampus is also pivotal 
for spatial memory formation through the activity of place cells, which fire when the 
animal is located at specific locations during exploration (O’Keefe et al., 1998; Booth 
& Poe, 2006). These neuronal representations of space are stable for a long time and 
have “replay” activation patterns during sleep, that are believed to underlie memory 
transfer to the cortex (Bird & Burgess, 2008).  
 
 
Figure 1.2: Architecture of the hippocampus. Τhe laminae of the hippocampus and the 
main neuronal circuits of the hippocampus are shown. Information enters the 
hippocampus though the entorhinal cortex (EC) and then projects into the dentate 
gyrus (DG) via the perforant pathway, and then from the DG to the CA3 via the mossy 
fibre pathway. The CA3 projects to the CA1 via the Schaffer collaterals and eventually 
the CA1 projects back to the EC. CA3 axons also contact CA3 somata in a recurrent 
feedback loop, while the EC contacts directly the CA3 and CA1 regions (not shown). 
Adapted from Uusisaari (2003).  
1.2.3. The medial prefrontal cortex (mPFC) 
The neocortex is the largest region of the cortex and is responsible for the more 
complex brain functions characterising mammals. The neocortex has a stratified 
pattern of six layers, each with different neuronal populations, connectivity and 
function, while it is also divided into different areas, characterised by a different 
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cytoarchitecture, connectivity, function and gene expression (O’Leary et al., 2007). The 
prefrontal cortex (PFC) is one of the most recently evolved neocortical areas in the 
history of mammals, and is highly interconnected with the thalamus, brainstem, basal 
ganglia, and limbic system (Fuster, 2001). In humans, the PFC is disproportionally 
large compared to other species including rodents and primates (Donahue et al., 
2018). Moreover, the human and non-human primate PFC can be divided into the 
ventromedial region (orbitofrontal and medial areas) that is associated with emotional 
processing, memory and higher-order processing, and the dorsolateral (posterior area) 
region that is associated with motor control, sensory processing and performance 
monitoring (Wood & Grafman, 2003).  
In the rodent brain, the medial PFC (mPFC) is functionally subdivided in a 
manner that was deemed anatomically and functionally similar to the ventromedial 
PFC in non-human primates, and to a lesser extent to the dorsolateral region (Uylings 
et al., 2003). Specifically, the rodent mPFC is important for higher order cognitive 
functioning including working memory, executive functioning such as decision-making, 
goal orientated behaviours and attentional selection (Euston et al., 2012). The rodent 
mPFC is divided on an architectural and functional basis into the anterior cingulate 
cortex (ACC), prelimbic (PrL), infralimbic (IL) and dorsal peduncular (DP) regions (Van 
De Werd et al., 2010). Moreover, there is a ventral-dorsal gradient of specialisation 
across the mPFC, with the ventral mPFC (DP, IL, ventral PrL) being involved in 
autonomic/emotional control, and the dorsal mPFC  (dorsal PrL and ACC) in the control 
of actions (Riga et al., 2014). This specialisation can be attributed to the 
interconnectivity of these regions with other structures, as the ventral mPFC 
communicates with areas involved in pain perception, homeostatic drive, stress and 
anxiety (Riga et al., 2014), while the dorsal mPFC communicates with sensory/motor 
areas and projects directly to the spinal cord (Euston et al., 2012).  
The mPFC network consists of pyramidal neurons (80 – 90%) and GABAergic 
interneurons including fast-spiking PV+ interneurons and somatostatin positive 
(SOM+) interneurons (Riga et al., 2014). PV+ interneurons exert powerful and 
widespread inhibition on pyramidal cell firing that generates fast local rhythms, while 
the effect of SOM+ interneurons on the pyramidal firing is weaker and more variable, 
as they are believed to control long-range inputs in the region (Kvitsiani et al., 2013).  
In terms of laminar organisation, pyramidal cells are located in both superficial (layers 
13 
 
2-3) and deep (layers 5-6) layers of the mPFC. The mPFC layers and regions are 
highly interconnected with one another, integrating the different inputs to the mPFC 
(see below), before projecting to numerous cortical and subcortical regions, exerting 
control over autonomic, limbic and cognitive function (Riga et al., 2014). 
Both deep and superficial mPFC layers receive long-range inputs from cortical 
and subcortical structures, including the thalamus (Riga et al., 2014). The thalamus is 
a complex of diencephalic nuclei that relays information to the cortex, mediating the 
processes of sensation, perception and consciousness (Rikhye et al., 2018). There is 
a strong thalamic input to the mPFC, with terminals on both pyramidal cells and 
interneurons (Cruikshank et al., 2012). The mPFC also receives dense afferents from 
the hippocampus but interestingly, the mPFC has no direct link back to the 
hippocampus in rodents and other species. The influence of the mPFC over the 
hippocampus is mediated via projections to the EC and to the nucleus reuniens, where 
mPFC terminals contact the dendrites of cells that directly excite hippocampal neurons, 
particularly in the CA1 (Vertes et al., 2007; Bertram & Zhang, 1999). The mPFC also 
receives noradrenergic and dopaminergic inputs, which play a role in working memory, 
attention, wakefulness and arousal (Riga et al., 2014).  
1.2.4. Brain oscillations  
The EEG signal is a composite of different sinusoidal waves that have been 
categorised according to their frequency into distinct bands named after Greek letter 
nomenclature. The main frequency bands that can be seen in the awake state in 
humans are theta (4 Hz – 8 Hz), alpha (8 Hz – 15 Hz), beta (15 Hz – 30 Hz) gamma 
(30 – 80 Hz) and high-gamma (> 80 Hz), and they are also characterised by distinct 
regional distribution and function (Teplan, 2002; Kropotov 2009). Faster rhythms are 
associated with more cognitively active states and are generally generated locally, 
while slow rhythms are more widespread and predominate during rest and sleep 
(Wang, 2010). Often, these rhythms are competing but they can also coexist within the 
same structures or networks, interacting with one another (Buzsaki & Draguhn, 2004). 
Therefore, analysis of oscillation patterns can provide rich information that can be 
traced to alterations in communication between and within neuronal networks in 
relation to behaviour in the different types of dementia (Babiloni et al., 2006; Barber et 
al., 2000; Jackson et al., 2008). Quantitative EEG (qEEG) is a computational approach 
of analysis that decomposes and recomposes the EEG signal (μV in time) as power 
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over frequency (μV2/Hz), allowing for the extraction of information about the patterns 
characterising the different rhythms (da Silva, 2009). 
1.2.5. EEG frequency rhythms during the awake state 
1.2.5.1. Alpha rhythm 
Alpha activity occurring at 8 – 15 Hz in humans is the resting rhythm of the brain. 
Spontaneous alpha activity in humans is upregulated during internal mental states, and 
downregulated with attentional shifts to the external world and during various cognitive 
tasks (Knyazev et al., 2011). Alpha activity is comprised of different components of 
thalamo-cortical and cortico-cortical origin (Moretti, 2015). Loss of long-range 
synchrony in lower frequency alpha activity (8 – 10 Hz) occurs during attentional 
demands; while upper frequency alpha activity (10 – 14 Hz) is local and occurs during 
active cognitive processing (Klimesch et al., 2007). Functional MRI (fMRI) and EEG 
studies in humans have shown that increases in long-range alpha power occur during 
rest, and are thought to reflect a widespread, top-down inhibition of non-essential 
activity, allowing a state of internal reflection. Decreases in alpha power reflect a loss 
of the aforementioned inhibition, as local, fast oscillatory activity emerges upon a shift 
of attention to the external world (Klimesch et al., 2007; Bazanova & Vernon, 2014).  
Resting state networks (RSNs) are widespread networks in the brain that show 
high levels of synchronous activity during rest (Knyazev et al., 2011). Hence, the 
widespread alpha oscillation is ideal for modulating faster oscillatory activity in the 
nodes of these networks, in a tightly regulated manner (Klimesch et al., 2007). The 
most extensively studied RSN is the default mode network (DMN). Spontaneous DMN 
activity is upregulated during internal states, self-referential thoughts, episodic and 
autobiographic memory retrieval and integration of cognitive and emotional 
processing, and downregulated upon attention-demanding states (Binnewijzend et al., 
2012). Key regions in the DMN are the precuneus/posterior cingulate cortex (PCC), 
the mPFC and the medial and lateral inferior parietal cortices (Knyazev et al., 2011).  
1.2.5.2. Theta rhythm 
Theta activity is recorded at 4 – 8 Hz in humans, and at 4 – 7 Hz in rodents. There 
are two main types of theta, frontal-medial (FM-theta) and hippocampal theta 
(Scheeringa et al., 2008; Wulff et al., 2009). FM-theta in humans is a task-related 
rhythm that appears during mental tasks that demand attention and working memory 
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(Mitchell et al., 2008). Functional MRI studies in humans have shown that theta power 
decreases during rest in the areas that are associated with DMN. Upon engagement 
in working memory related tasks, FM-theta increases in the hippocampus and the 
temporal, cingulate and frontal cortices (Scheeringa et al., 2008), suggesting that it is 
actively involved in cognition. FM-theta originates from the mid-cingulate cortex, an 
area that receives and integrates cortical and sub-cortical information and the pre-
supplementary motor area. This topology suggests a role for the theta rhythm in 
synchronising goal-orientated information in order to make a decision (Cavanagh & 
Frank, 2014). Recently, similar synchronisation of FM-theta was shown between motor 
areas and the mPFC in rodents, suggesting that theta activity underlies behavioural 
adaptation in these animals, similar to humans (Narayanan et al., 2006).  
Hippocampal theta activity has been most extensively studied in rodents 
(Gottesmann, 1992) and arises during movement, while it is also involved in active 
perceiving of stimuli, as it is presents while whisking and sniffing (Molter et al., 2012). 
Thus, it has been suggested that hippocampal theta contains ongoing sensory 
information linking it with information from other modalities or related to motivational or 
emotional states (Colgin, 2013). In rodents, this rhythm is generated in the medial 
septum (MS) through pacemaker GABAergic cells that fire rhythmically at theta 
frequencies and are phase-locked to theta rhythms in the hippocampus (Stewart & 
Fox, 1989). Although theta oscillations have been recorded in the human hippocampus 
(Cantero et al., 2003), rodent hippocampal theta activity is believed to be analogous to 
a slower, 1.5 – 3 Hz rhythm in humans (Ferrara et al., 2012). Hippocampal and cortical 
theta oscillations are separate rhythms. Nonetheless, rodent studies have shown that 
the two theta rhythms become synchronous during exploratory activity in the context 
of decision-making (Scheeringa et al., 2008; Remondes & Wilson, 2013).  
1.2.5.3. Beta rhythm 
Beta frequency activity (15 – 30 Hz) was originally thought to reflect an idling 
rhythm of the human motor system, as it maintains the status quo and resists new 
movement (Kropotov & Kropotov, 2009b). However, beta activity is now known to be 
associated with cognitive functions, specifically in normal awake states, when a person 
is attentive or engaged in problem solving and decision-making (Engel & Fries, 2010). 
Similar to its function in the motor system, the beta rhythm is also associated with 
maintaining the current cognitive state, as beta activity increases with top-down 
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control, and decreases with the input of external information (Engel & Fries, 2010). 
Consistent with this, beta activity decreases during attention demanding tasks and 
increases upon self-referential thinking, a profile that is similar to the activation in DMN 
regions such as the parietal cortices, precuneus and mPFC (Mantini et al., 2007). Thus, 
beta frequency activity seems to maintain the status-quo of the DMN (Neuner et al., 
2014). 
In the somatosensory cortex beta frequency oscillations are generated by layer 
5 pyramidal cells influenced by low-threshold spiking SOM+ interneurons in layer 1, 
that fire at 5 – 30 Hz (Li et al., 2013). SOM+ interneurons are interlinked through 
assemblies of intercellular channels called the gap-junctions that allow direct cell–cell 
transfer of ions and small molecules (Roopun et al., 2006). Moreover, PV+ 
interneurons are modulated by pyramidal cells in a feedforward manner (Roopun et 
al., 2006), and receive corticothalamic input (Nigro et al., 2018). Interestingly, it was 
recently shown that the local silencing of PV+ interneurons induced an increase in beta 
power in the cortex, especially in deep cortical layers. Thus, PV+ interneurons might 
control the emergence of the beta rhythm by inhibitiing the SOM+ interneurons that 
drive beta oscillations (Kuki et al., 2015). Hence, the interaction between PV+ and 
SOM+ interneurons drives the balance between gamma and beta rhythms (see below 
about the gamma rhythm). 
1.2.5.4. Gamma and high-gamma rhythms 
Gamma frequency oscillations (30 – 80 Hz) have been identified in several 
cortical and sub-cortical regions, especially the hippocampus (Buzsáki & Silva, 2012). 
Gamma activity can be viewed as a “signature of engaged networks”, as it is modulated 
by sensory input and internal processes like attention, working memory and learning 
(Jia & Kohn, 2011). The gamma rhythm therefore, provides a means of linking 
distributed cell assemblies processing relevant information together to carry out higher 
cognitive tasks (Colgin et al., 2009). In the rodent hippocampus, gamma frequency 
oscillations have been shown to interact closely with theta oscillations in the context of 
learning. During spatial learning paradigms, the “place cells” encoding different spatial 
information fire at gamma frequencies on a progressively earlier phase of the theta 
cycle across successive theta cycles. Hence, early gamma activity on the theta cycles 
may represent compressed representations of space and/or future locations (Colgin, 
2013). Hippocampal theta phase also influences the amplitude of gamma waves and 
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the phase of high-gamma frequency waves during active exploration REM sleep 
(Belluscio et al., 2012).  
Gamma frequency oscillations have been particularly well studied in the 
hippocampus, although this rhythm can also be recorded in the neocortex (Bartos et 
al., 2007; Whittington & Traub, 2003). The generation of gamma oscillations depends 
upon the activity of fast-spiking, PV+ interneurons, as their firing is phase-locked to 
gamma oscillations, in both the hippocampus and cortex (Klausberger & Somogyi, 
2008; Colgin & Moser, 2010; Tukker et al., 2007; Sohal et al., 2009). Two main models 
of gamma-generation have been proposed for the hippocampal gamma generator, the 
interneuron network gamma (ING) model and the pyramidal-ING (PING) model. 
According to ING, gamma generation depends on interneurons and is maintained and 
propagated by gap-junctions (Jia & Kohn, 2011; Craig & McBain, 2015). However, this 
model applies to more local neuronal assemblies, and cannot explain the wide spread 
of the gamma rhythm seen in the neocortex (Neske & Connors, 2016). The PING 
model suggests that pyramidal cells fire EPSPs on PV+ interneurons that in turn evoke 
IPSPs that inhibit the pyramidal cells. This recurrent cycle gives rise to gamma 
oscillations and is a favourable model of gamma generation in both the CA3 region of 
the hippocampus and the cortex (review by Whittington et al., 2000).  
The hippocampus generates both low frequency gamma (30 – 80 Hz) and high 
frequency gamma activity (> 80 Hz). These two rhythms have different functional roles 
and are generated by partly distinct, and partly overlapping, classes of GABAergic 
interneurons (Colgin & Moser, 2010). Fast-gamma in the hippocampus and the EC is 
thought to promote the transition and encoding of sensory information to the 
hippocampus and dominates during exploration (Colgin et al., 2009). On the other 
hand, slower gamma activity is important for memory retrieval as it increases with 
exploration in familiar environments and with correct performance in associative 
memory tasks (Colgin et al., 2009). These two gamma rhythms are also of different 
origins, with slower gamma activity generated in the CA3 region and propagated to the 
CA1, and faster gamma activity generated in the EC and then relayed to the DG (Colgin 
& Moser, 2010). Both low gamma and high-gamma are relayed to the CA1 region from 
the CA3, and modulate its activity, although the CA1 can also generate its own, faster 
gamma rhythm in vitro (62 – 100 Hz) (Butler et al., 2016; Wulff et al., 2009).   
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1.3. Electroencephalography as a diagnostic and research tool in DLB 
1.3.1. EEG changes in DLB 
Numerous studies have shown alterations in the EEG of patients with different 
dementia subtypes. A well-established EEG finding is a shift of the dominant alpha 
rhythm towards the lower theta range that is evident throughout the cortex, especially 
in posterior regions (Briel et al., 1999; Neufeld et al., 1994; Stylianou et al., 2018). This 
dominant frequency (DF) slowing has been included as a supportive biomarker with 
the new diagnostic criteria for DLB (McKeith et al., 2017). A similar “EEG slowing” can 
also be seen in AD patients but only in the more advanced stages of the disease 
(Jackson et al., 2008). A number of studies have shown that a variety of qEEG 
measures, including measures of reactivity and paroxysmal activity (Roks et al., 2008), 
coherence (Snaedal et al., 2012), temporal variability in frequency (Andersson et al., 
2008), even combinations < 25 different qEEG variables, could differentiate DLB 
patients, AD patients and controls with high sensitivity and specificity (Garn et al., 
2017).  
1.3.2. EEG signatures of cognitive fluctuations in DLB 
Specific qEEG patterns have also been shown to relate to cognitive fluctuations 
(CF), one of the core symptoms for DLB diagnosis. CFs are defined as spontaneous 
alterations in cognition, attention and arousal (McKeith et al., 2004). Although CF-like 
events are seen in all major dementia diseases, they have been established as a target 
for differential DLB diagnosis due to their higher prevalence in DLB, reaching 90% of 
cases compared to 20% of AD, 35 - 50% of vascular dementia and 29% of PDD cases. 
CFs are also qualitatively different between DLB and AD as in DLB they relate more 
to executive and perceptual performance, and in AD they are primarily linked to 
forgetfulness and confusion (Zupancic et al., 2011). Recent studies have identified CFs 
at the prodromal stage of DLB, where the presence of CFs predict the conversion from 
non-amnestic mild cognitive decline to full DLB (Sadiq et al., 2017). Clinical scales 
have been devised for the psychometric assessment of fluctuations, including the 
Clinician Assessment of Fluctuation (CAF) scale (Walker et al., 2000). One systematic 
review has demonstrated that the clinical scales of CFs are of moderate quality in 
differentiating between the commonalities of AD and DLB (Lee et al. 2012). The 
authors of this review suggested that the restricted capacity of these clinical scales to 
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identify CFs, may be attributed to the high variability in severity and in the time window 
in which CFs occur (Lee et al. 2012).  
The nature of CFs, and the fact that they appear and disappear irrespective of 
external stimuli, suggest that they are the product of internally driven processes 
(Bradshaw et al., 2004). Thus, qEEG was considered a suitable means of detecting 
underlying network changes related to CFs that could possibly be developed into a 
DLB biomarker. Early qEEG work showed a correlation between epoch-by-epoch 
variability in the dominant frequency (DF) and CFs, as measured by the CAF score, in 
DLB patients compared to healthy controls (Walker et al., 2000). Another study also 
showed that DLB patients had greater DF variability (DFV) compared to AD patients in 
posterior derivations, and used the DFV (together with other qEEG measures) to group 
the patients into diagnostic groups with high accuracy (Bonanni et al. 2008; Figure 1.3). 
The Bonanni group later applied the same method on the data from different cohorts 
of patients from different institutions, and obtained similar results (Bonanni et al., 
2016). The increase in DFV found in DLB patients was interpreted as an increase in 
dynamic brain function, resulting in abnormal shifts of the DMN from the resting state 
to attentional states and vice versa, giving rise to CFs. 
Recent evidence contradicts the aforementioned theory of increased dynamic 
brain function in DLB, and suggest that DLB is characterised by a lack of dynamic brain 
function instead. FMRI studies have shown prolonged cognitive processing in the DMN 
of DLB patients (Firbank et al., 2018), and a more temporally rigid global network in 
DLB patients compared to healthy controls (Schumacher et al., 2018). Moreover, 
Schumacher et al. (2019) showed a reduction in shifts between the EEG-microstates, 
~100 ms long periods that represent the EEG correlates of fMRI resting-state networks, 
in DLB compared to AD patients and healthy controls. Interestingly, the magnitude of 
the reduction in the EEG-microstate shifts was correlated with CFs in the DLB patients. 
These findings led the authors to suggest that CFs in DLB patients are related to a 




Figure 1.3: The dominant frequency variability in patients with AD and DLB and 
healthy controls. The compressed spectral array (CSA) of EEG recordings from 
occipital derivations in one control, one AD patients and one DLB patient. The CSA 
shows the dominant frequency (DF) which is the frequency with the highest power, as 
recorded in 2 s-long epochs. The occurrence of more than one peaks and the shift in 
the DF over time in the DLB group represents the DF variability (DFV). Adapted from 
Bonanni et al. (2008).  
1.3.3. Polysomnography 
Another EEG-related biomarker of DLB is polysomnography. As mentioned 
earlier, RBD is one of the core symptoms of DLB and polysomnography, which is a 
sleep EEG, can help identify these events (Donaghy & McKeith, 2014). 
Polysomnography can help detect REM sleep that is characterised by theta frequency 
activity in the brain, while simultaneous electro-occulography records the 
accompanying increase in eye movement. The concurrent loss of muscle atonia that 
characterises RBD can be measured by chin movements recorded though the 
electromyogram (Boeve et al., 2003). This biomarker has a very high specificity of 98% 
for synucleinopathies (Boeve et al., 2003), and 84% for DLB cases confirmed post-














1.3.4. Hyperexcitability in dementia 
Seizures manifest in the EEG as uncontrolled activity in the brain and an 
epilepsy diagnosis is given to a patient following two or more seizures (Stafstrom & 
Carmant, 2015). The clinical picture of seizures can differ according to their site(s) of 
onset and extend of spread in the brain (Stafstrom & Carmant, 2015). Seizures of focal 
onset can be accompanied by impairment of awareness or not, and can have a motor 
or non-motor manifestation. Generalised onset seizures are characterised by impaired 
awareness and can have non-motor (absence seizures) or a motor manifestation 
(Stafstrom & Carmant, 2015). The most common type of seizures are tonic-clonic 
seizures, which last about a minute and involve a mix of sudden muscle stiffness and 
rhythmic jerking in a set pattern, as well as other symptoms (Guerrini & Takahashi, 
2013).  
There is increasing evidence for a relationship between epilepsy and dementia, 
with most studies focusing on AD. AD patients have a 10-fold increased risk of 
developing seizures and epilepsy compared to age-matched controls, while the 
incidence of seizures amongst AD patients reaches 8 – 20% (Friedman et al., 2012). 
Moreover, patients with early onset AD are even more likely to develop seizures, 
suggesting a connection between AD-pathology and epilepsy (Sánchez et al., 2018). 
The most common type of seizures seen in AD are complex partial seizures that are 
characterised by déjà vu or jamais vu, speech arrest, staring spells, unexplained 
emotions or sensory phenomena (Vossel et al., 2014). These seizures are highly 
associated with AD-related hippocampal sclerosis. Models of temporal lobe epilepsy 
have shown that the cell loss and/or changes in the hippocampal circuits result in 
excitability within the network that cannot be contained, so-called hyperexcitability 
(Vossel et al., 2014). Changes in hippocampal circuits, such as cell-loss and gliosis in 
the CA1 region, are one of the pathological hallmarks of AD and are associated with 
Aβ accumulation (Serrano-Pozo et al., 2011). 
Early demographic studies led to the assumption that epilepsy was a late result 
of AD pathology. However, recent evidence suggests that epileptiform activity can in 
fact contribute to dementia-related cognitive decline as epilepsy emerges soon after 
(within 6 years) or even before any cognitive symptoms (Sarkis et al., 2016). In line 
with these findings a study by Vossel et al. (2017) investigated for epileptiform activity 
in 33 AD patients without seizure history using overnight video-EEG and 
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magnetoencephalography (MEG) with simultaneous EEG. The study found that 41% 
of AD patients had some form of epileptiform activity compared to 11% in healthy 
controls, mostly recorded from the temporal cortex. Importantly, AD patients with 
epileptiform activity had a steeper cognitive decline compared to AD patients without 
evidence of seizure activity (Vossel et al., 2017). In addition, another study that 
introduced implants in 2 AD patients without epilepsy found prominent epileptiform 
spikes in the medial temporal lobe of both patients (Lam et al., 2017).  
There is less evidence from LBD patients regarding epilepsy prevalence, 
although there are clear indications of a relationship between the two diagnoses. One 
of the best established qEEG findings in LBDs is the presence of transient sharp-
waves, predominantly in posterior derivations (Briel et al., 1999), that are also used as 
a supportive feature for diagnosis (McKeith et al., 2017). Interestingly, there are also 
reports in the literature of epilepsy cases mimicking DLB (Park et al., 2014; Ukai et al., 
2017). Furthermore, a recent study investigated the incidences of epilepsy-related 
manifestations in AD, DLB and FTD, and found that DLB patients had an 11.5% 
cumulative probability of developing seizures compared to 13.4% in AD and 5% in 
FTD, while in patients with mixed AD/DLB pathology the probability reached 20.7% 
(Beagle et al., 2017). Moreover, the DLB patients were more likely to develop 
myoclonus with a probability of 58.1% (Beagle et al., 2017). Myoclonus describes the 
involuntary jerking of a muscle, or group of muscles, that is due to aberrant neuronal 
activity in the motor cortex (Guerrini & Takahashi, 2013). Morris and colleagues (2015) 
showed that DLB patients had changes in molecular markers indicative of 
hyperexcitability in the hippocampus, while a mouse model overxpressing α-syn had 
epileptiform and seizure activity in the parietal cortex (Morris et al., 2015). 
One of the core symptoms of DLB are visual hallucinations (McKeith et al., 
2017). According to the deafferentation hypothesis, visual hallucinations are the result 
of impaired processing from the eye to the primary visual cortex, resulting in a 
compensatory cortical hyperexcitability that manifests as visual hallucinations (Elder et 
al., 2019). Transcranial magnetic stimulation (TMS) studies have shown that visual 
cortical excitability correlated with visual hallucinations in DLB, although it was not a 
characteristic of DLB per se (Taylor et al., 2011). This correlation may be the result of 
inherently more hyperexcitability and/or a loss of inhibition. MRI studies have shown a 
loss of regional visual cortical inhibition in PDD, while neuropathological studies have 
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shown a similar finding in DLB (Erskine et al., 2017). These studies indicate a potential 
importance for hyperexcitability in the generation of DLB symptoms. However, we need 
to keep in mind that there are other theories for the generation of visual hallucinations 




1.4. Sleep  
1.4.1. Sleep architecture and microstructure 
Although we have all experienced sleep and the effects of its deprivation, we 
rarely hear the textbook definition: Sleep is a natural and reversible state of reduced 
responsiveness to external stimuli that involves loss of consciousness (Rasch & Born, 
2013). Sleep is regulated by sleep-wake homeostasis mechanisms as the 
accumulation of waking by-products inhibits the systems that promote wakefulness, 
resulting in sleep induction (Watson et al., 2016). These systems interact with the 
circadian rhythm (Zhang et al., 2019), an internal clock of the 24-hour sleep/wake cycle 
(Videnovic & Golombek, 2013). 
All mammals experience sleep that consists of two main states that can be 
recorded via the EEG all over the cortex: REM and non-REM sleep (NREM). NREM 
sleep can be further subdivided into NREM sleep stages N1, N2 and N3/4 in humans 
(Wolpert, 1969). These stages comprise sleep architecture / macrostructure. The EEG 
faster rhythms characterising the awake state shift to the slower theta rhythm with the 
emergence of N1 sleep. N2 sleep is characterised by slow wave activity (SWA) which 
describes oscillatory power at 0.1 – 4 Hz, bursts of 8 – 15 Hz activity known as sleep 
spindles, and K-complexes that describe a slow wave followed by a spindle (Brown et 
al., 2012). N2 sleep is followed by N3/4 or slow-wave sleep (SWS; < 1 Hz), and greater 
SWA (< 20%). Spindles persist during N3 while hippocampus-derived events of high 
frequency known as sharp-wave ripples also appear (Brown et al., 2012). Then, we 
enter REM sleep, which is characterised by faster, low-amplitude activity that 
resembles awake-like oscillations, and is characterised by muscle atonia (Peever & 
Fuller, 2017). In humans, each NREM/REM cycle lasts about 90 minutes (Rasch & 
Born, 2013). In rodents, sleep is much more fragmented, and the N2 sleep stage and 
SWS are not distinct. However, REM and NREM sleep stages are clearly distinct 
(Lacroix et al., 2018). 
1.4.2. Neuronal mechanisms of SWS in the cortex 
In humans, SWS originates in different prefrontal-orbitofrontal regions, with 
some regions like the insula and cingulate gyrus being particularly involved. The SWS 
then propagates from anterior to posterior cortical regions though the cingulate gyrus 
(Murphy et al., 2009; Riedner et al., 2011). Rodent studies have helped elucidate the 
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cellular mechanisms that underlie SWS. Intracellular recordings in rodents have shown 
that SWS consists of periods of neuronal firing known as the Up-state, and neuronally 
silent periods known as the Down-state (Steriade et al., 1993a). Up-state induction 
requires an initial activation that “kick-starts” the system and is derived from local 
activity in cortical layer 5 (Silva et al., 1991). Proposed mechanisms for this include the 
summation of EPSPs in a number of pyramidal neurons and/or the persistent firing of 
some of the pyramidal cells in this layer during the Down-state (Neske, 2015). The 
intrinsic properties of the pyramidal cells in this region are crucial for the initiation of 
the Up-state, as some of them exhibit intrinsic rhythmicity while others produce bursts 
of action potentials (Lőrincz et al., 2015). The excitatory input that generates an Up-
state in the local cortical network then spreads, recruiting pyramidal cells in other areas 
to enter an Up-state. This spread of SWS has been shown in rodents both during 
natural sleep and under ketamine/xylazine and urethane anaesthesia  (Luczak et al., 
2007).  
During the Up-state, both excitatory and inhibitory synaptic inputs are present, 
as shown in numerous studies in animal models (Neske, 2015). Glutamate, acting via 
NMDAR activity is particularly important, as following NMDAR blockade the Up-state 
duration is reduced in vivo and abolished completely in vitro (Steriade et al., 1993a; 
Major et al., 2013). GABAergic inhibition is also important for Up-state maintenance, 
as the application of a GABAAR antagonist in vitro leads to shorter and less frequent 
Up-states (Haider et al., 2006). PV+ basket cells contact the pyramidal cell soma and 
vice versa, giving rise to a feedback loop where excitation is followed by equal amounts 
of inhibition. This balanced system maintains the pyramidal neurons at a near-firing 
threshold membrane potential (Haider et al., 2006; Shu et al., 2003). The inhibition 
arises mostly from the recruitment of local interneurons including PV+ basket cells, 
which are contacted by long-distance excitatory axons (Sanchez-Vives et al., 2010).  
The Up-states of the slow oscillation (SO) are terminated in a highly 
synchronised manner across neurons (Volgushev et al., 2006). The main proposed 
mechanism for termination of the Up-state is the activation of K+ conductances, which 
reduce the excitation in the neurons maintaining the Up-state, resulting in network 
disfacilitation. Network disfacilitation describes a form of inhibition where cortical 
networks become hyperpolarised and hence inactive due to lack of excitatory input 
(Timofeev et al., 2001). Recent data in naturally moving mice also suggest that a small 
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proportion of interneurons might fire towards the end of the Up-state (Funk et al., 2017). 
These interneurons are SOM+ Martinotti cells in layer 1, which are activated by 
pyramidal cells through synaptic facilitation (a form of short-term plasticity that 
enhances synaptic transmission for < 1s; Silberberg and Markram, 2007), and are 
interlinked through gap-junctions (Roopun et al., 2006). Thus, the output of the SOM+ 
Martinotti cells is widespread and strong enough to inhibit pyramidal cells by synaptic 
spill-over of GABA, which then binds to pre-synaptic GABABRs on pyramidal cells 
inducing hyperpolarisation (Funk et al., 2017; Zucca et al., 2017). A role for PV+ 
interneurons is also supported by evidence that GABA depletion, specifically in these 
cells, results in a shortening of the Up-state and increased firing of pyramidal neurons 
in naturally sleeping and anaesthetised mice (Kuki et al., 2015). PV+ cells exert their 
action by inhibiting pyramidal cells but if this inhibition is impaired, it results in a higher 
level of depolarisation of the pyramidal cells that can then easily shift to another Up-
state (Kuki et al., 2015). 
The thalamus and brainstem structures also influence the SO, in all mammalian 
species. With the end of the Down-state, T-type Ca2+ channels in the thalamus become 
activated, resulting in low-threshold Ca2+ spikes, which elicit an influx of Ca2+ across 
the thalamocortical neurons, bursts of action potentials and an Up-state in the cortex 
(Crunelli & Hughes, 2010). In turn, corticothalamic input activates GABAergic neurons 
in the thalamic reticular nucleus (TRN), an almost exclusively GABAergic nucleus that 
responds with a high frequency discharge onto thalamocortical neurons. The TRN 
spiking inhibits the thalamocortical projections, thus terminating the cycle (Destexhe et 
al., 1998). Although the cortex can generate an SO independently of the thalamus 
(Timofeev, 2000), thalamic inactivation has been shown to affect the cortical SO in 
anaesthetised cats, and specifically to reduce the SO amplitude and the Up-state 
density (Lemieux et al., 2014). Thus, although the thalamocortical input is not 
necessary for Up-state initiation, it is important for maintaining a stable oscillation 
across the cortex (Steriade et al., 1993a).  
The cortical SO is also influenced by cholinergic modulations. The basal 
forebrain (BF) is the main source of cholinergic input to the neocortex and also projects 
to the limbic regions including the cingulate cortex, EC, hippocampus and amygdala 
(Ballinger et al., 2016). A second major source of cholinergic input to the cortex is the 
brainstem cholinergic system that contacts sub-cortical structures such as the basal 
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forebrain, the hippocampus and the thalamus that in turn projects to the cortex 
(Newman et al., 2012). Pharmacological reactivation of the severed cholinergic input 
in naturally sleeping rats resulted in rhythmic Up- and Down-states (David et al., 2013). 
The SO generation relied on a population of intrinsically bursting pyramidal neurons at 
cortical layer 5, which fire at 0.2 – 2 Hz and are activated via cholinergic input on 
mAChRs (Lőrincz et al., 2015). These neurons may correspond to the population 
mentioned earlier that initiates the Down-state to Up-state transition. Other deep brain 
structures that may influence the SO are cholinergic inputs from the pedunculopontine 
tegmentum (PPT), noradrenergic input from locus coerulius (LC) and serotonergic 
input from the dorsal raphe nucleus, as they all contain neurons that preferably fire on 
the Up- or Down-state, although their effect is less prominent (see review by Neske, 
2015).  
1.4.3. Neuronal mechanisms of SWS in hippocampus 
SOs have also been characterised in the rodent hippocampus, including the 
DG, subiculum, CA1 and CA3 subregions (Penttonen et al., 1999). On the Up-state, 
the majority of CA1 pyramidal neurons fire action potentials both during natural sleep 
(Isomura et al., 2006) and under urethane anaesthesia (Sharma et al., 2010). Τhe CA1 
has a local SO rhythm that is independent of the cortical SO rhythm in terms of 
initiation, coordination and coherence and is sensitive to cholinergic modulation 
(Wolansky et al., 2006; Lockmann et al., 2016; Sharma et al., 2010). However, the 
hippocampal SO activity still correlates with SO activity in the EC and the neocortex, 
and it is never present in the absence of cortical SOs, while the opposite is observed 
regularly (Wolansky et al., 2006). Moreover, an anterior-posterior direction of 
information flow from the prefrontal cortex to the hippocampus has been extensively 
shown in rats, with the SO starting in the prefrontal cortex and progressing to the DG 
and then the CA1 and CA3 regions (Isomura et al., 2006; Vyazovskiy et al., 2009). 
Furthermore, deep recordings in the human brain have confirmed that the SO 
propagates from the prefrontal cortex to the hippocampus (Nir et al., 2011). The 
aforementioned studies clearly suggest that the cortex has control over the local 
hippocampal SO, although it is possible that both regions are also modulated by 
ascending activating systems and/or the thalamus (Wolansky et al., 2006).  
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1.4.4. Oscillatory patterns accompanying SWS and their mechanisms of 
generation 
The organisation of the SO into Up- and Down-states provides the framework 
for higher frequency oscillations to emerge, which interact with the SO and are involved 
in memory consolidation and plasticity (Sirota et al., 2003). The oscillations that will be 
discussed in detail are the sleep spindles, the sharp wave ripple (SWRs) and the beta 
(15 – 30 Hz), gamma (30 – 80 Hz) and high gamma rhythms (80 – 130 Hz) nested on 
the Up-state (Valderrama et al., 2012; review by Neske, 2015). 
1.4.4.1. Sleep spindles  
Sleep spindles describe spontaneous waxing and waning oscillations between 
8 and 15 Hz that occur during N2 and N3/4 stages of sleep (Destexhe et al., 1998). 
Sleep spindles appear mostly at the Down- to Up-state transition, although some 
higher frequency spindles (> 13 Hz) occur at the Up- to Down-state transition in more 
central and posterior regions of the brain (Cox et al., 2017). These two types of spindles 
do not seem to have a distinct functional role, as they both interact with the SO and 
are involved in the processes of plasticity and memory consolidation (Cox et al., 2017).  
Spindles are generated in the thalamus during SWS through an interplay with 
the TRN, and are relayed to the cortex where they are sustained and synchronised, in 
both humans and animal models (Steriade et al., 1987; Andrillon et al., 2011). This 
interaction between the thalamus and TRN results in thalamocortical oscillations 
composed of cycles of excitatory (spike) and inhibitory (wave) phases. Thalamocortical 
neurons send excitatory outputs from the thalamus to cortical pyramidal neurons in 
layers 3 – 6. In turn, corticothalamic pyramidal neurons mainly from layer 6, project 
back to the thalamus. Although GABAergic cells are found in both the thalamus and 
cortex, the main inhibitory input that drives the spindle comes from the TRN (Bonjean 
et al., 2011; Luczak & Barthó, 2012).  
At the start of the cycle, thalamocortical neurons generate highly synchronised 
EPSPs in the TRN that elicit a burst of action potentials in TRN GABAergic 
interneurons (Brown et al., 2012). This inhibitory activity induces large and prolonged 
IPSPs in thalamocortical neurons, at a spindle frequency (4 – 7 Hz). The resulting 
hyperpolarisation removes the inactivation of low-threshold (T-type) Ca2+ channels in 
thalamocortical neurons, which allow the influx of Ca2+ in thalamocortical dendrites 
(Fuentealba et al., 2004). This Ca2+ pool can be immediately utilised by thalamocortical 
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neurons upon their recovery from the IPSP, in order to produce a low-threshold Ca2+ 
spike at a low depolarisation level (Coulon et al., 2012). The resulting burst of firing 
activity in thalamocortical neurons leads to EPSPs in cortical neurons, giving rise to a 
spindle (Blumenfeld, 2005). Spindles do not occur during high frequency activity, i.e. 
during wakefulness and REM sleep (Brown et al., 2012).  
1.4.4.2. Sharp wave ripples  
The sharp –wave ripple (SWR) complex is composed of sharp-waves which are 
large negative potentials (40 – 100 Hz) recorded in the CA1 stratum radiatum, and high 
frequency ripples (100 – 300 Hz) which occur in the stratum pyramidale (Buzsáki and 
Silva, 2012). In rodents, SWRs are most frequent during SWS but they can also occur 
during immobility at wakefulness (Wang & Ikemoto, 2016). SPWs are generated by the 
synchronous bursting of pyramidal neurons in the CA3 that induce the depolarisation 
of the apical dendrites in the CA1 through Schaffer collaterals. SWRs are considered 
the default state of the hippocampus but during REM sleep and active wakefulness, 
CA3 projections are inhibited, preventing SWR activity. During NREM sleep the CA2 
projections become disinhibited, allowing SWRs to occur (Chenkov et al., 2017). Fast-
spiking PV+ are also crucial for SWR generation as their stimulation is sufficient for 
SWRs to emerge (Buzsáki, 2015). By eliciting fast spiking perisomatic inhibition on the 
pyramidal neuronal soma, PV+ interneurons create a temporal window for rebound 
activation that increases the probability of a SWR to occur. SWRs are terminated by 
hyperpolisation and a refractory period mediated by K+ channel conductance (Buzsáki, 
2015). SWRs are crucial for memory consolidation (see section 1.5.2.2). 
1.4.4.3. Higher frequency oscillations nested on the Up-state 
The SO modulates the high frequency rhythms that are nested within the Up-
state, including beta (15 – 30 Hz) and gamma (30 – 80 Hz) frequency oscillations in 
the cortex (Jing et al., 2016), and gamma and high-gamma frequency (80 – 130 Hz) 
oscillations in the hippocampus (Valderrama et al., 2012; Steriade et al., 1996). In 
rodents, neurons in the mPFC fire more action potentials per Up-state compared to 
motor and sensory regions, with a discharge of 3 – 6 spikes per Up-state, while they 
also have greater power in the beta (15 – 30 Hz) and gamma (50 – 80 Hz) oscillations 
on the Up-state (Ruiz-Mejias et al., 2011). In the rodent hippocampus, gamma 
oscillation power is recorded during the Up-state in most layers and regions, including 
the CA1 and CA3, and is accompanied by greater neuronal firing (Colgin, 2011). 
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Beta and gamma band oscillations are governed by similar mechanisms in the 
awake and asleep brain (Destexhe et al., 2007). NMDAR blockade in ferret PFC slices 
not only resulted in decreased Up-state duration and Up-state frequency in the 
spontaneously generated SO, but also in increased power of the nested beta/gamma 
oscillations (Rebollo et al., 2018). PV+ interneurons also modulate both the Up-state 
length and the high frequency oscillations on the Up-state (Brown et al., 2012). In a 
mouse model of GABA depletion in PV+ interneurons, the authors found decreased 
gamma and high-gamma power in superficial cortical layers and increased beta power 
in deeper layers (Kuki et al., 2015). The authors concluded that PV+ cells maintain the 
Up-state and gamma and high-gamma frequency oscillations in superficial layers, 
while suppressing beta in deeper layers through inhibiting SOM+ interneurons. SOM+ 
are disinhibited with decreasing PV+ function, giving rise to beta activity, as previously 
described (Kuki et al., 2015). Finally, thalamocortical cells contact PV+ cells in upper 
cortical levels, as well as pyramidal cells in the mammalian prefrontal cortex 
(Cruikshank et al., 2012). Thalamic inactivation results in an immediate decrease in 
beta/gamma oscillations on the Up-state, suggesting that the thalamic input is also 
important in driving high frequency oscillations on the Up-state (Lemieux et al., 2014). 
1.4.5. REM sleep and waking 
REM sleep describes periods of active sleep accompanied by rapid eye 
movements, loss of muscle tone, muscle twitches, elevated arousal level and 
autonomic and respiratory activation. The EEG also changes, with emerging low 
amplitude, high frequency oscillatory activity in the cortex that is similar to the activity 
seen during waking (see review by Peever and Fuller, 2017). REM sleep is seen in all 
vertebrate species, but there are some differences in REM sleep between humans and 
rodents (Peever & Fuller, 2017). In humans REM periods appear every 90 - 120 min 
and last for about 10 min (Carskadon & Dement, 1980), while in rodents REM periods 
appear every 10-15 min and last about 1 min (Yasenkov & Deboer, 2012). Most 
importantly, in rodents, REM sleep is mostly defined by hippocampal theta activity. 
Specifically, there is a long-lasting burst of low-theta (4 – 7 Hz) acitivity and intermittent 
bursts of high-theta (7 – 12 Hz) activity during normal sleep and under urethane-
induced anaesthesia, that can also be recorded in the cortex (review by Brown et al., 
2012). In contrast, chronic electrode implant studies in humans have shown that REM 
sleep is characterised by intermittent theta activity limited to 1 s-long epochs and a 
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rhythmic delta (1.5 – 3 Hz) that might represent high and low theta respectively (Bódizs 
et al., 2001). 
Waking and REM sleep are controlled by the ascending reticular activating 
system (ARAS) composed of nerve fibres ascending from the brain stem and 
brunching off on their way to the forebrain (Pal & Mallick, 2007). The ARAS is 
composed of the dorsal and ventral pathways (Figure 4.1; Brown et al., 2012b). 
Acetylcholine (ACh) is a major neurotransmitter in the ARAS (Hentschke et al., 2007) 
and it generally promotes oscillations that are associated with wakefulness and REM 
sleep, particularly theta activity and theta/gamma coupling in the hippocampus and 
beta/gamma oscillations in the hippocampus and cortex, in rodents (Whittington et al., 
2000; Cantero et al., 2003). The cholinergic drive of ARAS is derived from cholinergic 
neurons originating from brain stem cholinergic system projecting to the thalamus, and 
from the basal forebrain (BF) projecting directly to the cortex and the hippocampus 
(review by Brown et al., 2012; Figure 1.4). In contrast, serotonin functions in an 
opposing manner to ACh, inhibiting both the BF and brain stem cholinergic neurons, 
hence blocking theta and gamma activity (Cape & Jones, 1998). REM/NREM sleep 
alternations rely upon the interaction between REM-on and REM-off neurons in the 




Figure 1.4: The dorsal and ventral pathways of the ascending reticular activating 
system (ARAS) in the rodent brain. The dorsal pathway (blue) originates in pontine and 
midbrain reticular formation, with cholinergic neurons from the pedunculopontine and 
laterodorsal tegmental nuclei (LDT/PPT) and glutamatergic neurons, which project to 
thalamic nuclei that in turn innervate several regions of the cerebral cortex. The ventral 
pathway (red) also originates in pontine/midbrain regions and projects to the lateral 
hypothalamic (LH) and tuberomammillary (TMN) nuclei of the hypothalamus, and the 
basal forebrain (BF). LH and TMN outputs also contact the BF, which in turn projects 
to the cortex. Noradrenergic neurons of the locus coeruleus (LC), serotonergic neurons 
in the dorsal raphe (DR), histamine neurons of the TMN and orexinergic neurons in the 
LH contribute to both pathways and send direct projections to the cortex. Adapted from 
Brown et al. (2012), originally adapted from Paxinos and Watson (1998). 
 
 
Figure 1.5: REM/NREM sleep alternations rely upon the interaction between REM-on 
and REM-off neurons in the dorsal ARAS pathway. REM-on neurons, which are 
cholinergic neurons in the LDT/PPT, increase their firing before and during REM and 
excite pontine reticular formation (PRF) glutamatergic REM-on cells, and activate 
GABAergic interneurons that inhibit their adjacent REM-off neurons. REM-on output 
also acts in a self-inhibiting manner by inhibiting GABAergic REM-off interneurons, 
releasing REM-on neurons in the PRF from their inhibition. REM-on cells increasingly 
excite REM-off cells in the dorsal raphe (DR) and LC, which inhibit LDT/PPT REM-on 
neurons, during waking and NREM sleep. For REM sleep to emerge, these REM-off 
neurons become self-inhibited, leading to disinhibition of REM-on neurons. Figure 






1.4.6. Sleep microstructure  
Sleep macrostructure is composed of dynamically alternating microstates 
(Halász, 2004). The cyclic alternating pattern (CAP; 0.002 – 0.02 Hz) is a rhythm that 
is well characterised in humans, and is composed of microactivation periods that reflect 
cortical arousal (phase A) and their intermediate SWS periods (phase B) (Terzano et 
al., 1985). The A phase can be catergorised into subtypes (A1, A2, A3) according to 
the percentage of SWA activity occurring in each phase (Figure 1.6). Hence, it appears 
that the CAP cycle offers a homeostatic mechanisms that buffers the levels of SWA 
(Parrino & Vaudano, 2018). The A phase subtypes have a variety of manifestations 
depending on the depth of sleep in which they occur, the age of the individual and 
homeostatic sleep pressure (Parrino et al., 2012). The A1 subtype consists of slow 
modulations (delta, K-complexes) and occurs mostly during sleep-stage transitions. 
Moreover, A1 events act as a gating mechanism, filtering external stimuli during SWS 
without inducing sleep discontinuation and thus, benefiting sleep-related cognitive 
processing (Combi et al., 2009; Ferri et al., 2008). The A3 subtype has faster oscillatory 
components (e.g. theta, alpha, beta activity). Phase A3 events occur at the NREM-
REM transition and reflect sleep discontinuity in the cortex, providing a window for 
monitoring sleep and driving arousal if necessary (Parrino & Vaudano, 2018). Finally, 





Figure 1.6: Example of the cyclic alternating pattern (CAP) in a human subject during 
slow wave sleep. Short CAP sequence composed by three A phases (A1, A2, and A3) 
and the intermediate B phase. As shown in the power spectra, the A phase subtypes 
are characterised by different levels of percentage of SWA activity: subtype A1 is 
composed mostly of SWA (> 80%), subtype A2 contains about 50% - 80% of SWA and 
the rest is low voltage fast activity, while subtype A3 is predominated by faster activity 




1.5. Sleep and memory consolidation 
1.5.1. Slow wave sleep as a framework for synaptic plasticity  
SWS plays an essential role in the strengthening of synapses in relation to 
learning and memory, as SWA is believed to reflect synaptic density and/or strength in 
the cortex (Marshall et al., 2006; Van Someren et al., 2011). A number of behavioural 
studies, have shown that sleep deprivation, and the selective deprivation of SWS, 
impairs episodic memory in humans (review by Walker, 2009). For example, Yoo et al 
(2007) showed that sleep deprivation affected the participants’ performance in a 
memory-encoding task, while comcomidant MRI revealed a decrease in activity in the 
hippocampus and prefrontal cortex during the memory acquisition phase (Yoo et al., 
2007). The communication between the hippocampus and cortex is facilitated by the 
Up-state, as it provides a widespread temporal framework for distant neurons in the 
two regions to communicate, and bind into the functional assemblies that underlie 
memory consolidation (Mölle et al., 2006). This communication allows the declarative 
memories acquired when awake, to become increasingly cortically-dependent and 
hippocampally-independent, thus protecting them from interference and forgetting 
(Mander et al., 2016). On the other hand, Down-states are crucial for synaptic strength 
homeostasis (Watson et al., 2016). According to the synaptic homeostasis hypothesis, 
synaptic plasticity-mediated changes in the cortex during wakefulness result in a 
widespread increase in synaptic strength, which if not limited, will not be energetically 
sustainable over time (Tononi & Cirelli, 2006). Thus, the Down-state offers the 
opportunity to downscale, allowing only “relevant” synapses to remain and promoting 
the efficient use of grey matter (Vyazovskiy et al., 2009; Vyazovskiy and Harris, 2013). 
1.5.2. High frequency rhythms are involved in memory consolidation 
1.5.2.1. Spindles  
Sleep spindles are very important for memory consolidation as they facilitate the 
communication between the hippocampus and the cortex (Sirota et al., 2003). There 
is evidence from healthy humans that inducing SO-like stimulation through TMS 
increased the SWA and sleep spindles, and improved the subjects’ performance on a 
memory task the following day (Marshall et al., 2006). Moreover, the spindle density 
and amplitude increased in normal subjects after performing tasks that require 
learning, while these changes in spindle amplitude and density predicted performance 
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in a memory task (Cox et al., 2012). In contrast, spindle dysfunction in patients with 
schizophrenia is associated with reduced memory consolidation (Manoach & 
Stickgold, 2019). Deficits in spindles are also seen in patients with dementia 
(Westerberg et al., 2012).  
1.5.2.2. Sharp–wave ripples (SWRs) 
During SWRs, the pattern of activation in the hippocampus is a temporally 
compressed version of neuronal firing patterns in waking animals, termed hippocampal 
replay. This led to the hypothesis that with novel information, there is a transient 
synaptic reorganisation of hippocampal circuits (Buzsáki, 2015). Moreover, the 
memory replay is thought to strengthen synapses and transfer memories to the cortex. 
The ACC is particularly relevant in this process, as it is involved in the storage and 
expression of long-term episodic memory (Meltzer et al., 2007). One study found that 
most ACC neurons showed increased activity before a SWR, while a small portion of 
neurons also showed increased activation after the SWR (Wang & Ikemoto, 2016). 
Thus, the cortically-generated SO triggers the SWR in the hippocampus which in return 
transfers information from the hippocampus to the cortex for long-term storage 
(Buzsáki, 2015).  
1.5.2.3. High frequency oscillations on the Up-state 
As outlined above, high frequency activity occurring on the Up-state of the SO 
is very similar to activity seen in the awake brain activity. Thus, gamma oscillations on 
the Up-state may resemble “microwake”- like activity patterns of “relevant” events that 
are transferred from the hippocampus to the cortex for permanent 
storage/consolidation (Destexhe et al., 2007). In support to this theory, gamma 
frequency activity patterns during SWS in humans resemble the activity of the DMN 
during the awake state, including activation of the mPFC (Valderrama et al., 2012). 
Gamma activity enhances the coordinated firing between cell populations in a manner 
that can then induce Hebbian like synaptic plasticity in their targets, strengthening 
synapses and imprinting memories (Le Van Quyen et al., 2010). Hence, gamma 
activity power in the regions normally engaged in the DMN during sleep, may partly 
enforce the large-scale dynamics of wakefulness, promoting memory consolidation 
(Dang-Vu et al., 2008).  
Fast oscillations in the hippocampus have been shown to also eliminate 
memories within the rodent hippocampal network. Isomura et al. (2006) suggested that 
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during the Up-state, the output of the DG to the CA3 can strengthen the connection 
between mossy terminals and new “relevant” pyramidal neurons, while suppressing 
the rest of the CA3 neurons through widespread inhibition. On the Down-state, this 
suppression is absent allowing for a local gamma/ripple activity to reorganise the CA1-
CA3 circuits locally (Isomura et al., 2006). Thus, fast oscillations in the hippocampus 
can function as a medium of communicating with the cortex via activity on the Up-state 
while allowing self-organisation of the hippocampus on the Down-state (Hahn et al., 
2007; Isomura et al., 2006).  
1.5.2.4. Interactions between spindles, SWRs and high frequency oscillations  
Gamma oscillations and hippocampal SWRs are distinct phenomena but they 
have multiple physiological mechanisms and anatomical substrates in common, in both 
humans and animal models (Colgin & Moser, 2010). In the absence of theta activity 
(wakefulness or REM sleep), the CA3 input to the CA1 can either result in the 
generation of SWR or of gamma activity (Colgin & Moser, 2010). The two rhythms also 
interact, as the frequency and amplitude of the gamma oscillations in the hippocampus 
was shown to correlate with the magnitude of the preceding SWR, in naturally sleeping 
rats (Sullivan et al., 2011). Moreover, both the hippocampal gamma activity and SWRs 
were modulated by gamma activity in the DG and EC, showing a cortical control over 
the hippocampal rhythm (Sullivan et al., 2011). There is also flow of information from 
the hippocampus to the cortex that is elicited by gamma and SWR activity on the Up-
state, as shown in both humans and anaesthetised rats (Clemens et al., 2011; Le Van 
Quyen et al., 2010). 
Spindles in the humans and animal cortex are also coherent with gamma and 
beta oscillations and SWRs in the hippocampus during SWS, serving as a substrate 
for memory consolidation (Rasch & Born, 2013). The spindle phase modulates spike 
activity as well as gamma and ripple activity, with hippocampal SWRs occurring on the 
troughs of the spindle cycle. This relationship was also demonstrated in the rodent 
mPFC and hippocampus. The mPFC is a region highly involved in memory and 
cognitive function (Varela & Wilson, 2019). The mPFC/hippocampus interaction is 
bidirectional as the spindle can reach the EC-hippocampal networks and induce a 
SWR, while the hippocampal SWR can prolong the duration and enhance the 
expression of the spindle in the cortex (Varela & Wilson, 2019). Moreover, mPFC 
neurons fire almost immediately after hippocampal neurons (100 ms) and preferentially 
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around the time of SWRs, and this mPFC neuronal firing is accompanied by the 
generation of a spindle (Wierzynski et al., 2009). This interaction between the mPFC 
and hippocampus is anatomically supported in rodents by inputs from the ventral CA1 
and subiculum of the hippocampus to the mPFC (Riga et al., 2014). Finally, 
computational modelling studies have supported that there is increased local and 
interregional coupling between spindles and beta oscillations in the cortex on the Up-
state of the SO (Kopell et al., 2000).  
1.5.3. REM sleep and memory  
REM sleep is important for preparing the brain for waking up and has a role in 
memory consolidation (Peever and Fuller, 2017). Recent optogenetic studies in 
rodents silenced the MS GABAergic neurons responsible for generating hippocampal 
theta during REM sleep (Salib et al., 2019; Yoder & Pang, 2005). Silencing the MS 
interneurons reduced the animals’ capacity to consolidate previously learned novel 
object recognition and fear-conditioned memories. REM sleep is thought to provide a 
period of functional disconnection between the hippocampus and the cortex that is 
necessary for the reorganisation of memory traces (Wierzynski et al., 2009), as REM-
related Ca2+ spikes within dendrites can maintain or prune synapses (Li et al., 2017). 
Moreover, there is evidence of neuronal replay in the rodent hippocampus during REM 
sleep, with neuronal firing being more likely to occur on the trough of the theta cycle 
than the peaks, as seen in wakefulness. Since spike induced plasticity depends on the 
theta phase, the firing of these neurons on the trough may suggest that their activity 
helps erase episodic memory from the hippocampus upon becoming encoded in the 





1.6. Sleep and dementia  
1.6.1. Sleep-related EEG alterations in dementia patients  
A reduction in sleep quality and quantity, accompanied by changes in sleep 
architecture, are a characteristic of ageing in humans (Vaz Fragoso et al., 2015). Age-
related changes in sleep include a shorter sleep duration, night-time awakenings, and 
daytime somnolence. EEG studies have shown a reduction in SWS, a higher 
percentage of stage 2 sleep, lower SWS amplitude and longer Up- and Down-states 
(Carrier et al., 2011). However, age-related sleep disturbances are distinct from sleep 
disturbances associated with different dementia subtypes and PD, and they often 
appear long before any cognitive or motor symptoms (Bohnen & Hu, 2019). In AD, 
night-time sleep fragmentation is the most common sleep-associated symptom along 
with early awakenings and increased daytime somnolence (Rothman & Mattson, 
2012). DLB patients are more affected by sleep disturbances than AD patients, with 
90% of patients reporting sleep fragmentation as well as other symptoms like poor 
sleep quality, insomnia, RBD, increased sleep latency and vivid dreams (Fernández-
Arcos et al., 2019). Moreover, sleep problems in DLB are associated with a greater 
degree of clinical impairment compared to patients with AD (Chwiszczuk et al., 2016). 
Polysomnographic studies in patients with dementia have shown alterations in 
sleep architecture. AD is associated with decreased SWS and REM sleep, increased 
time spent in stages N1 and N2 of NREM sleep, prolonged REM latency and increased 
sleep fragmentation, resulting in an overall decrease in sleep duration (Lim et al., 
2014). Recently, AD patients at an early stage of the disease demonstrated a 
correlation between a reduction in SWA levels and greater Tau pathology, and to a 
lesser extent greater Aβ pathology (Mander et al., 2015; Lucey et al., 2019). 
Polysomnographic studies in DLB patients and PDD patients have also found poor 
sleep continuity, longer sleep latency and REM sleep latency, RBD and reduced REM 
sleep while DLB patients specifically, had less N1 and more N2 sleep (Terzaghi et al., 
2013). In addition, a recent video-polysomnographic analysis in DLB patients showed 
additional features including persistence of wake-like activity (alpha/theta rhythms) 
occipitally, intermittent rhythmic delta activity frontally and rapid-eye movement and 
sustained EMG activity at sleep onset (Fernández-Arcos et al., 2019). The authors also 
found transient sharp waves in NREM sleep, low-frequency sleep spindles in stage 
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N2, an absence of sleep spindles and K complexes in NREM sleep and a delta slowing 
during REM sleep (Fernández-Arcos et al., 2019). 
1.6.2. Sleep and cognition in dementia 
Considering the pivotal role of sleep, especially SWS, in memory consolidation, 
one would expect that the sleep disturbances seen in patients with dementia should 
affect memory processing (Mander et al., 2016). This has been extensively described 
in AD, as memory impairment appears years before any hippocampal Αβ deposits or 
atrophy, but concomitantly to pathology in cortical regions (Westerberg et al., 2012). 
Interestingly, the levels of Αβ burden in the mPFC of AD patients has been associated 
with lower levels of SWA and a decrease in hippocampus-mediated memory retention 
assessed by a memory task (Mander et al., 2015). A reduction in SWA has also been 
correlated with increased tau levels in patients with early stage AD (Lucey & Holtzman, 
2015).  
As outlined above (sections 1.4.4.1, 1.4.4.2), cortical spindles and their 
synchrony with the SWRs on the SO are important in for memory consolidation. Lower 
spindle density and amplitude in posterior cortical areas has been observed in DLB 
(Fernández-Arcos et al., 2019; Ozaki et al., 2012) while in PD, these EEG 
characteristics predict dementia development (Latreille et al., 2015). Spindles are 
dependent on thalamocortical reciprocal connectivity while MRI studies have shown 
functional and structural alterations in these regions (Kotagal et al., 2012), as well as 
early decrease in cholinergic neurotransmission that progresses with dementia in DLB 
patients (Schmeichel et al., 2008). Thus, reduced/altered sleep spindles could have 
cognitive implications in DLB patients, supporting a possible relationship between 
sleep and cognitive dysfunction in relation to α-syn pathology. In addition, Lewy body 
pathology is evident in the hippocampus of DLB patients , which is directly implicated 
in declarative memory consolidation and recall (Marshall et al., 2006). DLB patients 
most prominently exhibit Lewy neurites in axon terminal in the CA2 region and Lewy 
bodies in the EC (Adamowicz et al., 2017), while lower levels of Lewy pathology are 
seen in the CA1, CA3 and subiculum. Lastly, Lewy pathology in the CA1 region, which 
is the main output of the CA2, correlated with memory testing results in these patients 
(Adamowicz et al., 2017).  
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Memory impairment is not a main characteristic of early stage DLB. In fact, 
relative memory preservation is one of the main differences between DLB and AD, with 
memory impairments only appearing at more advanced stages of DLB (McKeith et al., 
2017). Other clinical features of dementia such as impairments in attention and in 
visuospatial and frontal-executive functions are more prominent at the early stages of 
the disease (Donaghy & McKeith, 2014). Interestingly, these cognitive functions are 
also affected by sleep deprivation, with highlighted decifits in selective attention and 
working memory tasks (Alhola & Polo-Kantola, 2007). Vigilance that describes 
sustained attention and requires robust working memory (Lim & Dinges, 2008) is highly 
impaired in sleep deprived individuals (Naghavi & Nyberg, 2005) and in DLB patients 
(Ferman & Boeve, 2007). Moreover, sleep deprivation as well as DLB have been linked 
with lower accuracy and speed in performing tasks of divided attention (Calderon et 
al., 2001). Hence, the cognitive impairment seen in DLB may at least party facilitated 
by sleep deprivation (Guarnieri & Sorbi, 2015). 
1.6.3. Sleep and epilepsy in dementia  
Aberrant neuronal activity is tightly linked to disruptions in sleep-related 
mechanisms (Beenhakker & Huguenard, 2009). In patients with epilepsy, epileptic 
seizures, interictal spiking and high frequency oscillations (> 80 Hz), which are thought 
to be the best EEG indicators of epilepsy, are more likely to occur during SWS 
compared to waking (Frauscher et al., 2015). There is also evidence to support a 
relationship between dementia-related hyperexcitability and sleep. An EEG study in 
five AD patients with epilepsy found a high correlation between the amount of 
epileptiform discharges detected during NREM sleep, compared to REM sleep and 
wakefulness (Horváth et al., 2017). Moreover, chronic electrode implant recordings in 
two AD patients (without clinical epilepsy) showed that epileptiform spikes were most 
prominent and frequent during sleep compared to awake states (Lam et al., 2017). In 
both these studies, the epileptiform activity was most prominent in the medial temporal 
lobe that is located directly above the hippocampus (Beenhakker & Huguenard, 2009). 
Therefore, dementia-related perturbations in hippomcampal circuits underlying SWR 
generation could have a devastating impact on the hippocampus and the surrounding 
cortical regions. An overnight polysomnographic study identified sharp-wave activity 
during NREM SWS in 2/31 DLB patients (Fernández-Arcos et al., 2019). However, 
there are no reports of chronic electrode implant recordings in DLB patients.  
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1.7. Modelling dementia and sleep  
1.7.1. Animal models of dementia  
Experimental models are essential to improve our understanding of 
neurodegenerative disorders. Over the last few decades animal models have been 
increasingly used in dementia research (Koprich et al., 2017). Models used so far 
include rodents, monkeys, worms and fruit-flies, which express/overexpress human 
mutant forms of the proteins that aggregate in the different dementia subtypes to form 
insoluble protein clusters. Such proteins are a human mutant form of tau, the amyloid 
precursor protein (APP) and the proteins that cleave APP to Αβ (presenilin 1 and 2) to 
model AD, and mutant α-syn to model PD/LBD. These mutations are often isolated in 
familial cases of the disease (Drummond & Wisniewski, 2017). Developing such 
models is a challenging task and there is no single animal model that encompass all 
aspects of the human disease, including cognitive, behavioural and histopathological 
abnormalities, in any dementia subtype. However, the variety of models that exist 
today allow us to study different aspects dementia (Fifel et al., 2016). 
A number of α-syn transgenic mice have been created to model LBD and PD 
(review by Koprich 2017). Models of α-synucleinopathy are created through inducing 
the over-expression of wild-type (WT) human α-syn, or the expression of human 
mutant α-syn. The mutations in the human α-syn encoding gene (SNCA) introduced in 
animal models are usually missense mutations identified in families with inherited Lewy 
body disease, including the A53T and A30P mutations (Polymeropoulos et al., 1997). 
Custom SNCA mutations have also been created that increase the “stickiness” and 
toxicity of α-syn, such as the Y39C mutation (Tofaris et al., 2006). In addition, more 
than one mutation can be introduced in the same model (Lelan et al., 2011). For 
example, the A30P*A53T mutant line, expresses the double mutant form of α-syn in 
dopaminergic neurons, thus modelling the cell loss and motor deficits seen in PD 
(Kilpeläinen et al., 2019). Most α-syn models are not capable of forming Lewy bodies, 
but they express the mutated protein at high levels, which is also phosphorylated at 
serine-129, ubiquitinylated (post-translation modification that targets proteins for 
degradation), proteinase K resistant and detergent insoluble, and induces 
neuroinflammation, as seen in humans (Koprich et al., 2017). Lewy body-like stuctures 
can be seen in the E46K expressing mice (Emmer et al., 2011), and in α-
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synucleionopathy models that also express amyloid-β and tau mutations (Clinton et 
al., 2010; Badiola et al., 2011).  
SNCA mutations are usually introduced in mice under the influence of a 
promoter (Koprich et al., 2017), and most promoters induce a widespread expression 
of the transgene (Hatami & Chesselet, 2014). For example, expression of the A53T 
mutation under the prion promoter leads to extensive pathology and motor deficits from 
2 months of age, but not to cognitive impairment (Giasson et al., 2002). In contrast, 
A53T expressed under the Ca2+/calmodulin-dependent protein kinase II (CaMKII) 
promoter induces α-syn expression in the forebrain, hippocampus and substantia 
nigra, as well as progressive cell loss, gliosis and cognitive impairment, combining both 
the motor and cognitive deficits of LBD (Nuber et al., 2008). The thymus cell antigen 1 
(Thy-1) promoter induces expression of the transgene mostly in the cortex and limbic 
system, but the levels and pattern of expression in other structures can often vary 
between models (Hatami & Chesselet, 2014). A53T-Thy-1 mice have severe motor 
impairments that lead to paralysis and death at 12 months and thus resemble PD 
(Martin et al., 2014), while A30P-Thy-1 mice are more similar to DLB in terms of protein 
expression, pathology and phenotype (see Section 1.7.1.1). The E57K mutation under 
the Thy-1 promoter also leads to expression in the neocortex, limbic system, thalamus, 
basal ganglia and substantia nigra, and to the development of cognitive deficits from 2 
- 4 months of age (Rockenstein et al., 2014). 
 Other promoters used to drive α-syn expression are specific to an neuronal 
subtype such as tyrosine hydroxylase (TH) -expressing neurons in the A30P*A53T 
mice (Kilpeläinen et al., 2019), or regions such as dopaminergic neurons in the 
substantia nigra and ventral tegmental area (Lin et al., 2012). More elaborate animal 
models of α-synucleinopathy involve tetracycline-controlled transcriptional activation 
of the mutant SNCA after birth (Lim et al., 2011), or utilise viral vectors. Rat models 
have been developed that express either the A53T or A30P mutations, or overexpress 
WT α-syn in the substantia nigra and reticular formation, to model PD (Kirik et al., 
2002). However, although viral injection studies may induce α-syn like cell loss, they 
do not result in cognitive impairment (Klein et al., 2002).  
1.7.1.1. The A30P mouse model 
The A30P is a mouse model of α-synucleinopathy that overexpresses human 
mutant α-syn (with the A30P missense mutation) under the Thy-1 promoter (Kahle et 
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al., 2001), which promotes expression mostly in neuronal cells, in particularly high 
levels in the hippocampus and striatum (Kemshead et al., 1982) and in lower levels in 
the subtantia nigra (Neumann et al., 2002). Hence, due to the topology of mutant α-
syn expression, A30P mouse models has cognitive symptoms of α-synucleinopathy in 
addition to motor symptoms, similarly to DLB. Specifically, A30P mice have motor 
deficits at 14 months of age as well as DLB-related cognitive deficits from 12 months, 
such as impaired spatial learning, memory and fear conditioning behaviour (Freichel 
et al., 2007; Newman et al., 2012).  
These cognitive and motor symptoms seen in A30P mice are accompanied by 
fibrilisation of α-syn in the brain stem, midbrain and spinal cord (Freichel et al., 2007; 
Newman et al., 2012). A30P mice also show evidence of serine-129 phosphorylated 
(PSer129) α-syn in the lateral hypothalamus, amygdala, hippocampus and cortical 
regions, at 16 – 19 months of age. PSer129 is one of the main pathological 
modifications in α-synucleinopathies and it was accompanied by dystrophic neurites 
and axon terminals in A30P mice (Schell et al., 2009). Moreover, A30P mice have an 
age-dependent reduction in gamma oscillatory power in the hippocampus shown in 
vitro, and an age-dependent mitochondrial dysfunction (Robson et al., 2018). More 
subtle α-syn-induced changes have been shown at earlier ages, such as evidence for 
a very fine motor impairment at 2 months (Ekmark-Lewén et al., 2018), and altered 
electrophysiological activity and behaviour defects in a locomotor test from 2 months 
of age (Tweedy et al., 2018). Thus, the A30P model was chosen because it is a well 
characterised model of DLB in terms of α-syn expression, pathology and phenotype, 
and we can relate out findings to previous studies that investigated different aspects 
of this model. 
1.7.2. EEG changes in mouse models of α-synucleinopathy  
Changes in EEG activity are common in animal models of dementia. One study 
in a mouse model of α-syn overexpression (Thy1-aSyn) has shown a shift of power 
from higher (alpha) to lower (delta, theta) frequencies during NREM and REM sleep, 
and a decrease in gamma activity at resting state, at 9 - 10 months of age (McDowell 
et al., 2014). A shift of the dominant frequency from alpha to theta frequencies was 
also identified at rest in mice expressing human WT α-syn (SYN mice) at 4 - 8 months 
of age (Morris et al., 2015). These findings can be directly related to the slowing of the 
EEG that is observed in LBD patients (Briel et al., 1999). In vitro data has also shown 
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an age dependent decrease in gamma power in the A30P mouse model at > 9 months 
of age (Robson et al., 2018). This EEG slowing was reversed in the SYN mouse model 
(Morris et al., 2015) with the administration of cholinesterase inhibitors, as seen in the 
patient groups (McKeith et al., 2004; Brassen & Adler, 2003), suggesting that the EEG 
slowing is the result of a cholinergic dysfunction. Finally, animal models of AD also 
show similar shifts of power towards lower frequencies during sleep (Wisor et al., 2005; 
Zhang et al., 2005) and wakefulness (Kent et al., 2018; Platt et al., 2011). 
As seen in patients with dementia, animal models of dementia also show 
changes in sleep architecture. The previously mentioned study in the Thy1-aSyn mice 
also looked at sleep architecture and found that otherwise healthy mice (9 - 10 months 
old) had increased NREM sleep (not of the SWS type) and an overall decreased in 
REM sleep (McDowell et al., 2014). In a mouse model of PD induced by MPTP (1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine) administration, a neurotoxin that causes 
PD symptoms by destroying dopaminergic neurons in the SN, decreased SWA during 
natural sleep  (Zavalko et al., 2013). These studies replicate the evidence of poor sleep 
continuity, altered NREM sleep patterns, longer REM sleep latency and reduced REM 
sleep seen in LBD patients (Fernández-Arcos et al., 2019). However, the number of 
sleep studies in rodent models of LBD are limited,  while rodent models of PD use 
neurotoxins such as MPTP that selectively ablate dopaminergic neurons and are thus 
more restricted (review by Fifel et al., 2016). Hence, most evidence of how the 
dementia-related pathology affects sleep comes from rodent models of AD, as the 
mechanisms between AD and DLB as well as other proteinopathies often overlap. 
Numerous sleep abnormalities have been identified in mouse models of AD 
(Sethi et al., 2015; Van Erum et al., 2019). Interestingly, the TgCRND8 mouse model 
of AD (double mutant form of the human APP protein) had increased wakefulness and 
reduced NREM sleep at all ages, even before the occurrence of cognitive dysfunction 
(Colby-Milley et al., 2015). It is therefore possible that the changes seen in sleep 
architecture in relation to AD pathology precede the dementia symptoms, reflecting 
early changes in the underlying circuits. Moreover, electrophysiological recordings 
from the prefrontal cortex of the triple transgenic model of AD (3xTg-AD; 20 months of 
age) expressing both progressive Aβ and Tau pathology during natural sleep, showed 
a decrease in SO frequency compared to WT mice due to longer Down-states 
(Castano-Prat et al., 2019). In addition, the authors found a greater SO cycle length 
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variability, a shift of EEG power towards lower frequencies and a reduced relative 
Up/Down neuronal firing rate in these animals (Castano-Prat et al., 2019). The earliest 
change observed at 7 months was a reduction in Up-state length. The authors 
interpreted these findings as difficulties into transitioning between Up- and Down-
states, due to alterations in cortical GABAAR and NMDAR function (Castano-Prat et 
al., 2019). A different study recording brain activity from a mouse model of tauopathy 
(rTg4510; 7 month old) under ketamine/xylazine anaesthesia, also found a slower SO 
frequency due to longer Down-states, reduced neuronal firing rates, and a longer 
latency to the first spike and inter-spike intervals (ISI) on the Up-state (Menkes-Caspi 
et al., 2015). In contrast, another sleep study in a mouse model of AD 
(APPswe/PS1∆E9; 6 – 8 month old) found an increase in the SO frequency and a loss 
of SO synchrony across the cortex, the hippocampus and thalamus (Busche et al., 
2015). These discrepancies might indicate differences between the animal models 
used and thus, more studies are necessary to delineate these inconsistencies.  
Over the last decade, numerous publications have reported evidence of early 
neuronal or network hyperexcitability in the cortex and hippocampus in animal models 
of neurodegeneration, most notable of AD, during sleep (Hall et al., 2015; Jin et al., 
2018; Palop et al., 2011; Hazra et al., 2013; Davis et al., 2014). In a Tau mouse model 
of AD (rTg4510; 7-8 month old), a decrease in the number and amplitude of SWRs 
was accompanied by greater pyramidal cell firing in the CA1 and decreased inhibition, 
suggesting a disruption in the control of neuronal recruitment and firing during SWRs 
(Witton et al., 2016). In the 3xTg-AD mouse model at 3 weeks of age, there was clear 
hippocampal and EC epileptogenicity before the occurrence of any cognitive 
symptoms, that could be reversed by immunisation for the mutant Αβ protein (Kazim 
et al., 2017). In a drosophila model of AD, it was shown that Αβ accumulation induced 
neuronal excitability and sleep loss (Tabuchi et al., 2015).  
Less research has been conducted in DLB in relation to hyperexcitability and 
sleep, with one study showing that the SYN mouse model at 4 - 8 months of age had 
interictal spikes in the parietal cortex and molecular changes indicative of 
hyperexcitability in the hippocampus (Morris et al., 2015). The Thy1-aSyn mouse 
model of α-syn overexpression progressively showed a hyperactive genotype that was 
accompanied by a reduction in REM sleep (McDowell et al., 2014). These studies 
provide crucial insight about the role of hyperexcitability in dementia as it is difficult to 
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identify such early, subtle changes in patients, particularly in deep structures like the 
hippocampus (Palop et al., 2011). 
1.7.3. The mechanisms underlying sleep changes in dementia 
Animal studies have been pivotal in improving our understanding of the 
mechanisms that underlie sleep-disturbances in relation to dementia. Hence, in the 
next paragraphs we will examine how the dementia-related pathology and sleep 
disturbances interact, in both patients and animal models.  
1.7.3.1. Dementia pathology interfering with sleep  
Sleep induction, maintenance and termination, as well as alternations between 
REM and NREM states, require tight control between and within several systems in 
the basal brain, midbrain and forebrain (Brown et al., 2012). Therefore, it is to be 
expected that the abnormal clustering and accumulation of proteins like Aβ and α-syn 
and the associated neurodegeneration, would affect sleep architecture (Porter et al., 
2015). In fact, AD, DLB/PDD and PD patients show early signs of pathology in the 
brainstem cholinergic system, with DLB/PDD and PD patients showing a particular loss 
of neurons in PPT/LDT nuclei, resulting in a substantial loss of cholinergic tone in the 
cortex (Tiraboschi et al., 2002; Contestabile, 2011; Kotagal et al., 2012). In view of the 
involvement of these nuclei in REM/NREM sleep control (Peever & Fuller, 2017) as 
outlined above (section 1.4.5), cholinergic cell loss is thought to be related to the sleep 
architecture alterations seen in DLB/PDD and PD patients (Carnicelli et al., 2019; 
Latreille et al., 2015; Pao et al., 2013; Rothman & Mattson, 2012). Moreover, DLB/PDD 
and PD are characterised by a decrease in the response of the thalamus to cholinergic 
inputs due to a loss of nAChRs (Pimlott et al., 2006). Lastly, a clear correlation was 
identified between cholinergic dysfunction and sleep disruption in animal models of AD 
(Wisor et al., 2005; Zhang et al., 2005).  
Circadian dysregulation is another common finding in dementia patients and 
animal models (Videnovic & Golombek, 2013). Neurons in the suprachiasmatic 
nucleus (SCN), which is the main “switch” of the circadian rhythm, are susceptible to 
abnormal protein deposition and cytotoxicity, with detrimental effects in the control of 
the SCN over sleep-wake patterns (Bohnen & Hu, 2019). In AD patients, the SCN and 
its output are disrupted (Goudsmit et al., 1990), while disruption of the SCN in a 
transgenic animal model of AD altered the circadian rhythms of wheel running, which 
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increased to > 24 hours (Wisor et al., 2005). Moreover, in patients with PD and AD, 
there are signs of pathology and neurodegeneration in the LC, the noradrenergic 
nucleus whose function is light dependent and is involved in the sleep/waking transition 
(Zarow et al., 2003). Furthermore, PD patients are less responsive to dopaminergic 
medications (levodopa) administered later in the day, suggesting a circadian rhythm-
related dopamine deficiency (Gehrman et al., 2005). A role of dopamine in circadian 
regulation is also evident in rodent and monkey models of dopaminergic neuronal loss, 
as they show altered sleep patterns including REM sleep reduction and RBD-like signs 
(Barraud et al., 2009). Thus, a number of neuronal cell types control the circadian 
rhythm and these are sensitive to protein misfolding-induced cytotoxicity, resulting in 
altered sleep/wake patterns (Rothman & Mattson, 2012).   
1.7.3.2. Sleep interfering with dementia pathology  
The mechanisms discussed so far concern changes in sleep architecture and 
involve pathology in sub-cortical structures. However, as previously described, animal 
models of dementia show disturbances in the SO which is a locally generated rhythm 
(Neske, 2015). It is possible that changes in the cholinergic nuclei, or the thalamus for 
example, affect the cortical SO (Lemieux et al., 2014; Steriade et al., 1993a), although 
abnormal protein accumulation within the frontal lobe can directly affect local receptor 
function and hence SWS (Colom-Cadena et al., 2017; Nikolaus et al., 2009).  
Although there is clear evidence for the impact of abnormal protein 
accumulation in sleep, there is increasing evidence to support that this relationship is 
not unidirectional and that sleep alterations exacerbate pathological protein 
accumulation (Mander et al., 2016). One of the main mechanisms linking sleep 
fragmentation and dementia is altered protein clearance. The metabolic and oxidative 
by-products which accumulate during waking are cleared via the glymphatic system 
(Bohnen & Hu, 2019), a waste clearance system in the brain that utilises a system of 
perivascular tunnels formed by astroglial cells, to remove soluble proteins and 
metabolites, including soluble Aβ (Jessen et al., 2015). During natural SWS and under 
anaesthesia, the levels of clearance in the glymphatic system increase due to a 
decrease in brain activity and increased interstitial fluid (ISF) flow (Jessen et al., 2015). 
While greater SWA and hence better SWS quality correlates with accelerated Aβ 
clearance in healthy humans, acute SWS-disruption increases overnight Aβ levels by 
25 - 30% (Lucey & Holtzman, 2015). In mice, acute sleep deprivation correlates with 
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increased soluble Aβ levels in the brain while chronic deprivation increases amyloid 
plaques. Long-term, low-quality sleep is also associated with increased Tau levels, as 
Tau is cleared in a slower fashion than amyloid-β (Ju et al., 2017).  
Although α-syn clearance through the glymphatic system has not been 
determined yet (Valdinocci et al., 2017), blocking α-syn clearance in a mouse model 
of PD was shown to aggravate the phenotype (Zou et al., 2019). However, more 
studies need to be conducted to determine the role of α-syn clearance and production 
in relation to SWS. Finally, in addition to the clearance deficit seen in AD, Aβ and tau 
production are also increased as a result of sleep fragmentation and the related 
disruption of SWS (Lucey et al., 2018). In time, this dysregulation increases the risk for 
plaque and tangle formation (Ju et al., 2017). A similar mechanisms might be in place 
in relation to α-syn production during SWS disruption but again, this theory needs to 
be investigated experimentally.  
Sleep is also a state that allows restorative cellular processes to occur, which 
counteract the negative impact of the accumulated oxidative stress of wakefulness by 
the replenishment of ATP, the repair of DNA damage etc. (Xie et al., 2013). The 
restorative function of SWS can be compared to that of anti-oxidative agents, as they 
have been shown to prevent the accumulation of oxidative stress markers in the 
hippocampus and improve Aβ-related memory deficits in animal models of AD (review 
by Cedernaes et al., 2017). Sleep fragmentation on the other hand has been shown to 
increase oxidative stress in the rodent brain, including the LC and hippocampus, both 
of which are inherently sensitive to cellular damage (Mathangi et al., 2012; Zhang et 
al., 2014; Silva et al., 2004). Furthermore, abnormal protein accumulation in healthy 
cells affects the endoplasmic-reticulum (ER) induced unfolded protein response 
(UPR). Studies in young, healthy mice have shown that the UPR limits the protein load, 
even under sleep deprivation. However with ageing and the emergence of fragmented 
sleep patterns the UPR system malfunctions, leading to protein accumulation (Naidoo 
et al., 2008). Consequently, the UPR may be even more affected by fragmented sleep 
patterns in dementia, obstructing toxic protein clearance within cells. It is therefore 
clear that sleep and the dementia-related pathology function in a vicious feedback loop, 
with one aggravating the other (Bohnen & Hu, 2019).   
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1.8. Thesis objectives  
The overall aim of this thesis was to investigate changes in network oscillatons 
due to α-syn pathology, in both the sleep and awake states using rodents and humans 
respectively. 
1.8.1. EEG changes in DLB patients  
In the third Chapter of this thesis, we present our analysis of resting-state EEG 
data from patients with DLB, PDD, AD and healthy controls. Our first aim was to identify 
DLB-specific changes in the EEG. Earlier studies focused on investigating the capacity 
of qEEG measures in aiding DLB differential diagnosis in clinical settings. Hence, they 
utilized methods such as assessment of DLB-related EEG changes by visual 
observation (Bonanni et al., 2010, 2008), or attempted to develop an online method 
that analyses several qEEG measures during EEG data acquisition (Garn et al., 2017). 
However, we took a less clinically-orientated approach as we were also interested in 
untangling the mechanisms underlying qEEG changes in DLB patients. Thus, we 
performed extensive pre-processing analysis of the EEG signal and proceeded with a 
thorough analysis of a number of qEEG measures within different frequency ranges 
and brain regions, between DLB, PDD and AD patients and healthy controls. We 
focused on variables described in previous studies such as the EEG slowing, the 
dominant frequency (DF) and DF variability (DFV). Our second aim was to investigate 
whether these qEEG variables correlated with CFs measured by the CAF score. Lastly, 
our third aim was to test whether these qEEG variables could differentiate between 
DLB and AD patients and thus, be potentially useful for the development of an EEG-
based DLB biomarker.  
1.8.2. Sleep study in the A30P mouse model of dementia  
Changes in sleep oscillatons occur in patients with DLB, but EEG sleep studies 
are difficult to conduct in patients with dementia.  Therefore, we aimed to make a 
detailed assessment of changes in network oscillations during sleep using a rodent 
model of DLB. Data from my experiments would hopefully help direct future reserach 
to deterime if any changes oberved  in rodents could translate to humans. 
In the fourth Chapter of this thesis, we present our analysis of 
electrophysiological recordings in young A30P mice (2.5 – 4 months) under urethane 
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induced anaesthesia, and contrast our findings with similar recordings from wild-type 
(WT) mice of the same age. Anaesthesia is a widely used model of sleep that mimics 
several of its elements: the loss of consciousness, the reduced sensory awareness 
and behavioural responsiveness, and the SO (Suzuki & Smith, 1988). Urethane is a 
particularly good model of sleep, as at moderate concentrations it exerts its effect by 
hyperpolarising cortical neurons through modulating potassium conductance, and not 
through GABAergic antagonism like other anaesthetics (Hara & Harris, 2002). 
Therefore, it does not disturb the balance between excitation and inhibition in the brain, 
nor does it inhibit neuronal firing, similar to isoflurane for example, which is an allosteric 
GABAAR agonist (Adragna & Klein, 2003; Ferron et al., 2009). The anaesthetic 
ketamine in combination with an α2-adrenertic agonist (xylazine or medetomidine) was 
also considered, as it induces spontaneous, natural-sleep like SO through the non-
competitive inhibition of NMDA receptors. However, ketamine can only induce deep 
anaesthesia for approximately 50 minutes in rodents (Swindle et al., 2002), while 
urethane has a more long-standing effect (> 2 hours), and was thus considered more 
appropriate for a sleep study (Lee & Jones, 2018).  
Urethane was traditionally used as a model of NREM and REM sleep by 
manipulating the levels of anaesthesia, with NREM sleep modelled with deeper levels 
of urethane anaesthesia and REM sleep with more superficial levels (Détári et al., 
1997). However, more recent studies have shown the presence of REM-like activity 
under deep urethane anaesthesia in rats and mice (Zhurakovskaya et al., 2016; 
Clement et al., 2008; Yanovsky et al., 2014; Pagliardini et al., 2013). These REM-like 
states or, as also called “activated states”, manifest abruptly as periods of increased 
theta activity in the rodent hippocampus, similarly to what we can observe under 
natural REM sleep (Katsageorgiou et al., 2018) and are accompanied by increased 
low-voltage fast activity (gamma; 25 – 40 Hz) in the cortex (Clement et al., 2008; 
Pagliardini et al., 2013). Moreover, each activated/deactivated state cycle lasts about 
9 minutes in rats (Clement et al., 2018), and 14 minutes in mice, with each activated 
state lasting about 4 minutes (Pagliardini et al., 2013). Thus, the NREM-REM cycle 
duration replicates findings in rodents under natural sleep (Trachsel et al., 1991; 
McShane et al., 2012). Thus, urethane anaesthesia also allows the investigation of 
REM-like activity, although caution is required before coming to any conclusions 
(Zhurakovskaya et al., 2019).   
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Our study utilises A30P mice at a young age of 2.5 – 4 months (Freichel et al., 
2007; Kahle et al., 2000). A30P mice at this age do not express gross cognitive and 
motor symptoms, proteinase-K resistance α-syn aggregates or neurodegeneration 
(Schell et al., 2009), although there is evidence of an early widespread expression of 
soluble mutant α-syn (Newman et al., 2012). Thus, it is possible that these young A30P 
animals have more subtle α-syn related changes. In fact, there is evidence for a very 
fine motor impairment (Ekmark-Lewén et al., 2018), altered behaviour in a locomotor 
test and abnormal electrophysiological activity at 2 months of age (Tweedy et al., 
2018). Moreover, these animals might have oligomeric α-syn forms that are less easily 
detected immunohistochemically, as A30P α-syn aggregates rapidly to form oligomers 
upon in vitro incubation (Li et al., 2019). Therefore, young A30P mice constitute a good 
model for studying the early stages of pre-symptomatic α-synucleinopathy, particularly 
DLB, as proposed by Kahle et al. (2001) due to the topographic expression of the 
mutant α-syn in the brain. 
We obtained acute electrophysiological recordings from the subregions of the 
mPFC: anterior cingulate cortex (ACC), prelimbic (PrL), infralimbic (IL), dorsal 
peduncular region (DP), and/or the CA1 of the hippocampus, in age-matched WT and 
A30P animals. These areas have Lewy-related pathology in both DLB patients (Mak 
et al., 2014) and A30P animals at later age stages of disease (Kahle et al., 2001), and 
are involved in memory consolidation (Euston et al., 2012) and the function of the DMN 
(Raichle, 2015). Moreover, the mPFC and hippocampus show synchronous SWS 
activity as well in sleep state alternations (Durán et al., 2018). The CA1 pyramidal layer 
was chosen in particular as it is the location where SWRs are best recorded (Buzsáki 
& Silva, 2012), and because it receives neocortical input thought the nucleus reuniens, 
and EC input though the CA3 region of the hippocampus (Vertes et al., 2007). 
We then proceeded to analyse our recordings for an array of EEG characteristics 
including the frequency and amplitude of the SO, the length of the Up- and Down-
states and the power in high frequency bands: beta (15 – 30 Hz), gamma (30 – 80 Hz) 
and high gamma (80 – 130 Hz), in the SO cycle. Moreover, several characteristics of 
sleep spindles were investigated in the mPFC, and of SWRs in the CA1 of the 
hippocampus. We also looked at unit data from the mPFC region, in order to identify 
possible changes in neuronal firing in relation to the SO cycle. Finally, we investigated 
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for changes in the SO synchrony between the mPFC and CA1 and hence, in the 
widespread synchronicity of the SO in the brain of these mice.  
During our recordings in both WT and A30P animals under deep-urethane 
anaesthesia, we noticed the occurrence of a cyclic event characterised by bursts of 
oscillatory power, which we named the infra-slow modulation (ISM). The same event 
was previously observed in our lab in the urethane-anaesthetised rat (Gretenkord, 
2015). Hence, in the fifth Chapter we proceeded to characterised this event in the WT 
animals, in the mPFC and hippocampus in terms of its rhythmicity, SO cycle state 
lengths, high frequency oscillatory power content on the SO cycle and neuronal-firing 
patterns. Finally, in the sixth Chapter, we compared the aforementioned characteristics 
of the ISM between WT and A30P animals, in order to identify any alterations that may 
be related to the α-syn pathology.  
1.8.3. Aims  
Human EEG analysis  
 To investigate for the “EEG slowing” in DLB patients and compare the power, 
DF and DFV distribution patterns in DLB patients to AD and PDD patients and 
aged-matched controls.  
 To investigate for correlations between qEEG measures with CFs measured by 
the CAF score.  
 To assess the capacity these qEEG measures to differentiate between AD and 
DLB patients. 
Electrophysiological investigation in the A30P mouse models  
 To identify electrophysiological changes in the mPFC and CA1 region of the 
hippocampus in young A30P animals compared to age-matched WTs, during 
urethane-induced anaesthesia mimicking SWS.  
 To characterise a cyclic phenomenon (ISM) observed under urethane 
anaesthesia in WT mice.  
 To identify differences in the electrophysiological characteristics of the ISM 


























2.1. Human EEG analysis  
2.1.1. Diagnostic groups 
EEG recordings were obtained before the start of this project as part of the 
Cognitive and Attentional Function in Lewy Body Diseases (CATFieLD) study. The 
patients included in this study were individuals who were referred to local old age 
psychiatry and neurology services and diagnosis was determined by two independent 
experienced clinicians (Alan J. Thomas and John-Paul Taylor). Controls were healthy 
age-matched volunteers. Patients with DLB fulfilled the 2005 and 2017 revised criteria 
for probable DLB (McKeith et al., 2005, 2017) and patients with PDD fulfilled the criteria 
for probable PDD (Emre et al., 2007). Individuals with AD met the revised criteria of 
the National Institute of Neurological and Communicative Diseases and Stroke/AD and 
Related Disorders Association for probable AD (McKhann et al., 2011). The clinical 
assessment of fluctuation (CAF) score was assessed by the clinicians and CFs were 
defined on the basis that they were typical of those seen in DLB and internally driven 
rather than a response to external environmental factors. Healthy participants 
demonstrated no evidence of dementia as determined by the Cambridge Cognitive 
Examination (CAMCOG) score (> 80) and from clinical history. Exclusion criteria for all 
participants included significant history of neurological or psychiatric conditions. 
Prescriptions of acetylcholinesterase inhibitors (AChEIs), memantine and 
dopaminergic medications were allowed. Ethical approval was provided by the 
Northumberland Tyne and Wear NHS Trust and Newcastle University ethics 
committee.  
2.1.2. EEG recordings  
As mentioned above, the EEG recordings were obtained as part of the 
CATFieLD study. These  high-density, eyes-closed resting-state EEG recordings were 
obtained using 128 channel ANT Waveguard caps (ANT Neuro, Netherlands) with an 
Ag/AgCl electrode montage set according to the 10-20 placement system (Oostenveld 
& Praamstra 2001; Figure 2.1). Electrode impedance with kept below 5 kΩ. A reference 
electrode (Fz) was used, no filters were applied during acquisition and the sampling 
frequency was set at 1024 Hz per channel. The patients that received medication had 
normally taken AChEIs at least 4 hours before recordings were performed, while the 




Figure 2.1: Placement of the 128 electrodes according to the 10-20 placement system. 
The signal recorded from the electrodes indicated with black colour was selected out 
as it was deemed too noisy. The colours indicate the grouping of the electrodes into 
four regions: blue = frontal, green = central, purple = posterior, yellow = lateral. Adapted 
from Stylianou et al. (2018). 
2.1.3. Pre-processing 
Pre-processing of the EEG recordings was performed off-line after acquisition 
on the MATLAB environment (MATLAB R2016b, The MathWorks Inc., Natick, MA, 
2016), using the EEGLAB toolbox version 13 (Delorme & Makeig, 2004) and scripts 
kindly offered by Dr Nik Murphy. The EEG signal was filtered with a 4 Hz high-pass 
and a 46 Hz low-pass filter. Lower frequencies were filtered out as they imposed noise 
on the higher frequencies that were of more interest, and because the EEG generally 
has a limited accuracy in estimating very low and very high frequencies (Niedermeyer 
& Lopes da Silva, 2004). A notch filter was applied at 50 Hz. Recordings from all 
electrodes were visually inspected in the power-time domain and rejected if they had 
a kurtosis value over 3, or if they contained clear and consistent artefacts such as 
electrooculogram (EOG) and electromyogram (EMG) artefacts. The number of EEG 
channels / electrodes removed was kept to the minimum possible (mean = 17.7 ± 6.7, 
min.= 0, max.= 33).  
Independent component analysis (ICA) was used to accurately estimate and 
remove the presence of additional ocular, muscular, and other non-neuronal activity 
(Kropotov & Kropotov, 2009c). Individual recordings were reduced to 30 principal 
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components and then decomposed using the extended RUNICA algorithm (Bell & 
Sejnowski, 1995; Delorme & Makeig, 2004). Components representing existing 
templates for muscular, ocular, and electrical (50 Hz line noise) artefacts (Jung et al., 
2000) were rejected (mean = 5.2 ± 1.6, min. = 0, max.= 9) and the remaining 
independent components remixed. The recordings were then segmented into 2 s-long 
epochs and were inspected for any remaining artefacts. Epochs containing large 
artefacts were removed across channels, in a conservative manner. Finally, the 
removed channels were replaced using spherical spline interpolation (Ferree, 2006). 
As a final step, the EEG montage was changed to average reference. 
2.1.4. Variable extraction 
The power spectral density (PSD) for each 2-s epoch was estimated using 
Bartlett’s method (Bartlett, 1950)  with a 0.25 Hz frequency resolution using a 4 s FFT 
(fast Fourier transform) size and a Hamming window. To compensate for the between 
subject variability in factors such as brain neurophysiology, anatomy and physical 
tissue properties, the data were transformed to relative power (Rodriguez et al., 1999). 
Seven subjects were rejected from further analysis due to an insufficient number of 
clean data (< 48 epochs). For the remaining 73 subjects (21 healthy controls, 18 AD, 
17 DLB and 17 PDD), the recordings were truncated to the first 47 epochs (total length 
of 94 s) and electrodes were grouped into four regions: frontal, central, posterior and 
lateral (Figure 2.1).  
The mean relative power distributed in each of three frequency bands: theta (4 
– 7.75 Hz), alpha (8 – 13.75 Hz), beta (14 – 20.75 Hz), was extracted as a percentage 
of the total power in that range. Higher frequencies were excluded as they are prone 
to contamination by electromyogram rhythms (Whitham et al., 2007). The DF - the 
frequency with the highest power - was extracted for each epoch to calculate the mean 
dominant frequency (DF) and DF variability (DFV; SD from the mean) across epochs, 
for the slow-theta (4 – 5.5 Hz), fast-theta (5.5 – 7.75 Hz), theta, alpha and theta/alpha 
(4 – 13.75 Hz) frequency ranges. Since the DF was limited within the theta-alpha 
range, beta band activity was excluded. The theta-alpha DF was used to calculate the 
Frequency Prevalence (FP) distribution, which is the percentage of epochs having a 
DF falling within the slow-theta, fast-theta and alpha frequency ranges. These 
measures were calculated for each patient, for each diagnostic group and for each 
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band and region combination. See Figure 2.2 for a full description of the methods of 
variable extraction. 
2.1.5. Statistical analysis  
All statistical analysis was performed on IBM SPSS Statistics 25. First, we tested 
our data for normal distribution using the Shapiro-Wilk test and logarithmically 
transformed the data if necessary to achieve it. We also tested the data for 
heteroscedasticity using Levene’s test for equal variances. The normally distributed 
data was then statistically compared using mixed repeated measures ANOVA 
(rmANOVA) analysis, with region as the within-subjects factor and diagnosis as the 
between-subjects factor. When a significant interaction was found we followed up by 
univariate ANOVA and post-hoc analysis with a Bonferonni correction.  
When the issues of heteroscedasticity could not be solved, we performed 
Welch’s ANOVA followed by the Games-Howell test. For non-normally distributed data 
we performed Kruskal-Wallis H test followed by post-hoc analysis. Pearson’s product-
moment correlation and Spearman’s rank correlation were used to investigate for 
correlations between these variables and the CAF score and the MMSE score for each 
diagnostic group. Manual correction for multiple comparisons by appropriating the level 
of α significance (α/N) was performed for the non-parametric statistical analyses and 
for the correlation analyses, where Bonferonni correction was not available with the 
statistical software (IBM SPSS Statistics 25). 
In order to assess the capacity of the qEEG variables that were significantly 
different between the AD and DLB, and the DLB and PDD groups to predict diagnosis, 
the generalised estimating equations (GEE) procedure were used. This method allows 
the analysis of repeated measurements without the assumption for normal distribution 
(Carr & Chi, 1992). The qEEG variables that introduce multi-collinearity to the model 
(variance inflation factor > 5) were excluded from this analysis. Region was defined as 
the within-subjects variable, diagnosis as the between-subjects variable and the qEEG 
variables and the CAF score as the co-factor. The variables that significantly predicted 
diagnosis were then used to calculate the receiver operating characteristic (ROC) 
curve, and obtain the area under the curve (AUC), sensitivity and specificity with 
asymptotic confidence intervals. The sensitivity/specificity cut-off was determined 






Figure 2.2: Schematic diagram illustrating the process of extracting each of the four 
main quantitative EEG variables used in this study, for one participant in the posterior 
region. The filtered, pre-processed EEG signal on each of the electrodes in posterior 
derivations (N = 35) is windowed in 2 sec long epochs. The signal undergoes fast-
Fourier transform (FFT) and using Bartlett’s method the absolute power spectral 
density (PSD) is calculated for each epoch, for each electrode. The relative PSD 
(rPSD) is then calculated to normalize the signal. The mean rPSD is obtained across 
posterior electrodes, for each epoch (up to 47 epochs) of the recording, and the 
percentage of the total power in the 3 Hz – 20.75 Hz range allocated to the theta (4 – 
7.75 Hz), alpha (8 – 13.75 Hz) and beta (14 – 20.75 Hz) frequency ranges is calculated. 
The frequency with the highest power within the slow-theta (4 – 5.5 Hz), fast-theta (5.5 
– 7.75 Hz), alpha and theta-alpha (4 – 13.75 Hz) frequency ranges was identified within 
each epoch, and that value corresponded to the dominant frequency (DF). The mean 
DF and the standard deviation of the mean DF (DF variability; DFV) across epochs 
were then calculated. Finally, the DF within each epoch was assessed and was 
characterised to be in the slow-theta, fast-theta or alpha range. The epochs that were 
characterised by a DF within each of these ranges are shown as a percentage of the 
total number of epochs. These percentages were the slow-theta, fast-theta and alpha 
frequency prevalence (FP). The same procedure was followed for the other three 




2.2. Animal electrophysiological recordings  
2.2.1. Animals 
A30P mice, which are mice of C57BL/6 background expressing human mutant 
A30P α-syn under the control of the CNS specific promoter Thy-1 (Kahle et al., 
2000, Neumann et al., 2002), were used. The line was generated from frozen sperm 
supplied by Dr. P. Kahle, University of Tubingen and used to inseminate a WT female to 
generate a heterozygous line. The pups were genotyped to obtain a homozygous A30P 
pair and a wild-type (WT) pair that founded the two lines of animals used for these 
experiments. These lines were bred in house and were stopped in a timely manner to 
avoid excessive inbreeding.  
All procedures described below were in accordance with the UK Animals (Scientific 
Procedures) Act 1986 and the European Union Directive 2010/63/EU. WT and A30P 
mice were bred in house at Newcastle University’s animal facility in a temperature- and 
humidity-controlled environment consistent with the ARRIVE (Animal Research: 
Reporting of In Vivo Experiments) guidelines. Mice were kept in an enriched environment 
(cage toys) under a 12 hour light:dark cycle (lights on 7 am - 7 pm) with access to food 
and water ad libitum. Mice were group housed and experiments were commenced ~2 
hours into the light (sleep) phase of the circadian cycle. Our previous in vitro studies using 
the A30P mouse line have suggested greater network cortical hyperexcitability in young 
male mice compared to female mice (Tweedy et al 2018). Therefore, in this study only 
male mice aged 2.5 – 4 months were used. 
2.2.2. Anaesthesia and Surgery  
The animals were initially anaesthetised with 4 % isoflurane in order to administer 
the first urethane dose (0.6 ml of 20 g/kg in water for injection; Sigma-Aldrich) by 
intraperitoneal (i.p.) injection. Ater injection, the mice were immediately fixed in a 
stereotaxic frame (Kopf, Tujunga, CA, USA). A heating pad with feedback temperature 
control via a rectal probe (Harvard Apparatus, Holliston, MA, USA) maintained the core 
temperature of the mouse at 36.8°C. The animal breathed spontaneously but to maintain 
an oxygen saturation of > 90%, medical oxygen (BOC Industrial Gases, UK) was supplied 
through a tube mounted to the nose bar of the stereotaxic frame. Right after the initial 
urethane injection and for the duration of the surgery (20 - 30 min), 1% isoflurane was 
also provided through the mask. The isoflurane concentration was gradually lowered to 
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0%, when deep urethane anaesthesia was achieved. The level of anaesthesia was 
confirmed by absence of the pedal withdrawal reflex. The reflex was checked regularly 
and additional doses of urethane (0.1 ml) were given i.p. at later stages of the 
experiments, usually > 4 h after the first dose, if REM sleep or the pedal reflex emerged. 
After a urethane top-up, recordings would re-commence about 30 min later, when stable 
SOs had re-emerged.  
A skin incision was made in the scalp and infused with lidocaine, before the 
periosteum was retracted to expose bregma. A craniotomy was drilled above the left 
mPFC and/or the right hippocampus. Electrodes (see below) were implanted into the left 
mPFC (AP = +2, ML = - 0.4, DV = 2.5 mm) and/or right hippocampus passing through 
the CA1 region of the hippocampus (AP = -2, ML = +2, DV = 2 mm, at 7.8° angle). The 
electrode was lowered ventrally, through the dura, using a one-axis oil-filled hydraulic 
micromanipulator (Narishige, Japan).  
2.2.3. Data recording and acquisition 
 Multi-channel recordings were made in all subregions of the mPFC in the left 
hemispheres and/or the contralateral hippocampus passing through the CA1 with 
single shank 16-channel silicon probes (150 μm inter-site spacing; 25 μm diameter, 
Atlas Neuroengineering, Leuven, Belgium). Before insertion, the silicon probe was 
coated with a fluorescent dye (DiI,) (1,1’-dioctadecyl-3,3,3’,3’-tetramethylindo-
carbocyanine; Molecular probes, Eugene, Oregon, USA), dissolved in DMSO (1.5 - 2.5 
mg/ml). Local field potential (LFP) and single unit recordings were carried out in each 
subregion of the mPFC: ACC, PrL, IL and DP. Post-hoc histology confirmed the correct 
positioning of the electrode probes (see below). Each of the signal channels was 
passed through a unity-gain headstage (Plexon, Texas, USA), and was then amplified 
(×1000) and filtered (0.07 – 300 Hz for LFP) by a Plexon preamplifier (Plexon, Texas, 
USA). Unit data was amplified at x40000 and filtered at > 200 Hz. The LFP was 
digitised at 1 kHz while unit data was digitised at 40 kHz and recorded on a PC (DELL 




2.2.4. Histological verification of recording site position 
After the experiment the mouse was sacrificed by injection with Euthatal (0.2 ml 
i.p.). The brain was removed from the skull and post-fixed in 4% paraformaldehyde 
(PFA) 0.1 M phosphate buffer solution (PBS) at 4°C, for approximately 48 hrs.  The 
brain was then transferred for cryoprotection in a 30% sucrose solution for 48 - 72 
hours. Coronal sections (60 μm) were cut on a cooled vibratome (Zeiss Hyrax V50, 
Zeiss, Oberkochen, Germany) and collected in 0.1 M PBS. DAPI (4′,6-diamidino-2-
phenylindole; Sigma-Aldrich) staining and DiI (D282, Thermo Fisher Scientific) was 
used to verify the position of the silicon probes (Figure 2.3A). After staining, sections 
were mounted and cover-slipped using mounting medium (Sigma-Aldrich). The 
location of the electrodes was verified using the Fiji plugin on ImageJ (Schindelin et 
al., 2012; Schneider, Rasband and Eliceiri, 2012). 
2.2.5. Data Analysis 
2.2.5.1. Data pre-processing  
The raw local field potential (LFP) signal contained 50 Hz noise as well as higher 
frequency harmonics and was therefore notch filtered around 50 Hz, 100 Hz, 150 Hz, 
200 Hz, 250 Hz, and 300 Hz, using a linear-phase finite impulse response filter (FIR) 
created using ‘fdatool.m’ in combination with the MATLAB (Mathworks, Nantick, MA, 
USA) ‘filtfilt.m’ function. Recordings from electrode contacts that were noisy or broken 
were not used in the analysis. The LFP recordings used were concatenated sections 
from the original 30 min-long recordings. Parts of the recording were automatically 
removed via a custom written code in MATLAB, to avoid including non-SO segments. 
The same segments were also removed from the unit data. The resulting LFP recordings 
were approximately 20 min long. For the mPFC we used all 16 channels, while for the 
hippocampus we only used the channel that was was located at the CA1 pyramical layer, 
as verified though the histological analysis. 
All data analysis was performed offline using custom MATLAB (Mathworks, 
Nantick, MA, USA) scripts. The Up- and Down-state detection and wavelet power 
extraction scripts were expansions of the original script written by Sabine Gretenkord. 
The unit spiking analysis and the spindle, SWR and non-SO segment identification and 
analysis scripts were custom made for this project. 
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2.2.5.2. Up- and Down-state detection 
During slow oscillations (SO), high frequency oscillations occur transiently during 
the Up-state, and are absent during the Down-state (Steriade et al., 1993a). Thus to 
investigate these nested oscillations in more detail it was first necessary to detect Up- 
and Down-states (UDS). UDS detection (Figure 2.3B) was performed using the phase of 
the SO, as described previously (Massi et al., 2012), except that the Hilbert transform 
(rather than the wavelet transform) was used to calculate the phase of the SO. The LFP 
was first band-pass filtered for the SO (0.1 – 0.9 Hz) and the instantaneous phase ϕ(t) 
was calculated using the Hilbert transform. The threshold to discriminate between Up- 
and Down-states was cos⁡(ϕ(t) = 0) (Gretenkord et al., 2017). To qualify as an Up-state, 
the duration of the event had to exceed 300 ms and the average amplitude of the Up-
state of the SO band-passed signal had to be larger than 0.05 mV. The mean Up- and 
Down- state lengths were calculated for each channel, for each recording. The SO cycle 
length was calculated as the length of the Down-state + the length of the following Up-
state. The variability over time in the Up- and Down-state lengths and the SO cycle length 
were calculated as the SD of the mean for each variable, across SO cycles. The number 
of SO cycles was used to calculate the frequency of the SO. 
2.2.5.3. Calculation of slow oscillation amplitude  
The amplitude of the SO was calculated using the SO-filtered LFP (0.1 – 0.9 Hz). 
The SO amplitude was calculated as the peak-to-trough amplitude (maximum during Up 
state – minimum during Down state) for each cycle.  
2.2.5.4. Calculation of the UDS phase vector 
Time points of Up- and Down-state transitions were calculated from the UDS 
detection logical vector. A cycle always consisted of a Down-state and an Up-state and 
contained three transitions: transition 1: Up-to-Down transition (i.e. end of the Up-state 
to beginning of the Down-state) 2: Down-to-Up transition (i.e. end of the Down-state to 
beginning of the Up-state) 3: Up-to-Down transition (i.e. end of the Up-state to beginning 
of the Down-state). A phase vector was calculated where 0 was the time point of transition 
1, 50 was the time point of transition 2, and 100 was the time point of transition 3. The 
time points in between were filled with linearly spaced intermediate values, so that a 
phase vector was achieved with linear phase progression during the Down-state, and 
linear phase progression during the Up-state. All UDS were then divided into 40 bins per 
state (Gretenkord et al., 2017; Figure 2.3B).  
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2.2.5.5. Calculation of power at higher frequencies 
Before calculating high frequency oscillatory power, the LFP data for each 
electrode channel was normalised with the zscore Matlab function, hence eliminating the 
unit of measurement. The normalised signal was then transformed using a continuous 
wavelet transform and specifically a complex Morlet wavelet, for the theta (4 –  7.9 Hz), 
beta (15 –  29.9 Hz), gamma (30 –  79.9 Hz) and high-gamma (80 –  130 Hz) frequency 
bands (Gretenkord et al., 2017; Massi et al., 2012; Figure 2.3C). The instantaneous area 
power was then calculated using trapezoidal numerical integration over all frequencies in 
the given band. The mean power per bin of the UDS phase vector was calculated for 
each UDS cycle, leading to the alignment of the power to a normalised cycle. This 
compensated for the variable lengths of UDS cycles within a particular data segment, 
and thus allowed a mean power over the normalised UDS cycle to be calculated for each 
electrode channel, for each animal (Gretenkord et al., 2017; Figure 2.3D) 
2.2.5.6. Single unit analysis 
Single units in the mPFC were sorted online first using the Plexon Sort Client 
and then offline using the Plexon Offline sorter. During offline sorting, all waveforms 
were aligned to the global minimum and inter-spike intervals (ISIs) that were shorter 
than the absolute refractory period (< 1ms) were automatically removed. Only units 
which could be well distinguished were included in the analysis. In most cases one unit 
per channel was recorded although occasionally, two units could be isolated. No units 
were obtained from the hippocampus. The unit firing time point data was down-
sampled to 1 kHz, accounting for the number of spikes at each of the down-sampled 
points. Measures of coherence between the SO-band passed LFP and the unit firing 
were obtained using the mscohere function in MATLAB with a 2^14 window and no-
overlap. The threshold for analysing a unit was set at 10 spikes/min (0.17 Hz) while for 
coherence analysis it was set at 30 spikes/min (0.5 Hz).  
The time points of unit firing were compared to the normalised Up-Down cycle 
to identify whether they occurred during an Up- or a Down-state (Figure 2.4). The 
percentage of firing on the Up- and Down-states was calculated as a percentage of the 
total firing. The unit firing frequency on Up-state was calculated as a fraction of the 
total number of spikes occurring on the Up-states by the length of all the Up-states 
combined. We also calculated the unit firing frequency for the duration of the recording, 
by dividing the total number of spikes recorded irrespective of state, divided by the 
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duration of the recording. In a similar way, we also calculated the inter-spike interval 
(ISI) on the Up-state and for the duration of the recording. We also estimated the 
latency to the first unit on the Up-state. Finally, we found the maximum coherence 
between the SO and unit firing on the Up-state and identified the frequency it occurred 

















































































































































C) High frequency oscillatory power extraction in the SO cycle 
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Figure 2.3: Methods of acute, in vivo electrophysiological recordings in mice under 
urethane-induced anaesthesia A) Example of the electrode tract in the medial 
prefrontal cortex (mPFC) and its 4 subregions: anterior cingulate cortex (ACC), 
prelimbic cortex (PrL), infralimbic cortex (IL) and dorsal peduncular (DP), and in the 
hippocampus passing though the CA1, stained with DiI and DAPI. B) Up- and Down-
state detection method. The a) LFP was b) band-passed for the SO (0.1 – 0.9 Hz) and 
c) a Hilbert transform) was used to calculate the phase of the SO. d) The threshold to 
discriminate between Up- and Down-states was cos⁡(ϕ(t) = 0). e) The mean Up- and 
Down state-lengths were calculated for each channel, for each recording. C) Example 
of power extraction in the gamma band in the mPFC. The LFP data for each electrode 
channel was normalised using the z-score and was then transformed using a Morlet 
wavelet, for that frequency band (here gamma: 30 – 79.9 Hz). The instantaneous area 
power was calculated using trapezoidal numerical integration over all frequencies in 
the given band. D) The average gamma band power distribution in the SO cycle across 
one recording. Each SO cycle (Down-state + Up-state) was normalised (0 = start of 
Down-state, 50 = Down to Up-state transition, 100 = end of Up-state) and the area 
under the curve (power) was calculated for each point in this cycle, for each frequency 
range. The high frequency power at each point was averaged across SO cycle (blue 
curve), allowing the extraction the average power on the Up- and Down-state and of 





Figure 2.4: Analysis of unit firing in relation to the SO cycle. The SO cycle composed 
of a Down-state (blue) and the following Up-state (red), in the ACC subregion of the 
mPFC. The peak coherence between unit firing and the SO band-passed signal is 
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2.2.6. Spindle detection 
Our methods for spindle detection were adapted from Kim et al. (2015) (Figure 
2.5). Firstly, the instantaneous amplitude of the spindle band-passed LFP (8 – 15 Hz) 
was computed using the Hilbert transform. Secondly, the instantaneous amplitude was 
smoothed with a 40 ms kernel. The points of the smoothed signal that crossed the 
upper threshold (2.5 x the mean amplitude of the smoothed signal) were identified as 
potential spindles. Peaks in the spindle that were less than 200 ms apart were 
considered part of the same spindle. The crossing points of the lower threshold (1.5 x 
the mean amplitude of the smoothed signal) determined the length of each spindle 
event. Finally, spindles that were shorter than 200 ms and longer than 2 s were rejected 
(Kim et al., 2015). The instantaneous frequency was calculated as the number of 
cycles of the spindle band-passed LFP that crossed the upper threshold encapsulated 
by the smoothed signal for each identified spindle, divided by the spindle duration.  
2.2.7. Sharp wave ripple detection 
We also adapted the methods described by Kim et al. (2015) for sharp-wave 
ripple (SWR) detection (Figure 2.6). We used only recordings where the CA1 pyramidal 
layer could be confirmed histologically. Firstly, the instantaneous amplitude of the SWR 
band-passed LFP (80 – 130 Hz) was computed using the Hilbert transform. The 
instantaneous amplitude was smoothed with a 15 ms kernel. The points of the 
smoothed signal that crossed the upper threshold (mean amplitude of the analytical 
signal + 2*SD) were identified as potential ripples. Ripples with peaks less that than 
100 ms apart were considered one SWR. The length of the ripples was determined by 
the crossing points of the lower threshold (mean amplitude of the analytical signal + 
4*SD). Finally, ripples that were shorter than 20 ms and longer than 400 ms were 
rejected. The instantaneous frequency was calculated as the number of cycles of the 
ripple band-passed LFP that crossed the upper threshold encapsulated by the 








Figure 2.5: Spindle detection method in the ACC subregion of the mPFC, during 
urethane-induced SWS. The local field potential (LFP) from the ACC channel, the 
band-passed LFP for the spindle frequency range (8 – 15 Hz) and the spindle detection 
technique for a 30 s-long segment of recording. An enlarged, 1 s-long segment of the 
spindle is also shown (on the right). The blue line indicates the spindle band-passed 
LFP normalised to the baseline. The red line indicates the smoothed instantaneous 
amplitude of the analytical signal (Hilbert transform on the band-passed signal). A 40 
ms kernel was applied (red line) and the points of the kernelled signal that crossed the 
upper threshold (2.5x the mean amplitude of the smoothed signal) were identified as 
potential spindles. The length of the spindles was determined by the crossing points of 
the lower threshold (1.5x the mean amplitude of the smoothed signal; dotted line). The 






Figure 2.6: Sharp-wave ripple (SWRs) detection method in the CA1 of the 
hippocampus during urethane-induced SWS. The local field potential (LFP), the SWR 
band-passed LFP (80 – 130 Hz) and the SWRs detection method for a 30 s-long 
segment of recording. The blue line indicates the SWRs band-passed LFP normalised 
to the baseline (80 – 130 Hz). An enlarged, 1 s-long segment of the SWR is also shown 
(on the right). The red line indicates the smoothed instantaneous amplitude of the 
analytical signal (Hilbert transform on the ripple band-passed signal). A 15 ms kernel 
was used for smoothing (red line). The points of the smoothed signal that crossed the 
upper threshold (mean amplitude of the analytical signal + 4*SD; continuous line) were 
identified as potential SWRs. The length of the SWRs was determined by the crossing 
points of the lower threshold (mean amplitude of the analytical signal + 4*SD; 




2.2.8. Statistical analysis  
Firstly, we ensured a Gaussian distribution of data and homogeneity of variance 
using the Kolmogorov-Smirnov and Levene’s Test respectively. If these could not be 
established we performed a logarithmic or a square root transformation of the data. 
Normally distributed data was analysed using one-way, two-way or mixed rmANOVA 
analysis, with different between- and within-subjects variables depending on the 
analysis (specified in each Chapter’s methods section). Identifying differences 
between mPFC subregions was out of the scope of our analysis, but subregion was 
included as a repeated measure due to the variability it can induce, particularly in high 
frequency power-related variables (Gretenkord et al., 2017). Thus, we do report 
findings of a significant effect of subregion when found, but we did not proceed with 
separate analyses between regions in the WT and A30P animals. Upon identifying a 
significant effect of genotypic group or an interaction between the group and a repeated 
variable, we proceeded with univariate ANOVA analysis with a Bonferonni correction. 
We also performed univariate ANOVA analyses in cases where there were no 
repeated measures. In cases where we had to proceed with non-parametric analyses, 
the exact test used is described in the Methods sub-section of that Results Chapter. 
Normally distributed data is presented as the mean ± standard error of the mean 
























Quantitative electroencephalography (qEEG) is emerging as a technique for 
early, and differential dementia diagnosis, as it can provide insight into changes in 
rhythmic brain activity and consequently, reveal local or widespread network 
dysfunction (Micanovic & Pal, 2014). The most prominent qEEG finding in DLB and 
PDD is a shift of power and dominant frequency (DF) from the alpha towards the high-
theta frequency range, described as “EEG slowing’’ (Briel et al., 1999). This EEG 
slowing is most prevalent posteriorly (Briel et al., 1999) and although it is also observed 
in AD patients (Jackson et al., 2008), it is not as prominent as in the Lewy body 
diseases – DLB and PDD (Roks et al., 2008). In studies quantifying differences 
between DLB or DLB/PDD, or AD and healthy controls, qEEG variables such as 
coherence (Snaedal et al., 2012), temporal dominant frequency variability (DFV; 
Andersson et al., 2008), the power ratio between frequency bands and combinations 
of ~25 qEEG measures (Garn et al., 2017), have achieved high diagnostic sensitivity 
and specificity, reaching 100% in the latter study. 
Previous investigations have found electrophysiological correlations of cognitive 
fluctuations (CFs) in DLB patients, one of the core symptoms of DLB, which refer to 
spontaneous alterations in cognition, attention and arousal (McKeith et al., 2017). As 
discussed in the Introduction (section 1.1.3), CFs are an important diagnostic feature 
for DLB (Ballard et al., 2002; Zupancic et al., 2011) and thus, their identification through 
a biomarker such as the EEG would be a valuable diagnostic tool. Early work using 
qEEG has shown a correlation between epoch-by-epoch DFV and CFs measured by 
the CAF score, in DLB patients compared with healthy controls (Walker et al., 2000). 
Later work also showed that DLB patients with CFs had greater DFV compared to AD 
patients in posterior brain regions, and used the DFV together with other qEEG 
measures to classify AD, PDD-CFs, PDD-without CFs and DLB patients and controls 
(Bonanni et al., 2008). More recently, a multi-center cohort analysis has verified these 
results (Bonanni et al., 2016).  
The ability of the qEEG to identify EEG patterns in DLB patients and signatures 
of CFs, a DLB-specific symptom, suggest that qEEG could be utilised to investigate for 
a neurophysiological divergence between DLB and other dementias. However, the 
qEEG investigations performed so far have not yet managed to identify differences 
(Garn et al., 2017; Engedal et al., 2015) between DLB and PDD. Generally, these LBD 
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subtypes are similar with respect neuropathological processes, symptoms and 
treatment, but they differ in the order of symptom manifestation (Metzler-Baddeley, 
2007). According to the 1-year rule, a PDD diagnosis is given if motor symptoms 
appear before or within a year of dementia onset, otherwise a DLB diagnosis is given 
(McKeith et al., 2004). This discrepancy between DLB and PDD suggests differences 
in the brain-regions involved and the evolution of the pathology (Outeiro et al., 2019). 
Thus, potential qEEG differences between PDD and DLB are of research interest, as 
they could provide insight for better understanding these LBD subtypes.  
Earlier qEEG studies focused on investigating the capacity of EEG measures in 
aiding DLB differential diagnosis in clinical settings. Hence, they utilized methods such 
as assessment by visual observation (Bonanni et al., 2008), or attempted to develop 
an online method that performs analysis during and right-after EEG acquisition (Garn 
et al., 2017). Here we took a less clinically-orientated approach, as our primary goal 
was to characterize and compare the resting EEG rhythm in AD, DLB and PDD patients 
in relation to healthy controls, and to investigate for DLB specific signatures of CFs. 
Thus, we performed extensive pre-processing analysis of the EEG signal and a 
thorough analysis for differences in qEEG measures within different frequency ranges 
and brain regions, between diagnostic groups.  
Based on the literature, we hypothesized that dementia patients will exhibit a 
differential pattern in the distribution of qEEG measures of power and DF within 
different frequency ranges compared to healthy controls. Moreover, we expected that 
these qEEG measures in addition to DF variability (DFV) in time  will differ between 
the dementia groups. We also hypothesized that greater DFV will only characterize 
patients with LBD and possibly only DLB, and that greater DFV will correlate with more 
CFs within these groups. Finally, to assess the possible utility of these qEEG measures 
in the development of biomarkers, the qEEG measures that were found to be 
significantly different between groups were used to predict dementia diagnosis.  




3.2. Methods  
3.2.1. Data extraction 
For our analysis we analysed eyes-closed, resting-state EEG recordings with a 
128-electrode resolution, from age matched DLB, PDD, AD and healthy control 
patients. A number of patients and recordings were excluded, and the remaining 
recordings were pre-processed, as described in Methods (section 2.1.1).  
The mean relative percentage power spectral density (rPSD) was extracted in 
3 frequency bands of interest: theta (4 – 7.75 Hz), alpha (8 – 13.75 Hz), beta (14 – 
30.75 Hz), in each of 4 cortical regions (frontal, central, posterior, lateral). Next, we 
extracted the dominant frequency (DF) which is the frequency with the highest rPSD, 
and the DF variability (DFV) indicating the standard deviation (SD) of the mean DF 
over time, in the theta, alpha and theta-alpha (4 – 13.75 Hz) frequency bands, in the 4 
cortical regions. We also looked in the DF prevalence (DFP) that was extracted for the 
theta, slow-theta (4 – 5.5 Hz), fast-theta (5.75 – 7 Hz), alpha and theta-alpha frequency 
bands. See the Methods section 2.1.4 for the detailed data analysis and data extraction 
method. 
 We also investigated whether the aforementioned variables correlated with 
cognitive fluctuations measured by the CAF score, and with cognitive decline 
measured by the Mini-Mental State Examination (MMSE) scale. Lastly, we investigated 
whether the qEEG variables that were significantly different between AD and DLB 
patients could be used to differentiate between the two diagnostic groups, and the 
levels of sensitivity, specificity and accuracy of this differentiation.  
3.2.2. Statistical analysis  
First, we tested our data for normal distribution using the Shapiro-Wilk test, and 
logarithmically transformed the data if necessary. We also tested the data for 
heteroscedasticity using Levene’s test for equal variances. The mean power, theta-
alpha DF and theta, alpha and theta-alpha DFV were normally distributed while the 
DFV (for all frequency ranges) and the theta-alpha DF values were logarithmically 
transformed to achieve homogeneity of variance/homoscedasticity.  
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The normally distributed data was then statistically compared using mixed 
rmANOVA analysis, with region as the within-subjects factor and diagnosis as the 
between-subjects factor. Our analysis did not aim to compare the aforementioned data 
between cortical regions, nor to investigate how this distribution could interact with 
diagnosis. Thus, we do not report significant changes in the repeated measures, as it 
is beyond the scope of this analysis. However, we still performed mixed rmANOVA 
analysis with the region as the within-subjects variable, to identify any interactions 
between variables. Upon identifying a significant effect of diagnosis in the mixed 
rmANOVA analysis, we followed up by univariate ANOVA and post-hoc analysis with 
a Bonferonni correction. Non-parametric analysis was performed for the theta and 
alpha DF as we could not solve the issue of heteroscedasticity. Hence we performed 
Welch’s ANOVA followed by the Games-Howell test. For the DFP data we could not 
solve the issue of normality and thus, we performed Kruskal-Wallis H test followed by 
post-hoc analysis. Manual correction for multiple comparisons by appropriating the 
level of α significance (α/N) was performed for the non-parametric statistical analyses, 
as Bonferonni correction was not available for these tests by the statistical software. 
Pearson’s product-moment correlation (parametric data) and Spearman’s rank 
correlation (non-parametric data) were used to investigate for correlations between 
these variables and the CAF score and the MMSE score, for each diagnostic group. 
Manual correction for multiple comparisons by appropriating the level of α significance 
(α/N) was also performed for the correlation analyses. Lastly, in order to assess the 
capacity of the qEEG variables that were significantly different between the AD and 
DLB, and the DLB and PDD groups to predict diagnosis, the generalised estimating 
equations (GEE) procedure were used. The variables that significantly predicted 
diagnosis were then used to calculate the receiver operating characteristic (ROC) 
curve, and obtain the area under the curve (AUC), sensitivity and specificity with 
asymptotic confidence intervals. Our method for this analysis is described in detail in 




3.3.1. Data and Demographics 
Data from a total of 73 individuals (21 healthy controls, 18 AD, 17 DLB, 17 PDD; 
Table 3.1) were further analyzed after data extraction. Participants were well matched 
for age at diagnosis and age at the time of the recording (p > 0.05), as well as MMSE 
score (p > 0.05). The PDD and DLB groups had significantly higher CAF scores than 
AD patients (p < 0.01; p < 0.05 respectively), with the PDD group also showing a higher 
CAF score than the DLB group (p < 0.01). Lastly, the neuropsychiatric inventory (NPI) 
total and Unified Parkinson’s disease rating scale (UPDRS) scores were higher in the 
DLB/PDD subjects compared to the other groups, and in the PDD compared to the 
DLB group (p < 0.01).  
 
 
Table 3.1: Demographics table for the healthy controls and dementia patients who 
participated in our study: controls (N = 21), AD (N = 18), DLB (N = 17) and PDD (N = 
17). L-DOPA = levodopa, LED = L-DOPA equivalent dose, AChEIs = 
acetylcholinesterase inhibitors, MMSE=Mini mental state examination, CAF = 
Clinician’s assessment of fluctuations scale, UPDRS = Unified Parkinson’s disease 
rating scale, NPI = Neuropsychiatric inventory total score. 1 PDD patient (5.9%) was 





(N = 21) 
AD 
(N = 18) 
DLB 
(N = 17) 
PDD 
(N = 17) 
Age in yrs ± SD 76.19 ± 5.32 76.06 ± 7.81 75.71 ± 5.34 75.44 ± 4.66 
Males (%) 66.7 % 88.9% 88.2% 100% 
L-DOPA - 0% 52.9% 100% 
LED - 0% 348.94 423.42 
AChEIs - 94.4% 88.2% 76.5% 
Age at diagnosis (yrs 
± SD) 
- 74.64 ± 7.63 73 ± 5.11 74.07 ± 6.29 
Diagnosis duration 
(yrs ± SD) 
- 1.5 ± 0.9 1.08 ± 0.70 0.94 ± 0.73 
MMSE 29.19 ± 0.87 23.67 ± 1.68 25 ± 2.89 23.94 ± 2.59 
CAF - 0.47 ± 0.87 2.76 ± 3.78 6.59 ± 4.29 
NPI total - 7.29 ± 7.61 8 ± 5.27 20.35 ± 12.9 
UPDRS 1.14 ± 1.42 1.67 ± 1.61 13.82 ± 5.32 27.06 ± 11.44 
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3.3.2. Changes in percentage power in patients with dementia  
The first variable we analysed was the rPSD/power distribution in the theta (4 – 
7.75 Hz), alpha (8 – 13.75 Hz) and beta (14 – 30.75 Hz) frequency bands, as a 
percentage of the total power (4 – 48 Hz). Statistical analysis showed a significant 
effect of diagnosis on the mean power in all bands: theta: F (3, 69) = 39.48, p < 0.01, 
alpha: F (3, 69) = 14.49, p < 0.01 and beta: F (3, 69) = 12.825, p < 0.01 (Figure 3.1). 
In all regions, PDD and DLB groups had higher theta power than AD patients and 
healthy controls. The opposite pattern was observed in the alpha and beta ranges. 
Specifically, in the alpha band, controls had significantly higher power than PDD 
patients in all regions, and compared to DLB patients frontally, posteriorly and laterally. 
Moreover, AD patients had greater alpha power than PDD patients posteriorly and 
laterally and also to DLB patients frontally, posteriorly and laterally. In the beta range, 
DLB patients had lower power than AD patients and controls in all regions. PDD 
patients had lower power than healthy controls in all regions and than AD patients 
frontally, centrally and posteriorly. 
 Our analysis revealed a shift of spectral power from higher to lower frequency 
bands in DLB and PDD patients, as they had significantly increased theta and alpha 
power and decreased beta power compared to AD patients and controls. AD patients 
have a similar percentage power content in each band as healthy controls. These 











































































































Figure 3.1: Analysis of percentage power of the resting state EEG in the dementia 
sub-groups. The mean percentage distribution of the total relative power in three 
frequency bands (Hz): theta (4 - 7.75), alpha (8 - 13.5) and beta (14 - 30.75), for each 
of four diagnostic groups: healthy controls (N = 21), AD (N = 18), DLB (N = 17) and 
PDD (N = 17) patients, for the anterior, central, posterior and lateral regions. Error bars 
indicate the SEM. Asterisks indicate statistical significance: ** = p < 0.05, ** = p < 0.01, 






































































3.3.3. Changes in the dominant frequency (DF) in dementia patients  
Next, we looked at the mean dominant frequency (DF), which describes the 
frequency with the highest power in the theta (4 - 7.75 Hz), alpha (8 - 13.75 Hz) and 
theta-alpha (4 - 13.75 Hz) frequency bands. This analysis aimed to clarify our findings 
of a shift of power towards lower frequencies in DLB and PDD groups compared to 
healthy controls and AD patients (Table 3.3). Mixed rmANOVA analysis showed a 
significant effect of diagnosis in the mean theta-alpha DF (F (3, 69) = 36.78, p < 0.001), 
which was significantly higher in all cortical regions in controls and AD patients 
compared to the other patient groups (Figure 3.2A).  
The theta and alpha DF were analysed using Welch’s ANOVA. The mean theta 
DF was significant in all regions (frontal: F(3, 69) = 6.92, p < 0.001; central: F (3, 69) = 
6.35, p < 0.01, posterior: F (3, 69) = 10.38, p < 0.001, lateral: F (3, 69) = 7.93, p < 
0.001; Figure 3.2B). Specifically, the theta DF was significantly higher in controls 
compared to the PDD group frontally, to the AD, DLB and PDD groups centrally and 
posteriorly, and to the DLB and PDD groups laterally. Significant differences between 
groups were also found in the alpha DF, in all regions: frontal: F(3, 69) = 5.06, p < 0.01; 
central: F (3, 69) = 8.55, p < 0.001, posterior: F (3, 69) = 9.6, p < 0.001, lateral: F (3, 
69) = 5.98, p < 0.01 (Figure 3.2C). The DLB group had significantly lower alpha DF 
than the control and AD group in all regions. The PDD group had higher alpha DF than 
the DLB group frontally, the AD group centrally and posteriorly and the control group 
laterally. A trend for a greater alpha DF in the AD compared to the control group was 
observed, but was not statistically verified. 
The DF analysis verified the previous observation of a shift of power from higher 
to lower frequencies, in DLB and PDD patients compared to healthy controls and AD 
patients (Bonanni et al., 2008; Walker et al., 2000). This analysis also revealed that 
the DF in the DLB and PDD patient groups now lies in the theta range (4 – 7.75 Hz) 






















Figure 3.2: Analysis of the dominant frequency (DF) in the dementia sub-groups. The 
mean DF is shown for the A) theta-alpha (4 – 13.75 Hz), B) theta (4 – 7.75 Hz) and C) 
alpha (8 – 13.75 Hz) frequency ranges, for each of four diagnostic groups: healthy 
controls (N = 21), AD (N = 18), DLB (N = 17) and PDD (N = 17) patients, in the frontal, 
central, posterior and lateral regions. Error bars indicate the SEM. Asterisks indicate 
statistical significance: ** = p < 0.05, ** = p < 0.01, *** = p < 0.001. Adapted from Stylianou 
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3.3.4. Changes in the DF prevalence (DFP) in dementia patients 
The next variable of interest was the dominant frequency prevalence (DFP) in 
slow-theta (4 – 5.5Hz) fast-theta (5.75 – 7.75 Hz) and alpha (8 – 13.75 Hz) frequency 
bands. The DFP describes the percentage of epochs (from the total number of epochs) 
in which each DF was measured. The average DFP was calculated for each recording. 
The theta range was sub-divided into slow-theta and fast-theta, to better comprehend 
the DFP distribution. 
The mean alpha DFP (Figure 3.3) was significantly higher in controls compared 
to all disease groups (DLB/PPD: p < 0.001; AC: p < 0.01), and in AD patients compared 
to DLB and PDD patients (p < 0.001), in all regions. In the fast-theta range the opposite 
pattern was observed, with controls exhibiting lower DFP compared to AD patients in 
all regions (p < 0.05), and to DLB and PDD patients in all regions (p < 0.001). Finally, 
in the slow-theta range controls had significantly lower DFP than AD patients in all 
regions (frontal, central: p < 0.01; posterior, lateral: p < 0.05), and to DLB (p < 0.01) 
and PDD patients (p < 0.001) in all regions. AD patients also have significantly lower 
slow-theta DFP than PDD patients frontally, posteriorly and laterally (p < 0.05). 
The DFP analysis has strengthen our findings of an EEG “slowing” in DLB and 
PDD patients compared to AD patients and controls. Interestingly, this analysis has 
also revealed a small EEG slowing in AD patients compared to controls, as they 





Figure 3.3: Analysis of the dominant frequency prevalence (DFP) in the dementia sub-
groups. The mean DFP (the percentage distribution of the mean DF in each frequency 
point in the theta-alpha frequency range with 0.25 Hz resolution) for each of four 
diagnostic groups: healthy controls (N = 21), AD (N = 18), DLB (N = 17) and PDD (N 
= 17) patients, in the frontal, central, posterior and lateral regions. Adapted from 
Stylianou et al. (2018).  
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3.3.5. The DF variability (DFV) in dementia patients  
The DF variability (DFV) describes the variability of the DF over time in the theta, 
alpha, theta-alpha frequency bands. The DFV is the SD of the DF over epochs and 
averaged across recordings and, therefore, shows how stable or variable the DF is 
over time.  
Our analysis revealed a significant effect of diagnosis in the theta/alpha (F (3, 
69) = 8.91, p < 0.001) and alpha (F (3, 69) = 6.29, p < 0.01) ranges, but not in the theta 
range (Figure 3.4). In the theta-alpha range, the AD group had a significantly higher 
DFV compared to the control, DLB and PDD groups in the frontal, central and posterior 
regions, and only to the DLB group laterally (Figure 3.4A). In the alpha band, AD 
patients had significantly higher DFV compared to the DLB group centrally and 
posteriorly, and to healthy controls posteriorly (Figure 3.4B).  
In contrast to previous studies (Bonanni et al., 2008; 2010) our study found 
greater DFV in AD patients compared to healthy controls and to DLB and PDD patients. 
The latter DLB/PDD did not show significantly different DFV compared to healthy 






Figure 3.4: Analysis of the dominant frequency variability (DFV) in the dementia sub-
groups. The mean DFV in the A) theta-alpha (4 – 13.75 Hz) and B) alpha (8 – 13.75  
Hz) frequency ranges, for each of four diagnostic groups: healthy controls (N = 21), 
AD (N = 18), DLB (N = 17) and PDD (N = 17) patients, in the frontal, central, posterior 
and lateral regions. Error bars indicate the SEM. Asterisks indicate statistical 
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3.3.6. Correlation between the CAF score and the DFV 
We assessed correlations between CFs as measured by CAF and the qEEG 
measures of DFV and EEG “slowing”, for all the different diagnostic groups, in each 
frequency band and cortical region. This analysis revealed that, only within the DLB 
group, was there a strong correlation between the CAF score and the theta DFV in the 
central (r = 0.789, p <0.000), posterior (r = 0.652, p < 0.005) and lateral regions (r = 
0.805, p < 0.001). A positive, DLB specific correlation with CAF was also found with 
slow-theta DFP in the frontal (r = 0.679, p = 0.003), central (r = 0.747, p = 0.001), 
posterior (r = 0.792, p < 0.001) and lateral (r = 0.794, p = 0.001) regions. A correlation 
between the CAF and MMSE score was only found in the PDD group (r = -0.671, p < 
0.05), while no significant correlation was found for any variable and the LED, for any 
group and region. Thus, although DLB patients do not have greater DFV compared to 
controls, they show a disease specific correlation between increased theta DFV (as 
the DF is now in the theta range) and CFs. The DF slowing in DLB patients also 
correlates with CFs. The correlations between the DF slowing and increased DFV with 
the CAF score are DLB specific. 
3.3.7. Exploratory GEE and ROC curve analysis 
Lastly, we decided to investigate the ability of our EEG variables to differentiate 
between DLB and AD, as these dementia subtypes often manifest in similar ways at 
disease onset (Ballard et al., 2002). Thus, we performed GEE analysis for the variables 
that were significantly different between the AD and DLB diagnostic groups (theta 
power, alpha power, theta-alpha DFV, alpha DFV, alpha DF and fast-theta DFP). The 
alpha-theta DF and alpha DFP were rejected from this analysis as they introduced 
marked multicollinearity. The qEEG variables that best predicted diagnosis were the 
theta power (%) (Wald chi-square = 15.74, df = 1, p < 0.01), the fast-theta DFP (Wald 
chi-square = 8.1, df = 1, p < 0.01) and the theta-alpha SD (Wald chi-square = 7.549, 
df = 1, p < 0.01). ROC analysis (Figure 3.5) yielded AUC = 94% (90.4% - 97.9%), 
sensitivity = 92.26% (CI = 80.4% – 100%) and specificity = 83.3% (CI = 73.6% - 93%). 
Thus, the extent of the DF slowing and DF over time can differentiate AD and DLB 













Figure 3.5: The capacity of quantitative EEG measures to enable differential DLB/AD 
diagnosis. Receiver operating curves (ROC) for a model composed of fast-theta 
dominant frequency prevalence (DFP), theta power and theta-alpha dominant 
frequency variability (DFV), for differentiating between Alzheimer’s disease (AD; N = 
18) and dementia with Lewy bodies (DLB; N = 17) with mild dementia. Adapted from 





3.4.1. Summary of the main findings 
A summary of the key findings from Chapter 3 is presented below:  
 Greater theta-alpha DFV in AD patients compared to controls, DLB and PDD 
patients. No differences in the DFV between the DLB group and healthy 
controls.  
 A significant, DLB specific positive correlation found between the CAF score 
and the theta DFV and the slow-theta DFP.  
 Increased theta and decreased alpha and beta power in DLB and PDD patients 
compared to AD patients and healthy controls. 
 A shift of the DF and DFP from the alpha to the theta frequency range in DLB 
and PDD patients, compared to AD patients and healthy controls. 
 A subtle shift of the DFP towards the fast-theta frequency range in AD patients 
compared to healthy controls.  
 A model composed of the theta power, fast-theta DFP and theta-alpha DFV 
could predict a DLB versus an AD diagnosis with high sensitivity (92.26%), 
specificity (83.3%) and accuracy (94%).   
3.4.2. DLB/PDD patients have a slower resting EEG rhythm than healthy 
controls and AD patients 
One of the best described qEEG features in DLB and PDD patients is a shift of 
power from higher to lower frequency bands compared to healthy controls and in some 
studies compared to AD patients, mostly in posterior cortical regions (Briel et al., 1999; 
Barber et al., 2000; Bonanni et al., 2008; Roks et al., 2008). In our analysis we looked 
within four different cortical regions (frontal, central, posterior, lateral) compared to a 
maximum of three regions previously reported (frontal, posterior, lateral; Bonanni et 
al., 2008), and analysed three measures of EEG spectral distribution, the percentage 
power, DF and DFP, all of which confirmed an “EEG slowing” in our DLB/PDD patients 
compared to AD patients and controls.  
In AD patients, a small EEG slowing was also evident by a shift of the DFP from 
the alpha to the fast-theta and slow-theta ranges, compared to healthy controls. This 
finding indicates that a higher percentage of the DF measurements occurred within the 
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theta-band, than in the alpha-band, in the AD patients compared to control subjects. 
This altered DF distribution towards lower frequencies in AD was “masked” with the 
calculation of the mean theta-alpha DF, as this measure does not account for 
variability. The DF in AD patients is highly variable over time and can take values 
towards the higher edge of the alpha band, thus influencing the mean DF. This is 
evident by the significantly greater theta-alpha DFV in the AD compared to the other 
diagnostic groups, and the trends for greater alpha DFV and alpha DF that characterise 
AD patients. 
A cholinergic deficit may partly account for the EEG slowing in DLB/PDD and 
AD, as it has been shown that the administration of AChEIs can reverse the EEG 
slowing observed in both diseases (Bosboom et al., 2009; Babiloni et al., 2013; Adler 
et al., 2004). However, the loss of cholinergic neurons projecting to the cortex is greater 
and has a faster progression in DLB and PDD compared to AD (Lippa et al., 1999) 
where the cholinergic deficit is not yet severe at early stages of the disease (Bohnen 
& Albin, 2011). Pathological protein-related synaptic dysfunction that occurs before 
neuronal degeneration has also been associated with cognitive decline in AD and is 
thought to be even greater in DLB (Selkoe, 2002; Schulz-Schaeffer, 2010). Thus, a 
more advanced cholinergic deficit and synaptic dysfunction in the LBD groups could 
account for the greater extent of EEG slowing observed compared to the AD group, 
particularly given the relatively early disease stage and mild cognitive impairment of 
our participant populations.        
3.4.3. The DFV and cognitive fluctuations correlate only in DLB patients 
Previous studies have shown a significant DFV increase in DLB patients 
compared to healthy controls, that correlated with CFs measured by the CAF score 
(Walker et al., 2000; Bonanni et al., 2008). Although we did not find an increase in the 
DFV of DLB patients compared to healthy controls, we did find a positive correlation 
between the DFV in the theta band and the CAF score within the DLB group (Bonanni 
et al., 2015). This correlation was only significant in the theta frequency range, likely 
due to the shift of the DF from the alpha towards the theta frequencies in DLB patients. 
A positive correlation was also found between slow-theta DFP and the CAF score in 
DLB patients. Both these correlations were only seen in the DLB group and not in the 
PDD or AD groups. 
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One of the main theories regarding CF generation is that they arise due to 
disturbances in large-scale networks that govern attention (O’Dowd et al., 2019). The 
aforementioned qEEG studies showing a correlation between DFV and CFs in DLB 
patients (Walker et al., 2000; Bonanni et al., 2008), led to the belief that DLB (and not 
AD) is associated with an increase in dynamic brain function and in the activity of the 
networks that govern the resting state, specifically the DMN (Franciotti et al., 2013). 
However, more recent studies have shown that the DMN might not be affected in DLB 
patients (Schumacher et al., 2018; Peraza et al., 2014; Firbank et al., 2016). Moreover, 
an fMRI study has shown prolonged DMN deactivation during a cognitive processing 
task in DLB patients, suggesting an inability of the DMN to shift back to the activated 
state rather than an increase in its function (Firbank et al., 2018). Another fMRI study 
showed a reduction in shifts between the EEG-microstates (~100 ms long periods that 
represent the EEG correlates of fMRI resting-state networks) in DLB compared to AD 
and healthy controls, with the magnitude of the reduction correlating with the extent of 
CFs (Schumacher et al., 2019). These findings suggest that DLB is characterised by a 
loss of dynamic brain function that is related to CFs.  
There is also evidence of an aberrant interaction between the fronto-parietal 
attention networks and the DMN in DLB patients. The fronto-parietal attention networks 
include the ventral and dorsal attention networks (VAN; DAN), where DAN mediates a 
top-down voluntary allocation of attention, while VAN is important for detecting 
unanticipated stimuli and shifting attention (Vossel et al., 2014). Moreover, the DAN 
and VAN networks have an anti-correlated activation pattern to the DMN. DAN and 
VAN have been previously shown to have altered activity in DLB patients during 
attentional tasks, including a DAN/VAN disconnectivity that obstructs the DAN 
regulation over VAN (Peraza et al., 2014; Kobeleva et al., 2017; Franciotti et al., 2013; 
Firbank et al., 2016; Chabran et al., 2018). One study also showed a correlation 
between CF severity and decreased fronto-parietal connectivity in DLB patients who 
showed increased DFV (Franciotti et al., 2013). Thus, we postulated that the DFV/CF 
correlation seen within the DLB group could indicate changes in the functional 
connectivity changes between attentional and the DMN networks.  
Given the neuropathological similarities between PDD and DLB and the absence 
of other qEEG differences between these groups (Jellinger & Korczyn, 2018), the lack 
of a correlation between CAF and our qEEG measures in PDD was unexpected. 
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Previous studies have reported that PDD patients with high CF scores show an EEG-
slowing (Bonanni et al., 2008) and have more DLB-like symptoms such as visual 
hallucinations, while patients with fewer CFs resemble PD (Varanese et al., 2010). This 
heterogeneity in our PDD patients may have affected our capacity to identify a 
correlation between the EEG measures and CAF score in this group. Moreover, DLB 
patients with parkinsonism have more impaired reaction times and vigilance measures 
that relate to CFs, compared to patients without motor symptoms, implying a 
connection between CFs and dopaminergic impairment (Ballard et al., 2002). 
Furthermore, there is evidence of a negative correlation between dopaminergic neuron 
numbers indicated by dopamine transporter scan (DaT) and CFs (Iizuka & Kameyama, 
2016) in DLB. Finally, a few studies have suggested that CFs can be slightly less 
common in PDD than in DLB, which can also account for the lack of qEEG/CF 
correlations in the PDD group (Ballard et al., 2002; Savica et al., 2013) 
Since PDD is characterised by greater dopaminergic impairment than DLB, this 
additional pathology could have a more dominant aetiological role in the CFs seen in 
PDD as compared to DLB. CFs are likely to have at least two dimensions - attention 
as discussed above and arousal (Bliwise et al. 2012). These dimensions are not 
discriminated by the CAF score but may be differentially expressed in our DLB and 
PDD groups given arousal/sleepiness is strongly influenced by dopaminergic 
medications (Piggott et al., 2007). Another factor may be the amyloid burden as this is 
significantly greater in DLB compared to PDD patients (Donaghy et al., 2015), while 
the cortical Aβ deposition relates more to dementia severity, visual hallucinations and 
delusion in DLB than PDD (McKeith et al., 2004). DLB is also characterised by a 
greater amyloid load in the putamen (Hepp et al., 2016), which is involved in attentional 
networks and in DLB has altered functional connectivity that correlates with CAF 
(Peraza et al., 2014). Ultimately, improved quantification scales of CFs may help to 
unpick these challenges. 
3.4.4. The DFV is greater in AD patients compared to all other diagnostic 
groups. 
Previous studies have also shown that DLB patients had a significantly higher 
DFV compared to AD patients, which did not differ significantly from controls, and that 
a higher DFV was an accurate indicator of DLB versus AD diagnosis (Bonanni et al., 
2008). Here, we found that AD patients had a significantly higher theta-alpha DFV 
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compared to all other diagnostic groups, in most cortical regions. A later study on the 
same initial cohort of patients as the one used in this study verified our finding of 
greater theta-alpha DFV in the AD group but only in posterior derivations due to the 
use of a lower EEG spatial resolution (Peraza et al., 2018). We also looked at the DFV 
in the theta and alpha bands independently and we identified a greater alpha DFV in 
AD patients compared to controls and DLB patients posteriorly, and to DLB patients 
alone centrally.  
These findings of an increase in DFV in AD patients could be part of the 
pathology or alternatively, the result of a compensation mechanism that may occur at 
early stages of AD. At rest, early stage AD patients may have increased activity, and 
functional connectivity, in resting state networks which correlate with a lower MMSE 
score (Peraza et al., 2015). However, at more advanced stages of the disease, activity 
and connectivity decrease to levels lower than those seen in controls (Agosta et al. 
2012). Therefore, increases in DFV may be associated with a compensation 
mechanism in early stage AD.  
A finding we have not discussed so far is the decrease in beta band power seen 
in DLB and PDD patients compared to controls and AD patients. This finding replicates 
previous reports in the literature (Andersson et al., 2008), although there is little 
research focused on the beta rhythm in relation to DLB. Beta frequency activity is the 
idling rhythm of the motor cortex while it is also involved in cognitive function and 
specifically in maintaining the current cognitive state (Neuner et al., 2014). Beta activity 
increases with top-down control and periods of self-referential thinking and decreases 
with attention demanding tasks and the input of external information (Engel & Fries, 
2010). It is, therefore, not surprising that beta activity overlaps with activation in DMN 
regions, the parietal cortices, precuneus and mPFC (Engel & Fries, 2010; Mantini et 
al., 2007). However, in DLB patients, beta power functional connectivity is reduced 
over long-distance, in fronto-parietal and fronto-temporal areas spatially overlapping 
with the DMN and the aforementioned attention networks (Pievani et al., 2011; 
Andersson et al., 2008; Peraza et al., 2018). Thus, changes in the underlying network 
dynamics could also affect beta band activity, in addition to theta/alpha band activity. 
However, we did not investigate for further changes in the beta rhythm in terms of the 
DF and DFV, nor for a relationship between these measures and CFs in DLB patients, 
as this analysis was outside of our scope. A study designed to investigate the power 
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content of higher-frequency oscillations such as beta and gamma would be of great 
interest.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
3.4.5. Our study contradicts previous reports in literature 
A number of other factors may account for the discrepancies between our 
findings and those of previous studies. The lack of a greater DFV in DLB patients 
compared to controls may be attributed to the fact that the majority of our DLB patients 
were on acetylcholinesterase inhibitors (AChEIs), although we would argue that this 
adds to the clinical relevance of our findings, particularly from a diagnostic perspective; 
it is likely that any use of the EEG will be when patients are beginning or have already 
been initiated on treatment. In DLB patients, CFs have been shown to correlate with 
cholinergic imbalances in networks involved in the resting state (Delli Pizzi et al., 2015). 
AChEIs restore this imbalance and improve both the cognitive symptoms of DLB and 
the electrophysiological markers, including the EEG spectrum and connectivity (Onofrj 
et al., 2003). That said, it is important to acknowledge that more AD (94.4%) than DLB 
(88.2%) patients were on AChEIs in our study groups and the former group showed 
greater DFV. However, as outlined above, cholinergic deficits are greater and occur 
earlier in DLB compared to AD (Tiraboschi et al., 2002), while the brainstem cholinergic 
innervations of the thalamus are relatively spared in AD (Mesulam, 2004), but not in 
DLB (Taylor et al., 2017). Hence, at the stage of mild dementia AChEIs could have a 
differential effect in DLB and AD.  
Although AChEIs may have normalized the DFV in DLB patients in relation to 
healthy individuals, the CAF/DFV correlation was still maintained within our DLB group. 
In previous studies, none (Walker et al., 2000), or only a small proportion (Bonanni et 
al., 2008) of the patients were on AChEIs. Differences in the participant cohorts, as 
well as methodological differences in the analysis of the recordings must also be 
considered. Specifically, we used a different pre-processing and spatial analysis 
approach, as well as a different way to estimate DFV; here DFV was defined as the 
standard deviation from the mean DF across epochs, in an epoch-by-epoch basis, 
while in Bonanni et al. (2008; 2016), DFV was defined using a visual rating of DF range 
on sequential EEG segments. 
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3.4.6. QEEG measures can differentiate between AD and DLB patients with 
high sensitivity and specificity  
We also proceeded with a preliminary analysis to investigate the capacity of the 
qEEG variables to correctly differentiate between AD and DLB patients with mild 
cognitive decline indicated by the MMSE score and hence, early dementia. The theta 
power, fast-theta DFP and theta-alpha DFV yielded accuracy of 94% (CI = 90.4% - 
97.9%), sensitivity of 92.26% (CI = 80.4% - 100%) and specificity of 83.3% (73.6% - 
93%). The high predictive accuracy of this model is in-line with previous classifications 
using qEEG variables, although different EEG pre-processing and analysis methods 
were used (Andersson et al., 2008; Garn et al., 2017). Hence, these qEEG measures 
of the DFV and EEG slowing could potentially be of clinical importance and become 
implemented in an EEG-based diagnostic tool for DLB. However, they would have to 
be tested in a separated patient cohort first, and be assessed for feasibility and cost-





Our findings confirm the well-established slowing of the EEG in the Lewy body 
dementia groups compared to healthy controls and AD patients. Although we did not 
find higher DFV in DLB patients compared to controls as expected, theta DFV and 
slow-theta DFP were positively correlated with CFs as measured by CAF. This DLB 
specific correlation suggests that a slower and more temporally variable DF specifically 
relates to the CFs seen in DLB, and could reveal differential mechanisms underlying 
CFs in dementia subtypes. Another novel finding was a significantly higher DFV in AD 
patients compared to the other diagnostic groups. Exploratory analysis showed that 
qEEG measures could predict a DLB versus an AD diagnosis with high accuracy, 
sensitivity and specificity. In conclusion, this study supports the hypothesis that qEEG 
analysis can be a valuable tool for identifying CFs in DLB and for differential diagnosis 
between dementia subtypes, once replicated with low density EEG currently used in 
standard clinical practice after the feasibility and cost-effectiveness of these 























Slow wave sleep (SWS) defined by the slow oscillation (SO; < 0.1 Hz), is the 
hallmark of NREM sleep in all vertebrate species including humans. SWS in rodents is 
often modelled by urethane anaesthesia, which induces the SO that can be recorded 
throughout the cortex (Clement et al., 2008; Pagliardini et al., 2013) and the 
hippocampus (Yanovsky et al., 2014; Wolansky et al., 2006). The SO is an oscillation 
between the so-called Up- and Down-states (Steriade et al., 1993a), and is governed 
by a balance between excitation and inhibition (see review by Neske, 2015). 
Intracellular recordings show that Up-states are periods of depolarisation and action 
potential firing, while Down-states are characterized by hyperpolarization and the lack 
of neuronal firing (Steriade et al., 1993a; Luczak et al., 2007). A high level of synchrony 
within, and across, cortical and subcortical regions suggests a regulatory input from 
the thalamus, driving local cortical circuits (Fernandez et al., 2018; Lemieux et al., 
2014). 
The mPFC is a cortical region that is involved in higher-cognitive function and 
that generates a strong SO (Varela & Wilson, 2019; Colgin, 2011; Gretenkord et al., 
2017). A recent study in the rat mPFC under urethane anaesthesia showed a highly 
synchronous SO of similar amplitude across its four subregions (ACC, PrL, IL and DP), 
and across hemispheres (Gretenkord et al., 2017). The mPFC SO rhythm, is 
synchronous to the hippocampal SO (Sharma et al., 2010; Wolansky et al., 2006; 
Colgin, 2011). Highly synchronous communication between the two regions during 
SWS is essential for memory consolidation (Wierzynski et al., 2009; Mölle & Born, 
2009; Riga et al., 2014; Varela & Wilson, 2019). This communication takes the form of 
higher-frequency rhythms that are nested on the Up-state of the SO under natural 
sleep and anaesthesia (Colgin, 2011). Beta and gamma rhythms can be recorded on 
the Up-state in the cortex (Steriade et al., 1996; Valencia et al., 2013; Gretenkord et 
al., 2017), while gamma and high-gamma rhythms are most prominent in the 
hippocampus (Colgin et al., 2009), during natural sleep and under anaesthesia.  
Both natural sleep and urethane-induced SWS are also characterised by two 
transient, high frequency electrophysiological events, the sleep spindles (Barthó et al., 
2014; Puig et al., 2008; Steriade et al., 1993a) and sharp-wave ripples (SWRs) 
(Buzsáki & Silva, 2012; Mölle et al., 2006; Buzsáki et al., 1983). Sleep spindles are a 
sleep-related phenomenon of great importance in memory consolidation (Astori et al., 
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2013), and sleep maintenance (Parrino & Vaudano, 2018). Sleep spindles are 
generated in the thalamus via the activity of excitatory thalamocortical neurons and 
inhibitory neurons in the TRN (Destexhe et al., 1998). Sleep spindles occur usually at 
the Down- to Up- state transition, although higher frequency spindles have also been 
characterised to occur at the Up- to Down-state transition (Kim et al., 2015).  
SWRs are highly synchronous hippocampal events reflecting the firing of CA1 
pyramidal cells and the accompanied high frequency oscillation in the CA1 (Buzsáki & 
Silva, 2012). SWRs occur on the Up-state of the SO during natural sleep and under 
anaesthesia (Mölle et al., 2006), but they are of a slower frequency (100 – 120 Hz) in 
the urethane-anaesthetized rat than during natural sleep (200 Hz; Ylinen et al., 1995). 
Cortical sleep spindles and hippocampal SWRs are synchronous with one another and 
their interaction facilitates the transfer of memories for consolidation from the 
hippocampus to the cortex (Eschenko et al., 2008; Sullivan et al., 2011; Valero et al., 
2017), particularly between the CA1 region of the hippocampus and the mPFC (Wang 
& Ikemoto, 2016; Kiss et al., 2013). 
DLB patients have early α-syn pathology in the mPFC, hippocampus and 
thalamus (Adamowicz et al., 2017; Taylor et al., 2017). Impairments in these regions 
could affect the generation of sleep-related oscillations and their function (Latreille et 
al., 2015). Aged A30P animals exhibit a range of cognitive deficits including impaired 
hippocampal spatial memory that as mentioned, also involves the mPFC (Kahle et al., 
2001; Freichel et al., 2007). After 12 months of age, A30P mice show non-soluble α-
syn pathology in the hippocampus and cortex (Freichel et al., 2007; Schell et al., 2009). 
However, it is possible that oligomeric, mutant α-syn species are present earlier in 
these regions, obstructing neuronal function (Diógenes et al., 2012). In our lab, we 
have found a number of subtle changes in young mice, including changes in the 
balance between excitation and inhibition that could potentially affect the SO cycle 
(Robson et al., 2018; Tweedy et al., 2018)  
In this study we aimed to identify changes in the SO in young A30P animals in 
the subregions of the mPFC and in the CA1 of the hippocampus. Therefore, we looked 
at the SO amplitude, frequency and the length of the components of the SO cycle; i.e. 
the Up- and Down-state, and how these vary over time. We also looked at higher-
frequency oscillations nested on the Up-state, the levels of high frequency activity and 
unit firing in the SO cycle and the unit firing / SO coherence. To investigate for changes 
102 
 
in long-range synchrony we looked at the coherence of the SO between the mPFC 
subregions and the CA1. Finally, we looked at the density and characteristics of 
spindles and SWRs in the mPFC and CA1 respectively, in WT and A30P mice.  
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4.2. Methods  
4.2.1. Animals  
For the WT cohort, we initially carried out mPFC recordings in 14 animals but 2 
animals without evidence of the infra-slow modulation (ISM; see Chapter 5 for detailed 
analysis) were excluded. Four more animals were excluded due to urethane-induced 
breathing artefacts that contaminated the data. In total therefore, we had mPFC 
recordings from 8 mice. We also had hippocampal CA1 region data for 6 / 8 mPFC 
recordings, but 1 was rejected due to an incorrect placement of the electrode probe, 
as verified by ex vivo immunohistochemistry. We also used CA1-only recordings for 2 
animals, giving a total of 7 CA1 recordings for analysis. Simultaneous recordings 
between the mPFC and CA1 were performed in 5/7 animals and could be analysed for 
preliminary SO coherence analysis between the two regions. 
The A30P cohort originally consisted of 19 animals for the mPFC and one 
without ISM was excluded. Two of the animals were excluded due to broken electrode 
contacts for at least one mPFC subregion and another 3 were rejected due to urethane-
induced breathing artefacts. We also obtained recordings from the CA1 from 6 of these 
animals. Three additional hippocampal-only recordings were obtained but one was 
rejected due to incorrect placement of the electrode, again revealed by ex-vivo 
immunohistochemistry. One of these recordings was excluded from power-related 
analyses as it had minor urethane artefacts, but it was included in the SO state length 
analysis and mPFC/CA1 coherence analysis. Thus, we overall analysed 6 
simultaneous mPFC/CA1 recordings for SO coherence between the two regions.  
Out of 8 mPFC recordings in WT animals one did not have unit data, resulting 
in N = 7 WT animals for mPFC unit analysis. In the A30P cohort, we also used the 2 
animals that were missing electrodes in one mPFC subregion, as subregion was not 
considered in this analysis. Thus, we analysed unit data from the mPFC of 15 A30P 
animals. We did not record unit data from the CA1.   
4.2.2. Recordings 
The data used for this analysis was recorded approximately 1 – 1.5 hours after 
the initial dose of urethane, when regular SWS had been established. Data was 
analysed from only the first 30 min of recording as, although SWS lasted about 3 hours 
after the first urethane dose before a top-up was necessary, we wanted to analyse 
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data obtained from a consistent, deep plane of anaesthesia. We observed that within 
the SO there were brief bursts of high oscillatory power, which reflect the ISM 
(described in detail in Chapter 5). For the recordings and analysis of SWA presented 
in this Chapter, segments containing the ISM were automatically removed and the 
remaining SWS segments were concatenated, resulting in  ~ 15-min long segments of 
data. Regular SO could be recorded simultaneously in all subregions of the mPFC 
(ACC, PrL, IL, DP) and the CA1 of the hippocampus in both A30P and WT mice aged 
2.5 - 4 months.   
4.2.3. Analysis of the SO cycle and wavelet power  
Several characteristics of the SO were analysed including the mean Up- and 
Down-state lengths and their variability over time (SD), the mean cycle length and its 
variability over time, the SO frequency and the mean SO amplitude. In addition, the 
high frequency oscillatory power in the SO was determined in 3 frequency bands: beta 
(15 – 29.9 Hz), gamma (30 – 79.9 Hz) and high-gamma (80 – 130 Hz), for the Up- and 
Down-states. All the aforementioned variables were extracted as described in Methods 
sections 2.2.5.1 - 2.2.5.5. High frequency gamma is within the SWR range in the CA1 
but in this study, SWRs were detected separately (Methods section 2.2.7) as high-
gamma oscillations and SWRs are separate rhythms (Sullivan et al., 2011).  
4.2.4. Analysis of neuronal firing in relation to the SO  
The unit data was extracted and analysed as described in Methods section 
2.2.5.6. We calculated the unit firing frequency and ISI on the Up-state and for the 
duration of the recording, and the latency to the first unit on the Up-state. We also 
looked at the percentage of the total firing occurring on the Up- and Down-states as 
well as the maximum unit firing / SO coherence.  
4.2.5. SO coherence between the mPFC and CA1 
For animals where simultaneous recordings were performed in the contralateral 
mPFC (4 subregions) and CA1, the SO coherence was calculated for the SO frequency 
range. The “mscohere” function in MATLAB was used with a 2^12 window and no-
overlap, to obtain the maximum coherence between the two signals and the frequency 
at which it occurred (Methods section 2.2.5.6) .   
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4.2.6. Sleep spindles and SWRs 
We also investigated for changes in the patterns of sleep spindles in the mPFC 
and of SWRs in the CA1 of WT and A30P animals, detected as described in section 
2.2.6. For both spindles and SWRs we looked at the event duration and variability in 
duration, the event amplitude and variability in amplitude, the event latency in the 
normalized SO cycle, the absolute (spindle no/ recording duration) and relative spindle 
density (spindle no / Up-state number), the instantaneous frequency and the 
percentage of large amplitude events.  
4.2.7. Statistical analysis 
As described in methods section 2.2.8, the data was first checked for a normal 
distribution and homoscedasticity and if necessary transformed to achieved these 
criteria. Specifically, we performed a logarithmic transformation for power on the Up- 
and Down-states and the mean peak power for all frequency bands in the mPFC and 
CA1, to achieve a normal distribution. Non-parametric Mann-Whitney U-test with a 
Welch exact-correction analysis was performed for the SWR data and the SO 
coherence between the CA1 and mPFC subregions. The later analysis was considered 
preliminary due to the small sample size: WT (N=5) and A30P (N = 6). Hence, we did 
not account for the relationship between mPFC subregions. The non-parametric data 
are presented as median and interquartile range (IQR). 
For the rest of the data that was normally distributed, we performed mixed 
rmANOVA analyses where mPFC subregion (4 levels) was set as the within-subjects 
variable and the animal genotype as the between-subjects variable. Differences 
between mPFC subregions were out of the scope of this study, however proceeded 
with mPFC subregions as a repeated measure to identify any mixed effects / 
interactions with the genotype (Gretenkord et al., 2017). The outcome of the rmANOVA 
analysis for the mPFC subregion is reported and if the assumption of sphericity was 
violated a Huyhn-Feldt correction was applied. If a significant difference was found for 
genotype or a subregion/genotype interaction, follow-up univariate ANOVA analysis 
with a Bonferroni correction was performed for each mPFC subregion. Univariate 
ANOVA analysis was also performed for unit data, as we combined units from all 
subregions of the mPFC. Parametric data is presented as mean ± standard error of 




4.3.1. Characterisation of the SO cycle in the mPFC of A30P mice  
In order to assess the impact of α-syn on the generation of SWS we used 
urethane anaesthesia which, as described previously, induces a regular SO in both the 
mPFC and CA1 of the hippocampus in WT animals (Clement et al., 2008; Pagliardini 
et al., 2013; Destexhe et al., 1998; Gretenkord et al., 2017). Under urethane 
anaesthesia in both genotypes in addition to regular SO, we also observed regular 
periods where the fast oscillations associated with the SO showed a marked increase 
in power (ISM) but as outlined in section 2.2.5.1, these are excluded in this analysis. 
4.3.1.1. A30P mice have altered SO cycle patterns in the mPFC  
Recordings in the mPFC showed robust SO in both WT and A30P mice (Figure 
4.1A). Thus, we proceeded to characterise and compare the SO amplitude, frequency 
and the lengths of the Up- and Down-states that compose it, in the mPFC subregions, 
in the two animal genotypes (Figure 4.1B). 
RmANOVA analysis revealed that the frequency of the SO in the mPFC was 
significantly faster in A30P mice compared to WTs (F(1, 19) = 9.64, p < 0.01) in all 
subregions of the mPFC. As expected, the SO cycle length was significantly shorter in 
A30P mice (F(1, 19) =9.41, p = 0.01), in all subregions of the mPFC. This change in 
SO frequency could be due to shorter Up- and/or Down-states in A30P mice compared 
to WTs. Therefore, we analysed the Up- and Down-states separately and found that 
the Up-state was significantly shorter (F(1, 19) = 5.93, p < 0.05) and less variable over 
time (F(1, 19) = 10.14, p < 0.01) in the IL and PrL regions in A30P mice. In addition, 
the Down-state was also significantly shorter F(1, 19) = 9.63, p < 0.01) and less 
variable (F(1, 19) = 14, p < 0.001) in all mPFC subregions in A30P mice. Consequently, 
the SO cycle length variability (F(1, 19) = 15.96, p < 0.01) was also significantly lower 
in A30P compared to WT animals. The amplitude of the SO was not significantly 
different between the WT and A30P mice (Table 4.1). 
 A significant overall effect of region was found for Down-state length (F(3, 57) 
=7.64, p < 0.01) and SO cycle length (F(2.115, 48.65) =7.65, p < 0.01), with lower 
values found in the ACC compared to the IL and DP (p < 0.05). Cycle length variability 
over time was also affected by region (F(3, 57) =6.48, p < 0.01), with the ACC showing 
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greater variability than the IL (p < 0.01) and DP regions (p < 0.05). Regarding the SO 
amplitude (F(3, 57) = 11, p < 0.01), the ACC had a significantly smaller SO amplitude 
than the DP (p < 0.001), PrL (p < 0.01) and IL regions (p < 0.05). No interactions were 
found between the genotype and region. 
Our findings indicate that A30P mice have a faster SO oscillation than WT 
animals that can be attributed mostly to shorter Down-states as well as shorter Up-
states and hence SO cycles. We also observed lower state length variability over time 
in A30P animals, suggesting a shortage of longer states.  
 
Table 4.1: Characterisation of the SO cycle in the mPFC of WT and A30P mice. The 
average of each variable ± SEM is shown for each of the four subregions of the mPFC 
(ACC, PrL, IL, DP), in WT (N = 13) and A30P (N = 8) mice. Variables also shown in 
Figure 4.1 are in Italics.  
 
Variable Genotype Region 
  ACC PL IL DP 
SO amplitude 
(mV) 
WT 0.43 ± 0.04 0.49 ± 0.06 0.55 ± 0.05 0.52 ± 0.04 
A30P 0.34 ± 0.03 0.42 ± 0.04 0.47 ± 0.03 0.47 ± 0.03 
SO frequency 
(Hz) 
WT 0.26 ± 0.02 0.28 ± 0.02 0.3 ± 0.02 0.29 ± 0.02 
A30P 0.36 ± 0.02 0.37 ± 0.02 0.37 ± 0.02 0.37 ± 0.02 
SO cycle length 
(s) 
WT 3.78 ± 0.32 3.47 ± 0.2 3.28 ± 0.17 3.32 ± 0.15 
A30P 2.89 ± 0.16 2.79 ± 0.13 2.77 ± 0.11 2.72 ± 0.12 
Up-state length 
(s) 
WT 1.47 ± 0.16 1.33 ± 0.08 1.33 ± 0.07 1.28 ± 0.05 
A30P 1.21 ± 0.04 1.16 ± 0.02 1.2 ± 0.03 1.16 ± 0.03 
Down-state 
length (s) 
WT 2.32 ± 0.17 2.14 ± 0.13 1.97 ± 0.14 2.05 ± 0.12 
A30P 1.75 ± 0.12 1.66 ± 0.1 1.65 ± 0.1 1.59 ± 0.1 
SO cycle length 
SD (s) 
WT 2.43 ± 0.28 2.22 ± 0.19 2.06 ± 0.21 2.15 ± 0.21 
A30P 1.45 ± 0.14 1.37 ± 0.12 1.3 ± 0.11 1.25 ± 0.13 
Up-state length 
SD (s) 
WT 0.69 ± 0.09 0.65 ± 0.08 0.64 ± 0.07 0.59 ± 0.04 
A30P 0.52 ± 0.04 0.46 ± 0.01 0.49 ± 0.02 0.45 ± 0.02 
Down-state 
length SD (s) 
WT 2.07 ± 0.27 1.91 ± 0.18 1.72 ± 0.22 1.86 ± 0.21 








Figure 4.1: Changes in the SO cycle in the mPFC of A30P animals. A) An example of 
Up- and Down-state detection in the ACC of a WT and an A30P mouse, and a 
spectrogram showing power in the beta/gamma frequency range. B) The Up-Down 
cycle characteristics examined are: the SO frequency (0.1 – 0.9 Hz), the mean length 
of the Up-state and Down-state and the mean Up-state, Down-state and SO cycle 
(Down-state + Up-state) length variability over time. Each variable is investigated in 
the 4 subregions of the mPFC (ACC, PrL, IL, DP), in WT (N = 13; blue) and A30P (N 
=8; grey) mice. Measures of variability reflect the SD of the mean for each variable, 
over time. Error bars indicate the SEM and asterisks indicate significance: * = p < 0.05, 
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4.3.1.2. A30P mice have an altered distribution of high frequency activity in the 
SO cycle in the mPFC  
Next, we looked at the power content of the SO (Figure 4.1A; Figure 4.2). 
Normally, neuronal firing and hence higher-frequency activity is restrained on the Up-
state of the SO, while the Down-state is neuronally “silent” (Steriade et al., 1993a). 
Hence, we examined the average power content of the Up-state and Down-state, and 
the peak power and its latency in the SO cycle in 3 frequency bands: beta (15 – 29.9 
Hz), gamma (30 – 79.9 Hz) and high-gamma (80 – 129.9 Hz), in the mPFC subregions 
of 8 WT and 13 A30P animals (Figure 4.2; Table 4.2). 
Our rmANOVA analysis revealed significant differences between A30P and WT 
animals only in the latency to the beta (F(1,19) = 6.36, p < 0.05; Figure 4.2A) and 
gamma (F(1,19) = 6.81, p < 0.05; Figure 4.2B) peak power in the IL and PrL regions. 
The normalized SO cycle consists of the Down- followed by the Up-state, where 0 is 
the beginning of the Down-state, 50 is the Down-to-Up-transition and 100 the Up-state 
termination. Hence, in the case of the PrL region for example, the beta peak latency of 
61.48 % ± 0.8 % in A30P animals is greater than the beta peak latency of 58.53 % ± 
0.84 % in WT animals. Thus, the beta peak power is “delayed” on the Up-state in A30P 
animals as it comes at a later point in the SO cycle, although it still occurs on the Up-
state as the latency is greater than 50. The high frequency power-related variables that 
were not significantly different between genotypes are shown in Appendix A. 
We also found a significant effect of region in a number of power-related 
variables, but not an effect of genotype or a genotype/region interaction and hence, 
we characterised this regional difference in A30P and WT animals combined. The 
mean power on the Up-state in the beta (F(1.83, 30.59) = 5.81, p < 0.01) and gamma 
bands (F(1.94, 36.89) = 10.06, p < 0.001) was greater in the PrL region compared to 
the DP (p < 0.01) and IL (p < 0.05) regions. Regarding the peak power, we found a 
significant effect of region in the beta peak power (F(1.84, 34.99) = 7.27, p < 0.001), 
with a greater peak power in the PrL compared to the DP (p < 0.01) and IL (p < 0.05) 
subregions and in the DP compared to the IL subregion (p < 0.05). The gamma peak 
power (F(2.01, 38.09) = 11.58, p < 0.001) was lowest in the DP compared to the IL (p 
< 0.05), PrL (p < 0.001) and ACC (p < 0.01), and the second lowest in the IL subregion 
as it was shorter than the PrL (p < 0.01). Finally the high-gamma peak (F(2.381, 45.18) 
= 5.16, p < 0.01) had a greater peak in the PrL compared to the DP (p < 0.05) region. 
Thus, power and the peak-power on the Up-state are greater in the dorsal mPFC, 
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mostly the PrL subregion, compared to the ventral mPFC (Table 4.2). In summary, no 
significant differences were found between WT and A30P animals in the average 
power on the Up- and Down-state, or in the peak power, in any frequency band. 
However, we found that the distribution of power on the Up-state is altered in A30P 
animals, as is evident from a greater latency to peak power in both the beta and gamma 
frequency bands. The beta band peak power also appears to have a bimodal peak 
distribution in A30P animals, but we only investigated the location and peak of the first 
maximum point and hence have no statistical evidence regarding this observation. The 
average power on the Up-state and the peak power in all frequency bands had a dorsal 





Table 4.2: Characterisation of the high frequency oscillatory activity in the SO cycle, 
in the mPFC of WT and A30P mice. The average of each variable ± SEM are shown 
for 3 frequency bands (Beta, Gamma, High-Gamma), in the mPFC subregions (ACC, 
PrL, IL, DP), in WT (N = 8) and A30P (N = 13) mice. Variables also shown in Figure 
4.2 are in Italics. 
 
 Band Genotype Region 























WT 9.28 ± 1.7 10.34 ± 1.39 7.64 ± 1.37 6.77 ± 1.19 
A30P 16.62 ± 3.51 12 ± 1.76 8.5 ± 1.22 6.98 ± 1.04 
Gamma 
WT 21.50 ± 4.75 19.78 ± 2.72 15.76 ± 3.27 11.95 ± 2.29 
A30P 29.93 ± 5.95 23.52 ± 3.49 15.99 ± 3.09 12.49 ± 2.33 
High-
Gamma 
WT 10.11 ± 1.94 9.26 ± 1.17 7.41 ± 1.2 6.78 ± 1.24 

























WT 4.41 ± 0.9 4.03 ± 0.7 3.16 ± 0.36 2.71 ± 0.53 





39.57 ± 4.6 
Gamma 
WT 8.29 ± 1.9 8.01 ± 1.9 6.41 ± 0.93 5.91 ± 1.41 
A30P 12.7 ± 2.55 8.56 ± 1.54 7.37 ± 1.68 7.02 ± 1.53 
High-
Gamma 
WT 6.53 ± 1.46 6.29 ± 1.26 5.71 ± 0.94 5.51 ± 1.14 







































53.48 ± 8.68 
High-
Gamma 




























WT 57.38 ± 2.43 58.53 ± 0.84 58.77 ± 1.13 60.72 ± 1.33 
A30P 60.35 ± 1.28 61.48 ± 0.8 63.22 ± 0.94 64.28 ± 1.43 
Gamma 
WT 67.17 ± 1.07 61.94 ± 1.02 60.41 ± 1.83 62.73 ± 0.86 






48.9 ± 8.66 40.01 ± 8.6 36.85 ± 8.42 




Figure 4.2: Changes in the distribution of the high frequency oscillatory power on the 
normalised SO cycle in the mPFC of A30P animals. The latency of the peak power in 
the A) beta (15 – 29.9 Hz) and B) gamma (30 – 79.9 Hz) frequency bands is shown 
for in the SO cycle (0 = start of Down-state, 50 = Down to Up-state transition,100 = 
end of Up-state), in the mPFC subregions (ACC, PrL, IL, DP), in A30P (N = 13) and 
WTs (N = 8) animals. Error bars indicate the SEM and asterisks indicate significance: 



















































































4.3.2. Characterisation of the SO cycle in hippocampus of A30P mice  
As shown by Wolansky et al., (2006), SOs are readily observed in the CA1 region 
of the hippocampus under urethane anaesthesia. Recordings in the CA1 of the 
hippocampus showed robust SO in both WT (N = 7) and A30P (N = 8) mice (Figure 
4.3A). Hence, we proceeded with similar analyses of the SO characteristics and its 
power content for this region (Figure 4.3).  
4.3.2.1. A30P mice have altered SO cycle patterns in the hippocampus  
Consistent with the changes outlined above for the mPFC, our analysis revealed 
that the hippocampal SO was also significantly faster in A30P mice compared to WTs 
(F(1, 13) = 17.57, p < 0.01). The increased SO frequency in A30P animals can be 
attributed to a shorter SO cycle length (F(1, 13) = 14.54, p < 0.01), composed of both 
shorter Up- (F(1, 13) = 6.49, p < 0.05) and Down-states  (F(1, 13) = 10.19, p < 0.01). 
Moreover, the state-length variability over time was lower in both Up- and Down-states: 
SO cycle (F(1, 13) =18.07, p < 0.01), Up-state (F(1, 13) = 8.27, p < 0.05) and Down-
state (F(1, 13) = 13.65, p < 0.01). Again, as observed in the mPFC, the SO amplitude 
did not differ between WT (0.56 ± 0.06 mV) and A30P mice (0.45 ± 0.05 mV). Thus, 
the SO is clearly faster in the CA1 of A30P animals as well as the mPFC, due to shorter 
Up- and Down-state and lower state-length variability that could indicate a reduction in 
the number of longer states (Figure 4.3B).  
4.3.2.2. A30P mice have an altered distribution of high frequency activity in the 
SO cycle in the hippocampus  
Higher-frequency oscillations are also nested on the Up-state of the hippocampal 
SO (Sharma et al., 2010; Figure 4.3A). Univariate ANOVA analysis for the power 
content of the SO, revealed increased latency to peak power in the normalised SO 
cycle in the gamma frequency band in A30P mice (F(1,13) = 5.48, p < 0.05). We did 
not see a shift of the beta peak power but this is expected as beta activity has only 
been described as a functional rhythm in the hippocampus during exploration (Berke 
et al., 2008; Leung, 1992). Thus, similar to the mPFC we found a delay in the 
occurrence of the gamma peak power on the Up-state, but we did not find any 
differences in the average power of fast-oscillatory activity on the Up- or Down-states 
(Figure 4.3C; Table 4.3). The data that was not significantly different between 
genotypes is shown in Appendix B. 
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Table 4.3: Characterisation of the high frequency oscillatory power in the SO cycle in 
the hippocampus of WT and A30P animals. The average of each variable ± SEM is 
shown for 3 frequency bands (beta, gamma, high-gamma), for the WT (N = 7) and 
A30P (N = 8) animal groups. Variables also shown in Figure 4.3 are in Italics. 
Variable Band WT A30P 
Power on the Up-
state (x103) 
Beta 40.86 ± 12.5 68.21 ± 8.42 
Gamma 76.8 ± 25.55 95.21 ± 14.95 
High-gamma 18.26 ± 5.28 24.49 ± 4.64 
Power on the 
Down-state (x103) 
 
Beta 17.45 ± 4.07 31.8 ± 6.03 
Gamma 27.5 ± 6.21 49.69 ± 12.03 
High-gamma 7.2 ± 1.78 16.47 ± 3.31 
Peak power (x103) 
 
Beta 60.36 ± 3.26 66.34 ± 1.68 
Gamma 59.47 ± 2.77 66.71 ± 1.38 
High-gamma 59.12 ± 1.79 63.9 ± 1.52 
Latency to peak 
power 
 
Beta 269.56 ± 115.57 292.02 ± 34.24 
Gamma 494.7 ± 211.99 445.33 ± 68.38 





Figure 4.3: Changes in the SO cycle in the hippocampus of A30P mice. A) Example 
of Up- and Down-state detection in relation to beta/gamma frequency power. B) The 
SO frequency, the mean length of the Up-state (UD), Down-state (DS) and SO cycle 
and the mean Up-state, Down-state and Up-Down cycle length variability over time 
(SD), in WT (N = 7; blue) and A30P (N = 8; grey) mice. C) Changes in the distribution 
of beta (15 – 30 Hz), gamma (30 – 80 Hz) and high-gamma (80 – 130 Hz) power in the 
SO cycle, in the CA1 of WT (N = 7; blue) and A30P (N=7; grey) mice. The bar chart 
shows the latency of the peak of power in the normalised SO cycle for the different 
frequency bands. The distribution of gamma power is shown in the normalised SO 
cycle (0 = start of Down-state, 50 = Down’ to Up-state transition,100 = end of Up-state), 
in A30P (N = 7) and WT animals (N = 7). Measures of variability reflect the SD of the 
mean for each variable, over time. Error bars indicate the SEM and asterisks indicate 
statistical significance: * = p < 0.05, ** = p < 0.01.  
Instantaneous beta/gamma area power 
 











































4.3.3. A30P mice have altered neuronal firing patterns in relation to the SO 
 During the SO, neurons fire predominantly on the Up-state of the field potential, 
which corresponds to depolarization of the cortical pyramidal cells (Figure 4.4A; 
Steriade et al., 1996; Dang-Vu et al., 2008). It is possible that abnormal α-syn 
expression in A30P mice could lead to changes in the neuronal firing. Therefore, we 
looked for differences in spike frequency and ISI on the Up-state and for the recording 
duration, the latency to the first spike on the normalized SO cycle, and the percentage 
of firing occurring on the Down-state. Measurements were made for neurons in the 4 
subregions of the mPFC combined in both A30P (N = 15 mice; N = 56 units) and WT 
animals (N = 7 mice; N = 28 units) (Figure 4.4; Table 4.4; Table 4.5). The maximum 
unit firing / SO coherence was also investigated in 12 A30P and 7 WT animals, with 
50 and 23 units respectively.  
The unit firing frequency and ISI on the Up-state and for the recording duration 
were not significantly different between WT and A30P animals, neither was the latency 
to the first unit on the Up-state (Table 4.5). However, in A30P mice the percentage of 
total neuronal firing occurring on the Up-state was significantly lower compared to WT 
animals (F (1, 20) = 4.75, p < 0.05; Table 4.5; Figure 4.4B,C), suggesting altered 
neuronal firing in relation to the SO cycle. Indeed when we analysed the unit firing / 
SO coherence we found that it was significantly lower in A30P compared to WT 
animals (F (1,17) = 4.95, p < 0.05). Our findings suggest that while there is no increase 
in neuronal firing in A30P animals, there is an increase in the percentage of “abnormal” 
firing on the Down-state. This shift of firing to the Down-state explains the decreased 





Table 4.4: The number of units and the mPFC subregion they were recorded from: 
ACC, IL, PrL, DP, in WT (N = 7; units = 23) and A30P animals (N = 15; units = 56).  
 
Table 4.5: Characterisation of the unit firing patterns in the mPFC of WT and A30P 
mice. The average of each variable ± SEM are shown for the WT (N = 7) and A30P (N 
= 15) mice, with 23 and 56 units respectively, except the unit firing / SO coherence: 
WT (N = 7; 23 units) and A30P (N = 12; 50 units). Variables also shown in Figure 4.4 
are in Italics. 
Variable WT A30P 
Spike frequency / recording 
duration (Hz) 
1.28 ± 0.19 1.58 ± 0.28 
Spike frequency on the Up-state 
(Hz) 
2.76 ± 1.47 3.39 ± 2.71 
ISI / recording duration (s) 1.04 ± 0.23 1.83 ± 0.65 
ISI on the Up-state (s) 0.29 ± 0.06 0.38 ± 0.05 
Percentage of firing on Up-state 
(%) 
89.87 ± 2.18 80.33 ± 3.38 
Percentage of firing on Down-
state (%) 
10.13 ± 2.18 19.67 ± 3.38 
Latency to the first unit on Up-
state 
61.85 ± 1.47 65.04 ± 1.33 
Unit firing / SO coherence 0.68 ± 0.06 0.57 ± 0.05 
Unit firing / SO coherence 
frequency (Hz) 
0.4 ± 0.05 0.45 ± 0.03 
 A30P animals 
Units / 
Region 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
ACC - - - - 1 1 - - 1 - 1 - 2 1 - 
PrL 2 2 - - 1 - - - 2 2 - 1 - 1 - 
IL 3 4 1 - 5 - 1 1 1 1 1 - - - 1 
DP 3 1 - 1 2 - 1 1 - 3 1 - - - 1 
 WT animals 
Units / 
Region 
1 2 3 4 5 6 7 
ACC - - 2 1 2 1 - 
PrL - 2 - - 2 - 2 
IL 1 1 - - 2 - 2 




















Figure 4.4: Changes in the unit firing patterns in relation to the SO in the mPFC of  
A30P mice. A) Example raster plots showing unit firing in relation to an ACC channel 
in a WT and an A30P mouse. B) The percentage of the total firing occurring on the 
Down-state, for all the units recorded from WT (N = 8, black) and A30P (N = 15, red) 
animals, across all mPFC subregions:  ACC (WT = 5/7 , A30P = 9/13 ), PrL ( WT = 
3/6, A30P = 8/16), IL (WT = 4/5, A30P = 7/13) and DP (WT = 4/5, A30P = 7/9). C) The 
percentage of firing on the Down-state for each mPFC subregion is shown but it was 
not statistically investigated. D) The average unit firing / SO coherence across all units 
recorded from each animal (WT = 8, A30P = 12), for all mPFC regions combined: ACC 
(WT = 5/7 , A30P = 10/15 ), PrL (WT = 3/6, A30P = 9/19), IL (WT = 4/6, A30P = 9/19) 
and DP (WT = 5/7, A30P = 6/12). Numbers indicate the N of animals / N of units. Error 














4.3.4. No changes in mPFC/CA1 SO coherence in A30P mice 
Due to the small size of the mouse brain we could only record simultaneously 
from the mPFC and hippocampus from contralateral hemispheres. However, these 
contralateral recordings have been previously shown to be synchronous with one 
another (Gordon et al., 2011). Mann-Whitney U-test with a Welch exact-correction for 
the dual recordings from WT (N = 5) and A30P (N = 6) animals showed no changes in 
coherence between the CA1 of the hippocampus and any of the mPFC subregions 
(Figure 4.5). As mentioned above, we did not investigate for an effect of mPFC 
subregion as this analysis is considered preliminary due to the small sample size.  
 
 
Figure 4.5: The maximum hippocampal/mPFC SO coherence and its frequency in 
A30P and WT mice. The median SO coherence ± IQR and the median frequency at 
maximum coherence ± IQR are shown for the four subregions of the mPFC (ACC, PrL, 




4.3.5. Sleep spindles are altered in the mPFC of A30P mice 
 Sleep spindles play a critical role in memory consolidation (Siapas & Wilson, 
1998) and are altered in DLB patients (Fernández-Arcos et al., 2019). Therefore, we 
compared the spindle properties between WT and A30P animals. Sleep spindles (8 - 
15 Hz) with a duration > 0.3 s, were observed in the LFP (Figure 4.6Α), in all subregions 
of the mPFC in both WT (N = 8) and A30P mice (N = 13). Instantaneous spindle 
frequency was not significantly different across the mPFC subregions, nor between 
WT and A30P mice. The average instantaneous spindle frequency in the mPFC 
(averaged across regions) was 10.65 Hz ± 0.039 Hz in WT and 10.7 Hz ± 0.06 Hz in 
A30P mice, values that are consistent with spindle frequencies recorded in the mPFC 
in other studies under urethane anaesthesia (Barthó et al., 2014). Moreover, as 
reported previously (Jobert et al., 1992), spindles were found to occur at the beginning 
of the Up-state in both A30P (62.3 ± 1.26) and WT (56.2 ± 1.14) animals in the 
normalized cycle (1 = Down-state beginning, 50 = Up-Down transition, 100 = Up-state 
termination΄Figure 4.6; Table 4.6). 
Although there was no difference in spindle frequency between WT and A30P 
animals, the spindle duration was significantly shorter in A30P mice compared to WT 
(F(1, 19) = 14.21, p < 0.01), in all mPFC subregions (p < 0.01). Spindle length was 
also less variable over time in A30P animals (F(1, 19) = 6.6, p < 0.05) in the DP, IL and 
PrL regions. Spindle amplitude was not significantly different between A30P and WT 
animals. Interestingly, spindle amplitude variability was significantly lower in A30P 
compared to WT animals (F(1, 19) = 8.27, p < 0.01) in the PrL and DP subregions, 
with a trend for the other subregions as well. These findings could suggest that A30P 
mice have fewer spindles of high amplitude compared to WT mice. See Figure 4.6B 
for the full comparison and Table 4.6 for all the values. 
To determine whether A30P mice have fewer high amplitude spindles, we 
looked at the percentage of spindles exceeding a threshold of mean amplitude + 5*SD. 
As expected, A30P animals had a significantly lower percentage of high-amplitude 
spindles (F(1, 19) = 6.17, p < 0.05) in all subregions. Finally, we compared the total 
number of spindles occurring on the Up-states in A30P compared to WT animals. 
When looking at the number of spindles occurring in relation to the total recording 
duration (absolute spindle density) we found no significant difference between the two 
groups. However, when looking at the number of spindles in relation to the number of 
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Up-states (relative spindle density) we found a significant decrease in A30P mice 
(F(1,19) = 4.71, p < 0.05), in the ACC and PrL regions, with a similar trend in the other 
subregions (Figure 4.6B; Table 4.6).  
We also found a significant effect of region in a number of variables but not a 
region/genotype interaction. Hence, we proceeded to characterise regional differences 
in the WT and A30P mice combined. A significant effect of region was identified 
(F(1.74, 33.05) = 14.76, p < 0.001) in spindle length, with longer spindles occurring in 
the DP and IL compared to the PrL (p < 0.001) and ACC (p < 0.05) subregions. 
Moreover, there was lower spindle length variability (F(2.04, 38.75) = 12.31, p < 0.001) 
in the PrL and ACC compared to the DP and IL subregions (p < 0.05). Spindles were 
also of shorter amplitude (F(2.29, 43.53) = 7.14, p < 0.01) in the DP compared to all 
the other subregions (p < 0.05), and had a lower spindle amplitude variability (F(2.16, 
41.01) = 4.77, p < 0.05) in the DP compared to the PrL (p < 0.01) subregion. Moreover, 
the number of high-amplitude spindles (F(2.17, 41.22) = 7.99, p < 0.001) was lower in 
the DP compared to the ACC, IL (p < 0.01) and PrL (p< 0.05) subregions, and in the 
IL compared to the PL (p < 0.05) subregion. Finally, the number of spindles/Up-state 
(F(2.05, 39.03) = 13.21, p < 0.001) was highest in the ACC compared to the other 
regions (p < 0.01).   
In conclusion, we found that the instantaneous spindle frequency was not 
significantly different between A30P and WT animals, but the length of the spindle was 
shorter in A30P animals. Moreover, although the average spindle amplitude did not 
differ between A30Ps and WT animals, A30P mice had lower spindle amplitude 
variability over time and fewer high-amplitude spindles. In addition, A30P mice had a 
lower relative spindle density (spindle no / Up-state) but not absolute spindle density 
(spindle no / recording duration), suggesting that the increased SO frequency in these 
animals (section 4.3.1) compensates for the total spindle number. However, A30P 
have fewer spindles per Up-state. This decrease in relative spindle density in A30P 
mice might be the result of an incapacity to produce longer and larger amplitude 
spindles. Finally, the regional differences we found suggest that more dorsal areas of 




Table 4.6: Sleep spindle characterisation in the mPFC region of A30P and WT 
animals. The average of each variable ± SEM is shown for the each mPFC.subregion 
(ACC, PrL, IL, DP), in A30P (N = 13) and WT (N = 8) animals. Variables also shown in 
Figure 4.6 are in Italics. 
 
Variable Genotype Region 



































59.91 ± 2.1 
63.45 ± 
1.57 
65.3 ± 1.78 
Absolute 
spindle density 
WT 0.33 ± 0.01 0.31 ± 0.01 0.31 ± 0.02 0.31 ± 0.02 
A30P 0.3 ± 0.01 0.28 ± 0.01 0.29 ± 0.02 0.29 ± 0.02 
Relative 
spindle density 
WT 1.25 ± 0.14 1.08 ± 0.1 1.02 ± 0.1 1.01 ± 0.09 
A30P 0.86 ± 0.06 0.79 ± 0.06 0.8 ± 0.07 0.79 ± 0.07 
Spindle length 
(s) 
WT 0.39 ± 0.01 0.39 ± 0.01 0.41 ± 0.01 0.41 ± 0.02 
A30P 0.36 ± 0.01 0.35 ± 0.01 0.37 ± 0.01 0.38 ± 0.02 
Spindle length 
variability (s) 
WT 0.16 ± 0.02 0.16 ± 0.01 0.19 ± 0.02 0.2 ± 0.03 
A30P 0.16 ± 0.02 0.14 ± 0.01 0.16 ± 0.02 0.17 ± 0.03 
Spindle 
amplitude (μV) 
























































Figure 4.6: Changes in the sleep spindle characteristics in the mPFC of A30P mice. 
A) Examples of spindles including the LFP, the spindle-band passed LFP and 
detection of the spindle, in the ACC of a WT and an A30P animal. B) The 
characteristics of the spindles that were analysed including the spindle density per Up-
state number, the spindle length and length variability over time, the spindle amplitude 
and amplitude variability over time and the percentage of “high amplitude” spindles. 
Measures of variability reflect the SD of the mean for each variable, over time. These 
variables were extracted for the four subregions of the mPFC (ACC, PrL, IL, DP) in WT 
(N = 8, grey) and A30P (N = 13, blue) mice. Error bars indicate the SEM and asterisks 




4.3.6. Hippocampal SWRs are normal in A30P mice 
 As cortical spindles are temporally correlated with hippocampal SWRs (Siapas 
& Wilson, 1998; Clemens et al., 2011), which also play a critical role in memory 
consolidation (Witton et al., 2016). We therefore also looked at hippocampal SWRs 
recorded in the CA1 pyramidal cell layer in A30P (N = 6) and WT (N = 7) mice (Table 
4.7). SWRs had an instantaneous frequency of 87.48 ± 6.46 Hz in WTs and 83.43 ± 
1.73 Hz in A30P animals. Moreover, they were located at the beginning of the SO 
cycle, with a latency of 59.58 ± 8.3% Hz in WTs and 61.84 ± 6.45% in A30P animals. 
Somewhat surprisingly we found no significant differences between ripples in any of 
the variables tested including the instantaneous ripple frequency, ripple duration, ripple 
amplitude and in the variability over time of these measures. Furthermore, the total 
number SWRs and the number of SWRs per Up-state were also not significantly 
different between genotypes.  
 
Table 4.7: Characterisation of sharp wave ripples (SWR) in the CA1 of the 
hippocampus in WT and A30P animals. The median of each variable ± IQR is shown 
for WT (N = 7) and A30P (N = 6) mice.  
 
Variable WT A30P 
Length (ms) 194.8 ± 74.37 160.64 ± 32.47 
Length variability (μs) 90.7 ± 28.3 88.02 ± 14.5 
Amplitude (μV) 34.63 ± 16.13 28.34 ± 12.45 
Amplitude variability (μV) 11.51 ± 7.79 9.77 ± 11.06 
Ripple no. / recording duration 
(s) 
0.16 ± 0.06 0.13 ± 0.05 
Ripple no. / cycle no.(x1000) 1.13 ± 0.91 1.24 ± 5.48 
Latency in the SO cycle (%) 59.58 ± 8.3 61.84 ± 6.45 
Peak in the SO cycle  24.6 ± 15.27 24.04 ± 4.79 
Instantaneous frequency (Hz) 87.48 ± 6.46 83.43 ± 1.73 
Instantaneous frequency 
variability (Hz) 






4.4.1. Summary of the main findings  
The key findings of our analysis of the SO in A30P compared to WT animals are 
presented below: 
 In the mPFC and CA1 region of the hippocampus, A30P mice had an increased 
SO frequency due to a decrease in Down- and Up-state length and a decrease 
in state-length variability over time.  
 A30P animals had an increased latency to the peak power in the beta and 
gamma bands on the Up-state in the mPFC region, and in the gamma band in 
the hippocampus. No other changes were found in relation to the high frequency 
oscillatory power in the SO cycle. 
 In the mPFC region, A30P animal had aberrant neuronal firing, indicated by a 
greater percentage of the total neuronal firing occurring on the Down-state and 
a lower coherence between unit firing and the SO. 
 A30P animals had fewer spindles per Up-state, a shorter spindle duration, lower 
spindle amplitude variability over time and fewer high-amplitude spindles.  
 No differences we found in SWR characteristics and in SO coherence between 
the CA1 and mPFC regions, between A30P and WTs mice.  
4.4.2. A30P mice have aberrant neuronal firing in the mPFC 
Two of the most interesting findings of this study are the increase in percentage 
firing occurring on the Down-state and the decrease in SO/unit firing coherence, in 
A30P animals compared to WT animals. These findings indicate aberrant neuronal 
firing as a consequence of early α-syn pathology, which might reflect an early cortical 
network hyperexcitability. We did not find any differences in unit frequency on the Up-
state (spike no / total time on Up-state), suggesting that the unit firing is untimely, but 
not excessive. Moreover, although we have not analysed unit data from the 
hippocampus, we have previously shown in our lab that CA3 slices from young A30P 
animals have a more depolarised resting membrane potential and show epileptiform 
activity in vitro (Tweedy et al., 2018). The CA1 region of the hippocampus receives 
projections from the CA3 through the Schaffer collaterals and thus, is alllso likely to be 
hyperexcitable in A30P mice.  
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Our findings of aberrant neuronal activity in A30P mice are consistent with an 
increasing number of studies in support of hyperexcitability in relation to dementia and 
DLB, in humans and animals models (Vossel et al., 2017; Jin et al., 2018; Morris et al., 
2015; Beagle et al., 2017). Hyperexcitability was shown molecularly through the use of 
molecular markers  in pyramidal neurons (Palop et al., 2011; Palop & Mucke, 2009; 
Drexel et al., 2012), and electrophysiologically in vitro and in vivo, in animal models of 
Aβ and Tau aggregation (Palop et al., 2007; Noebels, 2011; Busche et al., 2012; Vucic 
et al., 2008). In relation to DLB, one study has provided molecular evidence of network 
hyperexcitability in the hippocampus of both DLB patients and a mouse model 
overexpressing α-syn (Morris et al., 2015). Moreover, DLB patients had a high-
prevalence of myoclonus while the α-syn mice had clear epileptic/epileptiform activity 
in the parietal cortex, over the hippocampus (Morris et al., 2015). Although the 
mechanism by which pathological α-syn can induce hyperexcitability is currently 
unknown, in the next paragraphs I will examine how our findings in A30P animals may 
be related to neuronal hyperexcitability and other α-syn related mechanisms.  
4.4.3. The SO frequency is faster and the Up- and Down-states are shorter in 
A30P animals  
Another main finding of this study was an increase in the SO frequency recorded 
under urethane anaesthesia, in both the mPFC and CA1 of A30P animals. The 
consequent decrease in the SO cycle period was mostly attributed to a decrease in 
Down-state length and to a lesser extent, a decrease in Up-state length. We also saw 
a decrease in Down-state length variability over time that may have contributed to the 
decreased SO frequency through the loss of longer Down-states. Considering that the 
SO cycle relies on a balance between the mechanisms that initiate, maintain and 
terminate the Up-state and Down-states (Introduction section 1.4.2; Neske, 2015), we 
believe that this balance has been altered in young A30P animals. In fact, previous 
studies have shown a relationship between an increase in SO frequency and 
hyperexcitability (Busche et al., 2015). In a mouse model of Aβ, a net decrease in 
Down-state duration was observed that was accompanied by disturbances in long-
range synchrony. Both defects were reversed after enhancing GABAAR function 
(Busche et al., 2015). In another study, the optogenetically-induced increase in SO 
frequency induced hyperexcitability in the hippocampus of an Aβ model of AD 
(Kastanenka et al., 2019). Thus, it is highly possible that the network hyperexcitability 
can influence the SO in A30P animals, and vice versa.  
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Although the hippocampus has a local SO generator (Lockmann et al., 2016; 
Wolansky et al., 2006; Sharma et al., 2010), the SO in the CA1 is heavily influenced 
by the cortex (Vertes et al., 2007; Beckstead, 1979; Sesack et al., 1989). Hence, it is 
possible that the changes in the SO in the CA1 region of the hippocampus can be 
attributed to changes in the cortical SO. Our analysis has shown that the two regions 
oscillate coherently in the SO frequency range as previously reported (Sirota et al., 
2003), in both A30P and WT animals, suggesting that even if there is a local 
dysfunction in the hippocampus, the influence of the cortex over the CA1 persists.  
4.4.4. Altered network dynamics and hyperexcitability underlie SO 
disturbances in A30P animals 
One of our main findings is a decrease in Down-state length and less Down-
state length variability over time in A30P animals, in both the mPFC and CA1. The 
main mechanism that controls the Down-state are K+ conductances, which are 
activated as a result of the intense pyramidal firing during the Up-state. K+ conductance 
activation results in a decrease in synaptic currents and to widespread disfacilitation in 
the network (Timofeev et al., 2001) that prevents intrinsically firing layer 5 pyramidal 
cells from inducing another Up-state until the resting membrane potential has been 
restored (Sanchez-Vives et al., 2010). Our findings of decreased Down-state lengths 
and of increased neuronal firing on the Down-state could, therefore, relate to a failure 
of long-lasting disfacilitation.  
This hyperpolarisation/disfacilitation mechanism can be the result of disturbed 
membrane dynamics relevant to K+ and/or Ca2+ channel dysfunction or altered  
neurotransmitter receptor function (see Discussion section 7.2.3.1). In fact, previous 
work in our lab has demonstrated that CA3 pyramidal cells from young A30P animals 
have a more depolarized resting membrane potential than WT animals (Tweedy et al., 
2018), while altered membrane dynamics have been extensively reported in mouse 
models of dementia (Hall et al., 2015; Moulard et al., 2001; Hazra et al., 2013). Hence, 
if the pyramidal cells in A30P animals are capable of recovering faster from the 
refractory period, they would also more easily transition to an Up-state. Thus, Up-states 
would emerge more frequently and the Down-states would be shorter, as seen in the 
A30P mice in our study. At the same time, some neurons could also fire on the normally 
“silent” Down-state state, resulting in the greater firing on the Down-state, again as we 
have observed in A30P mice. 
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The Up-state is highly dependent on NMDAR-mediated gluatamatergic activity 
(see below section 4.4.5) and GABAergic inhibition (Haider et al., 2006). GABAergic 
PV+ basket cells contact the pyramidal cell soma while pyramidal axons contact PV+ 
interneurons, giving rise to a feedback loop where excitation is followed by equal 
amounts of inhibition. This balanced system maintains the pyramidal neurons close to 
firing threshold, thus, if the excitation/inhibition (E/I) balance is disturbed, the duration 
of the Up-state will be altered too (Haider et al., 2006). In fact, reduced GABAAR 
function can shorten Up-state duration in the ferret neocortex in vitro (Sanchez-Vives 
& McCormick, 2000). Recent data showed a decrease in PV+ interneuron numbers in 
young A30P mice (Tweedy et al., 2020, unpublished). Such a loss in inhibition on 
pyramidal neurons would result in an uncontrolled increase in the membrane potential 
of these neurons and consequently in the activation K+ conductances, the 
hyperpolarisation of the pyramidal neurons and the premature termination of the Up-
state, as seen in our experiments.  
Inhibitory activity is also actively involved in the termination of the Up-state 
(Funk et al., 2017; Zucca et al., 2017). SOM+ interneurons are particularly important, 
as GABA depletion in SOM+ interneurons induced an increase in Up-state duration in 
naturally sleeping mice (Kuki et al., 2015). This effect relied on a small population of 
SOM+ GABAA neurons in cortical layer 1, which can inhibit pyramidal cells by synaptic 
spill-over to pre-synaptic GABABRs, and distal dendrites of pyramidal cells through 
GABAARs and possibly GABABRs (Silberberg & Markram, 2007). In fact, the 
application of GABABRs antagonists in the rat EC in vitro was also shown to increase 
the Up-state duration (Mann et al., 2009). However, we must keep in mind that 
although SOM+ mediated inhibition can facilitate the synchronous termination of the 
Up-state, it is not capable of solely driving the Up-state termination (Mann et al., 2009).  
GABABRs can also be found on the presynaptic terminals of GABAergic 
interneurons in the mouse hippocampus, including PV+ and SOM+ interneurons (Liu 
et al., 2019). Presynaptic GABABRs are less efficient in influencing GABA release in 
PV+ interneurons compared to other subtypes, such as SOM+ interneurons (Sloviter 
et al., 1999). Thus, α-syn related changes in the release of GABA or its binding to 
GABABRs could affect the release of GABA in the hippocampus in an interneuron-
specific manner. If SOM+ interneurons are involved in the generation of the 
hippocampal SO, we would expect that an alteration in the release of GABA or the 
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efficiency of GABABRs could also affect the local SO, but we cannot know the extent 
and nature of the effect.  
In conclusion, both a decrease in GABAA PV+ interneuron-mediated inhibition, 
and an increase in GABAB and/or SOM+ interneuron-mediated inhibition, could result 
in a decrease in Up-state length, as seen in our A30P mice. Although we have some 
evidence that young A30P mice have a decrease in PV+ interneuron numbers 
(unpublished data), we currently have no indications about changes in SOM+ neurons 
or in the function or composition of GABABRs. We also postulate that SOM+ 
interneurons could also be hyperexcitable, exerting their inhibitory effect under lower 
depolarization levels as seen in other neurodegenerative disorders (Zhang et al., 
2016). As SOM+ interneurons are activated by pyramidal cells, if both these cell types 
are hyperexcitable, the effect of SOM+ interneurons over GABABRs on pyramidal 
neurons would be greater, terminating the Up-state earlier (Niethard et al., 2018). In 
another scenario, the function of GABABRs could be altered, resulting in earlier 
hyperpolarization of the pyramidal neurons (Gerrard et al., 2018). These ideas would 
be interesting to explore in the future.  
4.4.5. Cοmpensation mechanisms may control α-syn-related network 
hyperexcitability  
Although we have evidence of altered network dynamics in A30P mice that shift 
the E/I balance towards a more excitable state, we do not see increased neuronal firing 
or high frequency power, or a decrease in SO synchrony between the mPFC and 
hippocampus. This discrepancy might indicate the occurrence of a compensation 
mechanism in the young A30P animals used in this study (Palop et al., 2011). In vitro 
and in vivo electrophysiological studies have shown evidence of compensatory 
mechanisms taking place in relation to hyperexcitability in rodent models of epilepsy 
and AD (Palop et al., 2007; Busche et al., 2012; Noebels, 2011).  
In animal models of AD, the hyperexcitability observed in the hippocampus of 
these animals was associated with impairment in NMDARs, such as changes in the 
phosphorylation of the subunit NR2B, or loss of pyramidal spines (Palop et al., 2007). 
The Up-state is highly dependent on NMDAR-mediated gluatamatergic activity, as 
NMDAR antagonists reduce Up-state duration and can even abolish them (Major et 
al., 2013; Rebollo et al., 2018; Sanchez-Vives & McCormick, 2000; Steriade et al., 
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1993b). Our findings of α-syn-related network hyperexcitability imply a more excited, 
rather than inhibited network, but it is still possible that this hyperexcitability could co-
exist with a compensation mechanism that downregulates NMDAR function. Such 
compensatory mechanisms that limit excitation would also explain our findings of 
aberrant but not increased neuronal firing in relation to the SO cycle, and could 
contribute to the decrease in Up-state length observed in A30P animals. 
Another potential compensatory mechanism in response to hyperexcitability is 
an increase in inhibitory activity. In fact, in vitro research in our lab has shown greater 
PV+ interneuron-mediated IPSP frequency and amplitude recorded in the pyramidal 
cells in the CA3 of the hippocampus in young A30P animals (Tweedy et al., 2018). A 
scenario of a compensatory mechanism driven by increased PV+ interneuron function 
is supported by findings that these neurons express mutant α-syn in the A53T model 
of DLB (Martin et al., 2014). However, a possible PV+ interneuron-mediated 
compensation mechanism does not imply a net increase in excitation in the SO 
generating network. In fact, such a net increase in GABAAR-mediated inhibition would 
result in longer Up-states as seen in a mouse model with PV-interneuron dysfunction 
(Kuki et al., 2015), and possibly a decrease in Down-state number as seen in a mouse 
model of AD (Busche et al., 2015). Thus, PV+ interneuron upregulation might be in 
place to control the hyperexcitability and the E/I balance. 
The hyperexcitability/compensation hypothesis proposed here corresponds to an 
early stage of α-syn pathology in A30P animals, as the mice are young (2.5 - 4 months) 
and have minimal evidence of insoluble α-syn inclusion formation at this stage (Kahle 
et al., 2001; Freichel et al., 2007). It is possible that with age and increased pathology 
the compensatory mechanisms will fail, which would lead to a different SO profile in 
older A30P mice. We have actually shown in our lab that the early hippocampal 
network hyperexcitability observed in young A30P mice in vitro, is reduced by 10 
months of age (Tweedy et al., 2018). Moreover, most studies in aged animal models 
of dementia during natural sleep have reported a lower SO frequency compared to the 
age matched control mice (Castano-Prat et al., 2019; Menkes-Caspi et al., 2015). 
These studies have also reported reduced high frequency oscillatory activity and unit 
firing on the Up-state, and lower intra-cortical and interregional synchrony. Hence, it is 
possible that A30P animals could age to show a similar slowing of the SO 
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concomitantly to cell damage and ageing, but this hypothesis needs to be verified 
experimentally.   
4.4.6. Possible cholinergic/thalamic implications in the altered SO in A30P 
animals 
Another candidate mechanism for the SO alterations observed in A30P mice 
are changes in the cholinergic inputs to the cortex, which can originate from the basal 
forebrain cholinergic system. Another source of cholinergic modulation is the brainstem 
cholinergic system (PPT/LDT) projection to the thalamus that in turn contacts 
numerous cortical regions (McCormick, 1989; Wester & Contreras, 2013), including 
the mPFC (Riga et al., 2014) and the nucleus reuniens that directly contacts the CA1 
region of the hippocampus in rodents (Bertram & Zhang, 1999; Brown et al., 2012). 
Moreover, the thalamic drive is important (but not necessary) for initiating the SO in 
these animals, as it acts to synchronise the SO across the cortex and hippocampus 
(Wang & Ikemoto, 2016). Therefore, a change in the cholinergic drive could directly 
influence cortical activity directly or indirectly through influencing the thalamus 
(Lemieux et al., 2014). For example, the addition of a cholinergic drive (mACh) in in 
vitro mouse thalamocortical slices initiates the SO, while in incremental doses it 
increases the Up-state duration and frequency of spontaneous SOs (Lőrincz et al., 
2015). In the same preparation, cholinergic signalling blockade during SWA reduces 
Up- and Down-state duration (Lőrincz et al., 2015), similarly to what we see in our 
study. Hence, it is possible that a loss of cholinergic drive would also alter the thalamic 
influence over the SO in A30P animals.  
 
A30P animals have indications of early α-syn pathology in the PFC and 
hippocampus at 4 months that increase with age (Schell et al., 2009). However, there 
is little evidence for α-syn pathology in thalamic or cholinergic nuclei (Kahle et al., 2001; 
Freichel et al., 2007). However, it is possible that the cholinergic changes in young 
A30P mice are subtle and have not been detected using the current 
immunohistochemical approaches. The aforementioned studies have focused on 
insoluble polymers of α-syn and not in soluble monomers and oligomers that can also 
influence neuronal function (Killinger et al., 2019). Hence, we cannot derive definitive 
conclusions without the appropriate immunohistolochemical analysis for insoluble 
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forms of α-syn. Such an analysis would be particularly interesting as DLB patients 
exhibit excessive thalamic pathology, including the reticulo-thalamo-cortical (dorsal) 
activating system in which the PPT/LDT belong (O’Dowd et al., 2019; Schmeichel et 
al., 2008). 
The function of the cholinergic system in relation to sleep is to monitor and pace 
the locally generated SO throughout the cortex. While a strong cholinergic tone has 
been shown to increase the signal-to-noise ratio of the ACh input to the cortex in in 
vivo rat slices, a low cholinergic tone favours the faster, locally generated SO (Wester 
& Contreras, 2013). In a human, overnight EEG study, the cholinergic system-
modulated SO has been characterised as a “Type I” SO, which is more prominent 
during sleep induction, and is synchronous across the cortex and of large amplitude 
(Bernardi et al., 2018). At deeper levels of sleep, smaller Type II SOs appear that have 
different cortical origins, and are less synchronous with one another (Bernardi et al., 
2018). These two types of SO persist during SWS and interact with each other, with 
type I synchronising Type II oscillations. Upon dysfunction of the thalamic input to the 
cortex, the local Type II SO could take over, resulting in a faster and less controlled 
SO, as seen in A30P animals (Bernardi et al., 2018). However, although we observed 
an increase in SO frequency we did not see a decrease in SO amplitude or high 
frequency power on the Up-state.  
This discrepancy can be attributed to the capacity of the cortex to compensate 
for the loss of cholinergic input. Although the acute loss of the cholinergic input to the 
cat cortex was shown to have a detrimental impact to the SO in terms of high frequency 
activity, SO amplitude and SO frequency (Steriade et al., 1996), local circuits recover 
quickly through up-regulating intra-cortical synapses (Lemieux et al., 2014). Thus, 
under the assumption of altered thalamocortical connectivity in A30P mice, a type II 
SO prevalence could explain our findings of a faster, less flexible SO rhythm. At the 
same time, the amplitude of the SO and the power of fast-frequency oscillations are 
not affected. The oscillation amplitude is proportional to the number of cells firing 
simultaneously as shown (Reichinnek et al., 2010), and to the the number of active 
synapses (Tononi & Cirelli, 2006), as shown in cat and rodent models respectively. 
Hence, a compensatory upregulation of synapses may account for our findings of a 
normal SO amplitude and high frequency oscillatory power. 
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4.4.7. Changes in high frequency oscillations on the Up-state in A30P mice 
The only significant finding in A30P mice in terms of the fast oscillations 
associated with the Up-state was an increase in latency to peak power in the beta and 
gamma frequency bands, in the mPFC (IL, PrL). There was also an increase in latency 
to peak power in the gamma frequency range, in the CA1 region of the hippocampus. 
We did not find any changes in terms of average high frequency power on the Up- and 
Down-states or peak power in any frequency band, in any mPFC subregion. These 
findings suggest that the amount of power on the Up-state is similar in A30P and WT 
animals, but the distribution of power on the Up-state is altered in A30P animals. This 
conclusion is consistent with the fact that we did not see any increase in firing rate on 
the Up-state either.  
The fact that the latency to peak power was altered in the beta frequency range 
in the mPFC, and in the gamma frequency range in the CA1, are clearly related to the 
rhythms these regions inherently generate (Colgin, 2011; Buzsáki & Silva, 2012). Beta 
band power is particularly high on the Up-state in the ACC compared to other cortical 
regions, including the somatosensory and motor cortices (Ruiz-Mejias et al., 2011), 
while gamma oscillations are well documented on the Up-state in both the mPFC and 
the CA1 region of the hippocampus (Sullivan et al., 2011; Colgin, 2011). Although we 
did see a greater percentage firing occurring on the Down-state, such small changes 
in firing rate might not translate to significant changes in oscillatory power. Indeed, we 
did not see any significant changes in power in any frequency band on the Down- state. 
Luczak and Barthó (2012) described two types of Up-states in rats under 
ketamine/xylazine anaesthesia. The first called simultaneous onset (so-) Up-states 
were short in duration, and characterised by strong interneuron firing that was phase-
locked to the spindle activity at the start of the state (Luczak & Barthó, 2012). 
Interneurons fired at the start of so-Up-states while pyramidal cells had a more variable 
timing profile between and within Up-states. On the other hand, traveling wave- (tw-) 
Up-states were of longer duration and were generated locally in the cortex and 
progressively spread across the cortical regions (Figure 4.7A,C). Tw-Up-states were 
characterised by a brief, variable increase in interneuron activity after tw-Up-state 
onset and a stronger, long-lasting activity of pyramidal cells (Figure 4.7Β,D; Luczak 
and Barthó, (2012). A close inspection of the so-SO shape (Figure 4.7A,C) reveals that 
it resembles the beta power distribution on the Up-state observed in the mPFC of A30P 
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animals (Figure 4.2A). In both figures we can see that the power distribution occurs in 
a bimodal way, a finding that was not described statistically in our study as we only 
investigated for location of the greatest peak power in the normalised SO cycle. 
The close resemblance between the high frequency power distribution on the 
Up-state in A30P animals in our study, and the so-Up-states, may indicate that more 
so-Up-states occur in these animals than in WTs. Moreover, this theory is compatible 
with our findings of a decrease in Up-state duration in A30P animals, as so-Up-states 
are shorter. However, under the assumption of an increase in so-Up-states we would 
also expect an increase in the number of spindles, as they are coherent with the so-
Up-state start (Luczak & Barthó, 2012). As will be discussed in the next paragraphs 
though, we observed a decrease in spindle density/Up-state number instead. Thus, it 
is unlikely that A30P mice have more so-Up-states, although this discrepancy could be 
associated with a spindle deficit (see the next section). 
Another possibility that we consider more likely is that changes in E/I balance in 
the local cortical networks of A30P mice result in altered neuronal dynamics that 
resemble the so-Up-state in terms of high frequency oscillatory power distribution on 
the Up-state. We have proposed that A30P animals have neuronal network 
hyperexcitability, and possibly an interneuron-mediated compensation mechanism, 
supported by in vitro findings of greater IPSPs in the CA3 of these animals (Tweedy et 
al., 2018). This mechanism implies synchronous interneuron activity and less 
synchronous pyramidal activity, similar to so-Up-states (Luczak & Barthó, 2012). Thus, 
the high frequency oscillations on the Up-state may be initiated with relatively high 
synchronicity due to the over-compensating activity of interneurons, but the 
engagement of pyramidal neurons during the Up-state is more variable due to their 
hyperexcitability.  
The cortex can also drive the Up-state initiation in the hippocampus and in turn, 
induce higher-frequency oscillation synchrony between the two regions that is 
necessary for memory consolation (Vertes et al., 2007; Beckstead, 1979; Sesack et 
al., 1989). Thus, if the neuronal engagement to the SO is altered in the cortex, the 
timing of neuronal firing would also be affected in the hippocampus. Consequently, we 
would expect a similar increase in latency in local fast-frequency rhythms, as seen in 
the gamma frequency range in A30P mice. Alternatively, the increased gamma peak 
latency in the CA1 observed in A30P mice could reflect a local dysfunction, as high 
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frequency oscillations are also generated by a pyramidal neuron/PV+ interneuron 
interplay in this region (Colgin, 2011).  
. 
Figure 4.7: Normalised firing rate of narrow‐spike cells (red; putative interneurons) and 
wide‐spike cells (blue; putative pyramidal cells) during Up-states. A) Normalised 
activity during the beginning of so‐UP-states and B) tw‐Up-states. So-Up-states show 
a bimodal distribution of narrow-spike cell activity. C) Normalized activity triggered at 
the end of so‐Up-states and D) tw‐Up-states. At the end, the activity of narrow‐spike 
cells returned to baseline before wide‐spike cells, especially in the tw‐UP-state case. 
Adapted by Luczak and Barthó (2012).  
4.4.8. A30P animals have a spindle dysfunction  
One of our most interesting findings was the spindle dysfunction observed in 
A30P animals, characterised by a lower spindle number per Up-state (relative density), 
and fewer high-amplitude spindles, accompanied by decreased variability in spindle 
amplitude. We also found a shorter spindle duration in A30P animals but the 
instantaneous spindle frequency was not affected, suggesting that spindle cycles had 
the same frequency but were composed of fewer events. These changes can be traced 
back to alterations in the dynamics of the spindle-generating network (Destexhe et al., 
1998). Sleep spindles are generated in the thalamus but their duration is determined 
by a feedback loop between excitatory thalamocortical cells and the inhibitory TRN 
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cells (see Introduction for details; Brown et al., 2012). This system is also influenced 
by a corticothalamic input (Blumenfeld, 2005).  
The decrease in spindle duration we observed in A30P mice can be related to 
the mechanisms that drive spindle termination. According to a study by Barthó et al., 
(2014) in rats during sleep and under urethane-induced anaesthesia, inhibitory activity 
from the TRN gradually declines during the spindle, allowing thalamocortical neurons 
to respond with a rebound burst that terminates the spindle cycle. Thus, the decrease 
in TRN activity towards the end of the spindle drives spindle termination. They also 
suggest that the oscillation is predetermined by the TRN network’s state at the 
beginning of the oscillation (Barthó et al., 2014). The network’s state is influenced by 
local neuromodulators and most importantly by cortical inputs that can desynchronize 
the network with spindle progression (Timofeev et al., 2001; Bonjean et al., 2011). 
Therefore, our observation of shorter spindles could be attributed to either altered 
engagement of TRN neurons in the spindle event, or due to an altered cortical input. 
Under our proposed model of network hyperexcitability in the cortex, this 
desynchronization between the thalamus and cortex could occur earlier in the spindle 
cycle resulting in shorter spindles.  
Spindle amplitude correlates with the level of cortical neuronal involvement in 
the spindle (Andrillon et al., 2011). Other factors including the type of spindle (fast or 
slow frequency), or the stage of sleep (kept consistent in our study) do not influence 
spindle amplitude (Cox et al., 2012). Hence, the lack of higher amplitude spindles we 
observe in A30P mice might reflect a lack of capacity for regional recruitment in the 
cortex (Martin et al., 2013). Moreover, we also found that the relative spindle density 
was decreased in A30P mice. Corticothalamic neurons are able to trigger bursts of 
spikes in the TRN, but if the cortical network is weakened and the corticothalamic input 
to the TRN is reduced, fewer spindles would be evoked (Barthó et al., 2014). Thus, the 
cortical networks in A30P animals may be incapable of producing and eliciting strong 
synchronous activity to the hippocampus. Finally, in vivo intracellular recordings from 
thalamic and cortical neurons in experimental models have shown that the spindle 
density inversely correlates with the thalamic hyperpolarisation levels (Steriade & 
Timofeev, 2003; Andrillon et al., 2011). Overall, our findings of spindle dysfunction in 
the young A30P animals reflect a loss of function in the thalamocortical system. 
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The TRN has different anatomical subregions with distinct connectivity (review 
by Vantomme et al., 2019). The prefrontal cortex, including the mPFC, is mostly 
interconnected with the rostral TRN, while sensory regions including visual, auditory 
and somatosensory modalities are interconnected with the medial and frontal TRN. All 
TRN regions receive input from thalamic nuclei. Thus, these various thalamic-TRN-
cortical networks can differentially control local SOs and spindle activity in the cortex 
(Vantomme et al., 2019). For example, manipulation of TRN GABAergic activity in mice 
by genetic inactivation of the T-type Ca2+ channels that facilitate TRN spiking, resulted 
in spindle depletion in the sensory cortex (Lewis et al., 2015). However, spindle activity 
in the prefrontal cortex was not altered. Moreover, rodent studies of optogenetic 
activation of hypothalamic GABAergic input to the TRN led to a shift from NREM to 
wake state in the sensory cortex, while variations in the membrane potential of TRN 
neurons result in a shift from delta to spindle-rich activity (Herrera et al., 2016). In our 
study we did see some changes in spindle activity in the mPFC of A30P mice, which if 
specific to the prefrontal cortex, might indicate disturbances in the thalamic-TRN-
prefrontal circuit that involves this region. Alternatively, if the spindle deficit is also seen 
in sensory regions, we could speculate of more widespread α-syn related changes in 
the TRN, or in its thalamic and/or hypothalamic input. Thus, it would be interesting to 
proceed with recordings from sensory cortices to see how extensive this spindle deficit 
is in A30P animals.  
Interestingly, spindle deficiencies have been observed in patients with LBD and 
PD as well as AD (Reynolds et al., 1988). A polysomnographic study found that several 
patients with DLB had no sleep spindles while others had lower-frequency sleep 
spindles and K-complexes in N2 and SWS (Fernández-Arcos et al., 2019). A similar 
decrease in spindle density was found in PD patients (Christensen et al., 2014). 
Furthermore, another study showed that the PD patients who went on to develop 
dementia had significantly decreased spindle and fast spindle density (13 – 15 Hz) and 
lower spindle amplitude in posterior cortical areas at an earlier stage (Latreille et al., 
2015). These reports from patients resemble our results of a lower spindle density and 
fewer high-amplitude spindles in A30P mouse model, although we did not distinguish 
between spindle subtypes.  
The above-mentioned electrophysiological spindle changes in LBD patients 
have been suggested to relate to the early cholinergic dysfunction characterising Lewy 
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body disease (Latreille et al., 2015). Cholinergic deficiency can also impact the spindle-
generating system. The brainstem sends cholinergic projections to the TRN via the 
pontine cholinergic projection system (Brown et al., 2012). However, PD, PDD and 
DLB patients show a reduction in thalamic cholinergic innervation from this system, 
particularly from the PPT/LDT nuclei, which are extremely susceptible to Lewy body 
pathology (Kotagal et al., 2012). If this cholinergic system is ablated spindle generation 
is decreased (Brown et al., 2012), while inhibiting acetylcholine breakdown increased 
spindle density (Ozaki et al., 2012). Furthermore, young A30P animals have insoluble 
α-syn aggregates in the pontine reticular formation (Freichel et al., 2007), which is 
involved in spindle formation through the dorsal ARAS pathway (Brown et al., 2012). 
Dysfunction of the pontine reticular formation could possibly contribute to the changes 
in spindles in A30P mice. There is evidence of α-syn pathology in the cortex, but not 
in the thalamus, of young A30P animals (Schell et al., 2009), although as discussed 
earlier we lack studies looking for soluble α-syn monomers and oligomers, which can 
also have detrimental effects in synaptic function (Kaufmann et al., 2016). 
4.4.9. SWS disturbances can have detrimental effects 
The loss of sleep spindles can have numerous implications for a patient. Firstly, 
spindles and SWRs in the hippocampus are highly coordinated with each other in the 
context of the SO, with SWRs clustering in the trough of spindles (Staresina et al., 
2015). This synchrony mediates the transfer of information from the hippocampus to 
the cortex facilitating memory consolidation (Colgin, 2011; Witton et al., 2016). In view 
of the high degree of synchrony between these events, we had expected SWRs to also 
be altered in A30 mice. However, we found no significant differences in SWRs between 
WT and A30P animals. Due to the low number of concomitant CA1/mPFC recordings 
in both WT and A30P mice we did not look at the spindle/SWR coherence. Thus, a 
next step would be to carry out more dual recordings to investigate the synchrony 
between spindles and SWRs occurring in each region respectively, and their 
synchrony with the SO. 
In addition to the importance of sleep spindles in memory consolidation, 
spindles are also considered pivotal in “protecting” sleep from internal or external 
perturbations. Thus, a disruption in spindle activity could allow these perturbations to 
induce awakenings (Terzano & Parrino, 2000). According to the glymphatic hypothesis 
of dementia, sleep interruptions and the resulting wake cortical activity prevent α-syn 
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clearance while promoting excess α-syn production (section 1.7.3.1; Bohnen & Hu, 
2019). Hence, a spindle dysfunction could set off a cycle of increasing levels of α-syn 
and SWS interruption (Mander et al., 2016). In addition, a recent study has shown that 
an increase in SO frequency can initiate a vicious cycle of increased Αβ production 
and cytotoxicity in a mouse model of AD (Kastanenka et al., 2019). We would not be 
surprised if a similar cycle underlies abnormal α-syn production and 
neurodegeneration in A30P mice.  
4.4.10. The subregional profile of the SO in the mPFC  
Comparing the electrophysiological SO patterns between mPFC subregions in 
relation to the WT and A30P genotypes was not one of the main aims of our study. 
However, although the mPFC subregions tend have a synchronous SO, they are 
characterised by different levels of high frequency activity on the Up-states 
(Gretenkord et al., 2017). Thus, we did consider the mPFC subregion in our rmANOVA 
analysis and reported its effects, but we did not proceed with separate rmANOVA 
analyses in A30P and WT animals. In terms of wavelet power, the highest peak power 
and average power on the Up-state were seen in the dorsal (mostly PrL, ACC) 
compared to the ventral (IL, DP) mPFC. These findings are consistent with a previous 
study in the rat mPFC, of a dorsal to ventral gradient of power in the mPFC (Gretenkord 
et al., 2017). The same study also found a shorter latency to peak power in the ventral 
mPFC but we did not see that in our mice in this study. Regarding SO cycle lengths 
we found small differences between the ACC and the other subregions, including a 
slightly longer SO cycle length. This finding was unexpected as the mPFC subregions 
have a synchronous SO (Gretenkord et al., 2017) and it might relate to a rat versous 
mouse difference. However, as already discussed this regional comparison was out of 
the scope of our analysis. 
More dorsal areas of the mPFC produced spindles of greater amplitude and 
relative density and of shorter duration. Previous work has also reported greater 
spindle power on the Up-state in the ACC and PrL (dorsal) subregions in the rat under 
urethane anaesthesia, suggesting that our findings are compatible with the existing 
literature (Gretenkord et al., 2017). Our findings could also relate to the different types 
of spindles, as there are two types occurring preferentially at the start and end of the 
Up-state respectively. The spindle subtypes may have a differential pattern of 




The A30P mouse model shows a number of alterations in SWS patterns such 
as aberrant neuronal firing in the SO cycle in the mPFC, a higher SO frequency and 
shorter Up- and Down-states in the mPFC and CA1 of the hippocampus. We also found 
that A30P animals have an altered distribution of power in the beta and gamma, and 
in the gamma frequency bands on the Up-state, in the mPFC and CA1 regions 
respectively. Finally, we found that A30P animals have altered spindle patterns, 
including a lower spindle density, shorter spindle-duration and fewer high-amplitude 
spindles. Again, spindle alterations may relate to α-syn-related changes in the cortical 
networks or a thalamic or cholinergic dysfunction. A30P mice had no differences in SO 
synchrony between the cortex and hippocampus, in SWR patterns or in higher 
frequency power levels in the SO cycle, compared to WT animals. We suggest that 
our findings can be attributed to mutant α-syn-induced hyperexcitability in the neuronal 
networks of young A30P animals. A compensatory mechanism and/or alterations in 
thalamic networks may also co-exist. 
Considering the importance of SWS, high frequency nested rhythms and 
spindles in higher cognitive function, we would expect these changes in their patterns 
to lead to cognitive impairments. Moreover, the reduced sleep spindles could allow for 
more sleep fragmentation, thus promoting more α-syn pathology via a glymphatic 
hypothesis-mediated mechanism. However, the fact that these changes appear early 
in A30P animals and are associated with low levels of α-syn pathology, highlights that 
sleep and hyperexcitability could constitute potential targets for early intervention, in 






























Urethane induced-anaesthesia has been used as a model of NREM and REM 
sleep by manipulating the levels of anaesthesia (Hara and Harris, 2002). More recent 
studies have shown the presence of faster-activity states under deep urethane 
anaesthesia in rodents that resemble the REM state (Clement et al., 2008; Pagliardini, 
Gosgnach and Dickson, 2013). The aforementioned REM-like states seen under 
urethane anaesthesia or, as also called “activated states”, manifest abruptly as periods 
of increased low-voltage fast activity (25 – 40 Hz) in the cortex and greater theta activity 
in the hippocampus in rodents (Clement et al., 2008; Pagliardini et al., 2013). These 
states can be detected by a decrease in the SO/theta band power ratio, similarly to 
REM sleep (Clement et al., 2008). Each activated/deactivated state cycle lasts about 
9 minutes in rats (Clement et al., 2018), and 14 minutes in mice, with each activated 
state lasting about 4 minutes (Pagliardini et al., 2013). During the activated state, the 
breathing rate and its variability increased in comparison to SWS periods, similarly to 
what is seen in humans during REM sleep (Pagliardini 2013). Therefore, urethane 
anaesthesia offers the opportunity to detect and analyse patterns of sleep 
macrostructure. 
Further cyclic alterations on a slower time scale have also been observed, called 
the infra-slow oscillations (ISO), which occur at a frequency < 0.1 Hz (Hughes et al., 
2011). ISOs in humans can be detected though the functional MRI (fMRI), where they 
appear as fluctuations in the local blood oxygenation level dependent (BOLD) imaging 
signal, indicating changes in local neuronal activity (Palva & Palva, 2012). Concurrent 
EEG recordings have shown that the ISOs identified in cortical and sub-cortical regions 
modulate higher frequency oscillation (Watson et al., 2016; Hughes et al., 2011). The 
resting human brain exhibits fluctuations < 0.1 Hz in the fMRI BOLD (blood oxygen 
level dependent) signal in resting state networks (RSNs) that correlate with activity in 
the alpha range (Hughes et al., 2011). A simultaneous fMRI/EEG analysis in rats has 
shown that ISOs during rest can modulate activity in the gamma frequency range (Pan 
et al., 2013), while in vivo intracranial recordings have revealed the occurrence of an 
ISO in the cortex during natural sleep in mice (Lecci et al., 2017). In in vitro 
preparations, induced ISOs in cholinergic nuclei were accompanied by alpha activity 
(8 – 13Hz) (Hughes et al., 2011) while computational models of cortical activity have 
also demonstrated that ISOs can modulate the power of 1 – 40 Hz oscillations 
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(Lundqvist et al., 2013). Hence, these widespread, infra-slow rhythms are able to 
control faster, local oscillations.  
One of the best studied ISOs in humans, in the context of sleep, is the cyclic 
alternating pattern (CAP) that occurs are 0.002 – 0.02 Hz (Terzano & Parrino, 1993; 
Parrino et al., 2006). CAP is composed of different electrophysiological events of 
higher frequency that occur in a cyclic manner in the form of an ISO, and compose the 
microstructure of sleep. CAP states regulate the balance between awake and sleep-
promoting systems, state shifts and the NREM/REM transition in humans (Parrino & 
Vaudano, 2018). Although CAP has not been reported under urethane-anaesthesia, 
CAP-like rhythms have been characterised during natural sleep in rodents (Lecci et al., 
2017). Hence, it would be particularly interesting if sleep microstructure could also be 
characterised under urethane anaesthesia.  
During our recordings under deep urethane anaesthesia, we noticed the 
emergence of periods characterised by a burst of power across frequency bands, 
which manifested as a sharp increase in power on the spectrogram, in both the mPFC 
and hippocampus. A similar event was previously described in our lab in the urethane 
anaesthetised rat (Gretenkord et al., 2015). Due to its stereotypic fashion we named 
this phenomenon the “infra-slow modulation” (ISM) and we proceeded to investigate it 





5.2.1. Animals and recordings 
To better understand the ISM, we proceeded to analyse 30 minute-long mPFC 
recordings from WT animals. From a total of 16 WT animals used in our study, 2 did 
not have ISM. We recorded SWS activity from the mPFC and/or CA1 regions of these 
animals, and after rejecting some of recordings as described in detail in section 4.2.1 
of the previous Chapter, we used 8 mPFC and 7 CA1 recordings for our analysis.  
To study ISM data, we analysed the same 30 min long-LFP recordings used for 
SO analysis, from both the mPFC and CA1 probes. In fact, the non-ISM data used for 
this analysis is the same data used in Chapter 4. Therefore, the anaesthesia regime, 
frame mounting and electrode techniques are the same. It is important to highlight that 
during these recording the animals were under deep anaesthesia characterised by 
SWS (< 1Hz) and the absence of a pedal withdrawal reflex. We also utilised the same 
unit data for the mPFC as in section 4.3.3. 
5.2.2. ISM identification technique 
The notch-filtered LFP recordings were visually inspected for epochs of 
incomplete ISM events at the start or end of the recording, which were then were 
rejected. The power spectral (PSD) density was estimated using 2 s-long FFT and 
Bartlett’s method (Bartlett, 1950) and a Hamming window with double the size (4 s), 
giving a 0.25 Hz frequency resolution (discrete fast Fourier transform). We then used 
the PSD/power to calculate power within different frequency bands: SO (0.25 – 0.75 
Hz); delta (1.5 – 3.75 Hz), theta (4 - 7.75 Hz), alpha/spindle (8 – 14.75 Hz), beta (15 – 
29.75 Hz) and gamma (30 - 79.75 Hz), for each electrode. The power for each band 
was averaged across each of the electrodes for each of the 4 subregions of the mPFC 
(Figure 5.1).  
The power in the beta frequency band was used to detect the ISM events, as 
the start of the ISM was visually most clear in the beta band-filtered EEG signal (Figure 
5.1). The power in the beta band was first smoothed using the “smooth” function in 
Matlab (level 6) and then the minimum point of the smoothed beta power was deducted 
to normalise it to the baseline (Figure 5.2A). An ISM-like template was automatically 
created for each recording using a fixed maximum point of 3 for the mPFC and 4 for 
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the CA1 of the hippocampus, the mean amplitude of the smoothed beta power and a 
minimum of 0. This template had a duration of 60 s that is approximately the duration 
of each ISM event, while different fixed maxima were chosen for the CA1 and mPFC 
regions to optimise detection. The template was used in a sliding window manner to 
identify the ISM, where each window had the size of the template (60 s), while the 
beginning of each window was 2 s away (1 epoch) from the beginning of the previous 
window and thus, the windows were overlapping. For each x-value of each window, 
we calculated the absolute difference between the y-value at the template and the 
smoothed beta power signal. These values were then summed up for each window, 
giving the total deviation of the beta power signal from the template. We then 
transformed the value for each window (total deviation from the template) into a 
percentage of the greatest deviation, thus creating a “disimilarity index” between the 
beta power signal and the template. All disimillarity values were subtracted from a 100, 
to get a “similarity index” instead. By setting a threshold of > 25% we could identify the 
windows that were so similar to the template they could be considered an ISM event. 
Consequtive windows that exceeded the threshold or were disrupted for up to 4 s (2 
epochs) were considered the same ISM event.  
For each of the identified ISM events we found the maximum point and prceeded 
to refine the ISM identification (Figure 5.2B). We found the first crossing point of the 
average line before and after the ISM peak, and if there was not another crossing within 
2 epochs before the start of ISM or 2 epochs after the ISM, that crossing was identified 
as the edge of the ISM. If there was another crossing within 2 epochs, the previous/next 
epoch was examined and so on. After detection of the ISM, we identified the 30 s (15 
epochs), before and after the ISM as pre-ISM, and post-ISM segments, respectively, 















Figure 5.1: The PSD across frequency bands during the slow-wave sleep in WT mice. 
A) 30 min-long recording from the mPFC, showing the occurrences of the ISM as seen 
in the spectrogram (PrL; electrode 12) and B) in the power spectral density (PSD) of 
the LFP signal. The average PSD is shown across all 16 channels of the mPFC, for 
each of 6 power bands: SO (0.25 – 0.75 Hz); delta (1.5 – 3.75 Hz), theta (4 – 7.75 Hz), 
alpha/spindle (8 – 14.75 Hz), beta (15 – 29.75 Hz) and gamma (30 – 79.75 Hz). The 





Medial prefrontal cortex (mPFC) 

















































Figure 5.2: The ISM identification technique. Α) Basic ISM identification. The power in 
the beta frequency band averaged across mPFC sub-regions, after being smoothed 
and normalised to the baseline, which was used to identify the ISM. The 60 s-long 
running template (red line) and its constituent parts are also shown (asterisks), 
including the average amplitude of the normalised beta power. This smoothed, 
normalised to the baseline, beta frequency power evolved over 2 s-long epochs. B) 
Refinement of the ISM periods (blue segments) and the ISM peak (blue dots) that was 
used to detrmine the beginning and end of the ISM.  
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5.2.3. ISM variable extraction  
All ISM data was extracted into MATLAB and plotted on Excel. To characterise 
the ISM we extracted the mean interval length between ISM events and used it to 
calculate the ISM frequency. We also calculated the ISM duration and its variability 
between ISM events within the same recording. To analyse the ISM in depth we 
extracted a number of variables for each of four segments: A) non-ISM: the 
concatenated non-ISM data used in Chapter 4, B) the 30 s-long pre-ISM segment, 3) 
ISM and 4) the 30 s-long post-ISM segment. The pre-ISM, ISM and post-ISM segments 
were treated as part of the same ISM event. All the variables were extracted for the 
four subregions of the mPFC (ACC, PrL, IL, DP) and for the CA1 region, except the 
unit and spindle data which were only extracted for the mPFC. Our findings are 
expressed as the mean ± SEM.  
5.2.3.1. PSD power  
In order to calculate the SO / theta band power ratio, we extracted the PSD for 
these two frequency bands for the non-ISM, pre-ISM, ISM and post-ISM segments.  
The PSD shows the absolute power in each frequency range. We used a 4 s-long FFT 
(fast Fourier transform) size and an 8 sec Hamming window, resulting in a sampling 
frequency of 0.125 Hz that is close to the minimum Up-Down cycle length of interest 
(0.1 Hz). The frequency ranges of interest were 0.125 – 0.875 Hz for the SO frequency 
range and 4 – 7.875 Hz for the theta frequency range.  
5.2.3.2. Up-Down cycle length and power content  
To characterise the Up-Down cycle we extracted the same Up-Down cycle 
characteristics investigated in the non-ISM analysis and looked for differences 
between the non-ISM, pre-ISM, ISM and post-ISM segments. The variables 
investigated were the mean Up-state, Down-state and SO cycle (Down-state +Up-
state) length and their mean length variability over time (SD), the SO frequency and 
the amplitude of the SO. The distribution of power in the SO cycle was also analysed 
as described in Methods (section 2.2.5.5). For this analysis, we only used the 
frequency bands that are known to have functional activity on the Up-state: beta (15 – 
29.9 Hz), gamma (30 – 79.9 Hz) and high-gamma (80 – 129.9 Hz), as well as the theta 
band that is involved in the activated/REM sleep (4 - 7.9 Hz). 
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5.2.3.3. Unit analysis 
To analyse unit data we performed two types of unit analysis. Firstly, we 
investigated 6 unit-related variables which were averaged for each animal: the number 
of spikes and the ISI for the duration of the recording and for the Up-state only, the 
percentage of units firing on the Up-state and the coherence between the SO and unit 
firing. However, we were concerned that this method that involves averaging across 
units for each animal and then for each segment, could mask changes in our variables 
between segments. To address this issue and better understand how unit activity 
evolves during the ISM, we proceeded with a second analysis where we treated all 
units as individual samples, without averaging across animals.  
Moreover, upon inspection of the raster plots we noticed that units changed their 
firing in different ways in relation to the ISM. To investigate the individual neurons 
behaviour, we calculated the percentage change in firing on the ISM compared to the 
non-ISM segment, for each unit. Units were then grouped into those that increased 
their firing rate (> 115%), did not change their firing rate (85% - 115%) or decreased 
their firing rate (< 85%) on the Up-state. However, we did not perform statistical 
analysis for these variables.   
5.2.3.4. Spindle density  
Spindles were identified as described in Methods section 2.2.6 and their density 
was calculated by dividing the number of spindles by the number of Up-states/cycles 
for that segment. This variable was only calculated for the mPFC.  
5.2.3.5. Statistical analysis  
To characterise the frequency and duration of the ISM in the WT animals in the 
mPFC, we performed one-way rmANOVA analysis. To analyse variables associated 
with the amplitude, frequency and Up-state, Down-state and SO cycle lengths, as well 
as variables related to oscillatory power in the normalised SO cycle, we performed two-
way rmANOVA analysis with 2 repeated measures, the ISM segment (non-ISM, pre-
ISM, ISM, post-ISM) and subregion (ACC, PrL, IL, DP). We only proceeded with 
further, one-way rmANOVA analyses for each subregion if a significant interaction was 
found between band and region. If not, only the data from the PrL region is presented 
and plotted. The PrL region was chosen, as together with the ACC these regions are 
of the greatest functional importance in relation to cognition (Euston et al., 2012). A 
similar analysis was also performed for characterisation of the SO cycle, the spindle 
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density and the SO/theta band power ratio in the mPFC. For unit related variables from 
the mPFC and all our variables from the hippocampus where we had no sub-regions, 




5.3. Results  
5.3.1. General characterisation of the ISM 
We termed the name infra-slow modulation (ISM) to describe the rhythmic 
occurrence of increased oscillatory power first seen in all mPFC subregions (Figure 
5.1). The ISM is characterised by a sharp-onset increase in power across all frequency 
ranges, clearly evident in the spectrogram. In some cases, the sharp onset of ISM is 
preceded by a longer Down-state. After the onset of the ISM, the increase in fast 
oscillatory activity generally decays slowly, before reaching baseline levels. Moreover, 
looking at the LFP we can observe that the SO rhythm persists during the ISM but is 
of higher frequency, before slowly returning to the baseline SO frequency (Figure 5.3). 
The ISM was also observed in the CA1 of hippocampus (Figure 5.4), synchronous with 
the ISM in the mPFC. These events were detected under urethane-anaesthesia 
induced SWS, characterised by the SO (< 1 Hz) and no response of the pedal 
withdrawal reflex. Overall, the ISM was present in 2/16 recordings in WT animals 
(section 5.2.1).  
To investigate the changes in oscillatory power during the ISM, we extracted the 
PSD (showing the absolute power) in a continuous range of frequency bands: SO (0.25 
– 0.75 Hz); delta (1.5 – 3.75 Hz), theta (4 - 7.75 Hz), alpha/spindle (8 – 14.75 Hz), beta 
(15 – 29.75 Hz) and gamma (30 - 79.75 Hz), over 2 s-long epochs. Visual inspection 
showed that the ISM was accompanied by an increase in absolute power across all 
frequency bands (Figure 5.1).  
The power in the beta frequency range was used to identify the ISM, as 
described in Method’s section 5.2.2. ISM detection revealed that in the mPFC, the 
mean ISM interval was 3.7 ± 0.2 min that translates to an ISM frequency of 0.0045 Hz 
± 0.0003 Hz (Figure 5.3). The mean ISM duration was 1 ± 0.11 min, while the mean 
variability of ISM duration was 0.38 ± 0.05s. In the CA1 region of the hippocampus, the 
average interval between ISM events was 3.89 ± 0.35 min that corresponds to an ISM 
frequency of 0.0043 Hz ± 0.0006 Hz (Figure 5.4). The duration of these events was 
0.95 ± 0.02 min while the variability in the duration of ISM events within the same 
recording was 0.29 ± 0.09 min. Therefore, the ISM in both the mPFC and CA1 of the 
hippocampus can be characterised as rhythmic and although we did not look at ISM-
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Figure 5.3: An example of the LFP and spectrogram of a recording from the mPFC 
subregions of a WT animal, illustrating the ISM events. The recordings from electrodes 
6, 15, 16 have been rejected and the remaining electrodes are grouped in the mPFC 
subregions (ACC, IL, PrL, DP). A) The LFP and spectrogram for a 30 min-long 
recording in the mPFC. The spectrogram for channel 12 is also shown. B) An 
expanded 2 min-long segment from 2 PrL and 2 ACC electrodes (electrodes 11, 12, 




















































































































































Figure 5.4: An example of the LFP and spectrogram of an electrophysiological 
recording from the hippocampus of a WT animal, illustrating the ISM events. This 
recording from the CA1 of the hippocampus was simultaneous with the mPFC 
recording from the contralateral hemisphere shown in Figure 5.3. A) The LFP and 
spectrogram for a 30 min-long recording in the CA1. B) An expanded 2 min-long 
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5.3.2. The ISM is characterised by increases in high frequency activity  
As discussed earlier, we observed that the ISM is characterised by an increase 
in power across frequency bands visible in the spectrogram, both in the mPFC (Figure 
5.1; Figure 5.3) and in the CA1 (Figure 5.4). In order to verify our observations and to 
determine whether the observed increase in power was on the Up-state, Down-state 
or both and how it was distributed in the SO cycle, we proceeded with analysis of the 
normalised power in the SO cycle. We extracted the average power on the Up-and 
Down-states, identified the peak power and calculated the latency to the peak power 
for the 4 frequency bands that were deemed most physiologically significant: theta, 
beta, gamma and high-gamma, in the mPFC (Figure 5.5) and CA1 (Figure 5.6). The 
high frequency power was extracted through wavelet analysis on the normalised LFP 

























Figure 5.5: Examples of an LFP trace, the high frequency oscillatory power in the SO 
cycle and the spectrogram from one PrL electrode of the mPFC during the ISM. A) A 
2 min-long-segment of recording is shown and B) an expanded 30 s-long segment. 
The wavelet power is extracted for 4 frequency bands: theta (4 – 7.75 Hz; black), beta 





























































































































































Figure 5.6: Examples of an LFP trace, the high frequency oscillatory power in the SO 
cycle and the spectrogram from the CA1 region of the hippocampus during the ISM. 
This recording is simultaneous with the mPFC recording in Figure 5.5, from the 
contralateral hemisphere. A) A 2 min-long segment of recording is shown and B) an 
expanded 30 s-long segment. The wavelet power is extracted for 4 frequency bands: 
theta (4 – 7.9 Hz; black), beta (15 – 29.9 Hz; red), gamma (30 – 79.9 Hz, blue), and 




























































































































5.3.2.1. Changes in high frequency activity in the SO cycle in the mPFC during 
the ISM 
Firstly, we looked for changes in (average) power in each frequency range, on 
the Up-state (Figure 5.7A; Appendix C, “WT” columns). We found a significant increase 
in power in the beta frequency range during the ISM (F(3, 21) = 23.66 , p < 0.001) 
compared to the pre-ISM, ISM and post-ISM segments. The segments also differed in 
power on the Up-state in the theta (F(2.04, 15.1) = 7.58 , p < 0.01), gamma (F(2.16, 
15.1) = 7.25 , p < 0.01) and high-gamma frequency ranges (F(1.16, 8.1) = 5.46 , p < 
0.05), with greater levels of power found in the ISM compared to the pre-ISM and post-
ISM segments. However, power in the theta, gamma and high-gamma frequency 
bands during the ISM was not actually significantly different to the non-ISM period.  
 Interestingly, we also found changes in high frequency oscillatory power on the 
Down-state where fast oscillations do not normally occur (Figure 5.7B). Specifically, 
we found a small but significant increase in theta (F(3, 21) = 9.8 , p < 0.01), beta (F(3, 
21) = 16.48 , p < 0.01) and gamma (F(3,21) = 11.74 , p < 0.01) power on the Down-
state during the ISM compared to all other segments. There was no change in the high-
gamma power on the Down-state between the segments. 
Another characteristic that describes power on the Up-state is the peak power 
in the normalised cycle and the latency to peak power in relation to the beginning of 
the cycle (Figure 5.7C). We found no effect of segment regarding the latency to peak 
power between segments (Appendix C; “WT” column). This demonstrates that the time 
of occurrence of the maximum power on the Up-state is the same during the ISM and 
non-ISM segments. However, we did find a difference in peak power amplitude in all 
frequency bands: theta (F(1.57, 11.01) = 19.53 , p < 0.001), beta (F(3,21) = 49.48 , p 
< 0.001), gamma, (F(3, 21) = 117.3, p < 0.001), high-gamma (F(1.01, 7.1) = 42.58 , p 
< 0.01). Interestingly, the peak power amplitude in the beta, gamma and high-gamma 
ranges was significantly greater in the non-ISM compared to the pre-ISM, ISM and 
post-ISM segments. In the theta frequency range, the peak power amplitude during 
the ISM was greater than the pre-ISM and post-ISM segments. In the beta and theta 
frequency bands, the post-ISM peak power amplitude was smaller than the ISM peak.  
We also found a small effect of region in the gamma peak power (F(1.47, 10.29) 
= 6.01, p < 0.05) as well as a band/region interaction (F(5.28, 36.96) = 3.95, p < 0.01). 
The effect of region was identified as a greater peak power in the PrL region compared 
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to the DP region (p < 0.01). One-way rmANOVA analysis for each region showed a 
very high effect of segment in all regions: DP (F(3, 21) = 90.52, p < 0.001), IL (F(3, 21) 
= 126.68, p < 0.001), PrL (F(3, 21) = 91.45, p < 0.001) and ACC (F(3, 21) = 46.92, p < 
0.001), that was attributed to a greater gamma peak power in the non-ISM compared 
to all other segments (p < 0.001). The high-gamma peak power (F(1.56, 12.27) = 5.28, 
p < 0.05) was greater in the PrL compared to the DP region (p  < 0.01). We did not 
identify a significant effect of region or region/segment interaction power on the Up-
state and Down-state, or in the latency to the peak power in any frequency range 
(Figure 5.7).  
Our findings reveal that the ISM period is characterised by an increase in 
power in the beta frequency band on the Up-state during the ISM, compared to the 
non-ISM periods. Furthermore, we also found an increase in theta, beta and gamma 
frequency power on the Down-state, in comparison to the non-ISM period. 
Interestingly, the ISM had significantly greater power in relation to the periods 
immediately preceding or following the ISM on the Up and Down-state, suggesting 
there are periods of reduced activity just before and after the large burst of power that 
defines the ISM. Finally, we found that the peak power for all frequency bands was 
smaller in the ISM-related segments compared to the non-ISM segment. In the ISM, 
this decrease in peak power could be attributed to more aberrant activity related to the 
increased high frequency power on the Down-state, while in the pre-ISM and post-ISM 





















































Figure 5.7: Changes in high frequency oscillatory power in the SO cycle in relation to 
the ISM, in the mPFC of WT animals. The power in the SO cycle is characterised in 4 
frequency bands: theta (4 – 7.9 Hz), beta (15 – 29.9 Hz), gamma (30 – 79.9 Hz) and 
high-gamma (80 – 130 Hz), in 4 segments: non-ISM, pre-ISM, ISM and post-ISM in 
WT (N = 8) mice. A) Mean power on the Up-state. B) Mean power on the Down-state. 
C) Peak power in the normalised SO cycle (Down-state + Up-state). Error bars indicate 


























































































































5.3.2.2. Changes in high frequency activity in the SO cycle in the hippocampus 
during the ISM 
In view of the findings of greater high frequency oscillatory power on both the 
Up- and the Down-state in the mPFC during the ISM, we proceeded to analyse the 
power content of the Up-Down cycle in the CA1 of the hippocampus, across the ISM 
segments in a similar manner (Figure 5.8; Appendix D - “WT” column). On the Up-state 
(Figure 5.8A), we found a significant increase in power in the beta (F(2.23, 13.35) = 
5.97, p < 0.05) and gamma (F(1.63, 9.76) = 5.39, p < 0.05) frequency bands, during 
the ISM compared to the pre-ISM and post-ISM segments, but not the non-ISM 
segment. This finding demonstrates that the slight reduction in power occurring just 
before and after the ISM that we saw in the mPFC, is more evident in the hippocampus. 
On the Down-state (Figure 5.8B), we found significantly greater gamma 
frequency power (F(3, 18) = 9.12, p < 0.05) during the ISM compared to the pre-ISM 
segment, while it is worth mentioning a similar trend for the post-ISM (p = 0.054) and 
non-ISM segments (p = 0.67), but these did not quite reach statistical significance. This 
lack of significance might relate to the wide confidence intervals (95%), that are -0.757 
– 0.007 for the pre-ISM Vs ISM segments, and -0.019 – 0.549 for the post-ISM Vs ISM 
segment. We also found significantly greater theta (F(3, 18) = 11.18, p < 0.001), beta 
(F(3, 18) = 8.41, p < 0.05) and high-gamma (F(1.43, 8.6) = 6.89, p < 0.05) band power 
on the Down-state during the ISM compared to the pre- and post-ISM segments. Thus, 
the ISM has greater high frequency oscillatory power compared to the pre-ISM and 
post-ISM segments, and possibly compared to the non-ISM segment, although it did 
not reach statistical significance as in the mPFC. 
We then looked at the peak power and the latency to peak power across the 
normalised SO cycle (Figure 5.8C), within each frequency band. The only significant 
difference found was in peak power in the gamma (F(3,18) = 3.7, p < 0.05) and theta 
(F(1.48, 8.89) = 17.01, p < 0.01) frequency ranges, as the non-ISM segment had a 
significantly greater peak power compared to the other segments similar to the 
changes seen in the mPFC. The pre-ISM segment also had significantly lower theta 
peak power than the ISM segment. The latency to the peak power did not differ 
between genotypes in any frequency band. 
Analysis of power in the normalised SO cycle during the ISM revealed an 
increase in power in the beta and gamma frequency bands on the Up-state, and in all 
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frequency bands on the Down-state, in comparison to the pre-ISM and post-ISM 
segments. Hence, the finding of lower high frequency activity preceding and following 
the ISM is replicated in the CA1 as well. However, no differences were found between 
power on the Up- and Down-states during the ISM compared to the non-ISM segment. 
Analysis of the peak power on the Up-state showed a reduced peak power in the theta 
and gamma frequency bands during the ISM compared to the other segments. Hence, 
a change in power distribution during the SO is also evident in the CA1, but to a lesser 
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Figure 5.8: Changes in high frequency oscillatory power in the SO cycle in relation to 
the ISM in the hippocampus of WT animals. The power in the SO cycle was 
investigated in 4 frequency bands: theta (4 – 7.9 Hz), beta (15 – 29.9 Hz), gamma (30 
– 79.9 Hz) and high-gamma (80 – 130 Hz), in 4 segments: non-ISM, pre-ISM, VMS 
and post-ISM, in WT (N = 8) mice. A) The mean power on the Up-state. B) mean power 
on the Down-state. C) The peak power in the normalised SO cycle (Down-state + Up-
state). Error bars indicate the SEM. Asterisks indicate statistical significance: * = p < 


























































































5.3.3. Changes in SO cycle patterns during the ISM 
As can be seen in Figure 5.9, the ISM is also characterised by an increase in 
SO frequency and amplitude in the mPFC and CA1 of the hippocampus. We also 
observed that occasionally the ISM is preceded by a longer Down-state (Figure 5.3 & 
5.4). Hence, we proceeded to analyse the SO cycle components, the Up- and Down-
states which were automatically detected, and to extract SO amplitude and frequency. 
To verify our observations, we performed two-way rmANOVA analyses with two 
repeated measures, the segment and mPFC region, for each relevant variable in the 
mPFC. A similar analysis of the characteristics of the SO was also performed for the 
CA1, with the ISM segment as the only repeated measure. 
5.3.3.1. SO cycle characterisation in the mPFC during the ISM 
Firstly, we analysed the SO cycle in the mPFC and its subregions (Figure 5.10, 
Appendix E) in relation to the ISM. Analysis of the SO amplitude revealed a significant 
effect of segment (F(1.17, 8.13) = 13.94, p < 0.01), with greater SO amplitude found in 
the ISM compared to all other segments (Figure 5.10A). We also found an effect of 
region (F(3, 21) = 13.94, p < 0.01), with lower SO amplitude in the ACC compared to 
the PrL region (p < 0.05).  
We then looked at the SO frequency and found a significant effect of segment 
(F(3, 21) = 11.25, p < 0.001), due to higher SO frequency in the ISM compared to the 
non-ISM and post-ISM segment (Figure 5.10B). As expected, we also found an effect 
of segment in SO cycle (Down-state + Up-state) length (F(3, 21) = 25.15, p < 0.001), 
with shorter SO cycles during the ISM compared to the non-ISM, pre-ISM and post-
ISM  segments (Figure 5.10C). The post-ISM segment also had shorter cycles 
compared to the non-ΙSM segment. The decrease in cycle length during the ISM can 
be attributed to both shorter Up- (F(3, 21) = 25.37, p < 0.001) and Down-states (F(1.77, 
12.37) = 19.84, p < 0.001; Figure 5.10C). Specifically, the Up-state was shorter during 
the ISM compared to the non-ISM and pre-ISM segments. The pre-ISM and post-ISM 
segments also had shorter Up-states compared to the non-ISM segment. The Down-
state was also shorter on the ISM segment compared to all other segments.  
We also found an effect of segment in state-length variability over time in the 
SO cycle (F(3, 21) = 11.29, p < 0.001), and in both the Up-state (F(3, 21) = 7.88, p < 
0.01) and Down-state (F(3, 21) = 9.32, p < 0.001; Figure 5.10D). The cycle length 
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variability was lower during the ISM compared to the non-ISM and post-ISM segments 
(p < 0.05). The Up-state length variability was shorter only during the ISM compared 
to the pre-ISM segment (p < 0.05). The Down-state length variability was shorter during 
the ISM compared to all other segments (p < 0.05; Figure 5.10). 
Our results verify our observations that the ISM is a period characterised by a 
greater SO amplitude and frequency, The higher SO frequency and hence the shorter 
SO cycle of the ISM, can be attributed to both shorter Up- and Down-states. The pre-
ISM segment was most similar to non-ISM periods, although we had observed that the 
ISM is often preceded by a longer Down-state. The fact that our observation was not 
verified through statistical analysis may be attributed to averaging the state lengths for 
the 30 s-long pre-ISM segments. A single long Down-state just prior to the ISM was 
insufficient to change the overall SO frequency for the pre-ISM period. The post-ISM 
period on the other hand, appears to be a transition between the ISM and non-ISM 
periods. We also found decreased variability in state length over time during the ISM, 
which may be interpreted as an absence of longer states. In conclusion, our findings 
are consistent with our observations of an abrupt start to the ISM characterised by an 
increase in SO frequency, followed by a period of gradual decline before the baseline 
SO frequency is restored. Moreover, it is important to note that our findings show a 











   
  








Figure 5.9: Example traces demonstrating the evolution of the ISM in the LFP and its 
expression as increased beta band power. The LFP and power (PSD) in the beta band 
for the same segment A) in the PrL subregion of the mPFC and B) the CA1 region of 
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Figure 5.10: Changes in the SO frequency and amplitude in relation to the ISM in the 
PrL subregion of the mPFC of WT mice. A) The SO frequency, B) SO amplitude, C) 
the mean Up-state, Down-state and cycle lengths and D) the variability of these 
variables in time (SD), in the non-ISM, pre-ISM, ISM and post-ISM segments in WT (N 
= 7) animals. Error bars indicate the SEM. Asterisks indicate statistical significance: * 




















































































































































































































5.3.3.2. SO cycle characterisation in the hippocampus during the ISM  
As can be seen in Figure 5.7B there also were marked changes in the SO during 
the ISM in the CA1 region of the hippocampus. Therefore, we performed one-way 
rmANOVA analyses to quantify the characteristics of the SO in the CA1 of the 
hippocampus as well (Figure 5.11; Appendix F, “WT” column).  
Firstly, we looked at the SO amplitude, which was significantly higher in the non-
ISM, pre-ISM and post-ISM periods compared to the ISM period (F(1.51, 9.03) =  
12.15, p <0.05; Figure 5.11A). There was also an increase in SO frequency during the 
pre-ISM and ISM segments compared to the non-ISM ones (F(3,18) =  8.08, p <0.05; 
Figure 5.11B). SO cycle length in the ISM was decreased compared to non-ISM 
periods (F(3, 18) = 4.58, p < 0.05). As observed in the mPFC, our findings of a shorter 
SO cycle can be attributed to both shorter Up- (F(3, 18) = 14.65, p < 0.001) and Down-
states (F(3, 18) = 3.54, p < 0.05) during the ISM (Figure 5.11C). The Up-state was 
shorter during the ISM compared to all other segments, while the Down-state was 
shorter during the ISM compared to the non-ISM segment. Finally, we looked at cycle 
length variability, which was significantly decreased during the pre-ISM, ISM and post-
ISM segments compared to non-ISM ones (F(3, 18) = 4.55, p < 0.05). This finding can 
be attributed to lower Down-state length variability in the same segments (F(3, 18) =  
4.5, p < 0.05; Figure 5.11D).  
Our analysis verified that the SO in the CA1 regions during the ISM is also 
characterised by a greater amplitude and frequency compared to non-ISM segments. 
Moreover, the SO cycle was significantly shorter in the ISM only compared to non-ISM 
segments. The Up-states were shorter during the ISM compared to all other segments, 
while the Down-state length did not differ between segments. It, therefore, appears 
that the changes in the SO and the evolution of the ISM are not as clear in the CA1 as 
in the mPFC, with respect to the pre-ISM and post-ISM segments. Moreover, we found 
more restricted changes in state length variability compared to the mPFC. Thus, the 
SO is also altered during the ISM in the CA1 of the hippocampus, but to a lesser extent 





Figure 5.11: Changes in the SO frequency and amplitude in relation to the ISM in the 
hippocampus of WT mice. The A) SO frequency, B) SO amplitude, C) the Up-state, 
Down-state and cycle lengths and D) the variability of these variables in time (SD) 
during the non-ISM, pre-ISM, ISM and post-ISM segments in WT mice (N = 7). Error 










































































































































































































5.3.4. The SO / theta band power ratio increases during the ISM 
The SO / theta power ratio has been used as a method to detect activated states 
under urethane-induced anaesthesia and REM states under natural sleep (Clement et 
al., 2008). Hence, we also looked at the SO/theta power ratio using the power (PSD) 
extracted for the SO and theta frequency ranges, in the mPFC and CA1 of the 
hippocampus (Table 5.1; Figure 5.12).  
In the mPFC, the SO/theta power ratio (F(3, 21) = 18.87, p < 0.05) was 
significantly lower during the ISM compared to the non-ISM and post-ISM segments  
(Figure 5.12A), while a similar pattern can be observed for the pre-ISM segment. In 
the CA1 of the hippocampus, the SO/theta band power ratio (F(3, 21) = 9.29, p < 0.05) 
was also lower during the ISM compared to non-ISM and pre-ISM segments (p < 0.05), 
while a similar pattern can be observed for the post-ISM segment (Figure 5.12B). 
Finally, we also found a significant effect of mPFC region in the SO/theta power ratio 
(F(3, 21) = 4.18, p < 0.05), with a lower SO/theta power ratio in the ACC compared to 









Figure 5.12: The SO/theta band power ratio in the PrL subregion of the mPFC and the 
hippocampus of WT animals. These variables were assessed in 8 WT animals in the 
mPFC and 7 WT animals in the CA1 of the hippocampus. Error bars indicate the SEM. 














































* * * 
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Table 5.1: The SO/theta band power ratio in relation to the ISM in the mPFC of WT 
animals. The average SO/theta band power ratio ± SEM is shown for each mPFC 
subregion (ACC, PrL, IL, DP), for a each segment (non-ISM, pre-ISM, ISM, post-ISM), 
in WT mice (N = 8).  
 
SO/theta band power ratio 
 Non-ISM Pre-ISM ISM Post-ISM 
ACC 17.53 ± 1.61 17.82 ± 1.75 15.83 ± 1.7 17.3 ± 1.86 
PrL 23.97 ± 2.2 23.41 ± 2.36 21.44 ± 2.13 23.55 ± 2.66 
IL 23.39 ± 2.01 23.05 ± 1.76 21.01 ± 1.87 23.37 ± 2.1 
DP 22.02 ± 1.2 22.08 ± 1.04 20.22 ± 1.22 21.79 ± 1.28 
 
5.3.5. Changes in neuronal firing during the ISM 
Finally, we looked at neuronal/unit firing in relation to the SO cycle during the 
ISM (Figure 5.13A; Normally, in WT animals neurons only fire on the Up-state, while 
during the Down-state neurons are “silent”. Hence, we were interested to see whether 
the increase in high frequency activity seen on the Up- and Down-state during the ISM 
would also translate to increased neuronal firing.  
As previously described (section 5.2.3.3) we performed two types of unit-related 
analysis. Firstly, we looked at the 6 variables of interest after averaging them across 
units for each animal: the ISI for the recording duration and on the Up-state, the spike 
frequency for the recording duration and on the Up-state, the percentage of units firing 
on the Up-state and the unit firing / SO coherence (Table 4.5, “WT” column). Our 
analysis in 7 WT animals with 23 units revealed a small effect of ISM segment on the 
ISI of neuronal firing for the recording duration (F(3, 18) = 3.72, p < 0.05), and in the 
spike frequency for the recording duration (F(3, 18) = 3.27, p < 0.05). Although all the 
assumptions of the test were met, post-hoc analysis did not identify significant 
differences between specific segments for these two variables. The failure of the post-
hoc analysis confirmed our concerns that this analysis would obscure the changes 
between ISM segments for each unit. Hence, we proceeded with the second analysis 
where we treated all units as individual samples. 
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One-way rmANOVA analysis for 23 WT units for each of the same 6 variables 
(See above; Table 5.2) revealed a significant effect of segment in the ISI for the 
recording  duration (irrespective of state; F(1.53, 33.68) = 6.03, p < 0.01), as the ISI 
was significantly shorter in the ISM compared to the non-ISM segment (p < 0.05). A 
trend for shorter ISIs for the recording duration was also seen in the ISM (p = 0.053; 
CI = -0.194 – 0.001) and post-ISM segments (p = 0.05; CI =-0.181 – 0.001) in relation 
to the pre-ISM segment. However when we looked at the ISIs on the Up-state alone 
there was no significant difference between groups, suggesting that the shorter ISI for 
the recording duration may be attributed to higher SO frequency and thus, more 
frequent Up-states. There were no significant differences in the firing rate on the Up-
state nor in the percentage of units firing on the Up-state. However, the unit firing / SO 
coherence (F(3, 57) = 5.89, p < 0.01; N = 20) was significantly lower in the ISM 
compared to the pre-ISM and post-ISM periods (p < 0.01; Figure 5.13B,C).  
Upon inspection of the raster plots for individual neuronal firing patterns (5.13A) 
we noticed that units changed their firing in different ways in relation to the ISM. Thus, 
we decided to look into each unit’s firing behaviour (N = 23) and calculated the 
percentage change in firing rate during the ISM compared to the non-ISM segment. 
Units were grouped into those that increased their firing rate (> 115%), did not change 
their firing rate (85% - 115%) or decreased their firing rate (< 85%) on the Up-state. 
Overall, about half of neurons increased their firing during the ISM (N = 9), with an 
average percentage increase of 72.55% ± 20.28%. The remaining units either showed 
no change in firing rate (N = 10; 106.2% ± 4.58%) or a decrease in firing rate (N = 4; 
62.19% ± 6.59%) during the ISM compared to the non-ISM segment (Figure 5.13D,E). 
Although no statistical analysis was performed, these data clearly demonstrate that 
neuronal firing rate is differentially affected by the ISM.  
In summary, neurons change their firing in different ways in response to the 
ISM, with ~40% of neurons in the mPFC increasing their firing rate while the rest either 
have unaltered (~40%) or reduced firing rates (~20%). This variability in neuronal firing 
in relation to the ISM has obscured the results of our statistical analysis. We only found 
a shorter ISI for the recording duration during the ISM compared to non-ISM segments 
which could relate to an increased firing rate, or the shorter SO cycle that occurred 
during the ISM. The ISM also appears to have less synchronised firing in relation to 
the SO, compared to its preceding and following periods. A more in-depth analysis of 
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single unit behaviour in relation to the ISM, including the pre-ISM and post-ISM 
segments, could provide valuable insight regarding the nature of the ISM, especially 
considering the increases in high frequency power during this event.  
Table 5.2: Changes in neuronal firing patterns in relation to the ISM in the mPFC of 
WT mice. These variables reflect the activity of 23 units recorded in WT animals (N = 
7), and were either averaged across all units/animal (± SEM), or treated as single units 
(± SEM). Each variable was calculated for the pre-ISM, ISM and post-ISM segments, 
for all mPFC regions combined. Variables also shown in Figure 5.13 are in Italics.   
 
Characterisation of averaged units/animal 
Variable Non-ISM Pre-ISM ISM Post-ISM 
Spike frequency  / 
recording duration (Hz) 
1.28 ± 0.19 1.26 ± 0.2 1.37 ± 0.21 1.47 ± 0.22 
Spike  frequency on the 
Up-state (Hz) 
3.18 ± 0.56 2.72 ± 0.42 2.84 ± 0.44 3.04 ± 0.45 
ISI / recording duration 
(s) 
1.04 ± 0.23 1.17 ± 0.17 0.98 ± 0.18 0.93 ± 0.15 
ISI on the Up-state (s) 0.29 ± 0.06 0.34 ± 0.08 0.33 ± 0.07 0.29 ± 0.06 
Firing on Up-state (%) 91.59 ± 2.3 93.04 ± 3.2 92.88 ± 2.11 90.62 ± 2.76 
Unit firing / SO 
coherence 
0.71 ± 0.07 0.74 ± 0.05 0.65 ± 0.06 0.71 ± 0.04 
Single unit characterisation 
Variable Non-ISM Pre-ISM ISM Post-ISM 
Spike frequency / 
recording duration (Hz) 
1.22 ± 0.14 1.24 ± 0.14 1.34 ± 0.15 1.44 ± 0.16 
Spike  frequency on the 
Up-state (Hz) 
2.94 ± 0.37 2.63 ± 0.3 2.79 ± 0.33 2.93 ± 0.34 
ISI / recording duration 
(s) 
1.25 ± 0.22 1.28 ± 0.14 1.09 ± 0.15 1.06 ± 0.13 
ISI on the Up-state (s) 0.33 ± 0.04 0.33 ± 0.05 0.33 ± 0.04 0.32 ± 0.04 
Firing on Up-state (%) 89.55 ± 1.61 91.98 ± 2.42 90.88 ± 1.35 88.07 ± 1.74 
Unit firing / SO 
coherence 
0.72 ± 0.04 0.77 ± 0.02 0.68 ± 0.03 0.75 ± 0.03 
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Figure 5.13: Changes in unit firing patterns in WT animals in relation to the ISM. A) 
An example of unit firing in the mPFC in relation to the spectrogram and LFP (red = 
Up-state, blue = Down-state). B-C) The variables that were significantly different 
across frequency bands: the ISI for the duration of the recording and the unit firing / 
SO coherence. D-E) The behaviour of units in the ISM in relation to non-ISM periods. 
D) The percentage of cells to decrease (< 85%), increase (> 115%) or not change its
firing rate (85% - 115%) and E) the percentage change in each category. These
variables were calculated using 23 units from WT (N = 8) animals. Error bars indicate
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5.3.6. The relative spindle density decreases during the ISM 
We also looked at the spindles in the mPFC during the ISM and characterised 
the relative spindle density, corresponding to the number of spindles per Up-state. We 
calculated the relative spindle density for the non-ISM, pre-ISM, ISM and post-ISM 
periods, in the 4 mPFC subregions. Two-way rmANOVA analysis showed a significant 
effect of segment (F(3, 21) = 6.41, p < 0.01), with post-hoc analysis showing 
significantly fewer spindles / Up-state during the ISM compared to the non-ISM period 
(p < 0.05). We also found a significant region/segment interaction (F(9, 63) = 3.06, p < 
0.01) which we investigated further with one-way rmANOVA analyses for each region. 
In the DP and PrL, although there was a significant effect of segment (DP: F(9, 63) = 
4.34, p < 0.05; PrL: F(9, 63) = 6.28, p < 0.05), post-hoc analysis only revealed a pattern 
for fewer spindles/Up-state in the ISM compared to the non-ISM period (DP: p = 0.054, 
CI = -0.003 – 0.394; PrL: p = 0.052, CI = -0.002 – 0.5). This lack of significance again 
might relate to the low sample size, as indicated by the wide CI. In the IL (F(9, 63) = 
5.88, p < 0.01) and ACC  (F(9, 63) = 7.38, p < 0.05) significantly fewer spindles / Up-
state were found in the ISM compared to ISM segments (p < 0.05). 
Table 5.3: The relative spindle density in relation to the ISM in the mPFC of WT mice. 
The average spindle density ± SEM is shown for each mPFC subregion (ACC, IL, PrL, 
DP) and ISM segment (non-ISM, pre-ISM, ISM, post-ISM), in WT mice (N = 8). 
 
  
 Non-ISM Pre-ISM ISM Post-ISM 
ACC 0.86 ± 0.06 0.77 ± 0.06 0.65 ± 0.05 0.67 ± 0.05 
PL 0.79 ± 0.05 0.77 ± 0.07 0.65 ± 0.06 0.65 ± 0.05 
IL 0.78 ± 0.06 0.79 ± 0.07 0.68 ± 0.07 0.68 ± 0.06 




5.4.1. Summary of the main findings 
The main findings of our characterisation of the ISM in WT mice in the mPFC 
and CA1 regions of the hippocampus are presented below: 
 The ISM had a periodicity of ~3.5 min (0.0047 Hz) in the mPFC, and of ~3.9 min 
(0.0042 Hz) in the CA1 region of the hippocampus, and lasts ~1 min.  
 In the mPFC during the ISM there was an increase in beta band power on the 
Up-state and an increase in theta, beta and gamma band power on the normally 
“silent” Down-state, compared to non-ISM segments.  
 The peak power on the Up-state was lower during the ISM, pre-ISM and post-
ISM segments compared to non-ISM periods, in all frequency bands in the 
mPFC, and in the beta and gamma frequency bands in the CA1 region.  
 In both the mPFC and hippocampus, the ISM had greater power across all 
frequency bands on the Up- and Down-states during the ISM compared to pre-
ISM and post-ISM segments. 
 The SO / theta band power ratio was lower during the ISM compared to the non-
ISM period.  
 In both the mPFC and hippocampus, the ISM segments had a greater SO 
amplitude and frequency, and shorter and less variable Up- and Down-states 
over time, compared to the non-ISM segment.  
 Neurons in the mPFC changed their firing rate in different ways during the ISM, 
with ~40% of neurons increasing their firing rate compared to non-ISM periods.  
 In the mPFC, the ISM had a lower relative spindle density during the ISM 
compared to the non-ISM segment.  
5.4.2. The ISM is characterised by a shift of power to higher frequency bands 
The most important feature of the ISM was a marked change in the power of the 
high frequency oscillations occurring during the SO. First, we looked at the average 
power on the Up-state, which is the part of the SO where higher frequency oscillations 
are expected to occur (Steriade et al., 1993b), and found that in the mPFC the ISM 
was characterised by an increase in beta band power. Interestingly, the ISM was also 
characterised by an increase in theta, beta and gamma band power on the normally 
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neuronally “silent” Down-state. In the CA1 region of the hippocampus, there was also 
a significant increase in power in these frequency bands on the Up- and Down-states 
during the ISM, but only in relation to the pre-ISM and post-ISM segments (discussed 
later at section 5.4.6). However, there was a clear trend for a general increase in high 
frequency power on the Down-state in the CA1 as well, especially in the gamma 
frequency range. Thus, our analysis confirmed our observation that the ISM is an event 
characterised by an increase in oscillatory power across a range of frequency bands, 
partly due to an increase in beta power on the Up-state but mostly due to “abnormal” 
high frequency activity on the Down-state.  
We also looked at the peak power and the latency to the peak power on the 
normalised SO cycle (Down-state + Up-state). We found that, as expected, the peak 
power occurred on the Up-state in all frequency bands: theta, beta, gamma, high-
gamma. However, in the mPFC the peak power was lower during the ISM compared 
to the non-ISM segment, in all frequency bands. This is an interesting finding as we 
also found that during the ISM, higher frequency oscillatory power on the Up-state was 
mostly unaltered or, in the case of beta band power, it was increased. Similarly, in the 
CA1 region, the peak power on the Up-state was lower during the ISM than the non-
ISM segment, in the theta and gamma frequency ranges. Therefore, our findings 
suggest that the peak power of high frequency activity occurs in a more distributed 
manner on the Up-state.  
5.4.3. The ISM does not reflect the activated state 
Although the ISM shares some similarities with the spontaneous alternations 
observed in natural sleep states described previously by Clement and colleagues 
(2006) and later by others in rodents under urethane-induced anaesthesia (Pagliardini 
et al., 2013; Zhurakovskaya et al., 2016), there are also key differences. In terms of 
the similarities, the activated states are characterised by a shift of power from the SO 
to the theta band (Clement et al., 2008), with the resulting increase in SO/theta power 
ratio being used to identify the activated state in relation to the deactivated state 
(Pagliardini et al., 2013). Similarly, we found an increase in ratio of SO and theta 
absolute power (PSD) during the ISM. The activated state is also characterised by an 
increase in gamma band power (Pagliardini et al., 2013) and indeed, we found greater 
gamma band power on the Down-state in both the mPFC and CA1 region of the 
hippocampus during the ISM. Finally, the ISM similar to activated states had an abrupt 
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onset (Clement et al., 2008) with a sudden increase in fast oscillatory activity that could 
be seen visually in the spectrogram.  
However, there are numerous differences between activated states and the 
ISM, which lead us to believe they are not exactly the same phenomena. One of the 
main differences is that we do not see a loss of the SO and a clear emergence of theta 
during the ISM, as would be expected with the activated states (Clement et al., 2008). 
In fact, the SO increases in both frequency and amplitude, clearly demonstrating that 
the ISM is not a REM-like transition. Moreover, the ISM had a much shorter periodicity 
(approx. 3.5 min) than the activated/deactivated state cycles (approx. 9 min; Clement 
et al., 2008; Pagliardini, Gosgnach and Dickson, 2013). One could argue that this 
discrepancy can be attributed to different levels of anaesthesia. In the previously 
mentioned studies, anaesthesia was achieved and maintained via intravenous 
urethane administration (Pagliardini et al., 2013; Clement et al., 2008), while we 
induced anaesthesia via intraperitoneal injections. Hence, the plane of anaesthesia 
could have been less constant in our study. However, we had no eye blink or pedal 
withdrawal reflexes suggesting that the animals were indeed under deep anaesthesia. 
Furthermore, Clement et al. (2008) did not find changes in the periodicity of 
activated/inactivated states with deeper levels of anaesthesia and although they did 
not investigate more superficial levels of anaesthesia, they concluded that the 
activated state had a consistent periodicity irrespective of anaesthesia level. Thus, we 
believe that this discrepancy in periodicity between the ISM and activated/deactivated 
states cannot be fully attributed to the plane of anaesthesia.  
Another key difference between the ISM and the activated states is that in 
addition to the increase in REM-like activity in the theta and gamma band power (on 
the Down-state) that is expected in the activated-state, we also see an increase in beta 
band power during the ISM. Specifically, we found a significant increase of beta band 
power on both the Up- and Down-state in the mPFC during the ISM compared to non-
periods. A similar trend for an increase in beta band power on the Down-state during 
the ISM is seen in the CA1 as well. These findings indicate a particular role for beta 
frequency activity during the ISM in the mPFC. The frequency range used here for the 
beta band overlaps with the gamma frequency range as described by Pagliardini and 
colleagues (25 – 40 Hz). Thus, the increase in power that we observe in the beta band 
could correspond to an increase in gamma activity as described by Pagliardini et al. 
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(2013). On the other hand, the increase in beta band power during the ISM could be 
distinct and functionally significant, as will be discussed below. Finally, we found a 
decrease in spindle density during the ISM compared to non-ISM periods in the mPFC. 
In contrast, both the activated states under urethane anaesthesia and REM during 
natural sleep are preceded by intense spindle activity in the rodent cortex instead 
(Clement et al., 2008). 
5.4.4. The ISM is an infra slow oscillation (ISO) 
An alternative family of rhythms that have been reported to occur during NREM 
sleep and which more closely resemble the ISM, are the infra-slow oscillations (ISO). 
ISOs have been observed under urethane anaesthesia in the rodent hippocampus 
(Penttonen et al., 1999), auditory cortex and thalamic and brain-stem nuclei (Filippov 
et al., 2008), and in a number of brain regions during natural sleep (see review by 
Palva & Palva, 2012). Several studies have also described ISOs in both the human 
(Ko et al., 2011; Vanhatalo et al., 2004), and monkey cortex (Leopold et al., 2003), 
where they regulate activity in the theta, alpha and beta/gamma frequency bands 
during sleep or awake states (review by Watson, 2018).  
One of the best studied ISOs during sleep seen in humans is the cyclic 
alternating pattern (CAP), composed of microactivation periods that reflect cortical 
arousal (phase A) and their intermediate SWS periods (phase B) (Introduction section 
1.4.6 , Terzano and Parrino, 1993; Parrino et al., 2006). The A phase can be further 
catergorised into subtypes according to the percentage of SWA activity present: 
subtype A1 is composed mostly of SWA (> 80%), with 20% of activity being low-voltage 
fast activity. Subtype A2 contains about 50% - 80% of SWA, and the rest is low-voltage 
fast activity, while subtype A3 is predominantly consists of faster activity (> 50%) 
(Parrino et al., 2006). Although the cyclic nature of CAP and the ISM are comparable, 
CAP has a frequency of 0.002 – 0.02 Hz, while the ISM has a lower frequency of 0.005 
Hz. However, considering that our experiments are in a mouse modelof sleep under 
urethane anaesthesia, it is not impossible that the two rhythms are related.  
One possibility is that the ISM is related to A1 subtype CAP modulations. A1 
events, which drive the staging of NREM sleep, are characterised by slow, high-
amplitude activity such as delta bursts or K-complexes, while a train of A1 events can 
be seen to coalesce within the SO (Mendez et al., 2016; Parrino et al., 2006). Hence, 
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the A1 modulation contains higher frequency activity that is integrated in the SO, 
similarly to the ISM. In rodents, a CAP A1-like rhythm was described by Lecci and 
colleagues (2017) in naturally sleeping mice, in four cortical regions including the 
mPFC (Lecci et al., 2017; Manconi et al., 2017). The rodent rhythm had a frequency 
of 0.02 Hz and has also been identified in the human supplementary somatosensory 
cortex during sleep, with a similar duration and interval (Lecci et al., 2017; Lázár et al., 
2019). This 0.02 Hz rhythm was deemed important for memory consolidation in 
humans, as it was preceded by SWRs in the CA1, and crucial for “sleep protection” 
against perturbations (Lázár et al., 2019). Hence, if the ISM we have observed is 
similar to the ISO described by Lecci and Lazar, then this suggests the ISM may also 
have a key role in in sleep protection and memory consolidation as well.  
One of the key similarities of the 0.02 Hz rhythm and the ISM is that the 0.02 Hz 
rhythm is also accompanied by increased theta and beta band power (16 – 20 Hz), 
although this result was not discussed further by the authors (Lecci et al., 2017). 
However, the 0.02 Hz rhythm was also characterised by increased sigma (10 – 15 Hz) 
power during NREM sleep and the occurrence of spindles. Although we did not 
investigate power in the sigma frequency range, we found a decrease in spindle 
density during the ISM compared to non-ISM periods in the mPFC. Moreover, the 0.02 
Hz rhythm has the highest frequency in the CAP frequency spectrum (0.02 – 0.05 Hz) 
which is much faster than the ISM frequency in the mPFC (0.005 Hz). The 0.02 Hz 
rhythm also has double the duration of the ISM (110 s). Again, these discrepancies 
might relate to the effect of urethane anaesthesia on sleep patterns, although this 
assumption needs to be verified. In conclusion, although the ISM and 0.02 Hz rhythms 
have a similar power content, the different time-frames and the decrease in spindle 
activity suggest that the two rhythms are distinct.  
Alternatively, the ISM could reflect an A3 subtype CAP modulation. A3 events 
can manifest as alpha activity, polyphasic bursts and arousals as described by the 
American Academy of Sleep Medicine (AASM), which involve a shift of SO frequency 
power to theta, alpha and beta rhythms (Parrino et al., 2012). Although the A3 CAP 
subtype has only been characterised in humans so far, it appears to contain higher 
frequency oscillations, similarly to the ISM. In addition, A3 events are characterised by 
< 50% SWA, suggesting a shift of power from the SO to higher frequencies (Parrino et 
al., 2006). In our study, we found a decrease SO/theta power ratio during the ISM, 
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although we did not investigate the actual percentage power content of the ISM for 
each frequency band. Finally, A3 events are believed to offer a window for assessing 
the current levels of sleep and, under the right circumstances, they can induce a 
transition from NREM to REM sleep. In our study, we do not see REM/activated states 
but we believe that the level of anaesthesia could have influenced the capacity of the 
A3/ISM events to shift NREM sleep to a REM state, although the A3 modulation may 
still be evident.  
Bearing in mind that the main characteristic of the A1 subtype CAP modulation 
is an increase in spindles (Lecci et al., 2017) and we did not see that during the ISM, 
together with the spectral content of the ISM, we can propose that the ISM is most 
likely an A3-like and not an A1-like event. During natural sleep or lower urethane 
anaesthesia levels it is possible that if the ISM corresponds to an A3-like event it could 
shift the NREM state to REM sleep. The A1 modulation might not be as evident under 
anaesthesia in the mPFC, as it is not prominent in this region anyway (Lecci et al., 
2017). A study in mice during natural sleep would help elucidate this theory.  
5.4.5. Neurons change their firing in different ways in relation to the ISM 
The analysis of single neuron firing in the mPFC during the ISM was 
inconclusive. In view of our findings of increased high frequency oscillatory activity on 
the Down-state during the ISM compared to the other segments, we also expected to 
see an increase in neuronal firing on Down-state. However, we only found a significant 
decrease in unit firing / SO coherence during the ISM compared to the non-ISM 
segment, which suggests a trend to more aberrant firing. In order to delineate this 
inconsistency, we closely inspected the raster plots showing neuronal firing for each 
unit, and noticed that different neurons changed their firing in different ways during the 
ISM. About 40% of neurons increased their firing during the ISM, while the remainder 
showed either no change or a decreased firing rate. 
Our findings of different neuronal firing responses in relation to the ISM, can be 
explained by the observation that that NREM sleep homogenises neuronal activity 
(Watson et al., 2016). Specifically, sleep appears to upscale slow-firing pyramidal 
neurons, and to decrease the activity of fast-firing pyramidal neurons in the cortex, 
which correspond to strong and weak synapses respectively (Vyazovskiy et al., 2009). 
During “arousals” such as A3-like events, or during activated states, it is proposed that 
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these neurons would revert to their normal firing patterns (Watson et al., 2016). Most 
pyramidal neurons are considered to be of the “fast-spiking” compared to the “slow-
spiking” type (Watson et al., 2016), and hence, they would decrease their firing rate 
during the SO. However, these suppressed “fast-spiking” cells could revert back to 
their high frequency spiking activity during the ISM, explaining our findings of an 
increase in neuronal firing rate during these events in about 40% of the recorded units.   
5.4.6. The pre-ISM and post-ISM periods are functionally important  
Sleep-related ISOs have also been quantified as periods of reduced high 
frequency activity instead of periods of greater high frequency activity (Miyawaki et al., 
2017). The small-amplitude irregular activity  observed in the mPFC, hippocampus and 
thalamus of naturally sleeping rats, is characterised by long-lasting periods of 
suppressed activity during NREM sleep that lasts longer (~ 4.5 s) than a Down-state 
(Bergmann et al., 1987; Jarosiewicz, McNaughton and Skaggs, 2002). These so-called 
LOW states are characterised by decreased neuronal firing along with a reduction in 
spindles and in oscillatory activity in the hippocampus, PFC and thalamus (Miyawaki 
et al., 2017). Although the LOW state does not describe an ISM-related event, LOW 
periods have been described to occur before and after periods of high-neuronal activity 
(Miyawaki et al., 2017). Pre-ISM segments were also characterised by a decrease in 
oscillatory activity in relation to the ISM, in both the mPFC and CA1 of the 
hippocampus. Thus the pre-ISM segments resemble LOW states.  
The pre-ISM segment in our study had longer Up- and Down-states and a lower 
SO frequency compared to the ISM, but it was not significantly different compared to 
the non-ISM segment. This finding was surprising, as we had noticed that the ISM was 
often preceded by an abnormally long Down-state. However, statistical analysis did 
not verify our observation in terms of average SO frequency, Down-state length or 
Down-state length variability, likely due to averaging our variables across each 30 s 
pre-ISM segment and then across recordings and animals. In a later analysis we could 
analyse a shorter pre-ISM segment, to assess the apparent prolonged Down-state in 
more detail. Moreover, the unit firing analysis did not provide reliable insight about the 
pre-ISM and post-ISM segments, except that they have a higher unit firing / SO 
coherence compared to the ISM period. This finding shows that the pre-ISM and post-
ISM segments are characterised by well-timed firing during the SO cycle. We would 
also expect to see a decrease in unit firing on the Up-state during the pre-ISM and 
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post-ISM segments compared to the ISM, that would correspond to the decrease seen 
in high frequency power in the SO cycle. However, probably due to the variable 
behaviour of single units in relation to the ISM we did not see such effects.  
Whether or not the pre-ISM period reflects the LOW states described by 
Miyawaki et al. (2017), the notion that high activity states are preceded by periods of 
low activity levels could still be relevant to the ISM. Periods of reduced activity just 
before energy-demanding events are considered necessary for cellular repair and 
restoration of organelles (Miyawaki et al., 2017). A homeostatic hypothesis may also 
apply to the post-ISM period, which also had lower oscillatory power on the Up- and 
Down-states, compared to the ISM periods. The post-ISM period appears as an 
intermediate period between ISM and non-ISM periods in terms of state lengths and 
their variability. Thus, the post-ISM period likely constitutes a period of adaptation back 
to the baseline SO and possibly, serves as a period of restoration. Overall, we believe 
that the ISM is an ISO, possibly initiated by a period of reduced activity (long Down-
state) followed by a period intense activity (the ISM) and then a gradual return to 
baseline levels (post-ISM). 
5.4.7. The ISM could be initiated by the thalamus or the cholinergic system 
The thalamus is the most prominent ISO generator, as it produces a widely 
described ISO characterised by cyclic paroxysms of action potentials with a 0.02 – 0.2 
Hz frequency (Destexhe et al., 1998). This rhythm is believed to be the result of 
astrocytic releases of ATP, occurring with a frequency of 0.003 - 0.1 Hz (Parri & 
Crunelli, 2001). During NREM sleep, the phase of the thalamic 0.02 - 0.2 Hz rhythm 
controls oscillations at 2 – 4 Hz and the amplitude of alpha oscillations nested in their 
troughs of the slower oscillation (Vanhatalo et al., 2004; Lőrincz et al., 2015). In turn, 
alpha oscillations control the occurrence of theta, beta and gamma oscillations in 
different brain regions (Hughes et al., 2011; Palva & Palva, 2012). Thus, the 0.02 – 0.2 
Hz rhythm, although much faster than the ISM (0.005 Hz in the mPFC, 0.004 Hz in the 
CA1), appears to control higher frequency oscillatory activity in a similar manner.  
The thalamus is a heavily interconnected region and, therefore, influences 
numerous cortical regions such as the mPFC, and sub-cortical structures such as the 
hippocampus. The deep layers of the mPFC are heavily connected to the thalamus, 
with inter-laminar connections driving feedforward inhibition between corticothalamic 
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circuits, mediating processes of sensation, perception and consciousness (Cruikshank 
et al., 2012; Riga et al., 2014). The thalamocortical projections also synapse directly 
with PV+ interneurons in the superficial cortical layers, promoting the generation of 
beta/gamma rhythms (Lemieux et al., 2015). Moreover, the thalamus can influence the 
cortical SO, as an Up-state is elicited immediately after a burst of firing in thalamic cells 
(Destexhe et al., 1998), as well as hippocampal pyramidal cells (Bertram & Zhang, 
1999). Hence, the thalamus could alter the SO frequency and faster oscillations nested 
on the Up-state in both the mPFC and CA1, in a synchronous and prominent way as 
the ISM does. 
As discussed earlier, our hypothesis is that the ISM may reflect the CAP, A-type 
event seen in humans during natural sleep (Terzano and Parrino, 1993; Parrino et al., 
2006). The exact origin of CAP is still unknown, but it is believed to result from a 
thalamo-cortical interplay (Parrino & Vaudano, 2018). In human subjects, it has been 
proposed that A1 activity is driven by thalamocortical inputs to the cortex, a theory that 
also fits the spindle-manifestation of A1 events (Ferri et al., 2008). On the other hand, 
A3 activity may be the result of the resting state networks (RSNs) which can be 
influenced by sub-cortical structures such as the thalamus (Mendez et al., 2016). The 
thalamus is the main pacemaker of alpha activity (Bazanova & Vernon, 2014) and has 
been shown to participate in RSNs (De Luca et al., 2006). Hence, it is reasonable that 
A3 induces increases in power in the theta and beta/gamma frequency bands that are 
regulated by alpha frequency activity, similarly to our study.  
The generation of the A3 event in the thalamus is believed to rely on the 
influence of the dorsal ascending reticular activating system (ARAS) pathway (Terzano 
& Parrino, 2000), which is pivotal for controlling the alternations between NREM sleep, 
REM sleep and waking. In fact, cholinergic neurons in the PPT/LDT nuclei in the 
brainstem cholinergic system directly modulate the thalamus (Brown et al., 2012). 
Thus, since these cholinergic nuclei control the REM to NREM sleep transitions, they 
likely modulate the A3 event, which occurs right before REM sleep starts (Parrino et 
al., 2006). If the ISM is indeed similar to the A3 CAP event then it might also be 
controlled by cholinergic inputs (Terzano and Parrino, 2000). However, to confirm the 
hypothesis that the ISM and A3 events are the same, we should investigate whether 




The cholinergic system could also influence the cortex and hippocampus 
directly via projections from the basal forebrain (BF) cholinergic system. The BF 
cholinergic system is part of the ventral ARAS pathway that is also involved in the 
homeostasis of NREM sleep, REM sleep and waking (Brown et al., 2012). Moreover, 
the BF cholinergic system participates in the regulation of RSNs including the DMN, 
and could, therefore, also be involved in the modulation of higher-frequency 
oscillations through RSN function (Nair et al., 2018).  
Whether the ISM is related to the A3 CAP modulation or not, we firmly believe 
that it most likely reflects a thalamic and/or a cholinergic phenomenon. Nevertheless, 
to confirm our hypothesis we would have to conduct the appropriate pharmacological 
and/or electrophysiological manipulation of the thalamic and BF cholinergic nuclei to 
see how these alter the ISM. 
5.4.8. The ISM influences the SO  
Another important finding that we have not discussed so far is an increase in 
SO frequency during the ISM that can be attributed to a decrease in both Up- and 
Down-state lengths. As extensively argued in the Chapter 4, the SO cycle is governed 
by the local balance of inhibition and excitation (Neske, 2015). Therefore, it is not 
surprising that under a state of altered excitation/inhibition (E/I) such as during the ISM, 
the SO is also influenced. The E/I balance that drives the SO can also be influenced 
by thalamocortical inputs. As discussed in the above section, the thalamus can induce 
the generation of Up-states in the cortex, resulting in an increase in Up-state number 
and shorter Down-states as seen during the ISM (Lemieux et al., 2014). Thus, changes 
in local mPFC neuronal circuits and/or in the thalamocortical inputs that possibly drive 
the ISM, could lead to a shift in the E/I balance that governs the SO in the cortex and 
in shorter Up- and Down-states. As discussed earlier, the cortical SO also influences 
the hippocampal SO rhythm (Sharma et al., 2010). 
Another important observation is an increase in SO amplitude during the ISM. 
Although we do not know how the ISM affects the SO amplitude, we can postulate that 
an increase in neuronal activity contributing to the SO may be the reason. Oscillation 
amplitude is proportional to the number of cells firing simultaneously (Reichinnek et al., 
2010). Furthermore, both the SO frequency and amplitude have been positively 
correlated with the number of activate synapses during learning (Molle et al. 2011, 
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Tononi and Cilrelli, 2006). Thus, it is possible that ultimately the ISM induces the 
participation of more neurons in the SO, giving rise to a greater SO amplitude and 
frequency. In fact, thalamocortical neurons contact the dendrites of pyramidal cells in 
cortical layer 5 of the rodent prefrontal cortex (Rah et al., 2015) where the Up-state is 
generated (Lőrincz et al., 2015), and PV+ interneurons in cortical layer 1 (Cruikshank 
et al., 2012). In the ISM, the increased activity of both neurotransmitter systems would 
promote not only the aforementioned changes in the SO but would also influence 





The ISM is a period characterised by an increase in power in high frequency 
oscillatory power during the Up-state, but especially during the normally neuronally 
“silent” Down-state. Moreover, the SO persists during the ISM, but is characterised by 
an increase in frequency and amplitude. In addition, the ISM is characterised by a 
decrease in spindle density while different neurons change their firing patterns in 
different ways, with 50% increasing their firing. Although we cannot be sure of the exact 
nature of the ISM, we believe that the it is a thalamically and/or cholinergically driven 
ISO that modulates higher frequency activity in a number of regions, including the 
mPFC and CA1 of the hippocampus. It is possible that the ISM reflects an A3 subtype 
CAP modulation and/or that is related to the activity of resting state networks. Finally, 
we believe that the ISM is of functional importance and should be investigated further 



















Sleep architecture and quality is affected early in the disease course in LBD 
patients (Pao et al., 2013). Polysomnographic studies in DLB patients and PDD 
patients have shown poor sleep continuity, longer sleep onset and REM sleep latency, 
RBD and reduced REM sleep (Terzaghi et al., 2013; Pao et al., 2013). A recent video-
polysomnographic analysis in DLB patients showed additional features including 
persistence of wake-like activity (alpha/theta) occipitally, intermittent rhythmic delta 
frontally and rapid-eye movement and sustained EMG activity at sleep onset 
(Fernández-Arcos et al., 2019). DLB patients also had transient sharp waves in NREM 
sleep, low-frequency sleep spindles in stage N2, an absence of sleep spindles and K 
complexes in NREM sleep, and a delta slowing during REM sleep (Fernández-Arcos 
et al., 2019). Overall, such a broad range of sleep-related activity dysfunction would 
be expected to affect the normal generation and function of slow-wave sleep (SWS). 
Abnormalities in SWS in DLB patients could then impact cognition and memory 
consolidation (Guarnieri & Sorbi, 2015), and the clearance of the toxic by-products of 
cellular activity (Bohnen & Hu, 2019). 
Changes in sleep architecture (sleep staging) are also expected to coincide with 
changes in sleep microstructure, the smaller building components of the different sleep 
stages (Carnicelli et al., 2019). In the previous chapter, we postulated that the ISM 
constitutes an ISO, possibly related to the CAP A-subtype modulation seen in humans 
during sleep (Parrino et al., 2012). Alternatively, the ISM may mirror a different type of 
ISO, as several ISOs have been described in rodents during sleep or anaesthesia 
(Lőrincz et al., 2015; Lecci et al., 2017; Hughes et al., 2011). Whatever the mechanism 
that underlies the ISM we have observed in WT mice, it reflects the state of the 
underlying network and could be informative about possible perturbations due to 
disease.  
In view of the changes in both the SO and the fast oscillations associated with 
the Up-state that we have observed in A30P mice (Chapter 4), we wanted to determine 





6.2. Methods  
6.2.1. Animals and recordings 
In order to compare the pre-ISM, ISM, post-ISM and non-ISM segments 
between WT and A30P animals, we used the same WT recordings used in Chapter 5 
to characterise the ISM (section 5.2.1). Hence, we had 8 mPFC and 7 CA1 recordings 
from WT animals. The A30P cohort originally consisted of 22 animals, out of which 1 
did not have ISM. We obtained recordings from the mPFC and/or the CA1 regions from 
these animals and after rejecting a few recordings on the grounds of excessive noise 
or due to broken electrode contacts (section 4.2.1), we analysed 13 mPFC and 8 CA1 
recordings from A30P mice. One of the CA1 recordings was excluded from power-
related analyses due to small urethane-anaesthesia breathing artefacts, but it was 
included in the SO state length analysis.  
The non-ISM data used for this analysis are the same data used in Chapter 4, 
for both WT and A30P animals, while all of the WT animal ISM data are that presented 
in Chapter 5. Hence, the data used in this analysis are derived from the initial 30 min-
long recordings decribed in the Methods section 2.2.1. The anaesthesia regime, frame 
mounting and electrode insertion techniques are also as described previously in 
sections 2.2.2 – 2.2.3. It is important to highlight that during these recordings the 
animals were under deep anaesthesia characterised by the SO (< 1 Hz), and the 
absence of a pedal withdrawal reflex. We also utilised the same unit data for the mPFC 
as in section 4.3.3. 
 
6.2.2. ISM variable extraction  
Firstly, we compared the mean ISM duration and periodicity between genotypic 
groups (WT, A30P). Moreover, we looked at the characteristics of the SO cycle and 
specifically at the average amplitude and frequency of the SO, the length of the Up- 
and Down-segments and SO cycle, as well as the length variability of these segments 
over time. We also analysed the average high frequency oscillatory power on the Up- 
and Down-states, as well as the peak power and the latency to the peak on the 
normalised SO cycle. All the above-mentioned variables were extracted for the ISM 
segments (non-ISM, pre-ISM, ISM, post-ISM), in the mPFC subregions (ACC, PrL, IL, 
DP) and in the CA1. For each segment we also calculated the relative spindle density 
(spindle number / Up-state number) and the unit firing properties for the mPFC region.  
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6.2.3. Statistical analysis  
To compare the ISM characteristics (frequency and duration) in A30P and WT 
animals in the mPFC, we performed mixed rmANOVA analysis with the mPFC 
subregion (ACC, PrL, IL, DP) as the repeated variable and the genotype as the 
between subjects variable. To analyse the SO cycle, amplitude, frequency and state 
lengths and oscillatory power in the SO cycle, we performed mixed rmANOVA 
analyses with the ISM segment (non-ISM, pre-ISM, ISM and post-ISM) and mPFC 
subregion as the repeated measures, and the genotype as the between-subjects 
variable. Upon finding a significant effect of genotypic group or a genotype/segment 
interaction, we performed univariate ANOVA analysis with a Bonferroni correction for 
that segment for the PrL region, unless a genotype/region effect was found when we 
performed univariate ANOVA analysis for each segment/region combination.  
Regarding our analysis for the CA1 region of the hippocampus, we performed 
univariate ANOVA analysis for the core characteristics of the ISM. For the rest of the 
hippocampal data, i.e. SO cycle, amplitude, frequency and state lengths and oscillatory 
power in the SO cycle, we performed mixed rmANOVA analysis with the ISM segment 
as the repeated measure and the genotypic group as the between-subjects variable. 
Follow-up univariate ANOVA analysis with a Bonferroni correction was performed upon 
identifying a significant effect of genotype, for each ISM segment. The effects of 





6.3. Results   
6.3.1. The ISM core characteristics in A30P mice 
In order to determine whether over-expression of human mutant α-syn had an 
impact on the occurrence of the ISM, we compared the frequency and duration of ISM 
events between A30P and WT mice. As performed in the analysis of WT mice (Chapter 
5), we looked at 30 min-long recordings from the period immediately after a stable SO 
was obtained following induction of anaesthesia (Figure 6.1A). 
In the mPFC, data from 13 A30P animals showed that the average ISM interval 
was 4.5 ± 0.21 min, which translates to an ISM frequency of 0.0037 ± 0.0004 Hz, 
compared to an ISM interval of 3.7 ± 0.2 min and an ISM frequency of 0.0045 Hz ± 
0.0003 Hz in the mPFC of WT animals (N = 8; Figure 6.1B). The mean ISM duration 
in A30P animals was 0.95 ± 0.05 min while the mean variability of ISM duration was 
0.38 ± 0.05s. In WT animals, the mean ISM duration was 1 ± 0.11 min, while the mean 
variability of ISM duration was 0.38 ± 0.05 min (Figure 6.1C).  
In the CA1 of the hippocampus of A30P animals (N = 8), the mean ISM interval 
was 3.8 ± 0.31 min that corresponds to an ISM frequency of 0.0044 ± 0.0005 Hz, 
compared an average 3.89 ± 0.35 min-long ISM intervals and an ISM frequency of 
0.0043 Hz ± 0.0006 Hz in WT animals (N = 7). The mean ISM duration 1.11 ± 0.11 min 
and the variability between ISM events in the same animal was 0.5 ± 0.1 min. In WT 
animals, the ISM duration was 0.95 ± 0.02 min while the variability in the duration of 
ISM events within the same recording was 0.29 ± 0.09 min. 
Statistical analysis between WT and A30P animals for the mPFC region showed 
a significant difference in interval length, which were longer (F(1, 19) = 6.48, p < 0.05) 
in A30P compared to WT animals (Figure 6.1C). Ultimately, this translates to a lower 
ISM frequency in A30P compared to WT animals in the mPFC. No group differences 
were found in ISM duration, or duration variability in the mPFC (Figure 6.1D), or in any 
ISM characteristic for the CA1 region of the hippocampus. 
  
194 
Figure 6.1: Changes in ISM frequency in the mPFC of A30P mice. A) Examples of the 
LFP and spectrogram in the PrL subregion of the mPFC. 30 min long extracellular field 
recordings are shown from a WT and A30P animal. B) The ISM frequency and C) the 
average ISM duration and duration variability over time, for the mPFC of 8 WT (blue) 
and 13 A30P (grey) animals. Error bars indicate the SEM. Asterisks indicate statistical 

























































































































































6.3.2. High frequency oscillatory activity in A30P mice during the ISM  
In Chapter 4, we reported that there were no major differences in the high 
frequency oscillatory power in the SO cycle between A30P and WT animals, during 
non-ISM periods. We did however identify an increase in latency to the peak power in 
the beta and gamma frequency bands in the mPFC, and an increase in latency to the 
peak power in the gamma frequency band in the CA1, in A30P mice. Furthermore, in 
Chapter 5, we found that in WT animals the ISM was characterised by increases of 
power in high frequency oscillatory activity, especially during the normally “silent” 
Down-state. Hence, we were interested to examine whether A30P animals exhibited 
changes in the ISM in terms of high frequency oscillatory activity in the SO cycle. Thus, 
we examined the power content of the SO for the different ISM segments, for four 
frequency bands that were deemed of physiological importance: theta (4 – 7.9 Hz), 
beta (8 – 14.9 Hz) and gamma (30 – 79.9 Hz) and high-gamma (80 – 130 Hz). In our 
analysis we included 8 WT and 13 A30P animals for the mPFC region analysis, and 7 
WT and 7 A30P animals for the CA1 region analysis. The variables of interest were 
the average power on the Up-state and the Down-state, and the peak power and the 
latency to the peak power in the normalised SO cycle, for each frequency band. 
6.3.2.1. A30P mice show no changes in high frequency oscillatory power in the 
mPFC during the ISM  
Our analysis in the mPFC revealed an effect of segment and/or region in a 
number of variables. All the values can be found in Appendix C and the statistical 
analysis in Appendix G. However, we found no differences between genotypes or any 
interactions between the segment and region with the genotype.  
6.3.2.2. A30P mice have increased high frequency oscillatory power in the 
hippocampus during the ISM 
In contrast to the mPFC, our analysis in the hippocampus revealed extensive 
differences in high frequency oscillatory activity in the SO cycle between A30P and WT 
animals (Figure 6.2). Regarding the mean high frequency oscillatory power on the Up-
state (Figure 6.2A) we found that it was significantly greater in A30P animals in all 
frequency bands investigated: theta (F(1, 12) = 11.89, p < 0.01), beta (F(1, 12) = 9.69, 
p < 0.01), gamma (F(1, 12) = 5.71, p < 0.05) and high-gamma (F(1, 12) = 4.9, p < 
0.05). Post-hoc univariate analysis showed that this difference between groups 
occurred in the pre-ISM, ISM and post-ISM segments but not in the non-ISM periods, 
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consistent with our data shown in Chapter 5 (section 5.3.2.2). High frequency 
oscillatory power on the Down-state (Figure 6.2B) was also greater in A30P compared 
to WT mice in all frequency bands: theta (F(1, 12) = 16.27, p < 0.01), beta (F(1, 12) = 
24.04, p < 0.001), gamma (F(1, 12) = 15.2, p < 0.01) and high-gamma (F(1, 12) = 6.87, 
p < 0.05), in the pre-ISM, ISM and post-ISM segments but not in the non-ISM segment.  
The peak power on the Up-state also differed between groups in the beta (F(1, 
12) = 8.13, p < 0.05) and theta (F(1, 12) = 6.76, p < 0.05) frequency ranges (Figure 
6.2C). Although there was no significant effect of genotype or a genotype/segment 
interaction regarding the gamma peak power, the p-value for an effect of genotype was 
quite low (p = 0.053). Although the partial Eta squared value was large (0.713) 
indicating a large effect size (Ferguson, 2009), we decided to proceed with post-hoc 
analysis for this variable as well. Univariate ANOVA analysis for the peak power 
showed a significant increase in theta, beta and gamma peak power in A30P mice 
during the ISM segment, compared to WT animals. Moreover, A30P mice had a higher 
beta and gamma peak power in the post-ISM segment, and a higher beta peak power 
in the pre-ISM segment, compared to WT mice. The latency to peak power did not 
differ between genotypic groups for any frequency band. Analysis of the non-ISM data 
in Chapter 4 showed a significant increase in latency to peak gamma power in A30P 
mice, but was not statistically significant is this analysis where the ISM segments were 
also considered. All the values can be found in Appendix D.  
To summarise, the mean high frequency oscillatory power on the Up- and Down-
states was greater in A30P animals during the ISM and the periods preceding and 
following these events, compared to WT animals. However, there were not differences 
in high frequency oscillatory power in the SO cycle during non-ISM periods, between 
the two genotypes. The theta, beta and gamma peak power was also higher during the 
ISM in A30P compared to WT mice, while an increase in high frequency peak power 
was also observed in the pre-ISM and post-ISM segments in these animals. Analysis 
of the ISM properties revealed interesting differences between WT and A30P animals 























































































































































































































































































































































Figure 6.2: Changes in high frequency oscillatory power in the SO cycle in relation to 
the ISM in the hippocampus of A30P mice. A) The mean power on the Up-state, B) 
the mean power on the Down-state and C) the latency to peak power on the normalised 
SO cycle (Down-state + Up-state), in the theta (8 – 14.9 Hz), beta (15 – 29.9 Hz), 
gamma (30 – 79.9 Hz) and high-gamma (80 – 130 Hz) frequency bands, during the 
non-ISM, pre-ISM, ISM and post-ISM segments, in WT (N = 7) and A30P (N = 7) 
animals. Error bars indicate the SEM. Asterisks indicate significance: * = p < 0.05, ** = 
p < 0.01.  
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6.3.3. The properties of the SO in A30P mice during the ISM 
In Chapter 4, we showed that A30P animals had a higher SO frequency, shorter 
Up- and Down-states, and less state-length variability over time compared to WT 
animals in both the mPFC and CA1 regions. Moreover, in Chapter 5, where we 
characterised the ISM in WT animals we found a number of changes in the SO during 
these events including an increase in amplitude and frequency and shorter Up- and 
Down-states. We therefore wondered whether additional changes would be observed 
in the SO in A30P mice during the ISM. Thus, we proceeded to compare the SO 
characteristics in the ISM segments (non-ISM, pre-ISM, ISM, post-ISM), in the mPFC 
subregions and in the CA1 region of the hippocampus, in WT and A30P animals. The 
variables of interest were the SO frequency and amplitude, the mean SO cycle, Down-
state and Up-state lengths and the mean variability of these variables over time. We 
analysed 8 WT and 13 A30P recordings from the mPFC, and 7 WT and 8 A30P 
recordings from the CA1.  
6.3.3.1. Α-syn related changes in the SO cycle in the mPFC during the ISM 
Our rmANOVA analysis revealed no differences in SO amplitude between A30P 
animals and WT animals, and no interactions between the genotype and the segment 
or region regarding this variable (Figure 6.3A). However, we did find a significant effect 
of genotype in the SO cycle length (F(1, 19) = 4.43, p < 0.05) and Up-state length (F(1, 
19) = 5.25, p < 0.05). We also found a genotype/segment interaction in the SO 
frequency (F(3, 57) = 4.07, p < 0.05) and the Up-state (F(3, 57) = 4.16, p < 0.05), 
Down-state (F(3, 57) = 6.6, p < 0.01) and SO cycle length (F(3, 57) = 7.7, p < 0.001). 
Thus, we proceeded with univariate ANOVA analysis for these variables, for each 
segment/region combination, to compare between genotypic groups (Figure 6.3B,C).  
The follow-up analysis revealed that A30P animals had a significantly higher 
SO frequency compared to WT animals during the non-ISM segments in all mPFC 
subregions (ACC, PrL, DP: p < 0.01; IL: p < 0.05; Figure 6.3B). A similar difference 
between the two groups was also shown in the pre-ISM segment in the DP subregion 
(p < 0.05). A30P animals also had a shorter SO cycle compared to WT animals during 
the non-ISM segment in all mPFC subregions (ACC, PrL, DP: p < 0.01; IL: p < 0.05), 
and during the pre-ISM segment, in the DP and ACC subregions (p < 0.05; Figure 
6.3C). Moreover, A30P mice had shorter Down-states compared to WT mice during 
the non-ISM (ACC, PrL: p < 0.01; DP: p < 0.01), pre-ISM (ACC, DP: p < 0.05) and 
199 
 
post-ISM segments (DP: p < 0.05). Finally, the Up-state was shorter in A30P animals 
compared to WT animals in the non-ISM, pre-ISM and post-ISM segments in the PrL 
subregion (p < 0.05), while the post-ISM segment was also shorter in the DP subregion 
(p < 0.05; Figure 6.3C). 
The initial rmANOVA analysis also revealed a significant effect of genotype over 
the length variability of the SO cycle (F(3, 57) = 18.27, p < 0.001), the Up-state (F(3, 
57) = 19.36, p < 0.001) and Down-state (F(2.76, 52.57) = 14.64, p < 0.001; Figure 
6.3D), over time. Furthermore, we found significant genotype/segment interactions in 
the SO cycle length variability (F(8.15, 53.6) = 9.23, p < 0.001) and Down-state length 
variability over time (F(2.77, 52.57) = 8.82, p < 0.001). Thus, we proceeded with 
univariate ANOVA analysis for the Up-state, Down-state and SO cycle length 
variability, for each segment / mPFC subregion combination. We found that A30P mice 
had significantly lower SO cycle length variability compared to WT animals during the 
non-ISM and pre-ISM segments in all mPFC subregions (p < 0.01), and during the 
post-ISM segment in the PrL (p < 0.05) and DP (p < 0.01) subregions. A30P mice also 
had a lower Down-state length variability compared to WT mice during the non-ISM 
and pre-ISM segments in all mPFC regions (p < 0.01), and during the post-ISM region 
in the DP (p < 0.01) and PrL subregions (p < 0.05). Finally, A30P animals had shorter 
Up-state length variability compared to WT animals during the non-ISM and pre-ISM 
segments, in the DP (p < 0.01; p < 0.05) and PrL (p < 0.05) subregions. An influence 
of segment and/or region was also found for these variables (Appendix E; Appendix 
H.i)  
In this analysis we replicated our previous findings outlined in Chapter 4 of an 
increase in SO frequency, shorter SO cycle and Down-state lengths, as well as lower 
SO cycle, Up-state and Down-state length variability over time, in non-ISM segments, 
in A30P animals compared to WTs. The findings of a decrease in SO cycle, Up-state, 
Down-state length variability over time in A30P mice also persist in the pre-ISM and 
post-ISM segments. However, the only difference between genotypic groups during 
the ISM is a decrease in Up-state length in A30P animals that is also seen in the pre-
ISM and post-ISM segments.    
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Figure 6.3: Changes in the SO cycle in relation to the ISM in the PrL subregion of the 
mPFC of A30P mice. A) The SO amplitude, B) SO frequency, C) the mean Up-state, 
Down-state and cycle lengths and D) the variability of state-length variables in time 
(SD), during the non-ISM, pre-ISM, ISM and post-ISM segments, in WT (N = 8) and 
A30P (N = 13) animals. Error bars indicate the SEM. Asterisks indicate significance: * 

















































































































































































































6.3.3.2. Α-syn related changes in the SO cycle in the hippocampus during the 
ISM 
Analysis of the SO amplitude in the CA1 region of the hippocampus did not 
reveal a significant difference between genotypic groups. However, our analysis did 
show a significant interaction between the genotype and segment. Follow-up univariate 
ANOVA analysis showed that A30P animals had a lower SO amplitude during the ISM 
and post-ISM segments, compared to WT animals (Figure 6.4A). We also found a clear 
effect of genotype in SO frequency (F(1, 13) = 8.4, p < 0.05), cycle length (F(1, 13) = 
10.45, p < 0.01) and Up-state length (F(1, 13) = 10.44, p < 0.01). Follow-up univariate 
ANOVA analysis showed that A30P mice had a higher SO frequency (Figure 6.4B), 
and a shorter SO cycle length and Up-state length (Figure 6.4C) compared to WT mice, 
in the non-ISM, pre-ISM and post-ISM segments. Regarding Down-state length, we 
did not find a significant effect of group but there was a segment/group interaction 
(F(1.79, 23.32) = 12.26, p < 0.001). Univariate analysis for each segment showed that 
A30P mice had significantly longer Down-states in the non-ISM segment compared to 
WT mice (Figure 6.4C). Finally, we found that A30P animals showed less variability 
over time in Down-state length (F(1, 13) = 21.31, p < 0.001) and SO cycle length (F(1, 
13) = 36.03, p < 0.001), in all segments (Figure 6.4D). A significant effect of segment 
was evident in most variables (Appendix F, Appendix H.ii). 
Our findings from the CA1 of the hippocampus regarding the SO generally 
replicate our findings from the mPFC region. We found that A30P mice had a higher 
SO frequency and shorter SO cycles, Up-states and Down-states as well as lower 
variability over time in the lengths of these variables, in the non-ISM, pre-ISM and post-
ISM segments, compared to WT mice. We also replicated the finding of shorter Up-
states during the ISM in A30P mice. The most interesting finding from the CA1 region 
was a decrease in SO amplitude in A30P animals that is significant in the ISM and 



























Figure 6.4: Changes in the SO cycle in relation to the ISM in the hippocampus of A30P 
mice. A) The SO amplitude, B) SO frequency, C) the mean Up-state, Down-state and 
cycle lengths and D) the variability of these variables in time (SD), during the non-ISM, 
pre-ISM, ISM and post-ISM segments, in WT (N = 7) and A30P (N = 8) animals. Error 
bars indicate the SEM. Asterisks indicate statistical significance: * = p < 0.05, ** = p < 
















































































































































































































6.3.4. The relative spindle density does not change in A30P mice during the 
ISM  
We found no differences in the relative spindle density measured by the number 
of spindles / Up-state number, in any segment of the ISM in A30P compared to WT 
mice (F(1, 19) = 2.81, p = 0.11; Table 6.1).  
Table 6.1: The relative spindle density in relation to the ISM in the mPFC of WT and 
A30P animals. The average relative spindle density (spindle number / Up-state 
number) ± SEM is shown for the mPFC subregions (ACC, PrL, IL and DP), for the non-
ISM, pre-ISM, ISM and post-ISM segments, in WT (N = 8) animals and A30P (N = 13) 
mice.  
 
6.3.5. Changes in neuronal firing patterns in A30P mice during the ISM   
As outlined above in Chapter 4 (section 4.3.3) we know that during the non-ISM 
segment A30P mice had increased firing on the Down-state, and a lower SO/unit firing 
coherence in the mPFC, compared to WT animals. In Chapter 5 (section 5.3.5) we 
showed that putative pyramidal neurons in the mPFC of the WT group changed their 
firing rate during the ISM in variable ways, with approximately 40% of the cells 
increasing their firing rate during the ISM, while the rest of the neurons either 
decreased or had no change in firing rate. Moreover, in section 6.3.2.1 we showed that 
A30P mice did not have any changes in high frequency oscillatory activity in the SO 
cycle compared to WT animals during the ISM in the mPFC region, that could indicate 
a similar neuronal firing activity in the two genotypic groups. However, we proceeded 
to specifically investigate for any alterations in unit firing activity in A30P mice during 
the ISM in the mPFC region.  






















































































We therefore assessed five properties of neuronal firing in WT and A30P 
animals during the ISM including: the spike frequency and ISI for the recording duration 
(Up- and Down-states) and only on the Up-state, and the percentage of unit firing on 
the Up-state, in 15 A30P and 7 WT animals with 56 and 24 units respectively (Table 
6.2). The maximum unit firing / SO coherence was also investigated in 12 A30P and 7 
WT animals, with 50 and 23 units respectively.  
We only found a significant effect of genotype in the percentage of the total unit 
firing occurring on the Up-state (F(1, 20) = 10.07, p < 0.001). Follow-up Univariate 
ANOVA analysis revealed that A30P mice had a lower percentage of neuronal firing 
occurring on the Up-state during the non-ISM (p < 0.05), ISM (p < 0.01) and post-ISM 
(p < 0.05) segments, compared to WT mice. This finding therefore implies that a 
greater percentage of unit firing occurs on the normally neuronally “silent” Down-state 
in A30P mice. It is also worth reporting that we found a trend for an effect of genotypic 
groups in the unit firing / SO coherence (F(1, 17) = 3.88, p = 0.066), and specifically a 
decrease in the unit firing / SO coherence in A30P compared to WT animals, although 
we did not proceed with a follow-up analysis for each segment. 
We also performed rmANOVA analysis for each unit separately. No differences 
were found for the ISI and spike frequency on the Up-state, or for the total recording 
duration (Figure 6.5A,B). This analysis also revealed a significantly lower percentage 
of the total neuronal firing occurring on the Up-state (F(1, 77) = 6.07, p < 0.05), and a 
lower unit firing / SO coherence in A30P compared to WT animals (F(1, 66) = 7.16, p 
< 0.01; Figure 6.5C). Post-hoc analysis showed that A30P animals had a significantly 
lower percentage of unit firing occurring on the Up-state compared to WT animals, in 
the non-ISM and ISM segments. The unit firing / SO coherence was significantly lower 
in A30P animals in all segments of the ISM (Figure 6.5D).  
The differences we identified between A30P and WT animals are consistent 
with differences that we showed in the SO analysis in Chapter 4. Interestingly, we 
found that the increased aberrant firing, reflected by a lower percentage of firing on the 
Up-state and decreased unit firing / SO coherence, also persists in the ISM and the 




Table 6.2: Unit firing patterns in relation to the ISM in the mPFC of WT and A30P mice. 
The average of each variable ± SEM was caluclated both across animals (WT: N = 7; 
A30P N = 15), and units (WT: N = 23, A30P: N = 56), in each genotypic group. 
Variables also shown in Figure 6.5 are in Italics.  
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Figure 6.5: Changes in neuronal firing patterns in relation to the ISM in the mPFC of 
A30P mice. A) The average inter-spike interval (ISI) on the Up-state and for the 
recording duration (Up-state + Down-state). B) The spike rate on the Up-state and for 
the recording duration (Up-state + Down-state). C) The percentage of unit firing that 
occurs on the Up-state. D) The unit firing / SO coherence. These variables were 
investigated in the non-ISM, pre-ISM, ISM and post-ISM segments in WT mice (N = 7) 
with 23 units and in A30P mice (N = 15) with 56 units. Each variable was averaged 
averaged across all units, irrespective of animal. Error bars show the SEM. Asterisks 
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6.4.1. Summary of the main findings 
Here we summarise the most important differences in SO patterns found 
between WT and A30P animals during the ISM.  
 A30P animals had a lower ISM frequency (0.0037 Hz) compared to WT animals 
(0.0045 Hz), only in the mPFC region.  
 In the CA1 region of the hippocampus, A30P animals had increased power in 
all frequency bands on the Up- and Down-states during the pre-ISM, ISM and 
post-ISM segments, and a greater theta, beta and gamma peak power during 
the ISM, compared to WT mice. No changes were seen in Up-state associated 
high frequency oscillations in the mPFC of A30P mice.  
 In the mPFC and CA1 regions, A30P mice had shorter Up-states during the 
ISM, pre-ISM and post-ISM segments compared to WT mice.  
 In the CA1 region of the hippocampus, A30P animals had lower SO amplitude 
in the ISM and post-ISM segments compared to WT animals.  
 In the mPFC, A30P animals had a greater percentage of the total firing occurring 
on the Down-state and a decreased unit firing / SO synchrony during the pre-
ISM, ISM and post-ISM segments, compared to WT animals.  
6.4.2. A30P mice show an increase of high frequency oscillatory activity in 
the hippocampus during the ISM 
We have shown in Chapter 5 that in WT mice, the ISM is accompanied by an 
increase in beta frequency power on the Up-state in the mPFC region. Moreover, we 
found that WT mice had an increase in power in the theta, beta and gamma frequency 
bands on the normally neuronally “silent” Down-state during the ISM, in both the mPFC 
and CA1 regions. In this chapter where we compared the ISM between A30P and WT 
animals, we found that A30P animals showed an even larger increase in high 
frequency oscillatory power on both the Up- and Down-states during the ISM. 
However, this increase in high frequency oscillatory power was specific for the CA1 
region of the hippocampus, adding to our hypothesis from Chapter 4 that the CA1 
region of the hippocampus of A30P mice is hyperexcitable. In the mPFC region in A30P 
mice, we did not see changes in high frequency oscillatory power during the ISM. 
However, in the mPFC there was more aberrant neuronal firing in relation to the SO 
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cycle, specifically, an increase in the percentage of the total firing occurring on the 
Down-state and a decrease in unit firing / SO coherence. These findings replicate the 
changes in the non-ISM segments as outlined in Chapter 4 and suggest that the local 
mPFC circuit is also hyperexcitable in A30P mice. Ideally, these observations of 
changes in unit firing patterns would also be tested in the hippocampus of A30P mice, 
but we did not have sufficient unit data from that region.  
6.4.3. A30P animals have hyperexcitable networks generating high 
frequency oscillations 
As described above, A30P animals showed a greater increase in high frequency 
oscillatory power in the SO during the ISM in the CA1 region of the hippocampus, 
compared to WT animals. Such an increase in oscillatory power suggests that the 
excitation/inhibition (E/I) balance that governs the local neuronal circuit has shifted 
towards excitability in A30P mice. A change in fast oscillation power can be related 
back to the neurons generating the high frequency rhythms in the hippocampus 
(Ferguson & Gao, 2018). We know that gamma/high-gamma frequency activity relies 
on feedback loops between pyramidal cells and PV+ interneurons in the CA3 region of 
the hippocampus, and are then relayed to the CA1 region via the Schaffer collaterals 
(Buzsáki & Silva, 2012), both during the awake state and the Up-state of the SO 
(Destexhe et al., 2007). High-gamma frequency activity is generated mostly in the EC 
and is also relayed to the CA1 region (Colgin et al., 2009). Although the CA1 is also 
capable of generating its own gamma/high-gamma activity in vitro, the in vivo recorded 
gamma/high-gamma activity in the CA1 reflects the influence of the CA3 and EC 
rhythms over this region (Craig & McBain, 2015). Hence, hyperexcitability in pyramidal 
neurons and/or in PV+ interneurons in the above mentioned hippocampal circuits could 
result in an increase in gamma/high-gamma frequency power in the CA1 of the 
hippocampus during the ISM (Rebollo et al., 2018), as seen in A30P animals.  
The CA3 region of the hippocampus can also produce theta and beta frequency 
oscillations that influence the CA1 region, both in vitro through carbachol application 
and in vivo, during REM sleep, through the activation of mAChRs (Cantero et al., 
2003). As argued in the previous chapter (section 5.4.3), we do not believe that the 
ISM reflects REM sleep but similar mechanisms of generating theta frequency 
oscillations could be implicated in REM sleep and the ISM, especially if the ISM is an 
ACh-mediated rhythm as considered in section 5.4.7. Beta and gamma frequency 
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oscillations can also be induced by carbachol in vitro, and rely on GABAAR and 
AMPAR/kainate receptor activity as the blockade of these receptors’ function reduces 
beta/gamma oscillatory activity (Whittington et al., 2000). Thus, the ISM could boost 
theta, beta and gamma frequency  activity, generated by the hyperexcitable pyramidal 
neurons in the hippocampus of A30P mice. 
The increase in high frequency oscillatory power during the SO in the CA1 of 
the hippocampus might also relate to the known properties of the hippocampus. The 
hippocampus is capable of producing highly synchronous activity and is prone to 
epileptogenicity as it constitutes the source of hypersynchronous activity in a number 
of epileptic and neurodegenerative conditions (Beenhakker & Huguenard, 2009; 
Buzsáki, 2015; Beagle et al., 2017; Vossel et al., 2017). Recent studies have shown 
that DLB patients also exhibit epileptiform activity (Beagle et al., 2017) and molecular 
signs of hyperexcitability in their hippocampus (Morris et al., 2015). The hippocampus 
has also been shown to be hyperexcitable and to exhibit epileptic-like activity in α-syn 
animal models, both in vitro (Tweedy et al., 2018) and in vivo (Morris et al., 2015). The 
SO offers a window of highly coherent activity, both spatially and temporally, while the 
hippocampal SO specifically (Wolansky et al., 2006) has been shown to lower the 
“epilepsy” threshold in a medio-temporal lobe epilepsy model (Nazer & Dickson, 2009). 
Thus, the local hippocampal SO rhythm may facilitate the large increase in high 
frequency seen in A30P animals.  
6.4.4. A30P mice have normal levels of high frequency activity in the mPFC 
during the ISM  
In the mPFC of A30P mice we also observed increases in high frequency 
oscillatory power on the Up- or the Down-state during the ISM, but these increases 
were comparable to our findings in WT mice (Chapter 5). The generation of 
gamma/high-gamma frequency oscillations in the mPFC also relies on feedback loops 
between pyramidal cells and PV+ interneurons, similarly to the hippocampus (Colgin 
et al., 2009; Wulff et al., 2009; Mann et al., 2009; Buzsáki & Silva, 2012; Sullivan et al., 
2011). Theta and beta oscillations in the cortex are generated by layer 5 pyramidal 
cells influenced by low-threshold spiking SOM+ interneurons in layer 1 (Li et al., 2013; 
Kuki et al., 2015). SOM+ and PV+ interneurons as well as pyramidal cells receive 
corticothalamic inputs that drive the increase in beta/gamma power on the Up-state by 
enhancing the aforementioned loops (Nigro et al., 2018; Lemieux et al., 2014). Hence, 
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in view of our  hypothesis that the ISM is a thalamically-derived rhythm, as suggested 
in Chapter 5 (section 5.4.7), we expected to see abnormal increases in high frequency 
oscillatory activity during the ISM in the hyperexcitable mPFC network in A30P 
animals, compared to WT animals.  
The fact that we did not see a significant difference in high frequency activity in 
the SO cycle in the mPFC of A30P mice perhaps suggests that a compensation 
mechanism might better preserve the E/I balance in this region at the early stage of 
pathology. In Chapter 4 (section 4.4.5) we suggested that PV+ interneurons may up-
regulate their function in response to the hyperexcitability. This hypothesis is supported 
by previous findings in our lab of an increase in IPSP amplitude and frequency in vitro 
in the young A30P mice (Tweedy et al., 2018). We also proposed that pyramidal cells 
might down-regulate their firing activity in relation to hyperexcitability, as seen in other 
animal models of dementia (Palop et al., 2007). It is therefore possible that such 
compensation mechanisms are present in both the hippocampus and mPFC of A30P 
mice, successfully containing the hyperexcitability during non-ISM periods. However, 
the ISM causes a large increase in excitatory drive that may override the compensation 
mechanisms, as it is evident through the aberrant increases in high frequency 
oscillatory power seen in the hippocampus of A30P mice during this event. In the 
mPFC the compensation mechanism may be more robust, maintaining the normal 
levels of high frequency activity during the ISM. Alternatively, the mPFC could have a 
lower level of α-syn pathology compared to the CA1 and thus, be less affected in terms 
of network activity. Further immunohistochemical studies  are needed to resolve this 
issue, although current evidence suggest that both the mPFC and hippocampus 
regions exhibit early, subtle evidence of α-syn pathology in A30P mice (Schell et al., 
2009). 
6.4.5. The pre-ISM and post-ISM segments are also altered in the CA1 in A30P 
mice 
In the previous chapter, we proposed that the pre-ISM and post-ISM periods are 
epochs of reduced activity that may be important for cellular restoration (Miyawaki et 
al., 2017). However, in A30P mice we found that the pre-ISM and post-ISM segments, 
as well as the ISM segment, had significantly greater levels of power in the theta, beta 
and gamma frequency bands on both the Up- and Down-states, compared to WT 
animals. We also saw that the pre-ISM and post-ISM segments were characterised by 
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an increase in peak power on the Up-state in the beta and gamma frequency bands, 
in A30P compared to WT mice. Again these findings were specific for the hippocampus 
and not replicated in the mPFC region and suggest that the pre-ISM and post-ISM 
might be less efficient is restoring the “neuronal fatigue” induced by high cellular activity 
during the ISM.  
6.4.6. Possible thalamic alterations in A30P mice can influence the ISM 
So far, we have suggested that the abnormal increase in high frequency power 
occurring in the hippocampus during the ISM are due to α-syn-induced changes in the 
local circuit. However, it is also possible that the external drive that generates the ISM 
is altered by the pathology, in addition to local circuit changes. As discussed in Chapter 
5 (section 5.4.7), the ISM may be related to the thalamic ISO characterised by cyclic 
paroxysmal bursts of action potentials and alpha oscillations (Lorincz et al., 2009). The 
thalamic activity is facilitated by the activation of mGluRs and mAChRs in addition to 
glial waves of Ca2+ release. The excessive, pathology-induced activation of these 
receptors, and an elevated Ca2+ influx driven by glial cell waves, could turn these 
paroxysmal events into epileptiform activity (review by Watson, 2018). In fact, young 
A30P mice have evidence of α-syn induced changes in glial cells (Tweedy et al., 2018), 
while Aβ1-42 has been shown to alter the properties of different receptors in animal 
models of AD (Texidó et al., 2011). Thus, while the thalamic ISO could lead to a 
moderate increase in high frequency oscillation power in WT mice (Lemieux et al., 
2014), in A30P animals it could result in excessive increases in high frequency power 
that cannot be contained on the Up-state (Hughes et al., 2011; English et al., 2014), 
as seen in our study. This theory of hyperexcitability in the thalamus of A30P mice 
needs to be investigated further through local electrophysiological recordings. 
6.4.7. A30P animals have altered sleep microstructure  
A key difference we observed between genotypes was that A30P animals had 
a lower ISM frequency (0.0037 Hz) compared to WT (0.0047 Hz) animals in the mPFC. 
Assuming that the ISM and A3 subtype CAP modulations are the same, or similar 
events (Chapter 5, section 5.4.4), a lower ISM frequency in A30P mice would be 
consistent with the decrease in CAP rate seen in patients with RBD. Moreover, the 
RBD patients who converted to DLB had fewer A1 and A3 events than those who did 
not convert (Melpignano et al., 2019). Similarly, MCI patients that also represent an 
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early dementia stage, had decreased A1 events and increased A3 events during SWS. 
However, in 2 years the MCI patients who developed amnestic dementia had 
decreased A3 and A1 events, disrupted SWS and less REM sleep (Carnicelli et al., 
2019). Thus, it appears that A1 events decrease and A3 events increase at the 
early/prodromal dementia stage, while A3 events eventually decrease with the 
development of dementia. Although we would expect that young A30P animals 
represent a prodromal DLB stage, our results of a lower ISM event frequency match 
the data from the dementia converters (Carnicelli et al., 2019; Melpignano et al., 2019). 
Finally, a decrease in A3 events is expected in dementia because a decrease in REM 
sleep episodes is seen in most dementia subtypes (Hita-Yañez et al., 2013; 
Fernández-Arcos et al., 2019). Thus, it is possible that if the ISM and A3 modulation 
are indeed the same event, fewer REM events could occur during natural sleep or 
lighter urethane anaesthesia in A30P animals. 
The fact that the reduced frequency of ISM events is seen in the mPFC of A30P 
animals and not the CA1, which is the region mostly affected in terms of high frequency 
oscillatory power, appears contradictory. A possible explanation is that the 
hippocampus and mPFC respond in different ways to a common thalamic or 
cholinergic ISM source, as previously argued. This assumption may relate back to the 
fact that the hippocampus has its own SO rhythm (Wolansky et al., 2006). Although 
the hippocampal SO is modulated by the cortex to a large extent (Vertes et al., 2007), 
it can also have a separate response to stimuli (Sharma et al., 2010). On the other 
hand, the cortex is capable of developing compensation mechanisms to counteract 
changes in its input from the thalamus during SWS (Lemieux et al., 2014). It is therefore 
possible that the compensation mechanism that better restores the E/I balance during 
the ISM in the mPFC also suppresses ISM frequency and/or its effects in this region.  
6.4.8. The ISM decreases the SO amplitude in the CA1 of A30P mice   
During non-ISM periods, and in most cases during the pre-ISM and post-ISM 
segments, we found extensive differences between A30P and WT animals in the 
duration of the SO and its constituent Up- and Down-states (as seen in Chapter 4). 
However, we did not find notable changes in the SO in A30P mice during the ISM, 
except for a decrease in Up-state length during the ISM in both the mPFC and CA1 of 
these animals compared to WT mice. Interestingly though, we found a decrease in SO 
amplitude in the CA1 of A30P animals, which could indicate a decrease in the number 
213 
 
of engaged pyramidal neurons, or a loss in synchrony of the synaptic activity 
(Eschenko et al., 2008; Marshall et al., 2006). This idea of a decrease in neuronal 
participation in the SO is consistent with the rest of our work, that supports that early 
α-syn pathology in A30P mice has influenced neuronal function, particularly in the CA1 
region of the hippocampus. 
6.4.9. A30P animals have a less efficient SWS  
It would be surprising if the increases in high frequency power in the SO during 
the ISM in A30P animals did not affect some of the essential functions of sleep, 
including waste clearance and memory consolidation (Porter et al., 2015). According 
to the glymphatic hypothesis, excess brain activation during SWS can result in lower 
levels of Aβ, tau and likely α-syn clearance (Mander et al., 2016). Inefficient clearing 
of these by-products of cellular function can induce cytotoxicity in local circuits, 
especially in regions that have fast-spiking, high energy demanding neurons like the 
CA1 of the hippocampus (Bohnen & Hu, 2019). Moreover, increased sleep 
fragmentation can induce greater production of Aβ, tau and α-syn (Lucey et al., 2018), 
that in turn further disrupts SWS, leading to a vicious cycle that drives further pathology 
(Ju et al., 2017). Therefore, the early changes in sleep microstructure in A30P mice 
could be related to early α-syn pathology and contribute to disease progression.  
If the ISM is an A3-like event, our result of reduced ISM frequency in the mPFC 
might suggest a decrease in REM sleep, as A3 events immediately precede REM 
transitions during natural sleep (Terzano & Parrino, 2000). Although we do not know 
the extent to which A3 events modulate REM sleep and vice versa, a decrease in A3 
under pathological conditions may reflect the incapacity of the cortical networks to 
achieve > 80% SWA or to transition to a REM state (Carnicelli et al., 2019). REM sleep 
is essential for the dissociation of the cortex and the hippocampus during SWS, 
allowing for the re-arrangement of local circuits that is pivotal for memory consolidation 
(Watson et al., 2016). Thus, a decrease in REM sleep would also affect the efficiency 
of hippocampal-cortical communication and ultimately, it could affect memory 
consolidation in A30P animals (Staresina et al., 2015). In fact, there is evidence that 
A30P have an age-dependent deficiency in memory consolidation (Freichel et al., 
2007). However, in view our findings in Chapter 4 of a spindle dysfunction in A30P 
mice, this memory deficit could also be related to an altered spindle/SWR coupling 
(Cox et al., 2014). 
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Finally, CAP A-type modulations are essential for guarding sleep against 
perturbations that could induce awakenings (Parrino & Vaudano, 2018). However, a 
loss of CAP related modulations implies that this sleep protection mechanism, 
enforced by A-type CAP modulations, fails more easily resulting in sleep fragmentation 
as seen in patients with DLB (Cagnin et al., 2017). In our study, we found a decrease 
in ISM frequency that, as argued earlier, is consistent with reports of a decrease in the 
frequency A-type CAP modulations in patients with DLB and amnestic dementia 
(Carnicelli et al., 2019; Melpignano et al., 2019). Hence, during natural sleep, ISM/A-
type CAP events may fail to prevent sleep disruption, resulting in sleep discontinuity, 
a further decrease in glymphatic clearance, α-syn accumulation and consequently in 





A30P animals showed greater high frequency activity on the Up- and Down-
states during the ISM in the CA1 region of the hippocampus, compared to WT animals. 
Although the high frequency oscillatory power content of the ISM in the mPFC is 
comparable between A30P and WT animals, the mPFC shows more disorganised 
firing during the ISM in relation to the SO, and a lower ISM frequency. Moreover, in 
A30P mice both the mPFC and CA1 regions showed an increase in SO frequency and 
a decrease in SO amplitude during the ISM, compared to WT animals. We believe that 
our findings indicate altered E/I dynamics due to the abnormal expression of mutant α-
syn in A30P mice. Furthermore, we believe that both the mPFC and hippocampus in 
A30P animals show evidence of network hyperexcitability and possible compensation 
mechanisms developed in response. However, the CA1 appears unable to contain the 
significant excitatory drive of the ISM, likely due to the fact that its inherently more 
epileptogenic compared to the mPFC. These changes in high frequency activity on the 
Up- and Down-states that occur during the ISM in the hippocampus of A30P mice are 
likely to affect the essential functions of SWS, such as memory consolidation and α-
syn clearance and production, exacerbating the α-syn pathology. In a similar way, 
abnormal sleep cycle or sleep-like rhythms, could also exacerbate α-syn pathology 





















7.1. Overview of the main findings  
In this study we analysed EEG data from patients with DLB, PDD and AD and 
compared findings with healthy age matched control subjects. Our analysis of human 
EEG data confirmed the well-established slowing of EEG power and dominant 
frequency (DF) from the alpha to the theta frequency range in DLB and PDD groups, 
compared to healthy controls and AD patients. In contrast to previous reports (Walker 
et al., 2000; Bonanni et al., 2008), the DF variability (DFV) over time within the 
theta/alpha range was similar between DLB/PDD patients and healthy controls. 
However, we found a DLB specific correlation between the theta DFV and slow-theta 
DFP, with CFs measured by the CAF score. These findings suggest that a slower, and 
more temporally variable DF, specifically relates to the CFs seen in DLB. We also 
found a significantly higher theta/alpha DFV in AD patients compared to the DLB, PDD 
and control groups, which is another novel finding. Previous studies had shown that 
AD patients only had a slight increase in DFV compared to healthy controls, and lower 
DFV compared to the DLB/PDD groups (Bonanni et al., 2008). Exploratory analysis 
showed that qEEG measures of the EEG slowing seen in DLB patients, and the 
increased theta/alpha DFV seen in AD patients could identify the correct diagnosis with 
high accuracy, sensitivity and specificity. 
We were also intetested to characterise the electrophysiological nature of 
another DLB symptom, early sleep disturbances. However, EEG sleep studies are 
difficult to conduct in patients with dementia. Thus, we proceeded to investigate for 
changes in network oscillations under urethane anaesthesia in the mPFC and CA1 of 
the hippocampus of A30P mice at a young age, which represent an early stage of DLB. 
We found that A30P mice had aberrant neuronal firing in the SO cycle in the mPFC, 
characterised by a greater percentage of the total firing occurring on the normally 
neuronally “silent” Down-state, and a lower unit firing / SO coherence. A30P animals 
also had a higher SO frequency in the mPFC and CA1 regions, that can be attributed 
to shorter Down-states ,and to a lesser extent shorter Up-states. Furthermore there 
was a reduction in the variability of these states’ lengths over time in the A30 mice 
suggesting a loss of longer states. A30P animals also had an altered distribution of 
power on the Up-state, specifically an increased latency to the peak power in the beta 
and gamma bands in the mPFC, and in the gamma band in the hippocampus. 
Importantly, A30P animals had altered spindle patterns, including a lower spindle 
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density, spindle-duration and fewer high-amplitude spindles. We found no changes in 
SO synchrony between the cortex and hippocampus, or changes in the SWR or in high 
frequency oscillatory power in the SO cycle between A30P and WT animals.  
During our EEG recordings in urethane-anaesthetised mice, we also observed 
a rhythmic phenomenon characterised by a sudden burst of activity across frequency 
bands. Thus, we proceeded to characterise this rhythm we termed the infra-slow 
modulation (ISM), in WT animals. The ISM events had a periodicity of 3.7 ± 0.2 min 
(0.0045 Hz) in the mPFC and 3.89 ± 0.35 min (0.0043 Hz) in the CA1. Analysis of the 
high frequency power content of the SO during the ISM showed an increase in the 
average beta band power on the Up-state. Moreover, the peak power in the theta, beta 
and gamma frequency bands on the Up-state was decreased during the ISM compared 
to the non-ISM segment, suggesting that the timing of the high frequency oscillatory 
activity on the Up-state is altered during the ISM. Moreover, the ISM was characterised 
by increased theta, beta and gamma power on the Down-state, where such rhythms 
are not normally observed. The abovementioned findings were more apparent in the 
mPFC compared to the CA1 region of the hippocampus, where the high frequency 
oscillatory power on the Up- and Down-states was greater in the ISM compared to the 
pre-ISM and post-ISM segments, but not the non-ISM segment. 
The ISM was also characterised by a higher SO frequency and amplitude, which 
shows that the SO is maintained during this period, in contrast to REM sleep that 
involves a transition to theta frequency activity. However, we did find a decrease in the 
SO/theta power ratio. We also found decreased spindle activity during the ISM. The 
pre-ISM and post-ISM segments were characterised by lower high frequency activity 
compared to the ISM, and an SO frequency similar to non-ISM segments. Finally, 
single neurons changed their firing in different ways in response to the ISM, with about 
40% of neurons in the mPFC increasing their firing rate while the rest had unaltered or 
reduced firing. 
Finally, we compared the ISM between WT and A30P animals. Our most 
important finding was that A30P mice had greater high frequency activity on the Up- 
and Down-state in the CA1 during the ISM, compared to WT animals. Although the 
mPFC was not affected in terms of high frequency oscillatory power in the SO cycle, 
neurons exhibited a more disorganised pattern of firing during the ISM compared to 
non-ISM segments. These findings suggest that the neuronal networks in A30P mice 
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are hyperexcitable in both the mPFC and hippocampus. Moreover, A30P mice showed 
a decrease in SO amplitude and Up-state length during the ISM, in the mPFC and CA1 
regions, compared to WT animals. Lastly, we found a lower ISM frequency in the 
mPFC of A30P compared to WT animals.  
7.2. Early DLB is characterised by an excitation/inhibition imbalance 
7.2.1. EEG disturbances in DLB patients  
One of the main theories regarding CF generation is that they arise due to 
disturbances in large-scale networks that govern resting state and attention (O’Dowd 
et al., 2019). Normally, the brain can shift between attentional networks and resting 
state networks (RSNs) such as the default mode network (DMN) in response to an 
internal or an external drive (Raichle, 2015). For example, the fMRI BOLD signal and 
hence the activity in the main DMN hubs increases during attention lapses in healthy 
individuals, while before such lapses, activity in the regions related to control of 
attention decreases (Weissman et al., 2006). These findings reflect competition 
between resources for internally and externally focused modes of cognition, governed 
by networks functioning antagonistically to one another (Buckner et al., 2008). 
In DLB patients, the activity of the DMN is comparable to healthy individuals 
during rest, but there is evidence of DMN hypoactivity during attentional tasks (Peraza 
et al., 2014; O’Dowd et al., 2019; Kenny et al., 2012; Firbank et al., 2018). Moreover, 
in DLB patients the transitions between RSNs and attention networks are more rigid 
(Schumacher et al., 2018; Peraza et al., 2014; Firbank et al., 2016), while the activity 
of attentional networks such as the dorsal and ventral attention networks (DAN; VAN) 
and their interaction with the DMN is also altered (Kobeleva et al., 2017). Thus, we 
postulated that although the DLB patients in our study might not have a significant DFV 
increase, the correlation between DFV and CFs could reflect altered interactions 
between the DMN and the attention networks.  
The abovementioned changes in network dynamics have been proposed to 
reflect an α-syn related alteration in the E/I balance (O’Dowd et al., 2019). The 
DLB/PDD patient cohorts used in this study had mild cognitive decline and, at this early 
stage of disease progression, the levels of neurodegeneration might be low but subtler 
synaptic changes have been extensively described (Calo et al., 2016; Colom-Cadena 
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et al., 2017; Peter et al., 2018). Early synaptic dysfunction can be largely attributed to 
small α-syn inclusions located in the pre-synaptic terminal (see review Schulz-
Schaeffer, 2010). A study showed that, the majority of the pre-synaptic α-syn is in the 
aggregated, phosphorylated form in DLB patients (Colom-Cadena et al., 2017). These 
small inclusions of α-syn are accompanied by lower levels of the normal synaptic 
proteins that are crucial for synaptic release. Furthermore, there were fewer dendritic 
spines observed post-synaptically, showing a clear synaptic deficit (Henstridge et al., 
2016; Lim et al., 2011). In vitro and in vivo studies have shown that toxic oligomeric 
mutant α-syn can also have detrimental effects, including the formation of membrane 
pores that change the cell’s membrane potential (Ghiglieri et al., 2018), induce 
mitochondrial damage and cellular stress, and impede long-term potentiation (van 
Diggelen et al., 2019). Thus, it is highly possible that α-syn mediated toxicity could 
influence the ability of different regions to engage synchronously in widespread RSNs 
and attention networks (O’Dowd et al., 2019).    
7.2.2. Hyperexcitability in the A30P mouse model  
In Chapter 4, we proposed that our findings of changes in the SO cycle such as 
an increase in SO frequency, a decrease in Up-state and Down-state length, an altered 
distribution of high frequency activity on the Up-state and aberrant neuronal firing can 
be attributed to an α-syn-induced hyperexcitability in the neuronal networks. 
Hyperexcitability is the result of the shift in the E/I balance and thus, can be attributed 
to changes in the function of excitatory and inhibitory neurons (Vossel et al., 2017). In 
fact, studies in LBD patients and animal models have shown that mutant α-syn can 
enter both pyramidal cells and PV+ interneurons and polymerise (Tsigelny et al., 2012; 
Rockenstein et al., 2014; Flores-Cuadrado et al., 2016; Martin et al., 2013). Human 
mutant α-syn localisation has also been reported in pyramidal cells and PV+ 
interneurons in A30P animals (unpublished observations) that could potentially 
influence the activity of these neurons and the properties of the SO. Since the mPFC 
and hippocampus are rich in pyramidal cells and PV+ interneurons and these cells are 
affected by mutant α-syn, we would expect alterations in these cells’ function to affect 
both regions (Ferguson & Gao, 2018; Sparta et al., 2014).  
Hyperexcitability has been more extensively described in relation to AD  
(Introduction 1.6.3; Jin et al., 2018; Vossel et al., 2017) although there is increasing 
evidence of hyperexcitability in LBD patients and animal models of α-
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synucleionapathy. A recent study found that DLB patients had an 11.5% cumulative 
probability of developing seizures compared to 13.4% in AD and 5% in FTD, while DLB 
patients were by far the most likely to develop myoclonus with a probability of 58.1% 
(Beagle et al., 2017). A relationship between the incidence of myoclonus and DLB was 
also shown by a second study that also identified molecular changes indicative of 
hyperexcitability in the hippocampi of these patients (Morris et al., 2015). The same 
study also looked at a mouse model of α-syn with evident epileptiform activity in the 
parietal cortex (Morris et al., 2015). In our lab, we have seen evidence of epileptiform 
discharges in the hippocampus of young A30P mice, in vitro (Tweedy et al., 2018). 
Therefore, it is not surprising that we found evidence of hyperexcitability in the A30P 
mouse model and it would be of immense interest to identify the mechanisms that 
underlie this shift in E/I balance.  
As mentioned above, hyperexcitability is the result of an altered E/I balance that 
can be directly linked to altered synaptic function (Vossel et al., 2017). At 4 months of 
age, A30P animals represent an early stage of α-synucleinopathy as they have no 
signs of major cognitive (Freichel et al., 2007) or motor impairments (Kahle et al., 
2000). Cognitive and motor symptoms, as well as proteinase-K resistance α-syn 
pathology in the brain stem, midbrain and spinal cord, appear at 12 months of age 
(Newman et al., 2012) and hyperphosphorylated α-syn at 16 months of age (Schell et 
al., 2009). However, it is possible that the young (2.5 – 4 months) A30P animals used 
in this study have more subtle α-syn-related changes. Consistent with this idea, there 
is evidence of very fine motor impairments in A30P mice at 2 months of age (Ekmark-
Lewén et al., 2018), hyperlocomotion from 2 months of age that persisted up to 10 
months, and altered electrophysiological activity at 2 – 4 months of age (Tweedy et al., 
2018). Moreover, these animals express monomeric mutant α-syn all over the brain 
(Kahle et al., 2001), that we know can impact neuronal function (Killinger et al., 2019). 
It is also expected that they express soluble oligomeric α-syn, as in vitro incubation of 
A30P α-syn forms oligomers extremely quickly (Li et al., 2019). Α-syn oligomers are 
known to impact neuronal function and to exert a neurotoxic effect (Chinta et al., 2010; 
Lashuel et al., 2002). Thus, although more studies need to be performed to 
characterise the immunohistochemical profile of α-syn aggregation in A30P mice, 
mutant α-syn very likely affects neuronal function early in these animals.  
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7.2.3. Possible mechanisms underlying hyperexcitability 
7.2.3.1. Hyperexcitability and altered neuronal membrane dynamics  
An interesting recent study has shown that doubling the frequency of the SO 
(from 0.6 to 1.2 Hz) for a month in a mouse model of AD using optogenetic tools, 
resulted in excess APP cleavage and increased amyloidosis (Kastanenka et al., 2019). 
The authors proposed that the increase in SO frequency led to an increase in Αβ 
production which elevated the intracellular Ca2+ levels and thus the resting membrane 
potential, inducing hyperexcitability (Arbel-Ornath et al., 2017). In AD, Ca2+ dysfunction 
is the result of a direct Aβ-mediated exacerbation in NMDAR function, and/or of an Aβ-
mediated blockade of glutamate uptake (Texidó et al., 2011). Moreover, Aβ has been 
shown to influence the intra-cellular capacity for Ca2+ buffering (Demuro & Parker, 
2013) as well as the function of astroglial cells, eliciting glutamate release (Kuchibhotla 
et al., 2009) and increasing neuronal excitability (Arbel-Ornath et al., 2017; Busche et 
al., 2008). The increase in SO frequency and the hyperexcitability we observed in A30P 
animals could involve a similar feedback loop that also implicates increased α-syn 
release and elevated Ca2+ levels.   
In both its wild-type and mutant forms, α-syn can alter neuronal network 
excitability through modulating ion channel function (Snead & Eliezer, 2014; Feng et 
al., 2010; Kaufmann et al., 2016). Voltage-gated Ca2+ channels are pivotal for neuronal 
activity as they modulate the levels of Ca2+ in the cell through the influx of Ca2+ from 
the extra-cellular space or its release from intracellular Ca2+ stores. In PD patients, 
dopaminergic neurons in the SNc become increasingly more dependent on type L 
voltage-gated Ca2+ channels (CaV1) which elicit long-lasting currents and are normally 
only activated at high-depolarisation levels (Chan et al., 2007). Hence, abnormal 
expression of these Ca2+ channels can lead to neuronal hyperexcitability. Similar 
changes were also observed in cortical neurons, as CaV1 channels are also widely 
expressed across cortical regions, in both projection neurons and in some interneurons 
(Hurley & Dexter, 2012). It is possible that intracellular Ca2+ levels are elevated in A30P 
mice through a similar mechanism, in pyramidal cells and/or interneurons of the mPFC 
and CA1 regions, making them hyperexcitable. Moreover, the pharmacological 
properties of these channels impose a large bio-energetic cost and mitochondrial 
oxidative stress (Schapira, 2013; Ilijic et al., 2011), which is evident in A30P mice 
(Robson et al., 2018). Interestingly, CaV1 channel blockade eliminated neuronal 
hyperexcitability in the mPFC in a mouse model of HIV-1 associated hyperexcitability 
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(Khodr et al., 2016), suggesting that these channels could also be a potential target for 
drug development.  
In Chapter 4, we argued that the increase in neuronal excitability seen in our 
study could be the result of changes in the K+ conductances that elicit long lasting after-
hyperpolarisations (AHPs) in pyramidal cells and govern the duration of the Down-
state. Ca2+-dependent K+ channels (KCa) are one of the main K+ channel subtypes that 
sustain the AHP (Lopantsev et al., 2003). Since KCa channels are modulated by the 
intracellular Ca2+ levels, α-syn related increase in Ca2+ levels could make a neuron 
more depolarised, reducing the effectiveness of the KCa channel-induced AHPs. K+ 
conductances can also be affected by the overall expression of the K+ channels and 
their subunit composition (Lopantsev et al., 2003). For example, alterations in the 
subunit composition of KCa channels have been seen in aged rats, resulting in 
decreased repolarization time of CA3 pyramidal neurons and hyperexcitability (Moyer 
et al., 2000; Simkin et al., 2015). K+ channels can also be voltage-gated. In a mouse 
model of AD, Tau induced the depletion of voltage-gated K+ channels in the dendrites 
CA1 pyramidal cells, inducing aberrant activity (Hall et al., 2015). Thus, it is possible 
that the function of K+ channels is directly, or indirectly, influenced by α-syn, impairing 
the AHPs and thus making neurons more hyperexcitable.  
Extracellular adenosine or intracellular ATP, both of which are increased with 
the energy demanding spiking activity, can also influence the properties of K+ channels 
(Phillis et al., 1975; Cunningham et al., 2006). Monomeric α-syn deficiency, that is 
associated with increased levels of misfolded protein, has been shown to reduce ATP 
synthase efficiency and ATP levels (Ludtmann et al., 2016), while mutant α-syn can 
lower ATP production (Paillusson et al., 2017). As mentioned, previous work from our 
lab has shown mitochondrial dysfunction in A30P animals (Robson et al., 2018), 
adding to the growing literature of the deleterious effects of pathological α-syn in 
mitochondrial function (Hsu et al., 2000; Martin et al., 2006; Chinta et al., 2010). 
Therefore, a mitochondrial dysfunction resulting in lower ATP and/or adenosine levels 
could affect the activation of K+ conductances in A30P animals, facilitating earlier 
depolarisation and hence, premature Up-states.  
Α-syn can also alter the E/I dynamics by influencing neurotransmitter release 
and receptor binding. The normal function of α-syn is elusive but we know it is 
implicated in pre-synaptic neurotransmitter release (Ghosh et al., 2017). Hence, a loss 
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or gain of α-syn function due to abnormal α-syn oligomerisation could influence the 
synaptic output of neurons, causing an E/I imbalance (Chesselet et al., 2012). The 
expression of wild-type α-syn in hippocampal glutamatergic cells in culture has been 
shown to impair neurotransmitter release by inhibiting synaptic vesicle re-clustering 
(Ghiglieri et al., 2018). Thus, impaired vesicle release due to α-syn aggregation could 
result in excess neuronal firing. In addition, α-syn can also impair post-synaptic 
function. As shown in cultured neurons, α-syn with the A53T mutation causes a 
decrease in the amplitude of post-synaptic currents in pyramidal neurons and in the 
AMPAR to NMDAR ratio, reflecting a decrease in synaptic plasticity (Teravskis et al., 
2018). Moreover, long exposure to α-syn oligomers has been shown to increase basal 
synaptic transmission between the CA1-CA3 regions of the hippocampus by 
increasing NMDAR function (Diógenes et al., 2012). Similar mechanisms might be 
applicable to our work, as changes in the synaptic output and/or the expression of 
specific receptors could render the networks more excitable. 
7.2.3.2. A compensation mechanism may control the hyperexcitability  
We have so far discussed the ways in which α-syn can increase neuronal 
excitability, however, our findings show aberrant firing on the Down-state but not 
increased firing on the Up-state. Thus, we proposed that a compensation mechanism 
might be in place that controls the levels of hyperexcitability and prevents excessive 
neuronal firing. The compensation hypothesis is strengthened by our findings in 
Chapter 6 that in A30P mice, the CA1 region of the hippocampus responds to the ISM 
drive with an abnormal burst in high frequency oscillatory power, irrespective of Up- 
and Down-states. This finding could relate to a failure of the compensation 
mechanisms to control the local excitation upon additional excitatory drive in the CA1, 
but not in the mPFC region where the high frequency content of the ISM is comparable 
between A30P and WT animals. As argued in Chapter 6, an alternative explanation is 
that the hippocampus is more susceptible to α-syn-induced changes and 
hyperexcitability compared to the mPFC (discussed in section 6.4.4).  
The development of compensation mechanisms is a common phenomenon in 
models of hyperexcitability, as argued in Chapter 4 (section 4.4.5), including evidence 
of a PV+ interneuron compensation mechanism in the hippocampus of A30P mice 
(Tweedy et al., 2018). Specifically, the IPSPs recorded from the CA3 of the 
hippocampus of young A30P mice in vitro were of greater amplitude and frequency, 
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(Tweedy et al., 2018) while at the same time, the numbers of PV+ interneurons were 
reduced (unpublished data). There are numerous possible compensation mechanisms 
with a net effect of either decreasing excitatory function and/or increasing inhibitory 
activity (Palop et al., 2007). For example, in the study in which the SO frequency was 
optogenetically increased in a model of AD, there was a compensatory decrease in 
spine density in cortical dendrites to counteract the hyperexcitability induced by 
increased Aβ production (Kastanenka et al., 2019). These compensation mechanisms 
develop in time, as acute, optogenetically-induced hyperexcitability in the 
hippocampus of Αβ animals also resulted to increased Αβ levels similarly to 
Kastanenka et al., (2019), but it also caused epileptic activity (Yamamoto et al., 2015), 
suggesting that there was no time for compensation mechanisms to develop that would 
control the hyperexcitability. In the figure below, we present the possible compensation 
mechanisms that may develop in A30P animals in response to the possible human 






Figure 7.1: Alterations in the dynamics that govern the Up- and Down-states in local 
neuronal circuits, in A30P compared to WT mice. A) Up- and Down-state generation 
in WT animals. The Up-state is maintained by the firing of pyramidal neurons and PV+ 
interneurons that act on NMDARs and GABAARs respectively, in the form of a 
feedback loop. The high levels of neuronal activity lead to the activation of K+ 
conductances and the AHP of the pyramidal neurons, terminating the Up-state. SOM+ 
interneurons influence both GABAARs and GABABRs on pyramidal neurons, 
contributing to the synchronous termination of the Up-state. The Down-state is 
sustained until the pyramidal neurons have recovered from the AHP, allowing for 
intrinsic-firing pyramidal neurons in cortical layer 5 to initiate a widespread wave of 
depolarisation across layers thus, starting the next Up-state. B) The mechanisms we 
proposed drive the altered SO in A30P animals. The K+ conductances that govern the 
Down-state are altered in a manner that the resulting AHP levels are lower, allowing 
pyramidal cells to recover faster from the AHP and engage in a premature Up-state, 
resulting in a shorter Down-state. We also see a decrease in Up-state duration that 
can be attributed to the altered dynamics between excitation and inhibition and hence, 
between hyperexcitability and compensation mechanisms. We propose the PV+ 
interneurons decrease in number due to α-syn pathology but at the same time, the 
remaining interneurons develop a compensation mechanism and increase their activity 
levels. Moreover, we propose that the hyperexcitable pyramidal neurons might also 
lower their firing to reduce the hyperexcitability, although the net effect could still be a 
shift of the network towards excitation. Finally, SOM+ interneurons are driven by 
pyramidal cells and thus, if the firing of the pyramidal cells is altered so will the function 
of these cells and consequently, the inhibition through GABABRs could induce a faster 
Up-state termination.  
7.3. The ISM and the resting state are governed by ISOs  
As discussed earlier, we propose that the CFs seen in DLB/PDD patients are 
the product of altered large-scale network dynamics between the networks that govern 
rest and attention. The activity of RSNs, and specifically of the DMN, can be viewed 
as an ISO of the fMRI BOLD signal (Vanhatalo et al., 2004). This signal reflects ISO-
mediated modulations of local, faster frequency oscillations (Van Someren et al., 
2011), while  a number of studies have reported  that the connectivity within the DMN 
nodes and between the DMN and attention networks reflected by the BOLD signal is 
altered in DLB (Kobeleva et al., 2017; Franciotti et al., 2013; Schumacher et al., 2019). 
In a similar manner, the ISM is a widespread ISO that also modulates higher frequency 
activity and appears to be altered in relation to α-syn pathology. Specifically, in A30P 
animals, the ISM has a lower amplitude and greater high frequency power content on 
the Up- and Down-states in the hippocampus. Moreover, it is possible that the 
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synchronicity of the ISM across regions is also altered, as we see different patterns of 
changes in the mPFC and CA1 regions in A30P animals, although we did not explicitly 
investigate for this hypothesis. We could therefore conclude that A30P animals and 
DLB patients show a deficiency in widespread ISO that reflects α-syn-induced changes 
in the E/I balance in the brain.  
Both the mPFC and hippocampus in which the ISM was characterised are also 
nodes of the resting state and attention networks. Human fMRI and PET scans have 
shown that the mPFC is one of the main DMN hubs, showing very high levels of 
baseline activity that decrease upon engaging in goal-oriented tasks (Raichle et al., 
2001). This decrease in activity upon engaging in a task is particularly obvious in the 
dorsal mPFC, which is involved in emotional and affective processes and is thus, 
expected to participate in a state of self-reflection such as rest. On the other hand, the 
ventral DMN is associated with more complex cognitive processing (Raichle et al., 
2001). The mPFC also shows functional connectivity with other nodes of the DMN and 
specifically the inferior parietal lobe and precuneus/posterior cingulate cortex 
(pC/PCC) (Fransson & Marrelec, 2008). In attention networks, the mPFC is strongly 
correlated with VAN during attention tasks (Kobeleva et al., 2017). There is also 
evidence that the hippocampus participates in RSNs including the DMN (De Luca et 
al., 2006), and has a strong interaction with the mPFC (Alves et al., 2019). Hence, we 
could extrapolate that α-syn-induced changes in the local mPFC and hippocampal 
networks could affect the function of the DMN during quiet wakefulness, although this 
theory needs to be addressed experimentally in awake animals.  
The dynamic function of RSNs and specifically of the DMN extends to sleep, 
with evidence of sleep ISOs engaging RSNs in rodents, monkeys and humans 
(Watson, 2018). The integrity of the DMN persists during sleep stages N1 and N2 but 
increasingly decays in SWS (Horovitz et al., 2009; Larson-Prior et al., 2009), although 
it is not completely abolished (Horovitz et al., 2009; Tagliazucchi et al., 2013). 
Interestingly, one study investigated correlations between the ISO (< 0.1 Hz) recorded 
by the EEG, and the DMN function imaged via fMRI, during SWS and found a positive 
functional correlation for sub-cortical nodes such as the hippocampus and para-
hippocampal gyri, and a negative correlation for para-median nodes including the 
mPFC and precuneus (Picchioni et al., 2011). The authors suggested that the ISOs 
organise the hippocampal and neocortical elements of the DMN in a manner that 
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promotes memory consolidation (Picchioni et al., 2011). Moreover, during the awake 
state, the DMN always engages after the hippocampus, while the opposite pattern is 
seen during SWS, suggesting a reversal of information flow to facilitate memory 
consolidation in the cortex (Mitra et al., 2016). Thus, a study regarding the integrity of 
the DMN in the A30P mouse model would be of particular interest, not only during the 
awake state but also during SWS.  
7.4. Cholinergic and thalamic implications  
DLB patients have a prominent cholinergic dysfunction that is thought to 
contribute to altered network dynamics and CFs. Early α-syn pathology is evident in 
cholinergic neurons in the basal cholinergic system including the nucleus basalis of 
Meynert (NBM), which results in decreased cholinergic innervation in the cortex (Lippa 
et al., 1999). The NBM is pivotal in directing attention in a bottom-up manner and thus, 
if dysfunctional, it can induce abnormal shifts in attention and CFs (Liu et al., 2015; 
Newman et al., 2012). In support to this theory, cholinesterase inhibitors reduce CFs 
in DLB patients while MRI studies have shown a correlation between grey matter 
atrophy and CFs (Onofrj et al., 2003). Moreover, the basal cholinergic deficit has been 
associated with the slowing of the EEG seen in the both DLB and AD patients, as it 
can be reversed through acetylcholinesterase inhibitor administration (AChI; Bosboom 
et al., 2009; Briel et al., 1999). 
The thalamus is also implicated in CFs as it has a central role in attention and 
awareness and can regulate the activity of numerous cortical networks in relation to 
goal-directed behaviour (Rikhye et al., 2018). In LBD, the thalamus shows high levels 
of α-syn pathology (Kotagal et al., 2012), while in DLB patients, the levels of thalamic 
atrophy and decreased connectivity with prefrontal and parieto-occipital regions 
correlate with the severity of CFs (Delli Pizzi et al., 2015). Moreover, lower levels of 
nAChRs have been measured in all the thalamic nuclei (including the TRN) of DLB 
patients with CFs than those without CFs (Pimlott et al., 2006). The TRN is also 
implicated in attention as part of a top-down selection process (Young & Wimmer, 
2017). Hence, the pathology observed in the thalamus of DLB patients could also 
impact attention.  
It has been suggested that there are two different types of CFs, one associated 
with attention (discussed above), and one associated with arousal, which  is controlled 
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by the same pathways that control sleep (Delli Pizzi et al., 2015). The ascending 
reticular activating system (ARAS) regulates sleep-wake homeostasis and REM sleep 
and, although it involves a number of neurotransmitters, ACh has a pivotal function 
(Watson et al., 2012). The dorsal branch of the ARAS originating in the brainstem 
cholinergic system and specifically the PPT/LDT cholinergic nuclei, projects to the 
thalamus that in turn projects to the cortex. The PPT/LDT also project diffusely to the 
basal forebrain cholinergic system that constitutes the source of the ventral ARAS 
pathway and also projects to the cortex (Brown et al., 2012). Thus, the aforementioned 
disturbances in the cholinergic system in DLB patients could have sleep related 
implications in these patients, although there is no evidence that CFs correlate with 
polysomnography disturbances at the moment (Pao et al., 2013).   
We have also suggested that cholinergic-related disturbances might be in place 
in the young A30P mice. One of our main observations in A30P mice was a decrease 
in relative spindle density (spindles number / Up-state number), as well as a decrease 
in spindle duration and in the number of large-amplitude spindles. Spindles require 
thalamocortical connections to be generated, while the TRN has a pivotal role in 
generating the bursts of inhibition that give rise to the spindle (Fernandez et al., 2018). 
Thus, although α-syn related pathology in the TRN could affect sleep spindles, spindle 
generation has an important cortical component as well (Mak-McCully et al., 2017) and 
we have discerned that the local mPFC network function in A30P mice is indeed 
altered. Interestingly, there are no differences in the relative sleep spindle density 
during the ISM between A30P and WT mice, which indicates that the spindle reduction 
that occurs during the ISM is also successful in A30P mice. Thus, we cannot 
definatively conclude that changes in the TRN in A30P mice definitely contribute to our 
observed alterations in spindle patterns.  
Moreover, in Chapter 5 (section 5.4.7) we hypothesised that the ISM is a 
thalamic and/or acetylcholine-mediated rhythm. According to this hypothesis, direct 
thalamic and/or cholinergic inputs to the cortex (Destexhe et al., 1998) and indirect 
inputs to the hippocampus (Vertes et al., 2007), drive higher frequency oscillations in 
the form of the ISM. Although we postulated that the increases in high frequency 
oscillatory power during the ISM in A30P animals can be related to hyperexcitability in 
the local hippocampal network, we also suggested that the ISM input itself may be 
altered in A30P animals. However, currently we have no evidence indicating the source 
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of the ISM, or showing a cholinergic deficit or α-syn pathology in the thalamus or the 
TRN of the young A30P mice.  
Finally, we do not believe that there is any relationship between the evidence of 
hyperexcitability in A30P mice and a cholinergic dysfunction. In support of this theory, 
Morris et al. (2015) investigated for a relationship between hyperexcitability in the CA1 
and the EEG slowing seen in a mouse model of DLΒ, which can be attributed to a loss 
of cholinergic tone (Bosboom et al., 2009). However, the authors found that the 
pharmacological blockade of hyperexcitability did not affect the EEG slowing in their 
mouse model. Conversely, a mouse model of Αβ that showed hyperexcitability did not 
have the EEG slowing, suggesting that the EEG slowing and hyperexcitability have 
different origins (Morris et al., 2015). In A30P animals, we have not looked for an EEG 
slowing as theta and alpha frequency rhythms are not evident during SWS (Castano-
Prat et al., 2019; Gretenkord et al., 2017; Kuki et al., 2015), but it would be important 
to explore this in future experiments in awake behaving animals.  
7.5. SWS disturbances can have detrimental effects  
One of our main findings was a loss of sleep spindles in A30P mice, which can 
have numerous implications in any mammalian species (Rasch & Born, 2013). Firstly, 
cortical spindles and hippocampal SWRs are highly coordinated with each other during 
the SO, with SWRs clustering in the trough of spindles in humans (Staresina et al., 
2015) and rodents (Wang & Ikemoto, 2016). This synchrony mediates the transfer of 
information from the hippocampus to the cortex facilitating memory consolidation 
(Colgin, 2011; Witton et al., 2016). Considering the synchrony between these events 
we would also expect SWRs to be altered in our analysis but we found not differences 
in SWRs between WT and A30P animals. However, due to the low number of 
concomitant CA1/mPFC recordings we did not look at the spindle/SWR coherence. 
Thus, a next step would be to carry out more simultaneous CA1/mPFC recordings and 
to investigate the synchrony between the spindles and SWRs occurring in each region 
respectively, and their synchrony with the SO.  
In addition to the importance of sleep spindles in memory consolidation, 
spindles are also considered pivotal in “protecting” sleep from internal or external 
perturbations that can cause a sleep disruption (Terzano & Parrino, 2000; Parrino & 
Vaudano, 2018). According to the glymphatic hypothesis of dementia, the disruption in 
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SWS and the resulting awake-like brain activity can prevent the clearance of 
pathological forms of amyloid-β, tau and possibly α-syn, and even promote excess 
production of these peptides (Mander et al., 2016). Hence, impaired spindle generation 
could set off a cycle of increasing levels of α-syn and SWS interruption (Bohnen & Hu, 
2019) . In fact, sleep fragmentation is one of the most common sleep-related symptoms 
in DLB patients, suggesting a relationship between awakenings and α-syn pathology 
(Cagnin et al., 2017).  
Out findings of changes in the SO in terms of frequency and high frequency 
power content in A30P mice can also contribute to α-syn pathology. Similarly to the 
previously presented study in a mouse model of AD (Kastanenka et al., 2019), the 
increase in SO frequency seen in the young A30P mice could further exacerbate α-
syn aggregation and cytotoxicity that in turn, further increases the SO frequency, 
leading to a vicious loop that results in neurodegeneration. We also observed an 
abnormal increase in the power of high frequency activity in the CA1 region of the 
hippocampus during the ISM in A30P animals. This burst of activity would be expected 
to add to the already increased levels of α-syn production and reduced levels of 
clearance, according to the aforementioned hypothesis of SWS disruption. Moreover, 
increased activity and lower levels of metabolic waste clearance can induce 
cytotoxicity in local circuits, especially in regions that have fast-spiking, high energy 
demanding neurons like the CA1 region of the hippocampus (Bohnen & Hu, 2019). 
Lastly, in Chapter 5, we proposed that the ISM is an A3 subtype CAP 
modulation. If this is the case, our results of a decrease in ISM frequency in the mPFC 
also imply a decrease in REM sleep as A3 events immediately precede REM 
transitions during natural sleep (Terzano & Parrino, 2000), although this hypothesis 
needs to be investigated during natural sleep. REM sleep is essential for the 
dissociation of the cortex and the hippocampus during SWS, allowing for the re-
arrangement of local circuits (Watson et al., 2016; Staresina et al., 2015). Thus, a 
decrease in REM sleep could further impede efficient hippocampal-cortical 
communication in A30P mice. 
7.6. The clinical significance of our findings in A30P mice 
Excess neuronal excitability in patients with epilepsy is treated with antiepileptic 
mediations. Hence, it was considered possible that these drugs could be beneficial in 
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patients with AD, where neuronal network hyperexcitability and epilepsy are well 
described (review by Pandis and Scarmeas, 2012). However, some antiepileptics have 
detrimental cognitive defects in AD patients (phenobarbital), while others improve 
aspects of cognition like attention (levetiracetam), or mood (lamotrigine; review by 
Cumbo and Ligori, 2010). Thus, according to the clinical guidelines, antiepileptics are 
only prescribed for AD patients with electrophysiological signs of hyperexcitability 
(Giorgi et al., 2017). Similarly, in view of our findings of early network hyperexcitability 
in A30P mice, and the evidence of myoclonus in DLB (Beagle et al., 2017), 
antiepileptics could be beneficial in patients with DLB. The antiepileptic drug 
zonisamide is currently in a phase-2 clinical trial for DLB patients as it has been shown 
to improve the parkinsonism symptoms, although it does not improve or worsen 
cognition (Murata et al., 2018). Moreover, cortical myoclonus which is frequently 
reported in DLB patients and reflects aberrant neuronal activity (Beagle et al., 2017), 
can be treated with levetiracetam (Caviness, 2019; Frucht et al., 2001). This 
antiepileptic medication may also be beneficial for RBD in DLB patients (Batalini et al., 
2016). Finally, the NMDAR antagonist memantine has been shown to improve 
cognitive function in DLB/PDD patients with mild to moderate dementia, including 
improving their performance in tests of attention and episodic memory (Wesnes et al., 
2015).  
Our study has also revealed a potential correlation between hyperexcitability 
and sleep abnormalities in young A30P animals, including an increase in SO 
frequency. The integrity of the SO rhythm is closely linked to to the level of metabolic 
by-product clearance during SWS, as in animal models of AD the levels of Aβ 
clearance through the glymphatic system correlate with SWA (Hablitz et al., 2019). 
Hence, sleep promoting agents may also be  beneficial in clearing α-syn, if is indeed 
cleared via the glymphatic system as hypothesised (Mander et al., 2015). A potential 
medication is gamma hydroxybutyrate, which promotes inhibition and has been shown 
to increase SWS in patients with narcolepsy and fatal familial insomnia (Reder et al., 
1995). It would be particularly interesting to test whether acute or chronic 
administration of gamma hydroxybutyrate, antiepileptic drugs or memantine could 
restore the SO and reduce hyperexcitability in the young A30P mice.  
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7.7. Limitations and future work 
7.7.1. Human EEG analysis 
A few issues relating to the studies in this thesis need to be considered. In 
relation to the human EEG analysis (Chapter 3), an important next step would be the 
confirmation of our findings in independent prospective cohorts, especially regarding 
the ROC analysis. Moreover, we excluded the delta frequencies in our study and 
hence, we might have missed changes occurring in the qEEG variables within that 
frequency range. In addition, the recordings were not always continuous as we focused 
on discarding as much of the noise as possible and preferred to occasionally reject 
epochs, across all channels. Furthermore, CFs were measured using the CAF score 
(Walker et al., 2000) which is considered a fairly reliable measure of CFs only if used 
by an experienced clinician (Van Dyk et al., 2016). However in this study, experienced 
old age psychiatrists calculated the CAF score and we do, therefore, consider the CAF 
score values used for our correlation analysis reliable.  
Another limitation was that the patients did not undergo post-mortem immuno-
histological examination and thus we did not account for mixed AD-DLB pathology that 
has been shown to relate to greater cognitive impairment in DLB patients and can alter 
the qEEG profile (Gomperts et al., 2012). However, our clinical diagnostic approaches 
were robust enough to enhance the specificity of our group selections. Evidence for 
this include DaT scans that were available for 9 of the DLB patients and were all 
positive, and a multi-modal MRI/EEG analysis on data from all the patients that were 
recruited in the same cohort as the patients included in this study, where AD and DLB 
patients were classified with 90% accuracy (Colloby et al., 2016).  
7.7.2. Investigation of the SO and ISM in A30P and WT mice 
In order to better understand the nature of the ISM observed in the mouse 
recordings, it would be very important to investigate additional parameters such as the 
cardiac rhythm, respiration and temperature, which are influenced both by CAP 
modulations in humans and REM sleep/activated state in animals (Terzano & Parrino, 
2000; Pagliardini et al., 2013). Moreover, we would like to investigate whether the ISM 
is followed by REM transitions in animals under lighter-urethane anaesthesia, as this 
would be the case if the ISM is indeed an A3 subtype CAP modulation. Moreover, it 
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would be extremely interesting to investigate the source of the ISM. We have proposed 
that the ISM could be a thalamic rhythm and hence, it would be valuable to obtain 
concomitant thalamic, mPFC and CA1 recordings. We also suggested that the ISM 
could be due to a direct cholinergic input to the mPFC. Thus, the application of 
cholinergic agonists and antagonists locally in the mPFC or the thalamus could start to 
delineate this hypothesis. We could also proceed with a direct electrical stimulation of 
specific thalamic nuclei, although the small size of the mouse brain may not allow a 
high level of spatial accuracy. In a more elaborate study we could use optogenetics to 
modulate the thalamus in relation to the ISM. 
Regarding our investigation of changes in the SO patterns in A30P animals, one 
of the main limitations of our study is the lack of unit firing data from the CA1 of the 
hippocampus, as we were not able to record sufficient, high quality unit firing data from 
this region. Although we support our conclusions of hyperexcitability in that region with 
in vitro results from out lab (Tweedy et al., 2018), performing single neuron recordings 
in the hippocampus would be pivotal to confirming our hypothesis. Moreover, we would 
need to carry out more concomitant recordings from the mPFC and CA1 in order to 
investigate more thoroughly for changes in SO synchrony and spindle/SWR synchrony 
in the two regions, in A30P mice.  
Although urethane is considered an excellent model of SWS, verifying our 
results during natural sleep would be an important next step. Up- and Down-states are 
comparable between anaesthetised and WT animals as are spindles, although the 
latter tend to be of lower amplitude under urethane anaesthesia (Barthó et al., 2014). 
In vivo recordings would also allow us to record electrophysiological data from these 
animals during quiet wakefulness (resting state) in order to compare with our data from 
the human EEG and specifically, look for an EEG spectral slowing. We would also be 
able to investigate changes in sleep architecture such as the time spend in NREM and 
REM sleep and the transition to deep sleep. Finally, in vivo recordings would allow us 
to record simultaneously from a larger number of cortical and sub-cortical regions 
including the thalamus (Varela & Wilson, 2019). 
We can also investigate our hypothesis of hyperexcitability and the development 
of a compensation mechanism though pharmacological manipulations in A30P animals 
under urethane anaesthesia. Specifically, we could administer incremental doses of 
NMDAR agonists or GABAAR or GABABR antagonists to see whether A30P mice 
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would exhibit hyperexcitability or even epileptiform activity, compared to WT animals. 
In contrast, we could also administer NMDAR antagonists and GABAR agonists to 
investigate whether the neuronal circuits would be less hyperexcitable and if the SO 
frequency would return to its normal levels. Ideally, we would like to perform these 
manipulations at the local level through intra-cortical injections instead of peritoneal or 
intravenous administration that influence the overall brain function. It would also be 
interesting to see whether these manipulations would influence the response of local 
networks to the ISM and whether they could restore the aberrant increases in power 
seen in the CA1 of these animals, or conversely, whether they would evolve to 
epileptiform activity. Moreover, the spindle impairment in A30P animals has its origin 
in the TRN and/or the cortex and thus, we could investigate whether stimulation and/or 
pharmacological manipulation in these regions has an impact on spindle density and 
amplitude. Finally, we could perfrom similar recordings in other mouse models of α-
synucleinapthy such as the A53T mouse model that also expresses a human mutant 










Appendix A: Changes in the levels of higher-frequency oscillation wavelet power in 
the normalised SO/Up-Down cycle (0 = start of Down-state, 50 = Down to Up-state 
transition,100 = end of Up-state) in A30P (N = 13) and WTs (N = 8) animals, in the 
mPFC subregions (ACC, PrL, IL, DP). The frequency bands examined are the beta 
(15 – 30 Hz), gamma (30 – 80 Hz) and high-gamma (80 – 130 Hz). Error bars indicate 
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Appendix B: Changes in the levels of higher-frequency oscillation wavelet power in 
the normalised SO/Up-Down cycle (0 = start of Down-state, 50 = Down to Up-state 
transition,100 = end of Up-state) in A30P (N = 13) and WTs (N = 8) animals, in the 
CA1 of the hippocampus. The frequency bands examined are the beta (15 – 29.9 Hz), 



















































































































Appendix C: High frequency oscillatory power in the SO cycle in the 4 mPFC 
subregions: ACC, PrL, IL and DP, in 4 frequency bands: Theta, Beta, and High-
gamma, in the non-ISM, pre-ISM, ISM and post-ISM segments, in WT (N = 8) and 
A30P (N = 13) animals. 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix D:  High frequency oscillatory power in the SO cycle in the CA1 region of 
the hippocampus, in 4 frequency bands: theta, beta, and high-gamma, in the non-ISM, 
pre-ISM, ISM and post-ISM segments, in WT (N = 7) animals and A30P (N = 8) 
animals. 
Mean power on the Up-state (x10^3) 
















































































Mean power on the Down-state (x10^3) 












































































Peak in the normalised SO cycle (x10^3) 
















































































Peak latency in the normalised SO cycle (x10^3) 



















































































Appendix E: Characterisation of the SO cycle in the 4 mPFC subregions: ACC, PrL, 
IL and DP, in the non-ISM, pre-ISM, ISM and post-ISM segments, in WT (N = 8) and 
A30P (N = 13) animals. 
 
SO Frequency ±  SEM (Hz) 




















































































Mean cycle length  ± SEM (s) 






















































































Mean Up-state length ± SEM (s) 






















































































Mean Down-state length  ± SEM (s) 
























































































Mean cycle length  variability ± SEM (s) 






















































































Mean Up-state length variability ± SEM (s) 






















































































SO frequency ±  SEM (Hz) 






















































































SO amplitude  ±  SEM (mV) 




























































































Appendix F: Characterisation of the SO cycle in the CA1 region of the hippocampus 
in the non-ΙSM, pre-ΙSM, ΙSM and post-ΙSM segments, in WT (N = 7) animals and 
A30P (N = 8) animals.  
 
  







































































































































































The significant effects of the between subjects variables (ISM segment, mPFC 
subregion) as indicated by rmANOVA analysis of the high frequency oscillatory power 
in the SO cycle in the mPFC region for WT and A30P animals. We did not pursue a 
further analysis as there was not effect of genotypic group, or a genotype/segment or 
genotype/region interaction unless otherwise specified. 
i. Effect of ISM segment  
Theta band power on the Up-state was highly affected by segment (F(3, 57) =  
20.14, p < 0.001) with greater power during the ISM compared to all other segments 
(non-ISM: p < 0.05; pre-ISM, post-ISM (p < 0.001). Beta band power on the Up-state 
was also greatly affected by segment (F(3, 57) =  46.45, p < 0.001), with greater power 
during the ISM compared to all other segments (p < 0.001), and in the non-ISM 
compared to the pre-ISM and post-ISM segments (p < 0.05). The power on the Up-
state in the gamma (F(2.69, 51.04) =  20.35, p < 0.001) and high-gamma (F(1.36, 
25.76) =  10.26, p < 0.001) frequency ranges was greater power in the ISM (p < 0.01) 
and non-ISM segments (p < 0.05) compared to the pre-ISM and post-ISM segments.  
On the Down-state, theta and beta band power were affected by segment (F(3, 
57) =  25.09, p < 0.001; F(1.4, 26.65) =  17.61, p < 0.001), with higher levels of power 
in these bands during the ISM compared to all other segments (p < 0.001). In the 
gamma band, power on the Down-state was affected by segment (F(1.32, 25.01) =  
11.92, p < 0.01) as the gamma band power was greater during the ISM segment 
compared to all other segments (non-ISM, post-ISM: p < 0.05; pre-ISM: p < 0.01), and 
in the post-ISM compared to the non-ISM segment (p < 0.05). Finally, high-gamma 
power was not influenced by segment.  
 The next variable of interest was the peak power. The theta band peak power 
was highly affected by segment (F(2.1, 39.83) =  20.46, p < 0.001), with a greater peak 
identified in the non-ISM compared to the pre-ISM and post-ISM segments (p<0.001), 
and in the ISM segment compared to the post-ISM segment (p < 0.05). The beta band 
peak power was also influenced by segment (F(1.25, 23.69) =  15.64, p < 0.001) and 
so was the high-gamma band peak power (F(1.76, 33.39) =  33.45, p < 0.001), as they 
were lower in the pre-ISM and post-ISM segments compared to the non-ISM segment 
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(p < 0.001). Finally, the gamma peak power power was affected by segment (F(1.18, 
22.46) =  15.1, p < 0.001), as it was greater in the non-ISM segment compared to all 
other segments (non-ISM, post-ISM: p < 0.001; pre-ISM: p < 0.05). We did not find 
specific effects of segment in the peak power latency. 
ii. Effect of mPFC subregion  
The mPFC subregion also affected a number of our high frequency power-
related variables. Gamma band power on the Up-state was significantly affected by 
subregion (F(1.95, 37.12) =  12.12, p < 0.001), with the greatest gamma band power 
found in the IL and ACC subregions compared to the DP (p < 0.01). Beta power on the 
Up-state was affected by region (F(1.86, 35.39) = 8.46, p < 0.01), with greater power 
in the PrL (p < 0.01) and ACC (p < 0.05) subregions compared to the DP subregion, 
and in the PrL compared to the IL subregion (p < 0.05). High-gamma power on the Up-
state (F(3, 57) =  7.02, p < 0.01) was also greater in the PrL and ACC subregions 
compared to the DP subregion (p < 0.05). We did not find an effect of region in power 
on the Down-state in any frequency band.  
 The mPFC subregion also influenced the peak power in most frequency bands. 
In the beta band (F(2.13, 40.37) = 9.76, p < 0.001), the peak power was lower in the 
DP compared to the ACC, IL (p < 0.05) and PrL (p < 0.01) subregions. The peak was 
also shorter in the PrL compared to the IL subregion (p < 0.05). Similarly in the gamma 
(F(2.29, 43.44) =  15.1, p < 0.001) and high-gamma bands (F(3, 57) = 10.07, p < 0.001), 
the DP peak power was the shortest, as it was lower than the IL (p < 0.05), PrL (p < 
0.001) and ACC (p < 0.01) subregions. The second smallest peak was in the IL, as it 
was shorter than the PrL (p < 0.01) and ACC (p < 0.05) subregions. The theta peak 
power was not affected by region. We did not find specific effects of region in the 





The significant effects of the between subjects variables (ISM segment, mPFC 
subregion) as indicated by rmANOVA analysis of the SO cycle characteristics, for WT 
and A30P animals. We did not pursue a further analysis as there was not effect of 
genotypic group, or a genotype/segment or genotype/region interaction unless 
otherwise specified.  
I. Medial prefrontal cortex (mPFC) 
The SO amplitude was significantly affected by segment (F(1.17, 3.05) =  34.12, 
p < 0.001), with significantly greater amplitude in the ISM compared to all other 
segments, and in the pre-ISM and post-ISM segments compared to the non-ISM one 
(p < 0.001). The SO frequency was also influenced by segment (F(3, 57) = 20.36, p < 
0.001), as it was highest in the ISM compared to all other segments (p < 0.001). As 
expected, the SO cycle length (F(1.17, 3.05) = 36.08, p < 0.001) was shorter in the 
ISM compared to all other segments (p < 0.001), and in the post-ISM compared to the 
non-ISM segment (p < 0.01). The Up-state length t (F(3, 57) = 71.59, p < 0.001) was 
significantly shorter during the ISM compared to the non-ISM (p < 0.001), pre-ISM (p 
< 0.01) and post-ISM (p < 0.05) segments, and in the post-ISM and pre-ISM compared 
to the non-ISM segment (p < 0.001). The Down-state (F(3, 57) =  18.27, p < 0.001) 
was shorter in the ISM compared to all other segments (p < 0.001). 
We next looked at measures of state length variability. The SO cycle length 
variability was affected by segment (F(3, 57) = 25.22, p < 0.001), with lower variability 
in the ISM compared to the other segments (non-ISM: p < 0.001; pre-ISM, post-ISM: 
p < 0.01), and in the post-ISM compared to the non-ISM segment (p < 0.01). Up-state 
length variability (F(3, 57) = 19.36, p<0.001) was greater in the non-ISM compared to 
all other segments (p < 0.001). Down-state length variability (F(2.78, 52.57) =  14.64, 
p < 0.001) was lower in the non-ISM compared to all other segments (non-ISM: p < 
0.001; pre-ISM, post-ISM: p < 0.01). 
The SO amplitude was significantly affected by region (F(3, 57) = 17.65, p < 
0.001), with lower amplitude in the ACC compared to the other regions (p < 0.01). The 
effect of region in the SO frequency (F(1.94, 36.9) =  4.59, p < 0.05) was also due to a 
lower frequency in the ACC compared to the PrL region (p < 0.05). The cycle length 
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was also affected by region (F(1.66, 31.61) =  5.51, p < 0.05) although we could not 
identify where that difference occurred. No effect of region was seen in the Up-state 
while Down-state length (F(2.41, 45.73) =  7.18, p < 0.01), was longer in the ACC 
compared to the DP and IL regions (p < 0.05). Region also affected the SO state-length 
variability over time (F(2.31, 43.82) =  9.29, p < 0.01), with more variability in the ACC 
compared to the DP (p < 0.01) and IL (p < 0.05) regions. This finding cannot be 
attributed to the Up-state as we did not find an effect of region in this variable. However, 
we found that the variability of the Down-state length (F(3, 57) =  8.05, p < 0.001) was 
also greater in the ACC compared to the IL and DP regions (p < 0.05). Generally, the 
ACC appears to differ a little to the other segments. However, this may be attributed 
to the shorter SO amplitude of this region that makes state-length detection harder. 
Hence, the differences in the ACC it might be the effect of less-accurate state detection 
rather than a physiological effect.  
II. CA1 region of the hippocampus 
The SO amplitude was significantly affected by segment (F(1.67, 21.7) =  20.09, 
p < 0.001), with significantly greater amplitude in the ISM compared to the non-ISM (p 
< 0.001) and post-ISM segments (p < 0.01) and in the pre-ISM and post-ISM segments 
compared to the non-ISM one (p < 0.01). The SO frequency was also influenced by 
segment (F(3, 39) = 20.93, p < 0.001), as it was lowest in the non-ISM compared to all 
other segments (p < 0.001). As expected, the SO cycle length (F(3, 39) = 8.53, p < 
0.01) was longer in the non-ISM compared to the ISM (p<0.001) and post-ISM segment 
(p < 0.01). Similarly, the Up-state length (F(3, 39) = 43.43, p < 0.001) was significantly 
longer in non-ISM compared to all other segments (p < 0.001). The Down-state 
(F(2.02, 26.21) = 4.66, p < 0.05) was only longer in the non-ISM compared the ISM 
segment (p < 0.05). 
The SO cycle length variability was affected by segment (F(2.49, 32.34) =  5.11, 
p < 0.05), with greater variability in the non-ISM compared to the ISM (p < 0.05) and 
post-ISM segments (p < 0.01). The Up-state length variability was not affected by 
segment, but the Down-state length variability (F(2.46, 32) =  4.4, p < 0.05) was greater 
in the non-ISM compared to the post-ISM (p < 0.05) and likely to the ISM segment (p 
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Quantitative electroencephalography EEG slowing was evident in dementia with Lewy bodies (DLB) and Parkinson’s disease dementia
(PDD) and less in Alzheimer’s disease (AD) patients compared to controls.
 Dominant rhythm variability was larger in AD but only correlated with cognitive fluctuations in DLB.
 QEEG variables classified DLB and AD patients with high sensitivity and specificity.
a b s t r a c t
Objective: We investigated for quantitative EEG (QEEG) differences between Alzheimer’s disease (AD),
dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) patients and healthy controls,
and for QEEG signatures of cognitive fluctuations (CFs) in DLB.
Methods: We analysed eyes-closed, resting state EEGs from 18 AD, 17 DLB and 17 PDD patients with mild
dementia, and 21 age-matched controls. Measures included spectral power, dominant frequency (DF),
frequency prevalence (FP), and temporal DF variability (DFV), within defined EEG frequency bands and
cortical regions.
Results: DLB and PDD patients showed a leftward shift in the power spectrum and DF. AD patients
showed greater DFV compared to the other groups. In DLB patients only, greater DFV and EEG slowing
were correlated with CFs, measured by the clinician assessment of fluctuations (CAF) scale. The diagnos-
tic accuracy of the QEEG measures was 94% (90.4–97.9%), with 92.26% (80.4–100%) sensitivity and 83.3%
(73.6–93%) specificity.
Conclusion: Although greater DFV was only shown in the AD group, within the DLB group a positive DFV –
CF correlation was found. QEEG measures could classify DLB and AD patients with high sensitivity and
specificity.
Significance: The findings add to an expanding literature suggesting that EEG is a viable diagnostic and
symptom biomarker in dementia, particularly DLB.
 2018 Published by Elsevier B.V. on behalf of International Federation of Clinical Neurophysiology.1. Introduction
Dementia with Lewy bodies (DLB) is a common type of demen-
tia after Alzheimer’s disease, accounting for approximately 10–15%
of cases at autopsy (McKeith et al., 2004). DLB is associated with
quality of life and significant carer burden. It is frequently under-
diagnosed and often misdiagnosed as AD, especially at early stages
where both diseases manifest with similar cognitive deficits
(Metzler-Baddeley, 2007). Estimates of sensitivity and specificity
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2017) have been quite variable but have a common tendency for
relatively high specificity but lower sensitivity (Huang et al.,
2013). The fact that DLB patients are sensitive to neuroleptics
(McKeith et al., 1992), and demonstrate a faster disease progres-
sion compared to other dementias (Ballard et al., 2001), underpin
the necessity to improve diagnostic accuracy for this group of
patients.
Cognitive fluctuations (CFs) are one of the core symptoms of
DLB and refer to spontaneous alterations in cognition, attention
and arousal (McKeith et al., 2017). CFs are of clinical importance
as they have been correlated with visual hallucinations (Varanese
et al., 2010), impairment in daily activities and care burden. More-
over, CFs are an important diagnostic feature for DLB as their
prevalence reaches 90% of cases, compared to just 20% of AD and
29% of Parkinson’s disease dementia (PDD; Ballard et al., 2002).
CFs are also qualitatively different between DLB and AD as in the
former case they relate more to executive and perceptual perfor-
mance, while in the later they are primarily linked to memory
impairment (Zupancic et al., 2011). The Clinician Assessment of
Fluctuation (CAF) is a clinical scale devised for the psychometric
assessment of CFs (Walker et al., 2000). Although CAF is regarded
as a fairly reliable measure of CFs if used by an experienced clini-
cian (Van Dyk et al., 2016), the high variability in fluctuation sever-
ity and duration of confusional episodes, along with difficulties for
informants in separating out what are true intrinsic fluctuations
from what are simply responses to external stressors, impose a
considerable limitation in CF identification (Bradshaw et al., 2004).
Electroencephalography is an emerging modality for differential
diagnosis between dementia subtypes as it is simple, cost-
effective, easily accessible and non-invasive compared to imaging
approaches. The most prominent QEEG finding in DLB and PDD is
a shift of power and dominant frequency (DF) from the alpha fre-
quency range towards high-theta, described as ‘‘EEG slowing”. This
EEG slowing is most prevalent posteriorly (Briel et al., 1999) and
although it is also observed in AD patients (Jackson et al., 2008),
it is not as prominent as in the Lewy body diseases – DLB and
PDD. In studies quantifying differences between DLB or DLB/PDD,
or AD and controls, QEEG variables such as coherence (Snaedal
et al., 2012), temporal dominant frequency variability (DFV)
(Andersson et al., 2008), power ratio between bands and statistical
measures such as Granger causality (Garn et al., 2017), have all
achieved high diagnostic sensitivity and specificity, reaching
100% in the latter study.
Previous investigations have found electrophysiological correla-
tions of CFs in DLB patients. Early work using quantitative elec-
troencephalography (QEEG) has shown a correlation between
epoch-by-epoch DFV and CFs in DLB patients compared with
healthy controls (Walker et al., 2000). Later work also showed that
DLB patients with CFs had greater DFV compared to AD patients in
posterior brain regions, and used the DFV together with other
QEEG measures to classify AD, PDD-CFs, PDD-without CFs and
DLB patients and controls (Bonanni et al., 2008). More recently, a
multi-centre cohort analysis has verified these results (Bonanni
et al., 2016).
The aforementioned findings of QEEG signatures in DLB in addi-
tion to the fact that the QEEG measures were shown to be corre-
lated with the clinical phenotype of DLB and specifically with
CFs, suggest that the QEEG could be utilised to investigate for a
neurophysiological divergence between DLB and other dementias.
The QEEG investigations performed so far have not yet managed to
identify differences (Engedal et al., 2015; Garn et al., 2017)
between DLB and PDD. Generally, these Lewy body dementia
(LBD) subtypes demonstrate great similarities in neuropathological
processes, symptommanifestation and treatment. However, DLB istypically characterised by greater executive dysfunction, more psy-
chiatric symptoms, poorer response to levodopa (L-DOPA) and
greater amyloid burden compared to PDD (Edison et al., 2008).
Moreover, the onset of motor symptoms precedes that of dementia
in PDD while in DLB, dementia appears concurrently or before
motor symptoms (McKeith et al., 1992). These discrepancies may
indicate differences in the spatio-temporal sequence of pathology,
with a predominant brain-stem start and rostral progression in
PDD and a cortical inception in DLB (Beyer et al., 2007). Potential
QEEG differences between PDD and DLB are of research interest,
as they could provide insight for better understanding these LBD
subtypes.
Earlier QEEG studies focused on investigating the capacity of
such measures in aiding DLB differential diagnosis in clinical set-
tings. Hence, they utilized methods such as assessment by visual
observation (Bonanni et al., 2008), or attempted to develop an
online method that performs analysis during and right-after EEG
acquisition (Garn et al., 2017). Here we took a less clinically-
orientated approach, as our primary goal was to characterise and
compare the resting EEG rhythm in AD, DLB and PDD patients
and in relation to healthy controls, and to investigate for DLB speci-
fic signatures of CFs. Thus, we performed extensive pre-processing
analysis of the EEG signal and a thorough analysis for differences in
QEEG measures within different frequency ranges and brain
regions, between diagnostic groups. Based on the literature, we
hypothesized that dementia patients will exhibit a differential pat-
tern in the distribution of QEEG measures of power and DF within
different frequency ranges compared to healthy controls, and that
these QEEG measures in addition to DF variability in time (DFV)
will also differ between the dementia groups. We also hypothe-
sized that greater DFV will only characterise LBDs and possibly
only DLB, and that greater DFV will correlate with more CFs within
these groups. Finally, to assess the possible utility of these mea-
sures in the development of biomarkers, the QEEG measures that
were found to be significantly different between groups were used
to predict dementia diagnosis.
2. Material and methods
2.1. Diagnostic groups
Initially we pre-processed EEG data from 21 healthy controls,
19 AD, 20 DLB and 20 PDD participants (Table 1 for the demo-
graphic data of the final groups). Patients were individuals who
were referred to local old age psychiatry and neurology services
and diagnosis was determined by two independent experienced
clinicians (Alan J. Thomas and John-Paul Taylor). Controls were
age-matched volunteers. Patients with DLB fulfilled the 2005 and
2017 revised criteria for probable DLB (McKeith et al., 2005,
2017) and patients with PDD fulfilled the criteria for probable
PDD (Emre et al., 2007). Individuals with AD met the revised crite-
ria of the National Institute of Neurological and Communicative
Diseases and Stroke/AD and Related Disorders Association for
probable AD (McKhann et al., 2011). The CAF score was assessed
by the clinicians and CFs were defined on the basis that they were
typical of those seen in DLB and internally driven rather than a
response to external environmental factors. Healthy participants
demonstrated no evidence of dementia as determined by the Cam-
bridge Cognitive Examination (CAMCOG) score (>80) and from
clinical history. Exclusion criteria for all participants included sig-
nificant history of neurological or psychiatric conditions. Prescrip-
tions of acetylcholinesterase inhibitors (AChEIs), memantine and
dopaminergic medications were allowed. Ethical approval was
provided by the Northumberland Tyne and Wear NHS Trust and
Newcastle University ethics committee.
Table 1
Demographics table for the healthy control (N = 21), Alzheimer’s disease (AD; N = 18), dementia with Lewy bodies (DLB; N = 17) and Parkinson’s disease dementia (PDD; N = 17)
groups that were used for our analysis. L-DOPA = levo-dopa, LED = L-DOPA equivalent dose, AChEIs = acetylcholinesterase inhibitors, MMSE = Mini mental state examination, CAF
= Clinician’s assessment of fluctuations scale, UPDRS = Unified Parkinson’s disease rating scale, NPI = Neuropsychiatric inventory total score. Although it is not shown in the table,
1 PDD patient (5.9%) was on memantine.
Controls (N = 21) AD (N = 18) DLB (N = 17) PDD (N = 17)
Age in yrs ± SD 76.19 ± 5.32 76.06 ± 7.81 75.71 ± 5.34 75.44 ± 4.66
Males (%) 66.7% 88.9% 88.2% 100%
L-DOPA – 0% 52.9% 100%
LED – 0% 348.94 423.42
AChEIs – 94.4% 88.2% 76.5%
Age at diagnosis (yrs ± SD) – 74.64 ± 7.63 73 ± 5.11 74.07 ± 6.29
Diagnosis duration (yrs ± SD) – 1.5 ± 0.9 1.08 ± 0.70 0.94 ± 0.73
MMSE 29.19 ± 0.87 23.67 ± 1.68 25 ± 2.89 23.94 ± 2.59
CAF – 0.47 ± 0.87 2.76 ± 3.78 6.59 ± 4.29
NPI total – 7.29 ± 7.61 8 ± 5.27 20.35 ± 12.9
UPDRS 1.14 ± 1.42 1.67 ± 1.61 13.82 ± 5.32 27.06 ± 11.44
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High-density, eyes-closed resting-state EEG recordings were
obtained using 128 channel ANT Waveguard caps (ANT Neuro,
Netherlands) with an Ag/AgCl electrode montage set according to
the 10-5 placement system (Oostenveld and Praamstra, 2001).
Electrode impedance with kept below 5 kX. A reference electrode
(Fz) was used, no filters were applied during acquisition and the
sampling frequency was set at 1024 Hz. The patients that received
medication had normally taken AChEIs at least 4 h before while the
time of the last Levodopa dose was 1–3 h prior to the EEG session.2.3. Pre-processing
Pre-processing of the EEG recordings was performed off-line
after acquisition on the MATLAB environment (MATLAB 8.5, The
MathWorks Inc., Natick, MA, 2015), using the EEGLAB toolbox ver-
sion 13 (Delorme and Makeig, 2004). The EEG signal was filtered
with a 4 Hz high-pass and a 46 Hz low-pass filter. Lower frequen-
cies were filtered out as they imposed noise on the higher frequen-
cies that were of more interest, and because the EEG generally has
a limited accuracy in estimating very low and very high frequen-
cies (Niedermeyer and Lopes da Silva, 2004). A notch filter was
applied at 50 Hz. Recordings from all electrodes were visually
inspected in the power-time domain and rejected if they had a kur-
tosis value over 3, or if they contained clear and consistent artifacts
such as electrooculogram (EOG) and electromyogram (EMG) arti-
facts. The number of channels removed was kept to the minimum
possible (mean = 17.7 ± 6.7, min. = 0, max. = 33).
Independent component analysis (ICA) was used to accurately
estimate and remove the presence of additional ocular, muscular,
and other neuronal activity (Kropotov and Kropotov, 2009). Indi-
vidual recordings were reduced to 30 principal components and
then decomposed using the extended RUNICA algorithm (Bell
and Sejnowski, 1995; Delorme and Makeig, 2004). Components
representing existing templates for muscular, ocular, and electrical
(50 Hz line noise) artefacts (Jung et al., 2000) were rejected (mean
= 5.2 ± 1.6, min. = 0, max. = 9) and the remaining ICs remixed. The
recordings were then segmented into 2-s long epochs and were
inspected for any remaining artefacts. Epochs containing large arti-
facts were removed across channels, in a conservative manner.
Finally, the removed channels were replaced using spherical spline
interpolation (Ferree, 2006). As a final step, the EEG montage was
changed to average reference.2.4. Variable extraction
The power spectral density (PSD) for each 2-s epoch was
estimated using Bartlett’s method (Bartlett, 1950) with a 0.25 Hzfrequency resolution using a 4-s FFT (fast Fourier transform) size
and a Hamming window, for each electrode. To compensate for
the between subject variability in factors such as brain neurophys-
iology, anatomy and physical tissue properties, the data were
transformed to relative power spectral density (rPSD; Eq. (1);
Rodriguez et al., 1999). The rPSD was extracted for each time point
of each epoch (sampling frequency = 1024 Hz), and for each elec-
trode. Then, for each epoch of a recording, the power was averaged
across electrodes for each of four regions: frontal, central, posterior
and lateral (Fig. 1). Seven subjects were rejected from further anal-
ysis due to an insufficient number of clean data (<47 epochs). For
the remaining 73 subjects (21 healthy controls, 18 AD, 17 DLB
and 17 PDD; Table 1), only the first 47 epochs of extracted power
per region were utilised (total length of 94 s).
gðf Þ ¼ gðf ÞP
f gðf Þ
ð1Þ
Equation (1): Calculation of the relative PSD/power ðgÞ across the
power spectrum (4–46 Hz). At each point in the frequency spectrum
the amplitude (gðf Þ) is divided by the sum of all amplitudes across
the frequency spectrum (
P
f gðf Þ) (Kropotov and Kropotov, 2009).
The mean power distributed in each of three frequency bands:
theta (4–7.75 Hz), alpha (8–13.75 Hz), beta (14–20.75 Hz), was
extracted as a percentage of the total power in that range, across
epochs per region (Table 2; Fig. 2). Higher frequencies were
excluded as they are prone to contamination by electromyogram
rhythms (Whitham et al., 2007). The DF – the frequency with the
highest power between 4 Hz and 20.75 Hz – was extracted for each
epoch to calculate the mean DF and DF variability (DFV; SD from
the mean DF) across epochs, for the slow-theta (4–5.5 Hz), fast-
theta (5.5–7.75 Hz; defined by others as pre-alpha; Bonanni
et al., 2008), theta, alpha and theta/alpha (4–13.75 Hz) frequency
ranges (Table 3; Fig. 2). Since the DF was limited within the
theta-alpha range, beta band activity was excluded. The theta-
alpha DF was used to calculate the Frequency Prevalence (FP) dis-
tribution, which is the percentage of epochs having a DF falling
within the slow-theta, fast-theta and alpha frequency ranges
(Table 3; Fig. 2). These measures were calculated for each patient,
for each diagnostic group and for each band and region
combination.
2.5. Statistical analysis
The mean power, theta-alpha DF and theta, alpha and theta-
alpha DFV were statistically compared using repeated measures
ANOVA, for region as the within-subjects factor and diagnosis as
the between-subjects factor. When a significant interaction was
found we followed up by univariate ANOVA and post hoc analysis
with a Bonferonni correction. The DFV (for all frequency ranges)
Fig. 1. Placement of the 128 electrodes according to the 10-5 placement system.
The signal recorded from the electrodes indicated with black colour was selected
out as it was deemed too noisy. The colours indicate the grouping of the electrodes
into four regions: blue = frontal, green = central, purple = posterior, yellow = lateral.
(For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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achieve homogeneity of variance/homoscedasticity. Heteroscedas-
ticity could not be solved for the theta and alpha DF and hence we
performed Welch’s ANOVA followed by the Games-Howell test. To
statistically compare the distribution of the FP in the slow-theta,
fast-theta and alpha frequency ranges we performed Kruskal-
Wallis H test followed by post hoc analysis. Pearson’s product-
moment correlation and Spearman’s rank correlation were used
to investigate for correlations between these variables and the
CAF score, the MMSE score and the levodopa equivalent dose
(LED), for each diagnostic group. Manual correction for multiple
comparisons by appropriating the level of a significance (a/N)
was performed for the non-parametric statistical analyses and for
the correlation analyses, where Bonferonni correction was not
available with the statistical software.
In order to assess the capacity of the QEEG variables that were
significantly different between the AD and DLB, and the DLB and
PDD groups to predict diagnosis, the generalised estimating equa-
tions (GEE) procedure were used. This method allows the analysisTable 2
The mean percentage of the total power distributed in each of three frequency bands: the
posterior, lateral, for each group: healthy controls (N = 21), Alzheimer’s disease (AD; N = 18
= 17) patients.
Regions Controls
Theta Frontal 20.19 ± 5.22
Central 19.18 ± 4.96
Posterior 19.79 ± 5.77
Lateral 19.32 ± 5.29
Alpha Frontal 35.12 ± 5.66
Central 34.74 ± 5.11
Posterior 38.91 ± 6.04
Lateral 35.41 ± 5.10
Beta Frontal 44.69 ± 7.09
Central 46.07 ± 6.75
Posterior 41.30 ± 7.09
Lateral 45.27 ± 7.71of repeated measurements without the assumption for normal dis-
tribution (Carr and Chi, 1992). The QEEG variables that introduce
multicollinearity to the model (variance inflation factor >5) were
excluded from this analysis. Region was defined as the within-
subjects variable, diagnosis as the between-subjects variable and
the QEEG variables and the CAF score as the co-factors. The vari-
ables that significantly predicted diagnosis were then used to cal-
culate the receiver operating characteristic (ROC) curve, and obtain
the area under the curve (AUC), sensitivity and specificity with
asymptotic confidence intervals. The sensitivity/specificity cut-off
was determined using Youden’s index.
3. Results
3.1. Data and demographics
Data from a total of 73 individuals (21 healthy controls, 18 AD,
17 DLB, 17 PDD; Table 1) were further analysed after data extrac-
tion. Participants were well matched for age at diagnosis and age at
the time of the recording (p > 0.05), as well as MMSE score (p >
0.05). The PDD and DLB groups had significantly higher CAF scores
than AD patients (p < 0.01; p < 0.05 respectively), with the PDD
group also having a higher CAF score than the DLB group (p <
0.01). Lastly, the neuropsychiatric inventory (NPI) total and Unified
Parkinson’s disease rating scale (UPDRS) scores were higher in the
DLB/PDD subjects compared to the other groups, and in the PDD
compared to the DLB group (p < 0.01).
3.2. EEG slowing
We found a significant effect of diagnosis on the mean power in
the theta: F (3, 69) = 39.48, p < 0.01, alpha: F (3, 69) = 14.49, p < 0.01
and beta: F (3, 69) = 12.825, p < 0.01 ranges (Table 2; Fig. 3). In all
regions, PDD and DLB groups had higher theta power than AD
patients and healthy controls (p < 0.01). In the alpha and beta
ranges the opposite pattern was observed. Specifically, in the alpha
band, controls had significantly higher power than PDD patients in
all regions (p < 0.01), and compared to DLB patients frontally, pos-
teriorly and laterally (p < 0.01). Moreover, AD patients had greater
alpha power than PDD patients posteriorly and laterally (p < 0.01),
and also to DLB patients frontally (p < 0.05), posteriorly and later-
ally (p < 0.01). In the beta range, DLB patients had lower power
than AD patients and controls in all regions (p < 0.01). PDD patients
had lower power than healthy controls frontally and centrally (p <
0.01) and posteriorly and laterally (p < 0.05), and from AD patients
frontally, posteriorly (p < 0.05) and centrally (p < 0.01).
We also found a significant effect of diagnosis in the second
measure of interest, the mean theta-alpha DF (F (3, 69) = 36.78,
p < 0.01), which was significantly higher in all cortical regions inta (4–7.75 Hz), alpha (8–13.5 Hz), beta (14–30.75 Hz), in each region: frontal, central,
), dementia with Lewy bodies (DLB; N = 17) and Parkinson’s disease dementia (PDD; N
AD DLB PDD
24.57 ± 6.26 37.63 ± 6.36 35.89 ± 7.46
23.02 ± 6.13 36.90 ± 7.05 35.33 ± 6.37
23.51 ± 6.63 39.62 ± 7.53 39.10 ± 7.63
24.39 ± 6.53 36.96 ± 6.07 35.35 ± 7.30
32.11 ± 4.31 28.96 ± 5.10 27.42 ± 2.57
32.61 ± 4.47 29.84 ± 4.91 29.04 ± 2.28
35.49 ± 5.81 29.26 ± 5.75 23.91 ± 2.50
33.43 ± 4.00 28.57 ± 4.98 26.75 ± 2.34
43.32 ± 7.03 33.40 ± 3.74 36.69 ± 7.52
44.37 ± 6.71 33.26 ± 3.85 35.65 ± 6.20
40.99 ± 8.38 31.11 ± 5.36 31.72 ± 7.67
42.17 ± 6.59 34.47 ± 5.52 37.90 ± 7.80
Fig. 2. Schematic diagram illustrating the process of extracting each of the four main quantitative EEG variables used in this study, for one participant in the posterior region.
The filtered, pre-processed EEG signal on each of the electrodes in posterior derivations (N = 35) is windowed in 2 s long epochs. The signal undergoes fast-Fourier transform
(FFT) and using Bartlett’s method the absolute power spectral density (PSD) is calculated for each epoch, for each electrode. The relative PSD (rPSD) is then calculated to
normalize the signal. The mean rPSD is obtained across posterior electrodes, for each epoch (up to 47 epochs) of the recording, and the percentage of the total power in the 3–
20.75 Hz range allocated to the theta (4–7.75 Hz), alpha (8–13.75 Hz) and beta (14–20.75 Hz) frequency ranges is calculated. The frequency with the highest power within the
slow-theta (4–5.5 Hz), fast-theta (5.5–7.75 Hz), alpha and theta-alpha (4–13.75 Hz) frequency ranges was identified within each epoch, and that value corresponded to the
dominant frequency (DF). The mean DF and the standard deviation of the mean DF (DF variability; DFV) across epochs were then calculated. Finally, the DF within each epoch
was assessed and was characterised to be in the slow-theta, fast-theta or alpha range. The epochs that were characterised by a DF within each of these ranges are shown as a
percentage of the total number of epochs. These percentages were the slow-theta, fast-theta and alpha frequency prevalence (FP). The same procedure was followed for the
other three cortical regions.
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(Table 3, Fig. 4). The mean theta DF was significantly higher in con-
trols compared to the PDD group frontally, to the AD, DLB and PDD
groups centrally and posteriorly, and to the DLB and PDD groups
laterally. Significant differences were also found between groups
in the alpha DF, in all regions. Specifically, the DLB group had sig-
nificantly lower alpha DF than the control and AD group in all
regions. The PPD group had higher alpha DF than the DLB group
frontally, the AD group centrally and posteriorly and the control
group laterally (Fig. 4). A trend for a greater alpha DF in the AD
compared to the control group was observed, but was not verified
by the statistical analysis.
Formeasures of frequency prevalence (FP; the percentage distri-
bution of the theta-alpha DF in time in the slow-theta, fast-theta
and alpha frequency ranges; Fig. 5, Table 3), the mean alpha FP
was significantly higher in controls compared to all disease groups
(p < 0.01), and in AD patients compared to DLB and PDD patients (p
< 0.01), in all regions. In the fast-theta range the opposite pattern
was observed, with controls exhibiting lower FP compared to AD
patients frontally (p < 0.01), and to DLB and PDD patients in all
regions (p < 0.01). Finally, in the slow-theta range controls had sig-
nificantly lower FP than AD patients frontally (p < 0.01), centrally
and posteriorly (p < 0.05), and to DLB and PDD patients in all regions
(p < 0.01). AD patients also have significantly lower slow-theta FP
than PDD patients frontally and centrally (p < 0.05).3.3. Dominant frequency variability
Comparisons of the DFV between groups for different frequency
band and region combinations revealed a significant effect of diag-
nosis in the theta/alpha (F (3, 69) = 2.77, p < 0.05 and alpha (F (3, 69)
= 6.29, p < 0.01) ranges (Fig. 6), but not in the theta range. In thetheta-alpha band, the AD group had a significantly higher DFV
compared to the control, DLB and PDD groups in the frontal, central
and posterior regions, and only to the DLB group laterally. In the
alpha band, AD patients had significantly higher DFV compared
to the DLB group centrally, and to DLB and controls posteriorly.
To further validate this finding we have included a short analysis
on the effect of each electrode on the DFV in AD and DLB patients
(Supplementary Material 1).3.4. Correlations
We assessed correlations between CFs as measured by CAF and
DFV measures similarly to previous studies (Walker et al., 2000),
and with QEEG measures of slowing for all the different diagnostic
groups and each band and region. This analysis revealed that
within the DLB group only, there was a strong correlation between
the CAF score and the theta DFV in the central (r = 0.789, p < 0.000),
posterior (r = 0.652, p < 0.005) and lateral regions (r = 0.805, p <
0.000). A positive, DLB specific correlation with CAF was also found
with slow-theta FP in the frontal (r = 0.679, p = 0.003), central (r =
0.747, p = 0.001), posterior (r = 0.792, p < 0.001) and lateral (r =
0.794, p = 0.001) regions. A correlation between the CAF and MMSE
score was only found in the PDD group (r = 0.671, p < 0.05), while
no significant correlation was found for any variable and the LED,
for any group and region.3.5. Exploratory GEE and ROC curve analysis
GEE analysis was performed for the variables that were signifi-
cantly different between the AD and DLB diagnostic groups (theta
power, alpha power, theta-alpha DFV, alpha DFV, alpha DF and
fast-theta FP). The alpha-theta DF and alpha FP were rejected from
Table 3
The mean dominant frequency (DF) ± DFV (mean SD of the DF), DFV ± SD and frequency prevalence (FP) ± SD for the theta (4–7.75 Hz), slow-theta (4–5.5 Hz), fast-theta (5.75–7
Hz), alpha (8–13.75 Hz) and theta-alpha (4–13.75 Hz) frequency ranges in each region: frontal, central, posterior, lateral, for each group: healthy controls (N = 21), Alzheimer’s
disease (AD; N = 18), dementia with Lewy bodies (DLB; N = 17) and Parkinson’s disease dementia (PDD; N = 17) patients.
Regions Variables Controls AD DLB PDD
Theta Frontal DF ± SD 6.93 ± 0.4 6.57 ± 0.54 6.49 ± 0.60 6.26 ± 0.31
DFV ± SD 0.93 ± 0.25 0.98 ± 0.24 0.73 ± 0.24 0.80 ± 0.19
FP ± SD 19.55 ± 22.14 44.92 ± 24.54 82.48 ± 21.00 91.36 ± 8.29
Central DF ± SD 7.11 ± 0.33 6.67 ± 0.59 6.65 ± 0.52 6.51 ± 0.35
DFV ± SD 0.81 ± 0.28 0.86 ± 0.29 0.63 ± 0.22 0.67 ± 0.16
FP ± SD 18.84 ± 24.96 41.02 ± 26.07 80.60 ± 21.02 90.49 ± 9.22
Posterior DF ± SD 7.17 ± 0.35 6.71 ± 0.60 6.57 ± 0.66 6.31 ± 0.29
DFV ± SD 0.78 ± 0.33 0.86 ± 0.31 0.60 ± 0.21 0.72 ± 0.18
FP ± SD 16.72 ± 23.49 34.99 ± 24.45 83.35 ± 23.68 94.99 ± 6.25
Lateral DF ± SD 7.18 ± 0.31 6.80 ± 0.54 6.65 ± 0.53 6.51 ± 0.36
DFV ± SD 0.80 ± 0.30 0.83 ± 0.33 0.64 ± 0.26 0.72 ± 0.18
FP ± SD 17.53 ± 22.06 39.24 ± 26.68 83.35 ± 18.76 89.36 ± 15.10
Slow-theta Frontal DF ± SD 4.88 ± 0.15 4.93 ± 0.17 5.01 ± 0.15 5.02 ± 0.14
DFV ± SD 0.55 ± 0.06 0.52 ± 0.07 0.49 ± 0.08 0.50 ± 0.08
FP ± SD 2.23 ± 4.28 10.52 ± 13.29 16.27 ± 21.06 18.77 ± 11.56
Central DF ± SD 4.95 ± 0.17 4.98 ± 0.18 5.16 ± 0.14 5.14 ± 0.13
DFV ± SD 0.52 ± 0.06 0.49 ± 0.06 0.42 ± 0.10 0.43 ± 0.10
FP ± SD 1.21 ± 3.05 9.46 ± 12.37 9.51 ± 14 11.14 ± 12.28
Posterior DF ± SD 4.91 ± 0.14 4.94 ± 0.18 5.11 ± 0.13 5.11 ± 0.15
DFV ± SD 0.54 ± 0.06 0.51 ± 0.06 0.45 ± 0.07 0.45 ± 0.10
FP ± SD 1.11 ± 3.34 6.97 ± 9.25 13.77 ± 23.03 16.15 ± 11.75
Lateral DF ± SD 4.86 ± 0.18 4.94 ± 0.16 5.09 ± 0.15 5.09 ± 0.16
DFV ± SD 0.56 ± 0.05 0.51 ± 0.08 0.44 ± 0.11 0.46 ± 0.09
FP ± SD 0.51 ± 1.15 5.44 ± 6.74 10.76 ± 17.41 11.76 ± 11.99
Fast Theta Frontal DF ± SD 7.20 ± 0.27 6.98 ± 0.32 6.74 ± 0.41 6.55 ± 0.22
DFV ± SD 0.59 ± 0.14 0.62 ± 0.11 0.53 ± 0.12 0.55 ± 0.09
FP ± SD 17.32 ± 21.02 34.4 ± 17.95 66.21 ± 20.86 72.59 ± 10.45
Central DF ± SD 7.31 ± 0.22 7.02 ± 0.31 6.79 ± 0.43 6.69 ± 0.24
DFV ± SD 0.53 ± 0.16 0.60 ± 0.14 0.50 ± 0.11 0.52 ± 0.07
FP ± SD 17.62 ± 24.30 31.56 ± 20.68 71.09 ± 20.34 79.35 ± 11.86
Posterior DF ± SD 7.35 ± 0.21 7.06 ± 0.36 6.76 ± 0.47 6.54 ± 0.20
DFV ± SD 0.52 ± 0.17 0.58 ± 0.16 0.48 ± 0.11 0.52 ± 0.09
FP ± SD 15.60 ± 22.51 28.01 ± 19.35 69.59 ± 27.37 78.85 ± 11.86
Lateral DF ± SD 7.36 ± 0.19 7.09 ± 0.30 6.81 ± 0.41 6.70 ± 0.24
DFV ± SD 0.50 ± 0.15 0.58 ± 0.18 0.49 ± 0.13 0.52 ± 0.08
FP ± SD 17.02 ± 21.95 33.81 ± 24.26 72.59 ± 21.64 77.60 ± 15.63
Alpha Frontal DF ± SD 9.13 ± 0.57 9.40 ± 0.88 8.64 ± 0.21 9.01 ± 0.44
DFV ± SD 0.88 ± 0.40 1.07 ± 0.43 0.85 ± 0.32 1.19 ± 0.27
FP ± SD 80.45 ± 22.14 55.08 ± 24.54 17.52 ± 21 8.64 ± 8.29
Central DF ± SD 9.13 ± 0.65 9.42 ± 0.90 8.48 ± 0.17 8.70 ± 0.39
DFV ± SD 0.82 ± 0.41 1.04 ± 0.40 0.60 ± 0.17 0.87 ± 0.37
FP ± SD 81.16 ± 24.96 58.98 ± 26.07 19.40 ± 21.02 9.51 ± 9.22
Posterior DF ± SD 9.03 ± 0.63 1.06 ± 0.96 8.49 ± 0.18 8.72 ± 0.33
DFV ± SD 0.64 ± 0.35 0.86 ± 0.45 0.62 ± 0.25 0.93 ± 0.37
FP ± SD 83.28 ± 23.49 65.01 ± 24.45 16.65 ± 23.68 5.01 ± 6.25
Lateral DF ± SD 9.12 ± 0.71 0.92 ± 0.82 8.48 ± 0.18 8.61 ± 0.41
DFV ± SD 0.82 ± 0.37 0.82 ± 0.40 0.65 ± 0.24 0.84 ± 0.35
FP ± SD 82.47 ± 22.06 60.76 ± 26.68 16.65 ± 18.76 10.64 ± 15.10
Theta-alpha Frontal DF ± SD 8.79 ± 0.75 8.24 ± 1.29 6.75 ± 0.80 6.45 ± 0.63
DFV ± SD 1.07 ± 0.46 1.29 ± 0.59 0.91 ± 0.27 0.98 ± 0.33
Central DF ± SD 8.81 ± 0.82 8.36 ± 1.30 6.93 ± 0.71 6.68 ± 0.76
DFV ± SD 0.92 ± 0.47 1.30 ± 0.60 0.80 ± 0.25 0.82 ± 0.25
Posterior DF ± SD 8.82 ± 0.79 8.65 ± 1.21 6.78 ± 0.86 6.41 ± 0.58
DFV ± SD 0.78 ± 0.38 1.21 ± 0.75 0.73 ± 0.23 0.84 ± 0.27
Lateral DF ± SD 8.88 ± 0.81 8.42 ± 1.13 6.90 ± 0.71 6.74 ± 0.81
DFV ± SD 0.93 ± 0.41 1.13 ± 0.51 0.79 ± 0.31 0.88 ± 0.35
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QEEG variables that best predicted diagnosis were the theta power
(%) (Wald chi-square = 15.74, df = 1, p < 0.01), the fast-theta FP
(Wald chi-square = 8.1, df = 1, p < 0.01) and the theta-alpha SD
(Wald chi-square = 7.549, df = 1, p < 0.01). ROC analysis (Fig. 7)
yielded AUC = 94% (90.4–97.9%), sensitivity = 92.26% (CI = 80.4–
100%) and specificity = 83.3% (CI = 73.6–93%). Since no significant
differences were found between the PDD and DLB groups for any
of the QEEG variables in the variance analyses, all the QEEG vari-
ables were included in the GEE analysis. This analysis deviated
from the analysis protocol and is therefore included in the supple-mentary material (Supplementary Material 2), without drawing
further conclusions.4. Discussion
Our analysis has revealed several novel findings, including
greater theta-alpha DFV in AD patients compared to controls,
DLB and PDD patients. Moreover, we did not identify any differ-
ences in the DFV between the DLB group compared to controls,
as was previously reported (Bonanni et al., 2016, 2008; Walker
et al., 2000). However, we found a significant, DLB specific positive
Fig. 3. The mean percentage distribution of the total relative power in three frequency bands (Hz): theta (4–7.75), alpha (8–13.5) and beta 20.75), for each of four diagnostic
groups: healthy controls (N = 21), Alzheimer’s disease (AD; N = 18), dementia with Lewy bodies (DLB; N = 17) and Parkinson’s disease dementia (PDD; N = 17) patients, for the
posterior region. Similar observations were made in the frontal, central and lateral regions but are not shown. Error bards indicate the standard deviation.
Fig. 4. The mean dominant frequency (DF) in the theta-alpha (4–13.75 Hz), alpha (8–13.75 Hz) and theta (4–7.75 Hz) frequency ranges, for each of four diagnostic groups:
healthy controls (N = 21), Alzheimer’s disease (AD; N = 18), dementia with Lewy bodies (DLB; N = 17) and Parkinson’s disease dementia (PDD; N = 17) patients, in the frontal,
central, posterior and lateral regions. Error bars indicate the standard deviation (SD), **p < 0.05, **p < 0.01.
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score and slow-theta FP. Our findings confirm the widely reported
shift of EEG power and dominant rhythm – from the alpha towardsthe theta frequency range in the DLB and PDD groups compared to
healthy controls and AD patients (Briel et al., 1999; Barber et al.,
2000; Bonanni et al., 2008). A subtler slowing of the EEG was also
Fig. 5. The mean frequency prevalence (FP; percentage distribution of the mean dominant frequency (DF) in each frequency point in the theta-alpha frequency range with
0.25 Hz resolution) for each of four diagnostic groups: healthy controls (N = 21), Alzheimer’s disease (AD; N = 18), dementia with Lewy bodies (DLB; N = 17) and Parkinson’s
disease dementia (PDD; N = 17) patients, in the (a) frontal, (b) central, (c) posterior and (d) lateral regions.
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nary analysis investigating the possible diagnostic value of QEEG
variables showed that the three QEEG variables describing the
extent of EEG slowing and DFV (theta power, fast-theta FP and
theta-alpha DFV) could predict a DLB versus an AD diagnosis with
high sensitivity and specificity.
A more marked EEG slowing in DLB/PDD groups compared to
healthy controls and AD patients has been extensively reported
in the literature, mostly in posterior derivations (Briel et al.,
1999; Barber et al., 2000; Roks et al., 2008). In our analysis we
looked within four different cortical regions compared to three
regions previously reported (Bonanni et al., 2016, 2008), and anal-
ysed three measures of EEG spectral distribution, the FP, DF and
power, all of which indicated a greater EEG slowing in DLB/PDD
patients compared to AD patients and controls.
In AD patients, EEG slowing of a lesser extent was observed,
that was evident by a shift of FP from the alpha to the fast-theta
and slow-theta ranges compared to healthy controls. This finding
indicates that a higher percentage of measurements of the theta-
alpha DF in time fell in the theta-band rather than in the alpha-
band in AD patients compared to controls. This altered DF distribu-
tion towards lower frequencies in AD was ‘‘masked” with the cal-
culation of the mean theta-alpha DF, as this measure does not
account for variability. The DF in the AD group is highly variable
and can take values towards the higher edge of the alpha band thus
influencing the mean DF. This is evident by the significantly greater
theta-alpha DFV and the trends for greater alpha DFV and alpha DF
in the AD group.
A cholinergic deficit may partly account for the EEG slowing in
LBDs and AD, as the administration of AChEIs can reverse the EEG
slowing in both diseases (Adler et al., 2004; Babiloni et al., 2013;
Bosboom et al., 2009). However, the loss of cholinergic neuronsprojecting to the cortex is greater and has a faster progression in
DLB and PDD compared to AD (Lippa et al., 1999) where the cholin-
ergic deficit is not yet severe at mild stages of the disease (Bohnen
and Albin, 2011). Pathological protein-related synaptic dysfunction
that occurs before neuronal degeneration has also been associated
with cognitive decline in AD and is thought to be even greater in
DLB (Schulz-Schaeffer, 2010; Selkoe, 2002). Thus, a more advanced
cholinergic deficit and synaptic dysfunction in the LBD groups
could account for the greater extent of EEG slowing observed com-
pared to the AD group, particularly given the relatively early dis-
ease stage/cognitive impairment that our participants exhibited.
Our analysis also revealed novel findings regarding temporal
variability in the dominant rhythm as measured by DFV. Previous
studies have shown a significant DFV increase in DLB patients com-
pared to healthy controls, that correlated with CFs measured by
CAF (Bonanni et al., 2008; Walker et al., 2000). Although we did
not find an increase in the DFV of DLB patients compared to con-
trols, we did find a positive correlation between theta DFV and
the CAF score within the DLB group (Bonanni et al., 2015). This cor-
relation was only significant in the theta frequency range, likely
due to the shift of the DF towards these frequencies. A positive cor-
relation was also found between slow-theta FP and the CAF score
in DLB patients. Both these correlations were only seen in the
DLB group and not in the PDD or AD groups.
Given the neuropathological similarities between PDD and DLB
and the absence of other QEEG differences between these groups,
the lack of a correlation between CAF and our QEEG measures in
PDD was unexpected. Previous studies have reported that PDD
patients with high CF scores show an EEG-slowing (Bonanni
et al., 2008) and have more DLB-like symptoms such as visual hal-
lucinations, while patients with lower CF scores resemble PD
(Varanese et al., 2010). This PDD heterogeneity may have affected
Fig. 6. The mean dominant frequency variability (DFV) in the (a) alpha (8–13.5 Hz) and (b) theta-alpha (4–13.75 Hz) frequency ranges, for each of four diagnostic groups:
healthy controls (N = 21), Alzheimer’s disease (AD; N = 18), dementia with Lewy bodies (DLB; N = 17) and Parkinson’s disease dementia (PDD; N = 17) patients, in the frontal,
central, posterior and lateral regions. Error bards indicate the standard deviation (SD), **p < 0.05, **p < 0.01.
Fig. 7. Receiver operating curves (ROC) for a model composed of fast-theta
frequency prevalence (FP), theta power and theta-alpha dominant frequency
variability (DFV), for differentiating between Alzheimer’s disease (AD; N = 18) and
dementia with Lewy bodies (DLB; N = 17) with mild dementia.
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and CAF score in this group. Moreover, DLB patients with parkin-
sonism have more impaired reaction times and vigilance measures
that relate to CFs, compared to patients without motor symptoms,
implying a connection between CFs and dopaminergic impairment
(Ballard et al., 2002). Since PDD is characterised by greater
dopaminergic impairment than DLB, this additional pathology
could have a more dominant aetiological role in the CFs seen in
PDD as compared to DLB and thus be less contingent on factors
(e.g. cholinergic tone) which might drive a QEEG change that asso-
ciates with CFs. Furthermore, fluctuations are likely to have at least
two dimensions (arousal and attention; Bliwise et al., 2012) which
are not discriminated by the CAF scale but which may be differen-
tially expressed in our DLB and PDD groups given arousal/sleepi-
ness is strongly influenced by dopaminergic medications.
Another factor may be the amyloid burden as this is significantly
greater in DLB compared to PDD (Donaghy et al., 2015) and the cor-
tical amyloid-b deposition relates more to dementia severity,
visual hallucinations and delusion in DLB than PDD (McKeith
et al., 2004). DLB is also characterised by a greater amyloid load
in the putamen (Hepp et al., 2016), which is involved in attentional
networks and in DLB has altered functional connectivity that corre-
lates with CAF (Peraza et al., 2014). Improved quantification scales
of fluctuations may help unpick these challenges.
Previous studies have also shown that DLB patients had a signif-
icantly higher DFV compared to AD patients, which did not differ
significantly from controls, and that a higher DFV was an accurate
indicator of DLB versus AD diagnosis (Bonanni et al., 2008). A QEEG
analysis on the same patient cohorts as in this study, but with less
spatial detail, also suggested a greater theta-alpha DFV in AD
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et al., 2018). Here, we found that AD patients had a significantly
higher theta-alpha DFV compared to the other groups in most
regions while DLB patients were not significantly different than
PPD patients or controls. In the current study looking within smal-
ler frequency bands in the theta-alpha range we also identified a
greater alpha DFV in AD patients compared to controls and DLB
patients posteriorly, and to DLB patients alone centrally. These
findings could be part of the pathology or alternatively, the result
of a compensation mechanism that may occur at early stages of
AD. At rest, early stage AD patients may have increased activity
and functional connectivity in resting state networks which corre-
late with a lower MMSE score (Peraza et al., 2016). However, at
more advanced stages activity and connectivity decrease to levels
lower than those seen in controls (Agosta et al., 2012). Therefore,
increases in DFV may be associated with a compensation mecha-
nism in early stage AD.
A number of other factors may account for the discrepancies
between our findings and those of previous studies. The lack of a
greater DFV in DLB patients compared to controls may be attribu-
ted to the fact that the majority of our DLB patients were on
AChEIs, although we would argue that this adds to the clinical rel-
evance of our findings, particularly from a diagnostic perspective;
it is likely that any use of the EEG will be when patients are begin-
ning or have already been initiated on treatment. In DLB patients,
CFs have been shown to correlate with cholinergic imbalances in
networks involved in the resting state (Delli Pizzi et al., 2015).
AChEIs restore this imbalance and improve both the cognitive
symptoms of DLB and the electrophysiological markers, including
the EEG spectrum and connectivity (Onofrj et al., 2003). That said,
it is important to acknowledge that more AD (94.4%) than DLB
(88.2%) patients were on AChEIs in our study groups and the for-
mer group showed greater DFV. However, as outlined above,
cholinergic deficits are greater and occur earlier in DLB compared
to AD (Tiraboschi et al., 2002), while the brainstem cholinergic
innervations of the thalamus are relatively spared in AD
(Mesulam, 2004) but not in DLB (Taylor et al., 2017). Hence, at
the stage of mild dementia AChEIs could have a differential effect
in DLB and AD. Although AChEIs may have normalized the DFV
in DLB patients in relation to healthy individuals, the CAF/DFV cor-
relation was still maintained within the DLB group. In previous
studies, none (Walker et al., 2000), or only a small proportion
(Bonanni et al., 2008) of the patients were on AChEIs. Differences
in the participant cohorts, as well as methodological differences
in the analysis of the recordings must also be considered. Specifi-
cally, we used a different pre-processing and spatial analysis
approach, as well as a different way to estimate DFV; here DFV
was defined as the standard deviation from the mean DF across
epochs, in an epoch-by-epoch basis, while in Bonanni et al.
(2008, 2016), DFV was defined using a visual rating of DF range
on sequential EEG segments.
Finally, we proceeded with a preliminary analysis to investigate
the capacity of the QEEG variables to correctly differentiate
between AD and DLB patients with mild dementia. The theta
power, fast-theta FP and theta-alpha DFV yielded accuracy of 94%
(CI = 90.4–97.9%), sensitivity of 92.26% (CI = 80.4–100%) and speci-
ficity of 83.3% (73.6–93%). The high predictive accuracy of this
model is in-line with previous classifications using QEEG variables,
although different EEG pre-processing and analysis methods were
used (Andersson et al., 2008; Garn et al., 2017).
A few issues relating to this study need to be considered and an
important next step would be the confirmation of our findings in
independent prospective cohorts, especially regarding the ROC
analysis. We excluded the delta frequencies and hence, we might
have missed changes in the QEEG variables within that range. In
addition, the recordings were not always continuous as we focusedon discarding as much of the noise as possible and preferred to
occasionally reject epochs, across all channels. Moreover, the
patients did not undergo post-mortem immunohistological exam-
ination and thus we did not account for mixed AD-DLB pathology
that has been shown to relate to greater cognitive impairment in
DLB patients (Gomperts et al., 2012) and which may alter the QEEG
pattern. However, our clinical diagnostic approaches were robust
enough to enhance the specificity of our group selections. Evidence
for this include DaT scans that were available for 9 of the DLB
patients and were all positive, and a multi-modal MRI/EEG analysis
on data from all the patients that were recruited in the same cohort
as the patients included in this study, where AD and DLB patients
were classified with 90% accuracy (Colloby et al., 2016).
5. Conclusions
Our findings confirm the well-established slowing of the EEG in
the Lewy body dementia groups compared to healthy controls and
AD patients. Although we did not find higher DFV in DLB patients
compared to controls as expected, theta DFV and slow-theta FP
were positively correlated with CFs as measured by CAF. This
DLB specific correlation suggests that a slower and more tempo-
rally variable DF specifically relates to the CFs seen in DLB, and
could reveal differential mechanisms underlying CFs in dementia
subtypes. Another novel finding was a significantly higher DFV in
AD patients compared to the other groups. Exploratory analysis
showed that QEEG measures could predict a DLB versus an AD
diagnosis with high accuracy, sensitivity and specificity. In conclu-
sion, this study supports the hypothesis that QEEG analysis can be
a valuable tool for identifying CFs in DLB and for differential diag-
nosis between dementia subtypes, once replicated with low den-
sity EEG currently used in standard clinical practice after the
feasibility and cost-effectiveness of these methodologies has been
investigated.
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